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Background: Chronic musculoskeletal pain is a common problem that is difficult to treat.
Self-management support interventions may help people to manage this condition better; however, there
is limited evidence showing that they improve clinical outcomes. Our overarching research question was
‘Does a self-management support programme improve outcomes for people living with chronic
musculoskeletal pain?’.
Aim: To develop, evaluate and test the clinical effectiveness and cost-effectiveness of a theoretically
grounded self-management support intervention for people living with chronic musculoskeletal pain.
Methods: In phase 1 we carried out two systematic reviews to synthesise the evidence base for
self-management course content and delivery styles likely to help those with chronic pain. We also
considered the psychological theories that might underpin behaviour change and pain management
principles. Informed by these data we developed the Coping with persistent Pain, Evaluation Research in
Self-management (COPERS) intervention, a group intervention delivered over 3 days with a top-up session
after 2 weeks. It was led by two trained facilitators: a health-care professional and a layperson with
experience of chronic pain. To ensure that we measured the most appropriate outcomes we reviewed the
literature on potential outcome domains and measures and consulted widely with patients, tutors and
experts. In a feasibility study we demonstrated that we could deliver the COPERS intervention in English
and, to increase the generalisability of our findings, also in Sylheti for the Bangladeshi community.
In phase 2 we ran a randomised controlled trial to test the clinical effectiveness and cost-effectiveness of
adding the COPERS intervention to a best usual care package (usual care plus a relaxation CD and a pain
toolkit leaflet). We recruited adults with chronic musculoskeletal pain largely from primary care and
musculoskeletal physiotherapy services in two localities: east London and Coventry/Warwickshire.
We collected follow-up data at 12 weeks (self-efficacy only) and 6 and 12 months. Our primary outcome
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was pain-related disability (Chronic Pain Grade disability subscale) at 12 months. We also measured costs,
health utility (European Quality of Life-5 Dimensions), anxiety, depression [Hospital Anxiety and Depression
Scale (HADS)], coping, pain acceptance and social integration. Data on the use of NHS services by
participants were extracted from NHS electronic records.
Results: We recruited 703 participants with a mean age of 60 years (range 19–94 years); 81% were white
and 67% were female. Depression and anxiety symptoms were common, with mean HADS depression and
anxiety scores of 7.4 [standard deviation (SD) 4.1] and 9.2 (SD 4.6), respectively. Intervention participants
received 85% of the course content. At 12 months there was no difference between treatment groups in
our primary outcome of pain-related disability [difference –1.0 intervention vs. control, 95% confidence
interval (CI) –4.9 to 3.0]. However, self-efficacy, anxiety, depression, pain acceptance and social integration
all improved more in the intervention group at 6 months. At 1 year these differences remained for
depression (–0.7, 95% CI –1.2 to –0.2) and social integration (0.8, 95% CI, 0.4 to 1.2). The COPERS
intervention had a high probability (87%) of being cost-effective compared with usual care at a threshold
of £30,000 per quality-adjusted life-year.
Conclusions: Although the COPERS intervention did not affect our primary outcome of pain-related
disability, it improved psychological well-being and is likely to be cost-effective according to current
National Institute for Health and Care Excellence criteria. The COPERS intervention could be used as a
substitute for less well-evidenced (and more expensive) pain self-management programmes. Effective
interventions to improve hard outcomes in chronic pain patients, such as disability, are still needed.
Trial registration: Current Controlled Trials ISRCTN22714229.
Funding: The project was funded by the National Institute for Health Research Programme Grants for
Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 4, No. 14. See the NIHR Journals Library website for further project information.
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Plain English summary
Many people live with long-term pain in joints and muscles (chronic musculoskeletal pain). Drugtreatments may have problems or be ineffective and so other strategies, including supporting people
to cope better with the different aspects of the problem (‘self-management’), are appealing. In this
research programme we sought to answer the question ‘Does a self-management support programme
improve outcomes for people living with long-term musculoskeletal pain?’.
First we needed to develop the best possible support programme. We started by looking at what is already
known about best practice for such programmes, including how to make such programmes accessible.
Based on this we developed the COPERS course, a group course spread over 3 days in 1 week with a
follow-up session 2 weeks later. The groups were run jointly by a health professional and a person with
experience of living with chronic pain. We tested the acceptability of the COPERS course by delivering it to
both English- and Sylheti-speaking (Bangladeshi) groups.
We then tested adding the COPERS course to best usual care for people living with chronic musculoskeletal
pain. We recruited 703 people from east London and Coventry/Warwickshire with an average age of 60 years.
We found that the COPERS course did not improve how pain affected people’s function, the outcome that
we were most interested in. It did, however, provide a worthwhile reduction in depression in participants with
symptoms of depression. This may be important as many people with long-term pain also have depression.
The COPERS course also appeared to be cost-effective. Overall, the COPERS course is highly likely to represent
good value for the NHS.
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Scientific summary
Introduction
Chronic pain (pain persisting beyond 3 months) is a common and increasing problem – one estimate
suggests that 7.8 million people in the UK suffer moderate to severe pain lasting for > 6 months.
Musculoskeletal disorders are costly to the UK, accounting for around 10% of the secondary health-care
budget (around £5.16B in 2011) and resulting in around 21 million primary care consultations per year.
In common with other health services worldwide, attempts to optimise patients’ own management of their
condition (so called ‘self-management’) have been one of the UK Department of Health’s key responses
to the increasing burden of long-term conditions among the population. However, despite better
understanding of the causes of chronic musculoskeletal pain, the best way to promote self-management
among those with chronic musculoskeletal pain is unclear.
Original aims and objectives of the programme
Our overall aim was to develop a method to improve the quality of life and clinical and social outcomes,
and reduce the health-care resource use of people living with chronic, non-malignant pain, specifically via
a self-management programme derived from a modified, condition-specific version of the Expert Patients
Programme. Following an extensive examination of the research evidence we departed from basing
the programme on the Expert Patients Programme to develop what we hoped might be a more
effective intervention.
The objectives were to develop a new self-management programme and evaluate its clinical effectiveness
and cost-effectiveness.
The report is divided into two parts: the first part describes the development work and the feasibility
testing of the new intervention; the second part describes a large randomised controlled trial (RCT)
including a cost-effectiveness study.
Part I: development
Identifying effective components and characteristics of self-management
programmes for chronic musculoskeletal pain and who is likely to respond
such programmes
We conducted a systematic review of RCTs of self-management courses for chronic musculoskeletal pain
to identify the most successful course content and the optimal delivery characteristics. We searched
10 databases for RCTs comparing self-management with usual care or a waiting list control for papers
published between January 1994 and April 2009, including MEDLINE, EMBASE, PsycINFO and The
Cochrane Library. Outcomes of interest included global health, pain intensity, functional capability, quality
of life, self-efficacy, anxiety, depression and social function. Interventions were categorised according to
the presence of psychological, mind–body therapy, physical, lifestyle and educational components; group
or individual delivery; tutor; setting; and duration. Data were extracted and meta-analysed (random-effects
models) as standardised mean differences (SMDs) when possible. We compared subgroups of studies with
and without particular features to explore their potential influence.
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We included 46 RCTs in the original review (n = 8539), covering a wide variety of chronic musculoskeletal
conditions. In summary, the findings suggested that these interventions resulted in small beneficial effects
across most outcomes in the short and medium term but that these positive effects were reduced in the
longer term. Self-efficacy showed small improvements in the short, medium and longer term. There was
most evidence to support group-delivered courses and health-care professional-delivered courses or
mixed professional-/lay-delivered courses. Results were inconclusive for course setting and duration.
Most interventions included a psychological component and there was little evidence in favour of those
that did not. There appeared to be evidence in favour of interventions with a physical activity component,
inconclusive positive evidence for educational and mind–body therapy components and no evidence that
interventions that included a lifestyle component were superior to those that did not or that interventions
with many different components were superior to those that had fewer components. These subgroup
analyses involved multiple testing and so our findings should be viewed as exploratory and tentative.
Using the same searches we reviewed the evidence for predictors, moderators and mediators of patient
outcomes. We also conducted a meta-regression of the studies looking for evidence of moderators.
We defined ‘predictors’ of treatment outcome as baseline variables that affect outcome but do not interact
with treatment. ‘Moderators’ are variables measured at baseline that interact with treatment to change
outcomes. ‘Mediators’ are variables measured during treatment that impact on outcome, with or without
interaction with treatment. There was evidence that self-efficacy and depression at baseline predict
outcome and evidence that pain catastrophising and physical activity can mediate outcome from
self-management. There was no clear evidence on moderators.
Exploring experiences of self-management courses for chronic
musculoskeletal pain
We conducted a qualitative study to understand how the different components and characteristics of
self-management courses are perceived by people with chronic musculoskeletal pain, tutors and experts,
with the aim of exploring the reasons why they might be associated with different outcomes and to inform
the new intervention. We interviewed 16 previous self-management course participants, including four
who had completed less than half a course, and conducted two focus groups, one with experts in
self-management and the other with course tutors.
We observed differences between patients whose lives revolved around their pain and patients who had
managed to achieve and sustain positive change in their lives. When asked what would be an important
outcome from a self-management course, although patients always mentioned a reduction in their pain,
other important outcomes related to personal confidence in their ability around functional, emotional and
social activities. Barriers to course uptake were explored. Good facilitation and the social aspects of group
courses appeared to be important for successful course delivery.
Selecting outcome measures for evaluating self-management programmes
for patients with painful musculoskeletal conditions
We reviewed relevant consensus statements and the literature to develop a preferred list of patient-centred
outcome measures for evaluating self-management programmes for patients with chronic painful
musculoskeletal conditions. Outcome domains were informed by the findings of the first two projects
(the systematic review and the qualitative project). We reviewed papers published between 2004
(i.e. subsequent to the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials
consensus statement) and 2009 (when we conducted the work) that had reported or reviewed clinimetric
data on outcome measures in three domains: pain and disability, depression and fear avoidance. For our
two other domains of interest, self-efficacy and social support, we carried out a systematic literature search
and reviewed the clinimetrics of the measures. The most validated and reliable measures were presented
to a panel of eight people and consensus was sought on the most appropriate instruments. Data from our
pilot study also informed our final choice of outcome measures for the main trial.
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Development and feasibility testing of the new intervention
Based on evidence from our previous work we designed and manualised a psychologically orientated
group course based on principles of cognitive–behavioural therapy with elements covering acceptance,
education about chronic pain, distraction, relaxation, visualisation, posture, social time, encouragement to
buddy up and an introduction to new hobbies and activities. We called the new course COPERS (Coping
with persistent Pain, Effectiveness Research into Self-management) after our study. The COPERS course
was underpinned by social learning theory and the theory of planned behaviour/reasoned action.
Twenty-four individual course components (sessions) were delivered over 3 days with a single 2-hour
follow-up session 2 weeks later. Teaching and learning modalities were varied and included a digital
versatile disk featuring a medical expert addressing frequently asked questions, group discussion, role play
and exercises. The course, for groups of up to 14 participants, was designed to be highly interactive and
included experiential learning. Courses were facilitated by two trained facilitators – a lay individual with
previous experience of facilitation of chronic pain and a health professional with experience of treating
chronic pain (general practitioner, psychologist, physiotherapist, chiropractor or osteopath). We designed a
2-day training programme for potential facilitators.
To test the feasibility of the intervention and inform a future definitive trial we planned a pilot RCT of
100 participants randomised to the COPERS intervention or usual general practice care plus a patient
advice leaflet on a 3 : 1 basis, favouring the active intervention. In addition, we planned a non-randomised
arm in which we delivered a version of the course translated into Sylheti to a cohort of Bangladeshi
patients not fluent in English. We used a mixed-methods approach with qualitative feedback from
course participants, facilitators and observers, and quantitative information obtained from self-report
questionnaires and activity data.
Systematically identifying eligible participants from general practice medical records proved difficult and
spurred us to develop better search strategies for the main trial. Very uneven initial randomisation
allocation led us to abandon the randomised design and offer everyone the intervention. A total of
167 (32%) of 526 potential participants expressed an interest in participating, 70 (42%) of whom were
recruited to the English-speaking courses and 40 (24%) of whom were recruited to the Sylheti-speaking
course. We ran nine COPERS courses, six in English and three in Sylheti. Forty-two people attended an
English-speaking course and 26 attended a Sylheti-speaking course. Nine facilitators were trained and
seven facilitated a course. A facilitator focus group was convened and 13 interviews were conducted with
participants, which indicated that the COPERS course was regarded as beneficial by most participants.
The influence of the group experience was important. Key recommended changes included:
l better facilitator training
l audio recording of each course to check quality and ‘treatment drift’
l shortening the outcome questionnaire
l adopting the pain-related disability subscale of the Chronic Pain Grade (CPG) as the primary outcome
l providing a more credible control
l conducting the trial in English only.
Part II: the main trial
Trial aims
To establish the clinical effectiveness and cost-effectiveness (expressed as the cost–utility) of the COPERS
self-management intervention for patients with chronic musculoskeletal pain added to usual care plus a
relaxation CD.
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Methods
We conducted a pragmatic, multicentre, individual patient RCT. Participants aged > 18 years with at least
a 3-month history of musculoskeletal pain were recruited from primary care or physiotherapy services in
east London and the Midlands. Patients were randomised to the intervention or the control (allocation
ratio 1.33 : 1) using varied permuted blocks and strict allocation concealment.
We collected follow-up data at 12 weeks (self-efficacy only) and 6 and 12 months. Our primary outcome
was pain-related disability (CPG subscale) at 12 months. We also measured NHS resource use and
costs (Secondary Uses Service data and general practice records), health utility [European Quality of
Life-5 Dimensions (EQ-5D)], anxiety and depression [Hospital Anxiety and Depression Scale (HADS)],
pain acceptance (Chronic Pain Acceptance Questionnaire), social engagement and integration in
populations exposed to self-management interventions (Health Education Impact Questionnaire social
integration subscale), self-efficacy (Pain Self-Efficacy Questionnaire) and pain intensity (CPG subscale) and
calculated defined daily doses (DDDs) of prescribed analgesics and weak and strong opioids.
To determine the fidelity with which the intervention was delivered we audio-recorded each COPERS
course and two researchers systematically assessed facilitator adherence to the course content and
competence in delivering the course material.
We sought to randomise 685 participants (391 intervention participants and 294 control participants) to
detect a SMD of 0.3 in CPG disability between the intervention group and the control group, with 80%
power at the 5% significance level. All main analyses followed intention-to-treat principles and accounted
for clustering by course in the intervention arm. We used multiple imputation for missing, or incomplete,
primary outcome data.
The EQ-5D scores were used to estimate the total quality-adjusted life-years (QALYs) for each participant
over the 12 months of follow-up. Missing data for costs and QALYs were imputed. We calculated the
incremental cost-effectiveness ratio (ICER) and examined the probability of the intervention being
cost-effective.
Results
We identified 5878 potentially eligible primary care patients in our electronic searches. These patients were
invited by post to participate and 531 (9%) joined the study. Including patients from secondary care we
recruited 703 participants in total, with a mean age of 60 years. In total, 81% were white, 67% were
female, 23% were in employment, 85% had pain for at least 3 years and 23% were on strong opioids.
Symptoms of depression and anxiety were common, with baseline mean HADS scores of 7.4 [standard
deviation (SD) 4.1] and 9.2 (SD 4.6), respectively.
We delivered 31 COPERS courses, 14 in London and 17 in the Midlands. Intervention integrity was
assessed as high, particularly for adherence. Overall, 282 (70%) intervention participants achieved our
predefined adherence criterion (≥ 17 sessions attended) and we considered 95 (24%) to be non-adherent
(attending ≤ 8 sessions), including 67 (17%) who did not attend any sessions.
At 12 months there was no significant difference between treatment groups in CPG disability [difference
–1.0 intervention vs. control, 95% confidence interval (CI) –4.9 to 3.0]. However, self-efficacy, anxiety,
depression, pain acceptance and social integration were significantly better in the intervention group at
6 months. At 12 months’ follow-up the differences favouring the intervention were sustained for
depression (–0.7, 95% CI –1.2 to –0.2) and social integration (0.8, 95% CI 0.4 to 1.2), with the results
for self-efficacy (1.4, 95% CI –0.2 to 3.1) and anxiety (–0.4, 95% CI –0.9 to 0.1) tending to favour
the intervention.
SCIENTIFIC SUMMARY
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Intervention patients received considerably more analgesics than control patients in the 12 months after
randomisation (mean difference in DDD 98, 95% CI 17 to 178). There was no evidence of any difference
in the prescription of strong opioids between study arms (mean difference in DDD –1, 95% CI –12 to 11)
nor in the proportions of those receiving strong opioids at 12 months.
Post hoc moderator analysis showed that the improvement in depressive symptoms seen in the
intervention arm at 12 months was concentrated in those who were depressed at baseline (SMD –0.50,
95% CI –0.74 to –0.25), with those who were not depressed at baseline experiencing no overall change in
depression (p-value for interaction = 0.004).
The total cost of the course per participant across the two centres was £145.24, including the cost of
facilitator training. Total costs were higher in the intervention group than in the control group (£2955 vs.
£2767). The difference in mean costs was £188 (95% CI –£125 to £501). Total QALYs were higher
in the intervention group (0.4475) than in the control group (0.4150). The difference in mean QALYs
was 0.0325, which is equivalent to approximately 12 quality-adjusted days (95% CI –0.0074 to 0.0724).
The ICER point estimate was £5786 per QALY. The COPERS intervention had a high probability (87%) of
being cost-effective compared with usual care at the National Institute for Health and Care Excellence
threshold of £30,000 per QALY.
All reported results proved robust in extensive sensitivity analyses and with different analytical approaches.
Conclusions
The COPERS intervention had marked psychological effects that were concentrated in those who were
depressed at baseline, but did not appear to affect health-care resource use or disability. We are not in a
position to say with certainty what the active elements of the intervention were but it seems likely that
these were the psychologically orientated components and the effect of being in a group of peers.
In the absence of more effective group self-management interventions, the COPERS intervention could be
used as a substitute for less well-evidenced (and more expensive) pain self-management programmes.
However, effective interventions to improve harder outcomes in chronic pain patients, such as disability,
are still required.
Trial registration
This trial is registered as ISRCTN22714229.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 Introduction
Background to the study
Chronic conditions, especially musculoskeletal conditions, impose an increasing burden on society and the
NHS.1 Despite increased understanding of the factors contributing to the development of chronic pain,
the population burden of chronic pain is rising, with more cases now than 40 years ago.2
A key component of the UK Department of Health’s response to the perceived growing burden of chronic
disease3 was to promote self-management4 and the most tangible aspect of this was the introduction and
promotion of its flagship, lay-led (i.e. peer-led), self-management training course, the Expert Patients
Programme.5 This decision was made based on a belief and some limited evidence, mainly from the USA,
that such self-management programmes for long-term conditions improve health status, slow disease
progression and reduce health-care use.6 The Expert Patients Programme was rolled out and implemented
within the NHS from 2005 onwards.3 By 2007 the Department of Health had invested £18M in the
programme.7 In 2008 the then prime minister, Gordon Brown, announced further expansion of
the programme.8
The Expert Patients Programme is a complex intervention. It is an anglicised version of the Stanford
Chronic Disease Self-Management Program developed in the 1980s.9 It is based on Bandura’s social
cognitive theory of behaviour,10 which suggests that positive behaviour changes are more likely to occur if
a person is confident of making the change and expects a good outcome. The Expert Patients Programme
consists of a structured, 6-week course (2.5 hours per week) covering education, coping strategies such as
relaxation, visualisation, positive thinking, action planning and goal-setting. It includes strategies to deal
with anger, fear and frustration, and aims to promote better communication with health-care professionals
(HCPs) and physical activity. The courses are led by trained and accredited laypeople who themselves have
a chronic condition. The objectives of self-management programmes are to encourage participants to take
responsibility for their own health, increase their knowledge about their health condition, identify positive
or dysfunctional coping strategies, teach more effective management strategies, create networks for
support and reduce isolation.11 The UK Department of Health’s aims were to increase quality of life,
reduce the demand for consultations and drugs and avoid unnecessary investigatory tests, thus generating
longer-term cost savings and increasing patient satisfaction.5 Despite a reduced emphasis on the Expert
Patients Programme in recent years, the concept of supporting better self-management among people
with chronic conditions remains central to the UK Department of Health agenda.12
The optimal way to support people with chronic musculoskeletal pain to manage their condition is unclear.
Systematic reviews report, at best, only modest benefits for lay-led self-management programmes
compared with usual care for long-term musculoskeletal conditions such as low back pain and
osteoarthritis (OA).13,14 For OA self-management there is moderate-quality evidence (11 studies including
1706 participants) that indicates small benefits up to 21 months in terms of self-management skills, pain,
OA symptoms and function, although the magnitudes of the effect sizes are of doubtful clinical
importance.13 The authors of this review found no improvement in positive and active engagement in life
or quality of life. Similar findings were reported from lay-led self-management courses for low back pain.14
Despite these modest effects there is still considerable popular support for these types of programmes.
Some authorities argue that a small average benefit for many patients may still be worthwhile compared
with a larger benefit for smaller numbers of patients with less common disorders.15 Nevertheless, the
Expert Patients Programme and other programmes of this nature need further research and validation.
Squire and Hill16 have argued that a clear policy based on good research and evidence is required to guide
clinicians, service delivery organisations and researchers in the content and delivery of self-management
programmes for chronic pain patients.
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1
A note on terminology
Although it is obvious that only the affected individual can ‘self-manage’ his or her condition, courses to
promote better self-management are commonly referred to as ‘self-management courses’, whereas a
more accurate term might be ‘self-management support courses’. For brevity we have used the term
‘self-management course’ throughout this report but it should be understood that by this we really
mean ‘self-management support course’.
Chronic musculoskeletal pain
The focus of this research programme is on chronic, non-malignant musculoskeletal pain. The International
Association for the Study of Pain (IASP) defines chronic pain as that which has persisted beyond normal
tissue healing time, usually interpreted as 3 months.17 Estimates of the prevalence of chronic pain vary,
but one estimate is that 7.8 million people in the UK suffer moderate to severe pain that has lasted for
> 6 months.2
Musculoskeletal health care is costly. In 2011 in the UK, NHS trusts (secondary care services) spent around
10% of their patient care expenditure on musculoskeletal disorders (around £5.16B), and in 2009/10
there were around 21 million primary care consultations for musculoskeletal conditions in the UK.6,18
Musculoskeletal pain is more commonly reported by women and those from socially or financially
disadvantaged groups.19 Chronic pain can cause considerable disruption to people’s lives. Around
one-quarter of those who have chronic pain report severe disruption (> 2 weeks in the last 3 months) to
their usual activities and chronic pain was associated with poorer mental health and well-being and lower
levels of happiness and higher levels of anxiety and depression.
Psychology and chronic pain
The presence of chronic pain is strongly associated with adverse psychological factors.20 European guidelines
on the management and prevention of low back pain21 include psychological criteria to identify those at risk
of poor outcomes, known as ‘psychosocial yellow flags’. These were developed to determine whether or
not patients required more detailed assessment and to identify those for whom physical intervention could
be less appropriate because of the dominance of psychological problems that would affect a successful
outcome of the treatment. Psychological factors that consistently predict poor outcome include:
l beliefs that back pain is harmful and potentially disabling
l fear-avoidant behaviour and reduced activity levels
l low mood and reduced social interaction
l expectation that passive rather than active participation in treatment will help.
These factors can be identified during a consultation or with screening questionnaires.22,23
Treatment approaches for people living with chronic low back pain that address some of the psychological
issues include cognitive–behavioural therapy (CBT) and reactivation and reassurance strategies.24 These
encourage new behaviours and activity to overcome and change the psychological constructs limiting
recovery and activity. Self-management courses incorporate some of the same strategies but more work is
needed to maximise and quantify the clinical effectiveness and cost-effectiveness of these programmes.
Redirecting resources to develop appropriate psychological interventions, with potentially more sustained
benefits and fewer side effects than drug treatment, may have long-term clinical and economic advantages.
The biomedical model as opposed to the biopsychosocial model might be of limited benefit, especially for
patients with high levels of health anxiety.25 Linton et al.24 suggest that a key component in establishing
reassurance in patients is empathy and emotional support from the clinician. Emotional support outweighs
the need for information and explanations in patients with unexplained pain.26 A systematic review,
however, found that cognitive reassurance was more effective in sustaining long-term improvements in
patient outcomes than affective reassurance.27 Cognitive reassurance includes objective information giving
with clear explanations, whereas affective reassurance includes concepts such as empathy and warmth.
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The components of an effective self-management intervention should be designed in the knowledge that
individual factors will determine different responses by patients to different components. Conceptually, the
identification of groups of people for whom the same components will prove effective must be considered
before implementing interventions. Indeed, the failure to adapt specific components that target the needs
of different subgroups may explain the negative findings in some recent trials of behavioural interventions.28
Self-management and evidence
We use the following broad definition of self-management throughout:
Self-management education programmes are distinct from simple patient education or skills training,
in that they are designed to allow people with chronic conditions to take an active part in the
management of their own conditions.
Foster et al.14
The UK national evaluation of the original Expert Patients Programme for the self-management of chronic
conditions reported a statistically significant increase in patients’ self-efficacy (which can be interpreted
as self-confidence in relation to a specific context) and self-reported energy levels but no reduction in
health-care utilisation.15 Others found that the beneficial effects of lay-led self-management programmes
for chronic conditions were modest in the short term and demonstrated a paucity of evidence on long-term
benefit.14 Two subsequent systematic reviews13,29 have reported improvements in patients’ confidence to
manage their symptoms and small effects on pain and disability; both studies concluded that the benefits
were too small to have any meaningful effect. Possible explanations for these findings included:
1. Suboptimal content of interventions.
2. Suboptimal delivery of interventions.
3. Programmes are effective only for some patients.
4. Measuring outcomes that may not be relevant to the intervention – the majority of studies measured
change in pain symptoms, which are unlikely to change in chronic conditions. Self-management
interventions may have a greater effect on confidence, positive outlook and coping methods than pain.
5. Poor targeting of the interventions (i.e. to those least likely to benefit).
6. Supporting self-management is an inherently ineffective approach.
Measuring outcomes
The fourth point above illustrates one of the key methodological challenges in measuring outcomes in
populations experiencing persistent symptoms resulting from long-term conditions: selecting suitable
outcomes. Typically, these will depend on the aim of the study. Measuring patient-centred outcomes, that
is, those that are meaningful, relevant and important to patients, has already been recognised in both the
Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT)30 and Multinational
Musculoskeletal Inception Cohort Study (MMICS)31 recommendations. IMMPACT and MMICS were
international consensus studies that recommended a list of outcome measures for research in chronic pain
and back pain populations, respectively. Both made recommendations with regard to measures for pain,
psychological states, patient satisfaction, disability, global health/well-being, health-care use, symptoms
and adverse events, physical functioning, work-related outcomes, tests and examinations, financial issues,
lifestyle, weight and social/demographic factors.
Predictors, moderators and mediators
In many areas of health-related research, attention has started to focus on better matching of subgroups
of patients to interventions. This aims to improve the effectiveness of treatment by targeting those most
likely to benefit and avoiding offering treatment to groups for whom treatment is neither acceptable
nor beneficial.
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For example, in research in the musculoskeletal pain and mental health population, identification of
subgroups is considered a priority.22 The terminology around subgroup effects can be confusing. We have
adopted the distinctions between predictors, moderators and mediators to describe how participant factors
affect outcomes in randomised controlled trials (RCTs) suggested by Kraemer et al.:32
l Predictors are baseline variables that affect outcome (significant main effect only) but do not interact
with treatment. Such factors significantly predict outcome equally for target interventions and
control conditions.
l Moderators are baseline variables (such as patient baseline characteristics) that interact with treatment
to change outcome for each subgroup. These specify for whom and under what conditions
treatment works.
l Mediators are variables measured during treatment (factors that change during the intervention) that
impact on outcome, with or without interaction with treatment, for example mood might be a
mediator for a different outcome such as employment status. Mediators help inform the process and
potential mechanisms (including causal mechanisms) through which treatment might work and
therefore can be used to improve subsequent interventions through strengthening the components
that best influence the identified mediators.
There is evidence from prospective cohort studies reporting predictors of outcomes for people with chronic
musculoskeletal pain, but far less from RCTs reporting moderators and mediators.20,33–35 Most of what is
published, at least for low back pain, is of poor quality.36 RCTs are the best study design to explore
moderators and mediators but those that include planned subgroup analysis require very large samples.37,38
Such subgroup analyses must also be based on good theoretical reasoning and previous evidence to
support the hypothesis that the correct subgroups have been identified a priori.39 In practice, these
analyses are usually undertaken as secondary analyses and, consequently, are statistically underpowered,
leading to a lack of robust data for mediators and moderators in self-management interventions.
Components of courses
Self-management involves undertaking tasks that enable a person to live with their chronic condition(s).
Component tasks may include addressing the medical, social or role and emotional management of their
condition(s).40 This suggests that interventions aimed at improving self-management may require several
different components. There are several meta-analyses of different treatments for those with chronic
musculoskeletal pain. Psychological approaches (such as CBT),41–43 exercise and activity21 are beneficial,
whereas patient education on its own has little or no effect.44,45 The evidence for mind–body therapies
(such as relaxation) is equivocal.46–48 Self-management education courses or programmes for chronic
musculoskeletal pain combine some or all of these approaches, but the evidence to date suggests that the
overall effects of such courses are modest.13,14
As the content and characteristics of interventions promoting self-management for chronic pain vary
considerably, there is a need to determine which components and course characteristics of these complex
interventions are most likely to be beneficial to participants. To date, there have been few attempts to
dissect the functional details of multicomponent, self-management programmes for chronic pain.
Adherence and dose
Attendance rates are a barrier to the effectiveness of self-management programmes. A national evaluation
of the Expert Patients Programme evaluated courses at different case study sites, with participation rates at
each site (participants attending at least four out of six sessions) ranging from 62% to 88%.49 The number
of sessions attended at group self-management courses may impact on outcomes, with many factors
influencing continued attendance or if participants attend at all. Participants’ physical and mental health,
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their confidence within a group environment and their expectations about the learning experience may
affect whether or not they attend the first session. Expectations can be influenced to some extent by the
recruitment process in terms of information giving beforehand, and appropriate screening may identify any
serious physical or mental impediments to attendance. However, after attending the first session, other
factors come into play. On an individual level, relevance of content and perceived difficulty of the material
are important, as well as whether or not the participant’s own diagnosis and disease experience chimes
with those of the rest of the group. One qualitative study sampling ‘completers’ of group CBT or group
education for chronic pain found that motivation to attend was influenced by group cohesion and the
actions of the facilitators for one group.50 Facilitator competency during the delivery of courses is
something that can be influenced by adequate training and preparation.
Reach and uptake
Identifying potential study participants with chronic pain from general practice is challenging. There are no
universally acknowledged Read codes to identify chronic musculoskeletal pain and each general practice may
have a different coding practice. Some UK-based studies have tackled this problem by sending out a blanket
screening questionnaire to all registered patients over a certain age, excluding any major physical or
psychiatric comorbidity.51,52 Eligibility was then assessed from the screening questionnaires returned and
suitable participants formally invited into the study. Enrolment rates for eligible patients were high at 53%51
and 50%,52 respectively, but the numbers of screening questionnaires sent out in the initial blanket
mail-out were 12,44851 and 45,994,52 respectively. Another approach is to directly query the general practice
patient record systems looking for indicator Read codes, prescriptions for analgesics and frequency of
consultations and to send out invitations to potentially eligible patients, excluding any major physical or
psychiatric comorbidity53–56 Once a potential participant has expressed an interest in the study, actual
conversion to enrolment into the study can be influenced by a number of factors, for example some
potential participants may not enrol because they think that the control arm is not a credible option or some
may not be able to attend courses on weekdays because of other commitments such as work or child care.
Summary of evidence gaps: the need for research in this area
Treatment for chronic musculoskeletal conditions such as low back pain has done little to reduce their
prevalence and health impact over the last two decades.57,58 Chronic pain frequently coexists with other
pain syndromes59 and traditional treatment approaches focus on conditions separately, which is unlikely to
have a substantial impact on the population, or individual, burden of chronic pain.59 There has been
a shift towards a more biopsychosocial approach.60 Two increasingly used psychosocial interventions are
cognitive–behavioural approaches and self-management support programmes. Both approaches are rapidly
expanding. However, the evidence has not been sufficient to justify such widespread and rapid introduction.
Some investigators have used RCTs to evaluate the effectiveness of self-management programmes but few
have explored the effectiveness of different components of these programmes or courses. RCTs have
found that self-management interventions may change attitudes but produce only modest improvements
in clinical outcome. Overall, these data do not indicate whether specific aspects of the courses are effective
or ineffective; it may be, for example, that social networking or the approach of the tutors is the most
important factor.
We proposed to explore the components or elements of chronic pain self-management programmes that
may be more effective than others and determine the most appropriate outcomes to measure. Without
this work there are the twin hazards of continuing to spend NHS resources on ineffective interventions or
failing to invest adequately in delivering an effective and cheap intervention. Even quite modest overall
effects may be worth identifying because of the enormous personal, social and economic costs of chronic
painful disorders.
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Aims and objectives
The overall aim of this programme of research was to develop and test a self-management intervention for
people living with chronic musculoskeletal pain.
The objectives were to develop a new self-management approach and provide evidence for, or against, its
clinical effectiveness and cost-effectiveness. We proposed developing an intervention to promote individual
independence, improve quality of life and reduce the level of need for health-care resources, thus
lessening a proportion of the economic, personal and social burden of chronic pain conditions.
To achieve this we first needed to identify what was already known about good-quality self-management
programmes for chronic pain by examining the existing scientific literature and evidence in a systematic
manner. We also wanted to consult experts and patients to identify and explore best practice, theoretical
underpinnings for self-management and ways to measure patient outcomes. Once this preliminary work was
completed we devised and evaluated our new programme/intervention in a feasibility study to ensure that we
had the best possible intervention and systems for measuring the effect of the intervention on patients.
Finally, we tested the new intervention in a pragmatic RCT. We collected information on both the clinical
effectiveness and the cost-effectiveness of our intervention. The findings provide the information needed
to decide whether or not the NHS should invest in such services in the future.
Overview of the study and the report
There are two parts to this report: the development of the intervention and testing the clinical
effectiveness and cost-effectiveness of the intervention. Figure 1 illustrates the overall design of the study.
Part I: development, design and feasibility testing of the intervention
The development phase consisted of two systematic reviews, a qualitative study, modelling, the design of
the intervention and a feasibility study. Chapter 8 summarises the findings from part I and is not shown as
part of the study design illustrated in Figure 1.
Part II: see Chapter 9
Effectiveness study:
methods
Part II: see Chapter 10
Fidelity
Part II: see Chapter 11
Effectiveness study:
results 
Chapter 12
Discussion and conclusions: implications and implementation
Part I: see
Chapter 2
Systematic
review for
evidence of
effectiveness
Part I: see
Chapter 3
Systematic
review for
identifying
subgroups
Part I: see
Chapter 4
Qualitative
study
Part I: see
Chapter 5
Outcome
measures
Part I: see Chapter 7
Feasibility testing
Part I: see Chapter 6
Modelling and
development
FIGURE 1 The structure of the study and report.
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Part II: clinical effectiveness and cost-effectiveness of the intervention
The testing phase consisted of a RCT and a cost-effectiveness analysis and study of the fidelity of the
delivery of the intervention in the RCT.
At the end of part II we bring together the findings and discuss these in relation to current thinking in the
field of chronic pain and self-management.
Patient and public involvement
We included patients and the public in phases 1 and 2 of the research. In phase 1 we recruited four
people (one male and three females) with a chronic condition to a patient advisory group. These people
gave advice and made comments on all of our patient-related documentation, resulting in substantial
improvements to the documentation. In addition, they played a role in the outcomes study (see Chapter 5)
by reviewing outcome measurement tools and commenting on their acceptability, brevity, comprehension
and ease of completion (in retrospect we feel that we could have included more patient advisors in this
phase of the study). People with experience of chronic pain were heavily involved in the development and
refinement of the intervention, particularly in terms of their collaboration during the feasibility study when
we collected data from all participants and from the lay facilitators on their experiences of every session
(using a questionnaire) and at focus groups and interviews following the completion of the courses.
The free and frank discussions at the focus groups enabled us to refine the intervention and the training to
deliver the intervention. We also consulted extensively with the Bangladeshi community through interviews
during the feasibility study of the intervention delivered in Sylheti. Two professional bilingual Bangladeshi
advocates also provided extensive advice on patient-related material, running the courses in Sylheti and
outcome measures in the Sylheti-speaking community.
In phase 2 we included two patient representatives with a chronic condition on the Trial Steering
Committee (TSC), one female and one male. Both were experienced representatives who had previously
sat on National Institute for Health Research (NIHR) research priorities panels. These people gave valuable
advice to the TSC and the excellent recruitment rates and low attrition seen in the study are, in part,
a reflection of their contribution.
In addition, Social Action for Health [see www.safh.org.uk (accessed 11 April 2016)] was a coapplicant in
the study. Social Action for Health is a community interest company providing socially orientated services
to the local community. Members of Social Action for Health were part of the trial study team and
represented the patient perspective for decisions made throughout the progress of the study.
Finally, and perhaps most importantly, patients were integral to the design and delivery of the intervention
as we recruited patients with experience of chronic pain to deliver our intervention for the feasibility study
and the main trial.
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Chapter 2 Systematic review: evidence for the
effectiveness of components and characteristics of
pain and self-management programmes
Abstract
Introduction: Evidence for self-management courses and course components that are beneficial for
participants has not been established.
Aims: To systematically re-examine the overall effectiveness and determine the most successful course
content and optimal delivery methods of self-management courses.
Methods: We searched 10 relevant electronic databases for RCTs and systematic reviews. RCTs were
categorised according to the presence of psychological, mind–body therapy, physical, lifestyle and
educational components; group or individual delivery; tutor; setting; and duration of the interventions
studied. Outcomes analysed were pain intensity, global health, quality of life, physical function, self-efficacy,
depression, anxiety and social function in the short term (< 4 months), medium term (4–8 months) and long
term (> 8 months). Data were extracted comparing self-management with usual care or a waiting list
control. Data were combined as a standardised mean difference (SMD) meta-analysis (random effects) with
subgrouping. When statistical pooling was not possible we carried out a narrative synthesis.
Results: Forty-six RCTs published from 1994 to 2009 were included in the original meta-analyses and a
further 18 RCTs were included in updated analyses to 2013. Heterogeneity between studies was generally
high. Overall, the number of components or duration of the interventions did not influence effectiveness,
but courses with a psychological component, courses delivered in groups and courses delivered by a HCP
appeared to work well, showing significant effect sizes on several outcomes during post-course follow-up
(short, medium and long term). Data were sparse on subgroup comparisons and on the detail of the
components of individual interventions.
Conclusions: Our analysis provided useful information to inform the design of our intervention.
Introduction
The evidence for the effectiveness of self-management support courses61 (commonly known as
‘self-management courses’ and sometimes referred to as ‘pain management programmes’) for chronic
musculoskeletal pain is limited. There is even less information on the effectiveness of specific components
or on the content of courses and the way that they are delivered.
Aim
The aim of this review was to identify the types of courses (content and characteristics) that are most likely
to be effective in helping those with chronic pain.
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We sought to identify the evidence on:
l the overall effectiveness of self-management courses
l the key components and characteristics of potentially effective self-management programmes
(including self-management education strategies) for people with chronic musculoskeletal pain.
We did this by comparing research on delivery characteristics (including setting) and components of
self-management programmes for chronic musculoskeletal disorders that appear to have been successful
or unsuccessful.
Method
We conducted a systematic review of RCTs examining the effectiveness of different types of
self-management interventions (with and without individual components).
In addition, we systematically searched for systematic reviews to see if any other researchers had
performed this type of work and used citation tracking from relevant reviews to supplement our searches.
We completed the initial systematic review of articles published between January 1994 and April 2009 to
inform the design of the intervention study. At the end of the study we updated the review for selected
outcomes [those measured in the COPERS (Coping with persistent Pain, Effectiveness Research into
Self-management) study] to September 2013 to allow us to put our final results into context (see Chapter 12).
The inclusion and exclusion criteria for the reviews are shown in Table 1.
Outcome measures
The outcomes that we were interested in were extracted and grouped into the following categories:
l global health measures
l pain intensity
l physical/functional capability
l quality of life
l self-efficacy
l anxiety
l depression
l social role/function
l Short Form questionnaire-36 items (SF-36)62 general mental health (excluded in update review)
l number of visits to HCPs (excluded in update review)
l fatigue (excluded in update review).
The mean and standard deviation (SD) of the final value and/or change scores for each group at each
follow-up interval were extracted.
Search method
Electronic literature searches
The initial searches were conducted between January 1994 and April 2009 as self-management courses
and the understanding of chronic pain have advanced considerably during this period. The following
electronic databases were searched to identify all relevant studies: MEDLINE and MEDLINE In-Process &
Other Non-Indexed Citations (Ovid), EMBASE (Ovid), PsycINFO (Ovid), Cumulative Index to Nursing and
Allied Health Literature (CINAHL), Allied and Complementary Medicine Database (AMED) using the Health
Information Resources [see www.library.nhs.uk (accessed 11 April 2016)], Web of Science Social Sciences
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Citation Index (SSCI) and The Cochrane Library [Cochrane Database of Systematic Reviews (CDSR),
Database of Abstracts of Reviews of Effects (DARE), Cochrane Central Register of Controlled Trials].
Other sources
We also checked the citation lists of relevant systematic reviews and guidelines identified in our electronic
database searches for any additional relevant studies.
Study selection
Two reviewers conducted the searches and independently screened all titles and abstracts for potentially
eligible studies. Full texts of all potentially relevant articles were obtained. Inter-rater reliability for screening
titles and abstracts was checked on a sample of the studies (approximately 10%). The full texts of all
retrieved articles were scrutinised by both reviewers to determine whether or not to proceed to full data
extraction. Disputed articles went to a third reviewer for arbitration.
TABLE 1 Inclusion and exclusion criteria for systematic reviews
Definitions Inclusion criteria Exclusion criteria
Type of study l Systematic reviews and RCTs evaluating
self-management interventions
l RCTs with at least 20 people in each trial arm at the
end of the study/trial (to exclude studies that were
underpowered to detect a SMD of < 0.8)
l Published between January 1994 and April 2009
l Non-English-language studies
l Studies without reported outcomes
l Conference abstracts
Types of
participants
l Patients with non-specific musculoskeletal pain,
degenerative joint disease, chronic widespread pain,
arthritis, OA, fibromyalgia and unexplained,
non-pathological neuropathic painful musculoskeletal
conditions
l For studies including individuals with different
long-term conditions, at least 50% of participants
had to have chronic musculoskeletal pain
(e.g. arthritis)
l If mixed groups of pain patients were included at
least 80% had to be chronic and at least 80% had
to have musculoskeletal pain
l The IASP definition of chronic pain was used.17 Only
studies with patients having pain lasting beyond the
normal expected healing time (a minimum of
3 months) were included
l Migraine, headache, facial pain, eye
pain, irritable bowel syndrome,
angina, chronic obstructive pulmonary
disease, non-cardiac chest pain,
inflammatory joint conditions such as
rheumatoid arthritis, ankylosing
spondylitis or chronic fatigue/myalgic
encephalopathy
l Patients with chronic pain arising
from malignant disease were
excluded as they require specific
management
l Studies involving people aged
< 18 years
Types of
self-management
interventions
l Self-management programmes that had the broad
goal of improving participants’ health status or
quality of life
l Aimed at (and delivered to) patients. Carers or tutors
may have been involved but the programmes were
principally directed at patients
l Structured programmes with individual elements that
were organised and delivered in a consistent way
l Taught or self-taught components that aimed to
increase participants’ skills and knowledge and
enabled participants to deploy these enhanced skills
in aspects of their lives beyond the intervention
l Psychological elements had to be behavioural and/or
cognitive and/or structured (i.e. not psychotherapy)
l Interventions with only one
component such as those involving
exercise training alone did not
constitute self-management
programmes
l Studies without a clear description of
programmes/interventions
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Assessment of study bias
Two review authors independently assessed trial quality according to the following criteria modelled on
The Cochrane Collaboration methods.39 We asked:
1. Did the study have an adequate randomisation sequence?
2. Was allocation concealment carried out?
3. Was there a description (i.e. numbers provided) of withdrawals and dropouts?
4. Was outcome assessment blinded?
5. Was there an intention-to-treat (ITT) analysis?
Each question was rated as yes/no or unclear (see Table 3).
Data extraction
The two reviewers working independently each extracted data about country of origin, number
randomised to each arm, who delivered the course (HCP or lay tutor or a combination), whether the
course was delivered to groups or individuals or was self-delivered, setting [community, medical,
occupational, remote (telephone/internet) or mixed], total number of sessions and contact hours, course
duration, course components (see Table 2), description of control group and the description and results of
any moderator analyses. Data were extracted, when possible, at four time points: baseline, short-term
follow-up (< 4 months), medium-term follow-up (4–8 months), long-term follow-up (> 8 months)
or a mixture of follow-up points.
Description of self-management components
To handle the vast number of data arising from the studies, we categorised self-management interventions
into psychological, mind–body therapy, physical, lifestyle or medical education components, as described in
Table 2. Each study was coded so that the intervention arm was described using two or more components
from the list. We accept that these categorisations represent our interpretation of the published reports of
studies and that some components may well have overlapped between our broad categories.
Final study selection
Following data extraction, the RCTs were further selected to include only comparisons of the
self-management intervention(s) with waiting list controls or usual care.
TABLE 2 Framework for organising aspects of interventions into components
Psychological Mind–body therapies Physical
Lifestyle
management
Medical
management
l CBT
l Operant conditioning
l Fear avoidance
l Coping skills
l Goal-setting/action
planning
l Modelling by others
l GEXP (graded exposure
in vivo)
l Problem-solving
l Pain reconceptualisation
l Attention distraction
(diversion)
l Guided imagery
l Visualisation
l Biofeedback
(electromyographic)
l Relaxation
l Meditation
l Self-hypnosis
l Prayer
l Alexander technique
l Mindfulness training
l Exercise
(any)
l Yoga
l T’ai chi
l Qigong
l Posture
l Pacing (activity)
l Diet
l Stress management
l Relationships
l Sleep management
l Financial
management
l Healthy lifestyle
advice
l Ergonomics
l Peer support
l Education about
condition
l Drug control
l Drug side effects
l Communication
with HCPs
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Meta-analysis methods
The meta-analyses were carried out using Review Manager v5 (The Cochrane Collaboration, The Nordic
Cochrane Centre, Copenhagen, Denmark). Calculations were based on final values as these were the most
commonly reported data. Change score data were also collected when possible. When studies reported
p-values for change from baseline for each group, this enabled a SD for the change score to be calculated.39
Change scores were analysed in the same way as the final value data for the outcomes when there were
sufficient data and compared with the final value results for the same outcomes as a sensitivity analysis.
We used a random-effects model because of the heterogeneity in study populations and interventions.
When there was more than one measurement tool for an outcome we combined data across studies using
a SMD meta-analytical approach (see section 9.2.3.2 of the Cochrane Handbook for Systematic Reviews of
Interventions39), where
SMD = difference in mean outcome between two groups ÷ SD of outcome among participants. (1)
For those instruments for which an increase in score indicates improvement we reversed the sign on the
mean score to enable us to combine these as a pooled SMD with measures from instruments for which a
decrease in score is beneficial.
The resulting SMDs were interpreted using Cohen’s d63,64 (where d is derived from the difference between
two independent means divided by the within-population SD as above). The effect sizes were
conventionally defined as follows: ‘minor’ < 0.2, ‘small’ ≥ 0.2, ‘moderate’ ≥ 0.5 and ‘large’ ≥ 0.8.
Meta-analysis comparisons
We tested:
1. Overall effectiveness. Total effect size or SMD for self-management interventions with regard to our
prespecified outcome categories compared with the control.
2. The effect of course delivery mode. We grouped the studies at each follow-up interval into different
course delivery modes [group, individual, mixed (group and individual) or remote (internet, mail,
telephone)] and compared the pooled SMDs for each subgroup.
3. The effect of course leader. We grouped the studies and outcomes at each follow-up interval into those
that were delivered by a HCP, those that were delivered by a lay tutor and those using a mix of delivery
methods and compared the pooled SMDs for each subgroup.
4. The effect of course setting. We grouped the studies at each follow-up interval into those delivered in
the community, those delivered in a medical setting (primary care or hospital) and those delivered in an
occupational setting and compared the pooled SMDs for each subgroup.
5. The effect of course duration. We grouped the studies at each follow-up interval into those with courses
of ≤ 8 weeks and those with courses of > 8 weeks and compared the pooled SMDs for each subgroup.
6. The effect of contributing self-management components. We tested whether or not the presence of a
particular self-management component improved the effectiveness of the interventions. We compared
the pooled SMDs of studies with psychological, mind–body therapy, physical, lifestyle and medical
education components with the pooled SMDs of studies without these components.
7. The effect of number of components. We tested whether or not the number of components (two,
three, four or five) influenced the effect size, comparing the pooled SMDs at short-, medium- and
long-term follow-up intervals.
We produced forest plots of final value data for each comparison showing the pooled SMD for
each subgroup.
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Assessment of publication bias
Funnel plots were generated using Review Manager v5 for the outcomes with the most studies. The funnel
plots were visually examined for symmetry about the y-axis and resemblance to an inverted funnel to
denote absence of bias.
We present data from the original review meta-analysis and the updated review data.
Results
The results of the review of the effectiveness of self-management interventions are shown first followed by
the effectiveness review of self-management courses with and without the different components
and characteristics.
Literature search
The initial search produced 4676 results and of these we included 46 RCTs. When we updated the search
to September 2013 we included a further 18 trials in the meta-analyses for the overall effectiveness of
self-management interventions.
Figure 2 shows the flow chart for the initial search and Figure 3 shows the flow chart for the updated search.
Searches combined and
deduplicated
(n = 4676)
Accepted titles
(n = 1090)
Accepted abstracts
(n = 305)
Randomised controlled
trials
(n = 250)
Included papers
(n = 243)
Included papers
with final value scores
(n = 46)
Systematic reviews/
guidelines
(n = 55)
Extra papers from citation tracking
(n = 48)
Excluded
(n = 197)
• Not SM, n = 34
• Not CMP, n = 40
• < 20 in study arm, n = 16
• Not RCT, n = 17
• No usable outcome data, n = 21
• Cost-effectiveness studies, n = 3
• Active controls or follow-up 
   studies, n = 59
• Change scores only, n = 7
Excluded by title
(n = 3586)
Excluded by abstract
(n = 785)
Reason
• No SM definition, n = 327
• Not CMP, n = 118
• Conference abstract literature
   review dissertation, commentaries, 
   guidelines, n = 164
• No relevant outcome data, n = 102
• Not RCTs, n = 72
• Duplicates, n = 2
Excluded by full text
(n = 55)
• Pilot RCT, n = 20
• Not RCT, n = 17
• Not in date, n = 18
FIGURE 2 Searches for the systematic review 1994–2009. CMP, chronic musculoskeletal pain; SM, self-management.
COMPONENTS AND CHARACTERISTICS OF PAIN AND SELF-MANAGEMENT PROGRAMMES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
14
Effectiveness analyses
For our original meta-analyses we included 46 RCTs54,65–111 with final-value data comparing self-management
programmes with usual care or waiting list controls (n= 8539) (Table 3). Thirteen RCTs were conducted in the
USA,72,74,77,83,85,86,91–93,95,104,106,108 seven in the Netherlands,69,81,94,96,98,102,110 five in the UK,54,67,70,88,97,103 five in
Canada,68,76,80,87,107 three each in Sweden,82,89,99 Norway75,78,79,84 and China,100,105,111 two in Germany71,73 and one
each in Turkey,65 Iran,66 Switzerland,90 Spain101 and Brazil.109 Of these studies, 13 (28%) were on OA (hip or
knee),74,81,88,91,92,94–97,101,104,105,111 12 (26%) were on low back pain,54,66,71,73,77–79,83,89,93,102,109,110 nine (20%) were on
mixed pain,68,70,75,76,80,84,99,100,106 five (11%) were on fibromyalgia,69,82,85,87,90 three (7%) were on mixed arthritis
(OA and rheumatoid arthritis)72,107,108 and one (2%) each was on temporomandibular joint disorder,86
osteoporosis,65 upper limb pain98 and knee pain.67,103 The mean age of participants for the 44 studies reporting
age was 55 years (range 38–82 years). In the 41 studies reporting gender breakdown, 72% were female
participants, with two studies having exclusively female patients. Thirty-six studies were health care
professionally led, six were mixed health care and lay led and four were lay led. Twenty-seven studies were
conducted in a medical setting, sixteen in the community and three in occupational settings. Twenty-seven
were delivered in groups, five were delivered remotely via the internet and five were delivered individually;
nine used mixed group and individual delivery.
Searches combined and
deduplicated
(n = 3901)
Accepted titles
(n = 342)
Accepted abstracts
(n = 93)
RCTs
(n = 53)
Included in final value meta-analysis 
(n = 18) + 1 FU report
Systematic reviews
(n = 22)
Extra papers added into full-text
evaluation as companion publications
(n = 3)
Included papers
(n = 31)
• New RCTs, n = 25
• FU data to RCT from previous review, n = 1
• Companion publications to RCTs, n = 5
Change scores reported
(n = 2)
Excluded by title
(n = 3559)
Excluded by abstract
(n = 249)
Reason
• RCT n < 20, n = 9
• Not CMP, n = 4
• Not RCT, n = 33
• Not UC/WLC, n = 19
• Not SM, n = 62
• Literature review only, n = 26
• Protocol paper, n = 1
• Included in previous review, n = 1
• Multiple reasons, n = 94
Excluded by full text
(n = 25)
Reason
• RCT n < 20, n = 3
• Not CMP, n = 6
• Not RCT, n = 3
• Not UC/WLC, n = 6
• Not SM, n = 5
• Protocol paper, n = 1
• Includes in previous review, n = 1
Guideline papers
(n = 18)
Excluded due to no outcome data
despite author contact
(n = 5)
FIGURE 3 Systematic review update June 2009–September 2013. CMP, chronic musculoskeletal pain; FU, follow-up;
SM, self-management; UC, usual care; WLC, waiting list control.
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For the update review we included an additional 19 sets of data; one trial67 was included in the original
meta-analyses but published longer-term follow-up data after our 2009 cut-off103 and we included this
study in the update analyses. Of the 18 new studies, five were from the USA,113,114,118,119,123 three from the
UK,51–53 two each from Australia112,124 and Spain120,126 and one each from Italy,121 Germany,115 Sweden,117
Norway,116 Taiwan125 and Canada122 (n = 3745). Five focused on low back pain,53,114,115,121,123 five on
OA,112,117,122,124,125 five on fibromyalgia,116,118–120,126 two on mixed pain52,113 and one on knee pain only.51
Fourteen were health care professionally led,51–53,113,115–118,120–122,124–126 one was mixed health care and lay led112
and three were self-led.114,119,123 Nine were conducted in a medical setting,112,115–118,120,121,125,126 eight in the
community51,52,113,114,119,122–124 and one in a mixed setting.53 Ten were delivered in groups,53,116–118,120–122,124–126
four were delivered remotely via the internet52,114,119,123 and three were delivered individually;51,113,115 one used
a mixed method of delivery.112 The mean age of participants for 17 of the 18 studies reporting age was
54 years (range when specified 25–84 years) and 2509 (67%) of the 3745 participants were female
(see Table 3).
Quality assessment
Around half of the original 46 studies (54%) reported an adequate randomisation sequence, and in the
remainder of the studies this was unclear. Allocation concealment was present in nine studies (20%),
absent in two (4%) and unclear in 35 (78%). Masked outcome assessment was reported in 19 studies
(41%), with the remainder unclear. Nearly all studies (91%) reported reasons for dropping out of the study
and, in the 44 studies reporting this, the mean attrition rate across all study arms was 18% (range
6–47%). One study reported a 100% completion rate and 11 studies had an attrition rate of > 20%. Only
22 studies (48%) reported that they had analysed their data on an ITT basis, using last observation carried
forward or imputation methods to fill in missing data (see Table 3). Quality assessment in the updated
articles showed that 17 out of 18 studies reported adequate randomisation procedures, 9 out of 18 used
concealed allocation, 10 out of 18 reported withdrawals, in 14 out of 18 researchers were masked to
outcomes and in 15 out of 18 ITT analyses were conducted (see Table 3).
Overall effectiveness of self-management programmes
We used the data from the original review (up to 2009) to inform our intervention design (Table 4). The final
column of this table includes the updated meta-analyses. The addition of studies from the updated search
made little difference to these findings with the exception that there are more studies reporting depression
and those reporting medium- and longer-term results show small effects on most outcomes. The differences
in results between 2009 and 2013 showed changes in effect sizes for anxiety (small significant medium
effect size in the long term) and social function (in the medium term) (see Appendix 1 for forest plots).
In summary, these data suggest that the interventions studied have small beneficial effects on global health,
pain intensity, physical function, quality of life, anxiety and social function in the short term and sometimes
the medium term but that these effects are much reduced in studies reporting longer-term follow-up
(beyond 8 months). For quality of life and anxiety, the effects in studies reporting longer-term follow-up
remain small rather than ‘minor’, but closer examination reveals that in each case there was only one small
study supplying longer-term follow-up data, raising the possibility of publication bias. For depression the
beneficial effects are ‘minor’ in the short term but small in the medium term; however, there are far fewer
studies reporting medium-term (or long-term) effects. Unlike the other outcomes, there appears to be a
small beneficial effect on self-efficacy in studies reporting short-, medium- and long-term follow-up.
Effectiveness of the different characteristics of self-management
programmes
The data for these analyses come from the studies identified in the original search (1994–2009).
For ease of reading we present the statistically significant SMD effect sizes [with 95% confidence intervals
(CIs)] only for data favouring self-management over waiting list control or usual care for each outcome
subgroup comparison except for fatigue, SF-36 general mental health and visits to HCPs. Tables showing
all of the results are available from the corresponding author.
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TABLE 4 Summary of total effect sizes by outcome and follow-up interval for the original systematic review and
including the studies from the updated search
Outcome
Follow-up
(months)
January 1994–April 2009 January 1994–September 2013
Number of
participants
(number of studies)
Effect size
(95% CI)
Number of
participants
(number of studies)
Effect size
(95% CI)
Global health
Short term < 4 632 (8) –0.34
(–0.59 to –0.08)
976 (10) –0.33
(–0.52 to –0.13)
Medium term 4–8 1082 (7) –0.46
(–0.73 to –0.19)
1575 (10)a –0.33
(–0.51 to –0.15)
Long term > 8 1101 (5) –0.05
(–0.18 to 0.08)
1818 (9)a –0.10
(–0.23 to 0.03)
Pain intensity
Short term < 4 2810 (26) –0.27
(–0.37 to –0.16)
4723 (35) –0.35
(–0.47 to –0.24)
Medium term 4–8 3911 (20) –0.25
(–0.38 to –0.12)
6038 (32)a –0.29
(–0.38 to –0.20)
Long term > 8 3332 (18) –0.18
(–0.28 to –0.07)
5104 (25)a –0.18
(–0.26 to –0.10)
Physical function
Short term < 4 2453 (19) –0.26
(–0.40 to –0.12)
4093 (26) –0.31
(–0.44 to –0.18)
Medium term 4–8 3759 (18) –0.15
(–0.23 to –0.07)
5546 (28)a –0.19
(–0.25 to –0.13)
Long term > 8 2482 (13) –0.12
(–0.20 to –0.04)
3980 (19)a –0.14
(–0.22 to –0.06)
Quality of life
Short term < 4 258 (2) –0.40
(–0.65 to –0.15)
258 (2) –0.40
(–0.65 to –0.15)
Medium term 4–8 399 (2) –0.11
(–1.05 to 0.82)
665 (4) –0.14
(–0.55 to 0.27)
Long term > 8 170 (1) –0.50
(–0.80 to –0.19)
170 (1) –0.50
(–0.80 to –0.19)
Self-efficacy
Short term < 4 1275 (12)a –0.37
(–0.50 to –0.24)
1173 (15)a –0.38
(–0.52 to –0.25)
Medium term 4–8 1214 (7) –0.29
(–0.44 to –0.14)
2030 (10) –0.25
(–0.34 to –0.17)
Long term > 8 1701 (7) –0.25
(–0.35 to –0.15)
2173 (8) –0.23
(–0.31 to –0.14)
Depression
Short term < 4 1162 (13)a –0.15
(–0.28 to –0.03)
1743 (15)a –0.15
(–0.24 to –0.05)
Medium term 4–8 597 (4) –0.25
(–0.47 to –0.03)
1899 (12)a –0.26
(–0.38 to –0.13)
Long term > 8 641 (3) –0.04
(–0.26 to 0.18)
1516 (7)a –0.20
(–0.44 to 0.03)
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In Tables 5–7 we present small (≥ 0.2), moderate (≥ 0.5) and large (≥ 0.8) effect sizes for different outcomes
at different follow-up intervals. Results that favoured the control arm, favoured neither subgroup, were
non-estimable or resulted in minor effect sizes are presented in the accompanying text for each outcome.
Effect sizes for course delivery mode (see Tables 5–7)
Of the 46 studies, 27 (59%) involved group interventions, five (11%) remote interventions and five (11%)
individually delivered interventions; the remaining nine (20%) used a mixture of both group delivery and
individual delivery (see Table 3). We assessed the four types of delivery methods against eight outcomes
over three time periods, giving a potential of 96 subgroup effect sizes. Twenty-three small to large
beneficial effects favouring self-management were found. Only one effect size comparison favoured the
control (mixed led, medium term, quality of life: –0.33, 95% CI –0.11 to –0.56). Forty of the subgroup
effect sizes showed no difference between self-management interventions and the waiting list control/
usual care, seven showed minor (< 0.2) benefits favouring self-management and 48 were non-estimable
because of a lack of data. Courses delivered to groups appeared to have the most statistically significant
beneficial effects compared with control groups in the short, medium and long term. Data on outcomes
for courses delivered to individuals were very sparse. Mixed and remotely delivered interventions may be
beneficial but not as much as courses delivered to groups.
Effect sizes for type of course leader (see Tables 5–7)
The majority of courses [36/46 (78%)] were delivered by HCPs, with six courses (13%) delivered by a
combination of HCPs and laypeople and four courses (9%) delivered by laypeople only (see Table 3). Effect
sizes were calculated for these three different types of leader combinations. A total of 90 comparisons
were made. Small to large beneficial effects sizes were shown favouring self-management in 12 instances
and minor benefits (< 0.2) were shown in nine. Thirty-nine subgroup comparisons showed no significant
benefit in either study arm and 28 comparisons were non-estimable because of a lack of data. No
comparisons favoured the control arm.
TABLE 4 Summary of total effect sizes by outcome and follow-up interval for the original systematic review and
including the studies from the updated search (continued )
Outcome
Follow-up
(months)
January 1994–April 2009 January 1994–September 2013
Number of
participants
(number of studies)
Effect size
(95% CI)
Number of
participants
(number of studies)
Effect size
(95% CI)
Anxiety
Short term < 4 282 (5) –0.23
(–0.54 to 0.08)
863 (7) –0.16
(–0.33 to 0.01)
Medium term 4–8 451 (3) –0.28
(–0.56 to 0.00)
878 (6) –0.14
(–0.31 to 0.03)
Long term > 8 50 (1) –0.28
(–0.84 to 0.27)
553 (3) –0.41
(–0.58 to –0.24)
Social function
Short term < 4 555 (7) –0.31
(–0.57 to –0.04)
899 (9) –0.33
(–0.53 to –0.12)
Medium term 4–8 286 (4) –0.19
(–0.61 to 0.22)
931 (8)a –0.24
(–0.40 to –0.09)
Long term > 8 205 (2) 0.19
(–0.09 to 0.47)
922 (6)a –0.11
(–0.26 to 0.05)
CI, confidence interval.
a Includes studies with two intervention arms viable for the comparison. Therefore, the number of studies shown
contributing to the plot is inflated by n + 1 and the total number of participants shown contributing to the plot is
inflated by double counting of the control arm. A sensitivity analysis in the original systematic review showed that
removing these multiarm studies made no difference to the results and so they have been kept in.
COMPONENTS AND CHARACTERISTICS OF PAIN AND SELF-MANAGEMENT PROGRAMMES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
22
TA
B
LE
5
Ef
fe
ct
o
f
co
u
rs
e
d
el
iv
er
y
m
et
h
o
d
s
o
ve
r
sh
o
rt
-t
er
m
fo
llo
w
-u
p
(<
4
m
o
n
th
s)
O
u
tc
o
m
e
C
o
u
rs
e
d
el
iv
er
y
m
o
d
e
(9
5%
C
I)
C
o
u
rs
e
le
ad
er
(9
5%
C
I)
C
o
u
rs
e
se
tt
in
g
(9
5%
C
I)
C
o
u
rs
e
d
u
ra
ti
o
n
(9
5%
C
I)
G
ro
u
p
In
d
iv
id
u
al
M
ix
ed
R
em
o
te
H
C
P
le
d
La
y
le
d
M
ix
ed
M
ed
ic
al
C
o
m
m
u
n
it
y
O
cc
u
p
at
io
n
al
≤
8
w
ee
ks
>
8
w
ee
ks
G
lo
ba
lh
ea
lth
0.
45
(0
.1
7
to
0.
73
)
0.
61
a
(0
.0
7
to
1.
15
)
0.
56
(0
.2
6
to
0.
86
)
0.
42
(0
.0
5
to
0.
80
)
0.
30
(0
.0
3
to
0.
58
)
0.
61
a
(0
.0
7
to
1.
15
)
Pa
in
in
te
ns
ity
0.
24
(0
.1
2
to
0.
35
)
0.
59
(0
.0
3
to
1.
15
)
0.
27
(0
.1
4
to
0.
39
)
0.
28
(0
.1
1
to
0.
45
)
0.
46
(0
.1
1
to
0.
81
)
0.
24
(0
.1
2
to
0.
36
)
0.
22
(0
.0
3
to
0.
42
)
Ph
ys
ic
al
fu
nc
tio
n
0.
25
(0
.0
9
to
0.
40
)
0.
28
(0
.1
0
to
0.
47
)
0.
24
(0
.0
3
to
0.
45
)
0.
21
(0
.0
7
to
0.
34
)
0.
78
a
(0
.2
7
to
1.
29
)
0.
26
(0
.1
0
to
0.
41
)
Q
ua
lit
y
of
lif
e
0.
40
a
(0
.1
0
to
0.
69
)
0.
40
(0
.1
5
to
0.
65
)
0.
40
a
(0
.1
0
to
0.
69
)
0.
40
(0
.1
5
to
0.
65
)
Se
lf-
ef
fic
ac
y
0.
37
(0
.2
5
to
0.
50
)
0.
38
(0
.2
3
to
0.
52
)
0.
37
a
(0
.0
3
to
0.
71
)
0.
37
(0
.0
7
to
0.
66
)
0.
41
(0
.2
6
to
0.
57
)
0.
39
(0
.2
5
to
0.
54
)
A
nx
ie
ty
0.
67
a
(0
.1
7
to
1.
18
)
0.
67
a
(0
.1
7
to
1.
18
)
D
ep
re
ss
io
n
0.
25
(0
.0
4
to
0.
46
)
SF
-3
6
so
ci
al
fu
nc
tio
n
0.
38
(0
.0
9
to
0.
68
)
0.
51
(0
.1
1
to
0.
91
)
0.
54
a
(0
.0
4
to
1.
04
)
a
D
at
a
fr
om
on
e
st
ud
y
on
ly
.
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
23
TA
B
LE
6
Ef
fe
ct
o
f
co
u
rs
e
d
el
iv
er
y
m
et
h
o
d
s
o
ve
r
m
ed
iu
m
-t
er
m
fo
llo
w
-u
p
(4
–
8
m
o
n
th
s)
O
u
tc
o
m
e
C
o
u
rs
e
d
el
iv
er
y
m
o
d
e
(9
5%
C
I)
C
o
u
rs
e
le
ad
er
(9
5%
C
I)
C
o
u
rs
e
se
tt
in
g
(9
5%
C
I)
C
o
u
rs
e
d
u
ra
ti
o
n
(9
5%
C
I)
G
ro
u
p
In
d
iv
id
u
al
M
ix
ed
R
em
o
te
H
C
P
le
d
La
y
le
d
M
ix
ed
M
ed
ic
al
C
o
m
m
u
n
it
y
O
cc
u
p
at
io
n
al
≤
8
w
ee
ks
>
8
w
ee
ks
G
lo
ba
lh
ea
lth
0.
54
(0
.2
1
to
0.
88
)
0.
67
(0
.2
0
to
1.
15
)
0.
54
(0
.2
2
to
0.
87
)
0.
36
(0
.1
2
to
0.
6)
1.
08
a
(0
.5
2
to
1.
64
)
Pa
in
in
te
ns
ity
0.
25
(0
.0
2
to
0.
47
)
0.
20
(0
.0
2
to
0.
37
)
0.
29
a
(0
.0
6
to
0.
51
)
0.
22
(0
.1
2
to
0.
32
)
0.
24
(0
.0
1
to
0.
47
)
0.
25
(0
.0
8
to
0.
42
)
Ph
ys
ic
al
fu
nc
tio
n
0.
26
(0
.0
9
to
0.
44
)
Q
ua
lit
y
of
lif
e
0.
62
a
(0
.0
9
to
1.
15
)
0.
62
a
(0
.0
9
to
1.
15
)
0.
62
a
(0
.0
9
to
1.
15
)
Se
lf-
ef
fic
ac
y
0.
29
(0
.0
8
to
0.
50
)
0.
29
a
(0
.1
3
to
0.
44
)
0.
37
(0
.1
6
to
0.
59
)
0.
30
(0
.0
9
to
0.
52
)
0.
27
(0
.1
1
to
0.
43
)
A
nx
ie
ty
0.
25
a
(0
.0
2
to
0.
48
)
0.
65
a
(0
.1
2
to
1.
19
)
0.
65
a
(0
.1
2
to
1.
19
)
D
ep
re
ss
io
n
0.
76
a
(0
.2
2
to
1.
30
)
SF
-3
6
so
ci
al
fu
nc
tio
n
a
D
at
a
fr
om
on
e
st
ud
y
on
ly
.
COMPONENTS AND CHARACTERISTICS OF PAIN AND SELF-MANAGEMENT PROGRAMMES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
24
TA
B
LE
7
Ef
fe
ct
o
f
co
u
rs
e
d
el
iv
er
y
m
et
h
o
d
s
o
ve
r
lo
n
g
-t
er
m
fo
llo
w
-u
p
(≥
8
m
o
n
th
s)
O
u
tc
o
m
e
C
o
u
rs
e
d
el
iv
er
y
m
o
d
e
(9
5%
C
I)
C
o
u
rs
e
le
ad
er
(9
5%
C
I)
C
o
u
rs
e
se
tt
in
g
(9
5%
C
I)
C
o
u
rs
e
d
u
ra
ti
o
n
(9
5%
C
I)
G
ro
u
p
In
d
iv
id
u
al
M
ix
ed
R
em
o
te
H
C
P
le
d
La
y
le
d
M
ix
ed
M
ed
ic
al
C
o
m
m
u
n
it
y
O
cc
u
p
at
io
n
al
≤
8
w
ee
ks
>
8
w
ee
ks
G
lo
ba
lh
ea
lth
Pa
in
in
te
ns
ity
0.
20
(0
.0
4
to
0.
36
)
0.
26
(0
.1
5
to
0.
36
)
0.
23
(0
.0
3
to
0.
42
)
Ph
ys
ic
al
fu
nc
tio
n
Q
ua
lit
y
of
lif
e
0.
50
a
(0
.1
9
to
0.
80
)
0.
50
a
(0
.1
9
to
0.
80
)
0.
50
a
(0
.1
9
to
0.
80
)
0.
50
a
(0
.1
9
to
0.
80
)
Se
lf-
ef
fic
ac
y
0.
23
(0
.1
0
to
0.
35
)
0.
29
a
(0
.1
3
to
0.
44
)
0.
25
(0
.1
0
to
0.
40
)
0.
29
a
(0
.1
3
to
0.
44
)
0.
26
(0
.0
1
to
0.
52
)
0.
23
(0
.1
1
to
0.
36
)
0.
39
a
(0
.0
2
to
0.
76
)
0.
26
(0
.1
4
to
0.
37
)
0.
23
(0
.0
4
to
0.
42
)
A
nx
ie
ty
D
ep
re
ss
io
n
SF
-3
6
so
ci
al
fu
nc
tio
n
a
D
at
a
fr
om
on
e
st
ud
y
on
ly
.
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
25
Health-care professional-led self-management courses showed beneficial effects in the short, medium and
long term over a range of outcomes. Lay-led courses had a small, statistically significant beneficial effect on
self-efficacy only. Mixed HCP- and lay-delivered courses showed moderate to large benefits for SF-36 social
function scores and global health status, but data for several comparisons were sparse with some effect
sizes obtained from only one study.
Effect sizes for course setting (see Tables 5–7)
Twenty-seven (59%) studies were conducted in medical settings, 16 (35%) in community settings and
three (7%) in occupational settings. A total of 90 comparisons were made. Small to large beneficial effects
favouring self-management were shown for 22 subgroup analyses, with one comparison favouring the
control (medical setting, medium term, quality of life: –0.33, 95% CI –0.11 to –0.56). In 31 comparisons
there was no difference between the study arms, five comparisons showed minor benefits (< 0.2) for
self-management and 28 comparisons were non-estimable because of a lack of data.
Pain intensity was significantly improved at all three follow-up time points in the studies conducted in
medical settings but not in the studies in community settings.
Self-efficacy showed small to moderate statistically significant improvements favouring self-management in
medical and community settings at most time intervals. Data for self-efficacy for self-management courses
in an occupational setting were sparse. Physical function appeared to show statistically significant effect
sizes favouring self-management in medical, community and occupational settings in the short term.
Overall, medical and community settings had better outcomes than occupational or remote settings but
there were too few studies in occupational settings to draw firm conclusions.
Effect sizes for course duration (see Tables 5–7)
Two course duration periods were assessed: ≤ 8 weeks and > 8 weeks. A total of 60 comparisons were
made. Around one-third of the comparisons (18/48) showed small to large beneficial effects favouring
self-management. However, one comparison favoured the control (< 8 weeks, medium term, quality of
life: –0.33, 95% CI –0.11 to –0.56). All other subgroup analyses showed no benefit for either arm or
minor benefits for self-management (25/48), or were non-estimable because of a lack of data (5/48).
Small to moderate statistically significant beneficial effect sizes were shown for a mix of outcomes for both
short and longer durations of self-management courses at all time intervals. Statistically significant effect
sizes did not appear to be enhanced by increased duration of courses.
Effectiveness of the different components of self-management programmes
In Tables 8–13 we present small (≥ 0.2), moderate (≥ 0.5) and large (≥ 0.8) effect sizes for different
outcomes at different follow-up intervals. Results that favoured the control arm, favoured neither
subgroup, were non-estimable or resulted in minor effect sizes are presented in the accompanying text.
Effectiveness of self-management courses that include a psychological
component (see Tables 8–10)
Only eight (17%) of the interventions in the included studies did not have a psychological component.
A total of 48 comparisons were made, 21 of which showed no differences or minor effect sizes of < 0.2
between self-management and control. Eleven of the comparisons were non-estimable because of a lack
of data. For interventions that included a psychological component we found small statistically significant
effect sizes favouring self-management for pain intensity, physical/functional capability, SF-36 social
function and self-efficacy for both short- and medium-term follow-up and there was evidence of benefit in
the long term for self-efficacy but not for the other outcomes. There was no evidence that depression
improved significantly for interventions with a psychological component although at medium-term
follow-up anxiety was improved compared with the control groups. There was little evidence to support
self-management interventions without a psychological component but most comparisons, except for pain,
physical/functional capability and self-efficacy, had only one study or none at all examining this subgroup.
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Effectiveness of self-management courses that include a lifestyle component
(see Tables 8–10)
We included a variety of elements for the lifestyle component such as sleep management, relationship
advice, diet advice, ergonomic guidance for return to work and stress management. Seven (15%)
of the included studies involved an intervention that did not include a lifestyle component. A total of
48 comparisons were made, 17 of which showed no differences or minor effect sizes of < 0.2 between
self-management and control. Ten of the comparisons were not estimable because of a lack of data.
Overall, there was no discernible difference in the effect on self-efficacy, physical/functional capability,
depression or global health status between interventions with and those without a lifestyle component.
Effectiveness of self-management courses that include a medical education
component (see Tables 8–10)
Thirty-five (76%) of the interventions included a medical education component. A total of 48 comparisons
were made, 21 of which showed no differences or minor effect sizes of < 0.2 between self-management
and control. Ten of the comparisons were not estimable because of a lack of data. There was some
evidence in favour of a medical education component with regard to anxiety in the short term and pain
intensity and depression in the medium to long term. Significant moderate benefits in terms of self-efficacy
were noted compared with control groups in interventions without an educational component in the short
term and in medium- and long-term single studies. Data for many comparisons were very sparse.
Effectiveness of self-management courses that include a physical activity
component (see Tables 8–10)
A total of 48 comparisons were made, 18 of which showed no differences or minor effect sizes of < 0.2
between self-management and control. Twenty of the comparisons were not estimable because of a lack
of data. Only six (13%) of the included studies involved an intervention that did not include a physical
activity component. Interventions that included a physical activity component showed some small
statistically significant effect sizes favouring self-management for the following outcomes: pain intensity
(medium term), self-efficacy (short term), SF-36 general mental health (short term) and global health status
(short term).
Most comparisons were limited by having only one study or no studies without a physical
activity component.
Effectiveness of self-management courses that include a mind–body therapy
component (see Tables 8–10)
Twenty-six (57%) of the included studies involved a mind–body therapy component. A total of
48 comparisons were made, 23 of which showed no differences or minor effect sizes of < 0.2 between
self-management and control. Six of the comparisons were not estimable because of a lack of data.
We found no discernible patterns with regard to the effect of including mind–body therapy in
self-management interventions. In the short term, interventions that did not include mind–body therapy
showed small significant benefits over a wide range of outcomes compared with control groups. In the
medium term the picture was mixed, with small benefits over control groups seen for different outcomes both
for interventions with a mind–body therapy component and those without. Depression consistently failed to
improve with self-management, irrespective of whether or not the course included mind–body therapy.
Effect of the number of components included in self-management courses
(see Tables 11–13)
We could potentially have estimated a total of 96 effects. No studies were available to estimate nine of
these effects. Sixty-one of these comparisons showed no differences or minor effect sizes of < 0.2
between self-management and control. When the effect estimates were > 0.2, increasing the number of
components present in self-management courses from two through to five did not appear to have an
overall beneficial effect on any outcome measure.
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TABLE 11 Effect of number of components over short-term follow-up (< 4 months)
Outcome
Two components
(95% CI)
Three components
(95% CI)
Four components
(95% CI)
Five components
(95% CI)
Global health 0.65 (0.27 to 1.04) 0.77a (0.16 to 1.38)
Pain intensity 0.37 (0.15 to 0.59) 0.23 (0.03 to 0.42)
Physical function 0.37 (0.19 to 0.55) 0.37 (0.07 to 0.67)
Quality of life 0.40a (0.10 to 0.69)
Self-efficacy 0.42a (0.03 to 0.81) 0.28 (0.10 to 0.47) 0.50 (0.04 to 0.96) 0.43 (0.15 to 0.72)
Anxiety 0.67a (0.17 to 1.18)
Depression
SF-36 social function 0.54a (0.04 to 1.04) 0.63a (0.03 to 1.23)
a Data from one study only.
TABLE 12 Effect of number of components over medium-term follow-up (4–8 months)
Outcome
Two components
(95% CI)
Three components
(95% CI)
Four components
(95% CI)
Five components
(95% CI)
Global health 0.77a (0.22 to 1.32)
Pain intensity 0.32 (0.06 to 0.59) 0.63 (0.11 to 1.16)
Physical function 0.21 (0.01 to 0.42)
Quality of life
Self-efficacy 0.58a (0.16 to 1.00) 0.30 (0.08 to 0.52)
Anxiety 0.38 (0.01 to 0.74)
Depression
SF-36 social function
a Data from one study only.
TABLE 13 Effect of number of components over long-term follow-up (> 8 months)
Outcome
Two components
(95% CI)
Three components
(95% CI)
Four components
(95% CI)
Five components
(95% CI)
Global health
Pain intensity 0.36 (0.20 to 0.52)
Physical function
Quality of life 0.5a (0.19 to 0.80)
Self efficacy 0.52a (0.09 to 0.96) 0.39a (0.02 to 0.76) 0.22 (0.11 to 0.32)
Anxiety
Depression
SF-36 social function
a Data from one study only.
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Discussion
Effectiveness of self-management programmes
This review identified 64 studies (65 papers) providing usable final-value outcome data for meta-analysis.
Overall, it showed ‘small’ statistically significant effect sizes in the short term (< 4 months) for pain
intensity, physical/functional capability, self-efficacy, SF-36 general mental health, global health status and
SF-36 social role. These effect sizes became ‘minor’ (SMD < 0.2) and/or statistically insignificant in the
medium term (4–8 months) and long term (≥ 8 months) for all outcomes except for self-efficacy (small
statistically significant effect size for all time intervals) and global health status (small statistically significant
effect size for medium-term follow-up).
Course content and components
We examined the effect of individual course components by comparing effect sizes for interventions with
certain components and interventions without these components. This approach was hampered by few
interventions not having the component of interest, in particular psychological and physical components.
Overall, the evidence suggested that:
l Increasing the number of components does not necessarily equate to improved effectiveness.
l There is strong evidence for beneficial effects of psychological components but the content and mode
of delivery to optimise effect is unknown.
l Any exercise can be recommended as long as the exercise is carried out regularly and is within
the capability of the individual. Initial exercise advice should be given on an individual basis
but physical activity can then be conducted in a group and/or supervised setting to encourage
adherence.
l Education and mind–body therapies are better placed as adjunct rather than stand-alone therapies.
Education should inform patients about their condition, managing their medication and
self-management strategies that can have positive effects on lifestyle.
l Of the mind–body therapies, the strongest positive evidence appears to be for relaxation.
Course delivery
The evidence suggested that group delivery was effective. Some cognitive–behavioural elements or
personalised exercise plans may be more effectively deployed on an individual basis but should perhaps be
discussed or practised as part of a group session.
Other reviews have found that individual classes127 were best or that individual, group and home-based
exercises were all equally effective.128 Guidelines on exercise129 recommend both individual structured and
group approaches to exercise. In addition, another study suggested that a group lecture format was most
effective for delivering education.130
Course leader
The evidence suggested that HCP-led courses were most effective, although there was also some evidence
for lay-led or mixed courses. We found limited evidence (three studies) to suggest that lay leaders are as
effective as HCPs.
Our subgroup comparison between HCP-, lay- and mixed-led courses showed that HCP-led content
produced small but significant effect sizes mainly in the short term There was some evidence for the
effectiveness of lay-led courses for pain, physical/functional capability and self-efficacy but the effect sizes
were either < 0.2 or the data were obtained from one study only.
Two other reviews52,127 have found that HCP-supervised or -monitored programmes were most effective.
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Course setting
The evidence suggested that the effects of setting were varied. Our subgroup analysis showed that the
medical setting and community settings were favoured compared with occupational and remote settings.
One review113 suggested that a ‘back school’ in an occupational setting was effective, whereas another
review131 felt that programmes should be conducted in primary care (UK). One review examining web-
based CBT132 found that ‘live’ internet sessions had the lowest dropout rate and that internet-delivered
self-management material showed promise, especially for people with limited mobility. Self-management
material available online may help to support participants during and after courses and provide a virtual
forum to complement any friendships formed during the group sessions.
Course duration
The evidence suggested that shorter courses were as effective as longer ones (and were likely to be more
cost-effective).
Other evidence from studies reviewing course duration is equivocal, with one review finding increased
effectiveness for courses > 100 hours133 and another suggesting that longer courses (3–6 months) are too
costly and impractical to implement134 and that, in a subgroup analysis, there is no evidence of a difference
in effectiveness between courses of ≥ 30 hours and courses of < 30 hours.
In summary, therefore, we found that shorter courses were as effective as longer ones and that
multicomponent courses were not necessarily more effective than those with two or three components;
however, we found weak or no evidence that self-management courses reduce the number of health-care
visits. Solely HCP-led courses were more beneficial for pain outcomes but would be more expensive to run
than lay courses. A mixed-led approach is probably more viable. Using a digital versatile disk (DVD) of a pain
consultant delivering an education component instead of being there in person, or perhaps having some
psychological material delivered by a student psychologist rather than a consultant, may be a worthwhile
alternative. Group and individual sessions were found to be effective, although individual sessions are more
labour intensive and are therefore more likely to be expensive. Self-management courses delivered in a
community setting may be less expensive than those delivered in a primary care venue. If any remotely
delivered online material for use as a supporting or follow-up aid is included then the costs of website
design and maintenance, website hosting and forum moderation would need to be considered.
Study limitations
Internal validity: study bias
Unfortunately, because of time constraints, it was not possible to write to the study authors to clarify their
methods or seek more data.
Although the funnel plot and metabias test suggested that there was no publication bias, the low number
of studies (n = 26) and uncertainty about the appropriateness of the metabias test for SMDs of continuous
outcomes make these conclusions tentative. We also found very few studies that showed negative effects
of self-management programmes and we did not consider literature in any other language than English
and so there is a possibility of publication bias.
Treatment of the control groups
We acknowledge that ‘usual care’ (the control condition in most of the studies included in this review) can
vary markedly from setting to setting and is often very poorly described in publications. Thus, there is likely
to have been considerable heterogeneity in the treatment received across the control groups.
Multiple testing
We made no adjustment for multiple testing. We are aware that some of the positive associations that we
report may have arisen by chance as a result of the large number of tests conducted.
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Component analysis framework
We employed a subjective approach to categorising studies into component categories for our subgroup
meta-analysis. It was sometimes difficult to distinguish the component elements from the intervention
descriptions and so there is an amount of subjectivity involved. We found that descriptions for CBT or
psychological interventions included elements from our psychological component framework and our
mind–body therapies component framework. It may have been more meaningful to group psychological
and mind–body therapies together.
We used the SMD to combine the results from different outcome measurement tools, using Cohen’s d63,64
as a measure of effect size. We are cognisant of the difficulties with interpretation of Cohen’s scale in a
clinical setting.
We expected a high degree of heterogeneity because of the variation in self-management courses and
particularly the variation between subgroups, with studies being subjectively grouped according to number
and type of components. We found moderate to substantial heterogeneity for most outcomes, with a
small statistically significant effect size, except for self-efficacy, which had < 25% heterogeneity across all
time intervals.
Our subgroup analyses did not completely resolve heterogeneity for all subgroups. Although some
subgroups showed an I2 value of 0%, some comparator subgroups had very few studies and so it was
difficult to draw any conclusions from these patterns.
Overall conclusions
Our meta-analysis echoed the findings from previous systematic reviews, showing that self-management
courses produce small statistically significant beneficial effects in the short term for outcomes such as pain
intensity and physical/functional capability, but that these effects are not maintained into the longer term.
We found that increasing the number of self-management components and number of sessions did not
necessarily result in increased effectiveness, which has implications for costs. We found strong evidence of
effectiveness for courses including a psychological course component and encouraging evidence for
courses delivered to groups. There was some limited evidence of beneficial effects for mind–body
techniques and medical education, and these are best provided as an adjunct.
The ways in which the findings of the systematic review influenced the design of the intervention are
described fully in Chapter 6.
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Chapter 3 Identifying who is likely to respond to
self-management programmes for chronic
musculoskeletal pain
Abstract
Introduction: Establishing the characteristics of groups of people who are likely to gain the most benefit
from self-management interventions is important but, as yet, this has not been accomplished.
Aim: The aim of this systematic review was to examine the evidence for predictors, moderators and
mediators of patient outcomes, as reported in RCTs of self-management support for people with chronic
musculoskeletal pain.
Methods: We searched relevant electronic databases for RCTs and systematic reviews that measured and
reported baseline measures and analysed them in relation to interventions and outcomes. We assessed the
evidence according to the methodological strengths of the studies. We carried out meta-regression
analyses for age and gender, as potential moderators.
Results: Most of the studies were compromised by lack of power for moderator and mediator analyses.
There was evidence that self-efficacy and depression at baseline predict outcome and evidence that pain
catastrophising and physical activity can mediate outcome from self-management. There was no clear
evidence on moderators.
Conclusions: Although the current evidence is scarce, it suggests that the development of interventions
should include careful consideration of self-efficacy, depression, physical activity and catastrophising.
Introduction
In this chapter we review the available evidence indicating which type, or types, of people may benefit
most from self-management courses for chronic pain. Specifically, we reviewed the literature identifying
predictors, moderators and mediators of the effects of self-management interventions.
We used a systematic review approach to identify:
l RCTs of self-management for chronic musculoskeletal pain that reported subgroup analyses looking at
predictors, moderators and mediators in different subgroups of patients
l RCTs of self-management for chronic musculoskeletal pain that included data on treatment moderation
suitable for a meta-regression.
Definitions
The definitions of predictors, moderators and mediators have been refined in recent years. We adopted
the approach of Kraemer et al.32 in which three types of subgroups are described and clearly defined:
Predictors of treatment outcome are defined as baseline variables that affect outcome (significant main
effect only) but do not interact with treatment. Such factors significantly predict outcome equally for target
interventions and control conditions.
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Effect moderators (or moderators) are variables measured at baseline (such as patient baseline
characteristics) that interact with treatment to change outcomes. The interaction should be related to
outcome in the linear model with or without a main effect. These specify for whom and under what
conditions treatment works and can improve power in subsequent trials by better selection of target
groups for stratification.
Mediators are variables measured during treatment (such as change-in-process factors) that impact on
outcome, with or without interaction with treatment. Mediators help inform the process and potential
mechanisms (including causal mechanisms) through which treatment might work. They can be used to
improve subsequent interventions through strengthening the components that best influence the identified
mediators. Mediators should not be a component of the treatment or outcome. There should be a clear
distinction between the constructs measured by the proposed mediators and treatment outcome.
Predictors and moderators may include:31,32,42
l demographic status [age, gender, education, marital status, lifestyle (alcohol consumption,
exercise, smoking)]
l clinical status (e.g. disability, duration of pain, pain intensity)
l psychological status (e.g. catastrophising, depression, fear avoidance and beliefs)
l work-related factors [e.g. employment status, type of work, reasons for not working, number of sick
days taken over previous year, financial factors (pending compensation, sickness benefit, insurance and
duration on current benefits), job satisfaction, social support at work, a sense of control at work]
l medication history.
Methods
Studies were identified as an eligible subset of those identified in Chapter 2.
Quality assessment of included studies
For the overall quality of the papers we used the assessment carried out for the review of main effects.
Early in the project we sought established methodological criteria for the assessment of subgroup analyses
within RCTs. We were unable to identify any such criteria suitable for our purpose. Consequentially, as
part of this programme of work we carried out a literature review and Delphi study to determine a
consensus on methodological criteria for the evaluation of studies reporting moderator analyses within
RCTs. We used these assessment criteria to assess the quality of our moderator studies and grade the
evidence for moderators.135
We applied the following criteria to included papers:
1. Was there an a priori specification of the subgroup?
2. Was there a theoretical or an evidence-based rationale for the selection of subgroup factors?
3. For moderator and predictor analyses only: was the measurement of subgroup factors carried out prior
to randomisation?
4. Was the measurement of subgroup factors adequate (reliable and valid) and appropriate for the
target population?
5. For moderator and mediator analyses only: does the analysis contain an explicit test of the interaction
between subgroups and treatment?
Papers were classified as providing either confirmatory findings or exploratory findings. Confirmatory
findings refer to studies that include a priori hypotheses in relation to subgroups, for which support was
obtained through adequate statistical testing. Exploratory findings inform future research (hypothesis
generating) and are the product of post hoc testing. Only studies that satisfied all of the above five criteria
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relevant to the analysis were regarded as providing confirmatory evidence. Papers satisfying criteria 3–5
were categorised as exploratory findings. Studies that did not satisfy these criteria were regarded as having
insufficient findings. For this review we applied these same criteria to predictor and mediator analyses
as appropriate.
We included any RCTs identified in the searches in Chapter 2 that reported predictor, moderator or
mediator analyses. For selected RCTs that did not report any subgroup analyses but which had ≥ 80%
completion rates for their primary analysis and > 200 participants in each arm, the authors were contacted
and asked if they had carried out, or were now able to carry out, such analyses. We also contacted authors
when any aspects of their reported subgroup analyses were unclear.
Data extraction
We extracted the following data from each RCT:
l country and setting
l population: brief description of participants, including size of eligible population identified and
actual uptake
l intervention/control
l baseline factors measured
l outcomes measured
l description of predictor, moderator and mediator analyses
l results of predictor, moderator and mediator analyses.
Finally, an independent statistician scrutinised the included studies to determine whether or not there were
appropriate data to include in the meta-regression and whether any moderator or mediator analyses were
carried out appropriately. The statistician checked for the presence of a reported power calculation;
whether there were any statistician authors or whether the authors described seeking statistical advice;
and the statistical methods used and the quality of reporting, paying particular attention to moderator and
mediator analyses. We also conducted a meta-regression to identify potential moderators. We included
any RCTs identified in our original search (see Chapter 2) whose final-value data were suitable for inclusion
in a meta-regression. For all potential moderators reported in ≥ 10 studies we performed a random-effects
meta-regression.39 We collapsed outcomes into the following domains: pain intensity, physical/functional
capability, self-efficacy, depression and global health status. When a variety of measurement tools had
been reported for a domain, we calculated SMDs (difference in mean outcome between groups/SD of
outcome among participants).39 To make the best use of the available data, and reduce the possibility of
making a type 1 error, we collapsed the different follow-up time points (early and late) to obtain one
average effect size per outcome. We considered results from the meta-regression to be statistically
significant if p < 0.10. We used this criterion because of a potential type II error as a result of the limited
number of studies in these effect size calculations.42,136 We used an I2 statistic to estimate the percentage
of residual variation attributable to between-study heterogeneity and an adjusted R2 statistic to estimate
the proportion of between-study variance explained by the covariate. We produced scatter diagrams using
circles as plotting symbols in which the areas of the circles indicated the value of a third variable.137
We fitted values and predicted random effects against age and gender separately, with 95% confidence.
Results
Of the 126 RCTs that looked at self-management programmes, a total of 20 articles67,75,93,104,107,110,138–151
covering 16 studies (n = 4047) met our inclusion criteria and included appropriate analyses of predictors,
moderators or mediators. In addition, 46 of 126 studies met our criteria for meta-regression to identify
potential treatment moderators.
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Of the 16 studies, five were from the USA,93,104,138–140 four were from the Netherlands,93,141–143 two each
were from Canada,107,144 Norway75,145 and Sweden146,147 and one was from the UK.67
Methodological quality
In the first instance we applied quality assessment criteria to the trial methodology, using criteria adapted from
The Cochrane Collaboration methods39 and described in Chapter 2. We independently analysed and coded
each publication separately, even though some studies were further analyses of previously published RCTs;
hence, in Table 14 we present the quality appraisal for 20 reports covering 16 studies.67,75,93,104,107,110,138–151
Nine RCTs were of high quality, six were of medium quality104,110,138,139,145,148 and one was of low quality.146
Eight of the subgroup studies provided confirmatory evidence, one study provided exploratory evidence93 and
seven studies provided insufficient evidence. For subgroup analyses we applied the criteria described in
Quality assessment of included studies. Only three studies67,107,142 used high-quality trial methodology and
carried out preplanned theoretically driven subgroup analysis, using correct statistical analysis. However, there
were no two trials in this category (for any predictors, moderators and mediators) that examined the
same subgroup.
We did not find any high-quality studies appropriately reporting moderator analyses.
Predictors
Hurley et al.67 found that higher levels of depression at baseline predicted poorer physical functioning at
6 months in people with chronic knee pain (effect size 0.48; p = 0.011), whereas higher levels of self-efficacy
at baseline, measured by positive exercise beliefs (effect size –0.24; p = 0.001) and confidence in the ability
to exercise (effect size –0.62; p = 0.001), predicted better physical functioning at 6 months, regardless of
intervention arm.
Mediators
Smeets et al.142 found that reduced levels of pain catastrophising during treatment led to a post-treatment
decrease in patient-specific complaints, disability and pain in people with chronic low back pain. Patients in
the intervention group scored, on average, 1.3 points lower for disability (out of 24) than patients in the
control arm, after adjusting for pain catastrophising. For current pain, the difference was 4.7 units on a
visual analogue scale (out of 100). For patient complaints, the difference was 6.7 (out of 100).
Laforest et al.107 reported that increases in physical activity mediated greater decreases in helplessness in
people with arthritis; however, the data were not available to quantify this effect. This effect was defined
by Laforest et al.107 as a moderator, although from the authors’ description it is a mediator. Because of
these limitations, we recommend that the findings for the mediating effects of physical activity be
reviewed with caution.
Meta-regression to identify potential moderators
All RCTs identified from the original search that supplied full data on age and gender at baseline against at
least one of our selected outcomes were included (n = 46/126).
We used bivariable meta-regression to determine whether or not the baseline characteristics (age and
gender) explained the variation in treatment outcomes. Age and gender were selected because they are
the most frequently reported demographic characteristics.39 They were the only variables reported in at
least 10 studies.
For one outcome, general mental health, a single measurement tool had been used, the SF-36.62 We
intended to combine the data as a weighted mean difference but because of anomalies in score values
between studies we judged that SMD analyses would be more robust. A variety of measurement tools was
reported for each domain; for these we also calculated SMDs.
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Forty-six studies were included in the meta-regression and eight in the 16 subgroup meta-regressions.
Gender was significantly associated with effect size for SF-36 general mental health and global health
status, indicating that self-management interventions were more effective for groups with a higher
proportion of females (all p < 0.10 and p ≥ 0.05) (Table 15). Inspection of bubble graphs (see Appendix 2,
Meta-regression) suggested a positive association between studies with an increasing proportion of males
(note that a fall in measures indicated improvement in our analyses). Gender was not statistically
significantly associated with effect size for pain intensity, physical/functional capability, self-efficacy or
depression. Age was associated with effect size for physical/functional capability and self-efficacy (all
p < 0.10 and p > 0.05). The bubble graphs (see Appendix 2, Meta-regression) suggested a positive
association between effect size and these outcomes, indicating that self-management interventions might
be more effective in younger samples. Age was not associated with effect sizes for the other outcomes.
Discussion
Summary of findings for predictors, moderators and mediators
There were only three studies with sufficient methodological rigour, including a priori planned subgroup
analysis, to inform on predictors and mediators. The findings from these studies suggest that high levels of
depression at baseline are associated with lower function and that self-efficacy, especially about the ability
to exercise, is associated with improved function 6 months later, regardless of any intervention.67 There
was also evidence that reduction in catastrophic thinking directly after the intervention was associated with
improved function 6 months later.142 Finally, engaging in exercise during the intervention was associated
with better function at outcome.107
TABLE 15 Meta-regression results for age and proportion of male participants as moderatorsa
Measure
Studies
(sample size), n Moderator I2 (%)
Regression
coefficient
95% CI for regression
coefficient p-value
Pain intensity 39 (6067) Proportion
male
47.7 –0.0006 –0.0062 to 0.0051 0.840
Functional capability 27 (4790) Proportion
male
51.8 –0.0019 –0.0084 to 0.0047 0.560
Self-efficacy 17 (2576) Proportion
male
32.4 –0.0017 –0.0115 to 0.0082 0.732
Depression 16 (1902) Proportion
male
24.2 –0.0025 –0.0108 to 0.0058 0.533
SF-36 general mental
health
11 (1117) Proportion
male
51.6 0.0097 –0.0021 to 0.0214 0.095b
Global health status 14 (1801) Proportion
male
59.1 0.0114 –0.0003 to 0.0230 0.055b
Pain intensity 39 (6012) Age 43.1 0.0004 –0.0114 to 0.0121 0.116
Functional capability 28 (4873) Age 45.8 0.0078 –0.0008 to 0.0164 0.074b
Self-efficacy 17 (2576) Age 17.3 0.0081 –0.0004 to 0.0165 0.060b
Depression 16 (1902) Age 13.3 0.0060 –0.0025 to 0.0144 0.156
SF-36 general mental
health
11 (1117) Age 53.2 0.0118 –0.0082 to 0.0317 0.176
Global health status 14 (1801) Age 61.2 0.0159 –0.0085 to 0.0402 0.223
a Positive regression coefficients imply worsening outcome.
b Significant effect (p< 0.10).
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Findings from the meta-regression looking at age and gender in relation to outcomes showed no
significant associations with pain intensity, physical/functional capability, self-efficacy, depression, SF-36
general mental health or global health status. As mentioned in the methods section, because of the small
number of studies for each outcome, marginally significant associations (p < 0.10), were considered as
hypothesis generating for future studies to explore possible relationships.42
Recommendations
Based on the above findings we can make the following recommendations:
l Findings for the predictive effect of self-efficacy on outcomes and the mediating effects of pain
catastrophising on function indicate that interventions should incorporate strategies to improve
self-efficacy and coping techniques.
l Based on the currently available evidence, we do not recommend targeting the intervention to a
particular age group or gender.
l There is currently no evidence to support an association between duration of pain/complaint, pain
intensity, work status, disability level or diagnosis of depression at baseline and outcome. Therefore,
access to current interventions should not be limited based on these factors.
l We recommend that study authors use the criteria that we identified for assessing the quality of
moderator studies to guide their methodology.
Limitations/considerations of this review
Because of the small numbers of studies carrying out appropriate analyses, we were unable to
quantitatively assess predictors, moderators and mediators of self-management programme outcome
success, other than age and gender. Overall, the evidence is insufficient to inform on moderators,
mediators and predictors of intervention success, other than for self-efficacy as a predictor and
catastrophic thinking as a mediator. We have only considered RCT data here rather than including
observational data. This is because we were specifically interested in factors to consider in the context of a
RCT rather than an observational cohort study.
Because of the lack of consistent reporting of potential predictors, moderators and mediators in research,
the meta-regression featured only two potential moderators, age and gender. These were selected as they
are the most commonly reported characteristics in studies and data were readily available. Only when
researchers report potential moderating variables as a standard can meta-analytical techniques be used to
calculate a more accurate estimate of the variance between studies.
Studies reporting significant predictor, moderator or mediator effects of self-management interventions are
more likely to be published than those studies that do not report significant effects. We did not include
unpublished studies or dissertations in this review and therefore the studies identified for this review are
likely to reflect those that escaped the ‘file drawer’ problem,152 which might be a result of publication bias.
An additional limitation, which most meta-analytical studies face, involves combining scores from different
tests. For example, several different tests measuring self-efficacy were combined and it was unclear
whether or not they were suitable for merging until an item analysis had been carried out on the
measures. It could be argued that only constructs that are measured using the same instrument should be
merged, to avoid this problem.
The analysis showed heterogeneity of findings for some outcomes. For example, a mild to moderate level
of heterogeneity of findings across studies was reported in the meta-regression. Heterogeneity may result
from the small number of studies available for each test. Other factors that have not yet been identified,
or not yet included in moderator research, might also explain some of this heterogeneity. It would be
premature to conclude that intervention effects do not vary by patient or study characteristics. We were
unable to examine several moderator effects because of insufficient data (i.e. education, self-efficacy, pain
duration, ethnicity, disability and depression).
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We aimed to identify moderators, predictors and mediators of efficacy of self-management programmes
for those with musculoskeletal pain. We believe that this systematic summary of the literature identifying
moderators, predictors and mediators, and meta-analysis to examine influences of moderating factors
provides useful recommendations based on evidence and we have also provided a checklist of
methodological criteria for assessing moderator studies.
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Chapter 4 Qualitative study
Abstract
Introduction: Our knowledge about the impact of self-management courses on individuals is limited.
This study aimed to understand how different components and characteristics of self-management courses
are perceived by people living with long-term conditions, course tutors and experts, to explore reasons
why they might lead to different outcomes and to consider the implications for the content of a
new intervention.
Methods: We used a qualitative approach with purposive sampling to maximise sample diversity. Face-to-face
interviews were conducted with people with chronic musculoskeletal pain who had attended self-management
courses. We then ran two focus groups, one with experts in the field of self-management for long-term
conditions and one with self-management course lay tutors, to explore our interview findings. Topics discussed
included referral, attendance, course content and character and outcomes.
Results: Sixteen previous course participants from Warwick and London were interviewed; in addition, six
experts attended one focus group and five tutors attended the other. We identified two types of chronic
pain behaviour: fixated and distracted. Promoters of positive change included support, motivation,
engagement in the process, high-quality tutoring and identifying with the learning process. Sustainers of
change included implementation of coping strategies, networking and socialising, distraction, support from
others and new identity creation. Those who responded well to self-management courses moved away
from absorption in their ‘pain world’ towards integrating into their social and/or work communities. We
grouped outcomes into six domains: functional, physical, emotional, social, economic and medical.
Conclusions: Courses should involve good-quality facilitation, cognitive–behavioural approaches to
promote change, medical education, a group/social setting and exposure to information about local
activities to encourage long-term lifestyle behaviour change. Flexibility in course structure is required to
accommodate social interaction and self-discovery to promote self-acceptance and the development of a
new identity other than that of a ‘pain patient’.
Background
In this study we explored participant experiences of self-management programmes for chronic pain to
identify and understand why some aspects of different courses may be more beneficial than others; the
uptake, retention in and acceptability of self-management courses; and why some participants feel that
they might do well on self-management courses, whereas others do not.
The findings are interpreted in the light of existing theory around concordance and living with chronic
conditions and, when necessary, we propose new explanations for the findings. This study provided
information for the development of the new self-management intervention. By exploring what people’s
perceptions were of important components of self-management courses we were able to emphasise these
components in our new course.
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Method
We adopted qualitative methods, using an iterative approach (each stage informed the next). We used
both in-depth interviews with participants and focus groups with experts in self-management of long-term
conditions and lay tutors to explore the findings from the interviews. Interviews were conducted with
participants in Tower Hamlets (inner-city London) and Warwick (a mix of urban and rural living in the
Midlands). These represent two very socially and economically different areas, chosen to increase the range
of views and opinions encountered. In Tower Hamlets there is a large Bengali population. First-generation
Bengali migrants in Tower Hamlets have a particularly high prevalence of chronic pain.153 As part of this
overall programme of work we wanted to ensure that our intervention was suitable for this population.
First, we conducted face-to-face in-depth interviews with participants who had attended self-management
programmes; the information from the interviews informed the questions and topic guide for the focus
groups. We convened focus groups with experts from the field of self-management and lay tutors.
Additionally, we used the focus groups to triangulate findings from the interviews.
Recruitment and sampling: individual interviews
We aimed for a diverse sample, with a total anticipated sample size of 20 (or fewer if data saturation was
reached earlier). We recruited people living with persistent pain who had attended self-management
courses. Two Expert Patients Programme community interest companies, one in London and one in
Warwick, and Social Action for Health in London approached participants who had attended their
self-management programmes and invited them to be interviewed by the study team. The invitation letter
contained a consent to contact form and a reply-paid envelope so that the researchers could approach
those willing to participate. We also invited people to participate via an internet chat forum for people
who had attended self-management courses.
Participant inclusion and exclusion criteria are shown in Table 16.
We used a purposive, diversity sampling method to obtain a good representation of different genders, age
groups, socioeconomic areas (by postcode) and self-management course attendance record. Further data
about the participants were collected after they had consented to participate in the study.
Conducting the interviews
Face-to-face interviews were arranged by the researchers at a time and place convenient to the
participants. With permission, interviews were audio-recorded, transcribed and anonymised, with each
interview lasting approximately 1 hour. The content of the topic guide was informed by knowledge of the
literature, the specific needs of this study and the study team’s past experience of issues in other trials and
evaluations of self-management programmes. The topic guide covered referral processes, motivation to
attend courses, memorable aspects of courses, most effective and least effective components, positive and
negative aspects of support/networking, follow-up, strategies for coping and long-term effects/outcomes
of courses. Most interviews were conducted by a medical anthropologist; as a substantial proportion of
TABLE 16 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
l Adults aged ≥ 18 years
l Presence of chronic musculoskeletal pain (pain lasting
> 3 months)
l Experience of attending a self-management course
l Willing to participate and can understand English
or has appropriate advocacy support to enable
participation
l Associated comorbidities that may affect their ability to
communicate and/or participate in an interview process
l The presence of a terminal illness
QUALITATIVE STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
46
first-generation Bangladeshi residents who live in Tower Hamlets are not fluent in English some interviews
were carried out by a health researcher fluent in Bengali/Sylheti and English.
The focus groups
We convened two focus groups (maximum six participants in each), one with UK-based self-management
academic researchers and opinion leaders in this field (the study team identified key personnel to approach
based on their own knowledge of researchers and policy-makers in this field) and one with self-management
course lay tutors and providers (a mix of programme leaders and tutors was approached). The focus groups
were facilitated by a health researcher familiar with self-management research and a musculoskeletal
clinician. We fed the findings from the individual interviews into the focus groups to test the ‘acceptability’
of our findings and to generate discussion about participant receipt of self-management courses and the
issues raised by participants who attended courses.
Analysis
All focus group conversations and individual interviews were audio-recorded and transcribed. NVivo
software version 9 (QSR International, Warrington, UK) was used to manage the analysis of the data. We
carried out thematic analysis using the framework method; this involves familiarisation with the literature
and the development of a framework based on emergent themes and subthemes.154 A third experienced
qualitative researcher was involved as an independent reviewer; to promote study validity, he commented
on the framework of themes and subthemes based on a sample of interviews and independently coded a
transcript. Three researchers coded the same three transcripts to test the framework and to compare the
inter-rater reliability of our coding. We used this as a training exercise to improve the consistency and
reliability of coding. The results from the focus groups with experts and lay tutors were also compared and
contrasted with the findings from the interview study.
Ethical approval was granted by the East London and the City Research Ethics Committee Alpha
(reference number 09/H0704/24).
Results
Sample
Twenty-six people participated in this study. We conducted 16 one-to-one interviews, at which point we
felt that we had reached data saturation. Twelve interviews were conducted with English-speaking
participants and four were conducted in Bengali/Sylheti. Four interviews were conducted in Warwickshire
and the remainder were conducted in East London. Table 17 shows the characteristics of the
interview sample.
We ran two focus groups. The tutor focus group included five self-management course tutors or
facilitators active in east London, south London and Essex (FG1.1–1.5). The expert focus group also
consisted of five participants (one primary care trust service commissioner, three academic researchers and
one self-management course service provider) (FG2.1–2.5). When the focus group discussion reflected the
thoughts and beliefs of the interviewees we have added this into the text. We also report dissonant data
from the focus group discussion when applicable.
Themes and subthemes from the interviews
We initially derived eight main themes (Table 18, first column). When we initially tested this framework we
found a lot of duplication of data in themes 3 and 8. There were many references to social aspects of life
(theme 3) but these were nearly always in the context of barriers to and/or promoters of change (theme 8);
these themes were therefore merged. Additionally, the original themes 1 and 4 were collapsed to
behaviour and thoughts, including empowerment and ‘negative’ behaviours, including self-absorption,
anger and frustration. We also identified a new theme about outcome expectations. The last two columns
in Table 18 show the final framework used for the analysis of the interviews.
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TABLE 17 Interview sample (n= 16)
Participant Male/female
Pain
duration
(years) Age (years)
Previous
self-management
course attendance
Location
rural/urban
Language fluency
English/Bengali
P1 M 4 > 45 < 50% U E
P2 F 23 > 45 < 50% U E
P3 F 10 ≤ 45 50% R E
P4 M 15 > 45 50% U E
P5 M 7 ≤ 45 50% U E
P6 F 20 > 45 50% R E
P7 F 16 > 45 50% R E
P8 F 6 ≤ 45 50% R E
P9 F 18 ≤ 45 Unsure U E
P10 F 23 > 45 50% U E
P11 F 20 ≤ 45 50% U B and E
P12 M 16 > 45 50% U B and E
P13 F 13 ≤ 45 < 50% U B
P14 M 17 > 45 < 50% U B
P15 F 10 ≤ 45 Unsure U B
P16 F 5 ≤ 45 ≥50% U B
TABLE 18 Framework: original and evolved themes and subthemes
Original framework
Reasons for evolving
framework
New framework
Theme Subtheme Theme Subtheme
Theme 1: personal
attitude and behaviour
(a) Self-responsibility/
empowerment
Overlap with theme 4.
Merged 1(a) with 4(b)
and 1(b) with 4(a)
and 4(c) to create
theme II
(b) Lack of self
responsibility/
empowerment
Theme 2: identity (a) Self (past, current
and future)
This theme is robust:
remains as theme I
Theme I: identity (a) Self (past, current
and future)
(b) Social (context of
self with others, family
and friends)
(b) Social (context of
self with others, family
and friends)
Theme 3: social
support/sharing/
networking
Overlap with theme 8.
Merged 3 and 8(a)
and 8(b) to create
theme VI
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TABLE 18 Framework: original and evolved themes and subthemes (continued )
Original framework
Reasons for evolving
framework
New framework
Theme Subtheme Theme Subtheme
Theme 4: psychological
aspects of living with
constant pain
(a) Self-absorption
(with condition,
self-justification,
legitimisation,
reinforcement, visual
‘badges’, carers and
caring)
See theme 1 Theme II:
pain-related
behaviours and
thoughts
(b) Positive emotions
(distraction, looking
beyond illness)
(c) Negative emotions
(anger, frustration,
depression, boredom)
Theme 5: knowledge
and information
This theme is robust:
remains as theme II
Theme III:
knowledge and
information
(a) Marketing, referrals
and recruitment
Theme 6: course-
specific details
(a) Referrals Renamed to more
accurately represent
data; expanded to
create theme IV(a)
Theme IV:
course
characteristics
(a) Marketing, referrals
and recruitment
(b) Relationship of
course with general
practitioner and
treatment plans
Merged with theme
IV(a)
(c) Expectations/long-
term effects/outcomes,
application of learning
A theme in itself and
therefore classified
accordingly as theme VII
(d) Tutor impact/
behaviour/delivery
Expanded to include
aspects of delivery.
Renamed and now
theme IV(b)
(b) Course delivery and
impact of tutor
(e) Attendance Unaltered (c) Attendance
(f) Mix and character of
attendees
Unaltered (d) Mix and character
of attendees
Theme 7: course
components
(a) Pacing Themes 7(a) and 7(b)
inseparable and
treated as one factor.
Combined to form
theme V(a)
Theme V: course
components
(a) Pacing, action
planning and goal-
setting(b) Goal-setting
(c) Medication advice Themes 7(c) and 7(d)
combined to form
theme V(b)
(b) Medical education
(d) Treatments
(e) Other Unaltered (c) Other
Theme 8: change (a) Promoters of
change
Combined with theme 3
to form theme VI
Theme VI:
change
(a) Promoters of
change
(b) Barriers to change (b) Barriers to change
Newly created theme VII
from theme 6(c)
Theme VII:
expectations and
outcomes post
course
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Findings
Theme I: identity
We noted a ‘persistent pain’ identity in some participants, some of whom had visual cues to help others
identify their condition, such as bandages, walking aides or strapping. These participants’ lives were busy
with being in pain, for example centring their days or weeks around medical appointments and/or personal
health regimes. Referring back to one’s previous self, that is, before pain, was common. Views expressing
boredom, social isolation, frustration and loneliness, predominantly caused by a lack of understanding
from others, were not unusual. Examples of reframing one’s self-identity were evident in those who had
adjusted well to their condition and who related positive stories about their quality of life. References to
past selves were present in those who did not appear to be coping as well, whereas those with more
positive attitudes to life described ways of adapting previous skills and experiences:
I was not like this before you know, they look at me and feel sorry for me, they say why is your health
like this?
P11
I was very fit and active up until about 4 years ago, I started to get really bad pains in my joints, well I
would say really chronic pains, it actually felt like my joints were being ripped apart.
P1
Because it’s like you revert back to like the young kid stage again; you have got to rely on your
parents to do everything for you, you know, and that’s how I feel sometimes
P8
I feel defeated, because basically it brings a lot of failure and it can actually let you sit down and feel
sorry for yourself, and because I was never that sort of person.
P4
So no wonder why I feel so bitter, absolutely bitter about all this, really – not a finger of help, nothing!
The help had to come from outside and my daughter had to really . . .
P15
I do art now, it’s really helped me . . . I feel I’ve achieved something.
P1
I volunteer at the HIV [human immunodeficiency virus] centre, it gets me out and stops me thinking
about myself and it’s good to go there.
P3
I’ve accepted I just have to do it [housework] differently now.
P16
Theme II: pain-related behaviours and thoughts
The behaviours and commentaries described by participants could be grouped into two areas: broadly
‘positive’ and broadly ‘negative’. Positive or adaptive behaviours were characterised by descriptions of
engaging in social activities and evolvement of new concepts of living within the current capabilities of the
individuals and not past ones; these participants did not overly dwell on their pain and described active
lives, hobbies and social interactions, and had realistic expectations. We grouped self-absorption, pain
fixation, dependency, isolation, frustration, anger, boredom and low mood and self-esteem into negative
or pessimistic behaviours. These participants tended not to identify with the self-management concepts
and not to incorporate self-management terminology in their speech. Some participants thought that they
were coping already and that the course made them more confident about their coping skills and so
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reaffirmed their behaviour, others found it difficult to apply the techniques learned on the course to
everyday life and some highly motivated participants continued their learning and had taken up new
activities and adapted their lifestyles:
When I’m bad, I just sit and stare at the vase on the mantel piece, I feel really low, I do nothing.
P10
Some days I cannot get off the couch, I just watch TV [television].
P11
I pray, my pain it does not go but my mind is on my praying, it gives me strength.
P12
If I get really involved in it [painting] I can forget about the pain, but most of the time it’s too painful.
P1
The relaxation helps, yeah, really helps, and the breathing – it sounds stupid breathing – but it does.
P10
Theme III: knowledge and information
Most self-management courses involve giving participants a course manual or handbook. These manuals
were generally well received and were used as reference tools and memory joggers and to supplement
knowledge from missed sessions. They were also used as ‘proof’ for ‘significant others’ to justify behaviour
and explain learning and new behaviours.
There was a strong suggestion from the interviews that a system of building up information and material
related to the course gradually was preferable to receiving information all at once, as this could be
overwhelming. Some participants took the manual at the first session and did not return to the course as
they thought that they had all the information that they needed. It was also mentioned that the internet
was underused. Some participants were computer literate; however, others were not and this form of
communication would have been inappropriate, unfamiliar and impossible because of a lack of equipment.
Someone actually called it [a course handbook] their bible. I can still remember on the course,
someone called it, it’s my bible.
FG 1.2
they take it, they take the handbook and then they do not come back!
FG 1.5
You cannot say, ‘right, I’ve got this terrible pain, now let me refer to the book and see how I can get
rid of this pain!’
P6
I’m not going to say I’ve read it! [laughter] But, no, I just browse through it and bits and pieces. And
certain things, I often turn round to the governor, and say, ‘You see look – told you! That’s what you
should be doing!!‘
P7
we do not give them [course handbooks] because people just do not read them!
FG 1.3
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But I think also to give them those in separate little . . . in stages [murmur of agreement] rather than
give them a big manual at the end.
FG1.5
Theme IV: course characteristics
In theme IV, we separated the data into four categories: marketing, referrals and recruitment; course
delivery and impact of tutor; attendance; and mix and character of attendees.
Theme IVa: marketing, referrals and recruitment
Two schools of thought emerged about recruitment and marketing. The participants did not want to be
told or coerced to go on a course, but they did want legitimisation of the course through recommendation
by their general practitioner (GP). They also felt that there was a need for a self-referral route, coupled
with increased marketing and information for the public, as many GPs were not aware of the different
courses. The tutors, however, were keen for recruitment to take place through GP registers and GPs
themselves, as this allowed for better targeting of those with greater need and gave access to a ready
source of potential participants.
Encouragement from those involved with the course from the initial point of contact was important.
Building rapport with potential participants helped manage expectations and encouraged engagement
with learning and the process. The presence of the recruiter at the first session was welcomed. The tutors
thought that the recruitment process was very important for managing expectations. Both unrealistically
high and very low expectations were seen by tutors:
And I think that’s a gap where some health care professionals will not understand what it is.
FG1.4
we are getting access to the GPs’ register, i.e. we have got a standard letter saying: a self
management course is coming to the area, and so on, and we have asked the GP practice would they
use that letter, you know, put their letterhead on it and also sign it and so on . . . And we are getting
a really, really good response that way.
FG1.6
Mile End itself phoned up: a new unit’s opened up dealing with persistent pain, we wondered if you’d
like to attend. So I thought, I’ll go anywhere where . . . there’s always ways of learning things.
P2
I must be honest, if that physiotherapist had not have put me forward, I would not have known
about it.
P4
you cannot lose anything but you might gain. I can tell her, but that’s me telling her; if somebody else
tells her, it’s totally different. It comes over different, you know what I mean?
P7
But I do think doctors need to know, because I do not think many doctors know that EPPs [Expert
Patients Programmes] exist!
P8
I think you have to be ready to be open-minded about helping yourself, and if you have gone there
because you have been referred, not because you want to go, I think that would be a bad reason.
P3
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When they are sort of at the stage where they are asking: I really want to do something. I want to . . .
I’m fed up of waiting for everything and I’d like to help. I think that would be when doctors should
refer them to EPP [Expert Patients Programme].
P4
They are professional people, they would think and say whether you’re doing it wrong or right and
advise you how else it would be good. We would comply with them.
P5
Because of the fact that some participants tend to be isolated in their everyday life, they do kind of
look for somebody to kind of latch on to, you get me?
FG1.5
Theme IVb: course delivery and impact of tutor
Both professional and lay leadership was valued. The tutor was generally perceived as a strong role model,
often with ‘more right’ to give advice and guidance than their GP:
Yeah, and the fact that the tutors themselves has an action plan as well. Yeah, the role modelling
is important.
FG1.3
Well, by relating, they were more or less relating to . . . they definitely knew about pain themselves,
that’s the main thing.
P1
The reason why because they know, they could understand the highs and lows.
P7
Participants generally had a need to feel ‘listened to’ and to be taken seriously. Some would have
preferred more time to tell ‘their story’, whereas others felt that this would incur too much competition.
The tutors felt that it was an important part of their job to contain comparisons between people. There
were lengthy discussions about mixed-disease courses and disease-specific courses. There were pros and
cons of both, with no clear conclusions possible.
Effective course tutors were described as friendly, open, honest and non-judgemental; they respected
others’ opinions, made people laugh, enjoyed the sessions and were relaxed; they listened and were
flexible, informal and engaging; they controlled the input of those who were very negative or those who
were overdominant and curtailed those who talked too much about themselves; they related to the group
culturally; and they had experience of chronic pain.
Conversely, the descriptions of poor tutoring involved reading from a crib sheet; rigidly sticking to
timescales at the expense of learning; not having experience of chronic pain; and not managing disruptive,
negative or self-absorbed people.
Theme IVc: attendance
A number of factors were mentioned with regard to attendance and non-attendance on courses.
Attendance was influenced by personal motivation to attend the course, the quality of the tutors and
receptiveness to information and participation in group activity and social bonding. When all or some of
these were mentioned the participants demonstrated good attendance. Those with poor attendance were
those with a low or depressed mood, a negative attitude to the course, lack of positive support and
demanding friends and family. Other factors that affected attendance were medical appointments,
sickness and holidays – these were common to those with both low and high rates of attendance
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(Figure 4). The interviewees and the tutors in the focus group indicated that people with low self-esteem
and those who felt intimidated about talking in front of others were unlikely to fare well on courses:
They’d be negative against everything and would not give things a try, but it could be they are actually
chronically, clinically depressed, but they actually left.
P9
but they have not got that something to help them, to drive, to push probably.
P9
It was nice to share ideas with other people and get ideas, get new ideas, fresh ideas, some of which I
have taken on board and some I have not! I wanted it to stop my illnesses, to be beneficial for my
body, that’s what I thought, it would be enough.
P10
There are seven of us in this house including my husband and I, it’s a two-bedroom house, and we are
living in such difficulties [she goes on to describe the problems encountered getting to the course] . . .
It was quiet a distance for me. I just went the one day.
P3
They do not get me to do exercise nor do they do it themselves. You have to do things yourself.
P4
Theme IVd: mix and character of attendees
Attending a course that was delivered to a group appeared to have an impact on several factors. It gave
participants motivation to achieve goals as they had to feed back progress to the group and it reduced
levels of isolation – some were inspired by others and some made friends and all appeared to learn from
each other or the course itself. Conversely, some participants felt that the action planning and feedback
could be false, that is, an exercise in creative storytelling, and others insinuated that the goal-setting could
potentially set them up for failure if they consistently did not achieve in front of the group and indeed this
was suggested as a reason for people not attending. ‘Eureka’ moments were described, such as the
Poor attendees Good attendeesFactors affecting both
Medical
appointments
Holiday
Sickness
Low mood
Negative attitude
Poor support
Demanding family/friends
Positive attitude
Good support
Responsive to learning
Good tutors
Like group activity
Social bonding
FIGURE 4 Factors influencing attendance.
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realisation that others felt the same and had the same issues to deal with, and some found this inspiring
and motivating:
It is that proper group work and I think that might be where the gap is where . . . maybe more
emphasis on forming as a group, like group activities, before just throwing at them the information,
might help in that process.
P4
You get ideas when they ask you questions but now I can’t say, you get it when talking, you can learn
things too. If you say your idea then that’s one way and I’ll think another way.
P8
Theme V: course components
There was a danger that self-management courses legitimised ‘the sick role’, especially pacing, as it
justified resting and not doing things under the guise of ‘I’m pacing myself’. With pacing, patients are
advised to schedule their activity evenly over a period of time; this may involve resting at points so that the
person does ‘not overdo it’. Sometimes this was described as being used constructively to explain
behaviour and at other times it was felt that pacing was used to manipulate circumstances to justify not
doing some things:
I just tell her [his wife] ‘I’m pacing myself’ and watch telly.
P4
I can go back to the computer or I’ll just sit and chill out for the rest of the hour, that’s entirely up to
me, but it’s pacing myself during the day.
P1
Encouragement of new activity and establishing contacts and generating new relationships were very
helpful. Participants did want more information about local resources and even more courses. Additionally,
participants liked being able to talk about their condition; however, the tutors actively discouraged this to
avoid competition and self-absorption. Narratives of conditions were ‘permitted’ within the context of
personal goal-setting, action planning and pacing:
The free-thinks [small amount of allocated time for discussion] I think there needs to be a little bit built
in where discussion can take place.
FG1.4
Mmm. People are itching to talk, are not they?
FG1.3
One woman, to get into the bath, she needed a handrail. They said, ‘Well, have you been in touch
with . . . some sort of organisation?’ ‘No!’ ‘Oh, get in touch with them and ask that . . .’. She came in,
I think it was a week or two later, and she said, ‘They have put one in for me!’
FG3.1
I’ve learnt to cope with it on my own; it’s like it’s all right people saying, ‘Oh, do this, do that!’, but
they are not with you all the time, they are not seeing you how you are.
P7
I’m really bitter about because no one helped me, no one advised me and I never got nothing.
P2
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The main components of courses that participants liked were breathing techniques, relaxation, visualisation
and social networking. They disliked the lack of involvement of ‘significant’ others and that feedback from
the goal-setting could be daunting. Here, both tutors and participants admitted that there was scope for
‘stretching the truth’. The content of the courses was seen as useful, but its sustained application was
considered difficult. The social networking and ‘doing something different’ was commented on and
expanded on more than any other component of the courses.
Theme VI: change
From the data we identified three main explanations/models of behaviour about change: behaviours of
those who remain fixated and absorbed in pain (Figure 5), factors that appear to promote and sustain
beneficial change (Figure 6) and the process of change as lifestyles expand, broaden and evolve to include
more things.
Figure 5 shows the behaviours associated with those who appeared to be fixated on their condition; their
lives and their identity revolved around being in pain, with few non-pain-related activities. As a result,
‘sickness’-related activity and behaviours were maintained. These participants were generally isolated,
bored and frustrated and they had a low mood and were dependent on family and friends. Conversely,
those who were not fixated on their pain used distraction techniques to broaden their activity and life
experience, often creating new activities and hobbies, leading to new social networks and a self-identity
associated with the activity rather than with their pain.
Figure 6 shows the factors that we found to be associated with participants who had managed to change
and sustain the changes that enhanced their quality of life. Those participants who had adapted and
coped well were motivated, were engaged in the process, had support and reported having good,
inspiring tutors.
Each figure illustrates the potential impact that group-related activities may have.
Absorption/
fixation
Maintenance of
sick self
Maintenance of sick
support network
New social networks and
support
Repeated negative
 behaviours leading 
to isolation (e.g. poor 
application of pacing)
Reduction in boredom and
frustration
New self-identity
Distraction/
activity
Pain
Behaviour
FIGURE 5 Observed behaviours and attitudes towards pain.
QUALITATIVE STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
56
Barriers to change included depression, lack of motivation, physical capability/disability, change in benefit
payments, change in family dynamics, stress/pressure/confusion and change in behaviour conflicting with a
‘sick role’.
Theme VII: expectations and outcomes post course
Those who were really engaged with the course enjoyed the social release it gave them and were inspired;
they felt that there was a void at the end of the course. These participants were very vocal about
continuing contact. Views expressed included a preference for ad hoc contact, such as top-up classes, and
‘buddying’ to maintain the social network and a need for local information about services, for example
walking groups:
because after the six weeks, they kind of say, ‘Well what can we do now?’
P2
Some of us decided to meet up and carry on the goal-setting and action planning.
P3
There are course junkies, other courses to combine with are the healthy moves and healthy guides.
FG1.3
it was not between the tutor and the course people, but the people themselves, so they did a
buddying up, mentoring thing.
P3
Engaged in process
Promoters of
change
Sustainers of
change
Self-motivation
Support
Coping strategies
Networking/follow-up,
mentoring
Quality of tutoring
Identifies with
learning process
New identity creation
Support from others
Distractions
FIGURE 6 Factors promoting and sustaining change behaviour.
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Outcomes
Outcomes that were seen as important to participants are summarised in Box 1. These are grouped into
the following categories: functional, physical, emotional, social, economic and medical; examples of each
are provided in parentheses in Box 1. Participants were rarely able to definitively outline success criteria
unless they were based on a pain outcome, that is, no more pain, less pain, functional ability to start doing
tasks that they used to be able to do. However, when asked what they wanted from the course the
outcomes mentioned related to personal confidence in their ability to do things and these were not
necessarily functional but also emotional and social. Confidence was inherent but rarely explicitly stated,
for example ‘I want to be able to . . .’, ‘I am going to try and do . . .’, ‘I have learned to do “x”, which is
great’ and ‘I feel more able to . . .’. Quotations were given in a positive context or the converse negative
context: ‘I can’t . . .’, ‘I wish I could . . .’, ‘I’m just hopeless . . .’, ‘others could but not me’. Self-efficacy was
not really an outcome but a means to achieving a better outcome.
Additional findings from the expert focus group
A key consideration for the expert focus group was the legitimacy and credibility of findings from some
studies and the transferability of some concepts in the Stanford self-management model9 to a UK audience:
It makes me wonder why people go on doing it [Expert Patients Programme] when there are better
things available.
FG2.8
if we had a drug which on balance produced no effect, would we be working so hard to get GPs to
put people on it?
FG2.5
Identifying those who do well and those who do not was discussed extensively but no firm conclusions
were made about subgroups and screening. Selecting a ‘choose all’ strategy to include those with varying
degrees of severity was, however, seen as a good way of recruiting:
Some people do benefit enormously . . ., it doesn’t make it unique to EPP [Expert Patients Programme]
. . . a good regime of analgesics leaves some people self managing.
FG2.5
Rather than working hard to try and understand who does benefit and how we can target them
better . . . what can we do about those who didn’t [benefit].
FG2.1
BOX 1 Domains that were seen as important to participants, which underpinned self-confidence
Functional (practical daily living requirements).
Physical (equipment aides, support and practical help).
Emotional (dealing with frustration, anger, boredom, isolation, depression).
Social (social networking, relationships with partners, family and friends).
Economic (financial support, benefits, etc., work-related issues).
Medical (pain and drug-management related).
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Cognitive reframing and linking pain and mood were flagged as lacking in current approaches to
self-management. The group postulated that without personal identity reframing and acknowledgement
of negative behaviours and cognitions no change would be made.
The involvement of GPs and other HCPs in referrals and recruitment lent credibility to the courses and was
seen as integral to the success of any programme; additionally, medical staff involvement encouraged and
motivated participants. However, the counter-argument that many chronic pain patients were disillusioned
with their GP was not seen as detrimental to the self-management courses as GPs themselves were not
running them.
the GP has assigned it, so it does make a difference.
FG2.5
All agreed that there was a need for aftercare or support. The Alcoholics Anonymous model was
discussed, as were approaches to smoking cessation. Buddying and mentoring concepts were discussed
and were thought to be helpful, but it was also thought that such schemes would be difficult to organise
and maintain and that it would be difficult to provide support for the ‘buddies/mentors’. Longer-term
thinking and support groups were discussed:
Education is an incredibly weak way to change behaviour . . . otherwise, you know, who would smoke?
FG2.4
Distraction is such a short-term thing . . . but developing interests and involvement which really
compete for space in someone’s life.
FG2.1
it took about a year to get them to own it [the support group], it’s a very different dynamic with a key
core of people.
FG2.5
Additional findings from the tutor/facilitator focus group
The tutor/facilitator focus group was characterised by the strength of the participants’ beliefs in the
concept and process of the Expert Patients Programme. The terminology used and the phrases used from
the Expert Patients Programme literature were common to all participants in this group:
We do not want cloned tutors . . . where you expand too big and you have got tutors for tutors sake,
and the empathy is not there.
FG1.3
Tutors relayed stories relating to very practical considerations, such as not being able to access rooms
because they were locked or centres were closed or had no disabled facilities. Participants had few
criticisms of the Expert Patients Programme courses; however, they did suggest that providing more time
for general discussion would be beneficial.
Discussion
Statement of principal findings
Our data indicate that those who got the most out of the courses were those who were motivated to
change at the outset and who became engaged in the process. The quality of the tutoring influenced
participants’ perceptions of the courses. Factors that helped people were social support (family, new and
old friends) and undertaking new activities that extended beyond the course; conversely, factors that did
not help were a low, depressed or negative mood at the outset and a reluctance to alter behaviour,
activities or lifestyle.
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Strengths and weaknesses of the study
Our study focused on participants with chronic pain who had untaken self-management courses as well
as tutors and experts. Each group’s perspectives were ‘triangulated’ with the perspectives of the other
groups to assess responses and reactions. Discordant data were mainly obtained from the ‘experts’,
who questioned the overall evidence for effectiveness for lay-led self-management in general, and,
conversely, the tutors, who provided very positive narratives about the effectiveness of the courses that
they had run.
One-third of our sample was Bangladeshi, reflecting our London population. We were able to identify
some cultural issues, for example running gender-specific courses and not organising sessions that
coincided with Friday afternoon prayers for men, but we were not able to draw any conclusions about
cognitive ethnic differences from this study as it was not designed for this purpose. A further limitation
was that we were not able to interview those who were invited to attend a self-management course but
who chose not to go. Our sampling strategy generated a range of views that enabled us to consider issues
relevant to the design and delivery of self-management programmes and some speculative data about the
traits of people who seem to respond or not to self-management courses. The model adds to the existing
literature by consolidating common findings about social interaction and activity and depression and
behaviour change.
Strengths and weaknesses in relation to other studies
Social interaction
Group cohesion was reported by those who had integrated self-management concepts and approaches
into their everyday lives. The loss of ‘the group’ at the end of the course was felt by all those we
interviewed. The development of support groups could provide a sort of continuity for participants.
However, support groups can provide both positive and negative effects, such as reinforcing and
maintaining dysfunctional pain behaviours.155 The quality of support groups can be enhanced by training
core members to facilitate groups, having a structure to support group meetings, having good facilitation
and appreciating that this type of service will not suit all those with chronic pain.156
Activity
New activities promoted self-esteem, distracted thoughts from pain and created a positive outlook.
Guidelines for the management of chronic low back pain recommend activity and the focus of this activity
is on exercise.21 However, research does not recommend any one particular form of exercise over another,
as any exercise would appear to have a benefit. We would argue from our findings that activity should
include the uptake of hobbies and non-exercise-related activities. These tasks will normally involve
mobilising the body and, although they would not typically be described as exercise for many people, for
those with chronic pain these types of activity constitute a form of exercise that they would not necessarily
consider doing. Activities and hobbies are more than a distraction or short-term solution; they normally
engage people in the longer term, which potentially encourages a lifestyle change.157 The mention of
exercise was problematic with this group of people as the idea of undertaking an ‘exercise programme’
was beyond their capability and capacity.
Recruitment and attrition
Low uptake, recruitment and retention in group self-management programmes remains an issue.158,159
The main barriers to attending self-management programmes were comorbidities, poor physical functioning,
lack of finance, depression and health-care use (coinciding appointments). In addition to these factors we
postulate that poor uptake may also result from the lack of credibility surrounding the courses, which could
be enhanced by medical professional endorsement, and the fact that many chronic pain patients are isolated
and find it difficult to make the transition to helping themselves and lack confidence to become social and
group orientated.
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Self-efficacy
Cognitive–behavioural therapy is a technique that is used to help enhance self-efficacy in the area of
chronic pain treatment.48,160 We too infer that cognitions are important for enhancing self-efficacy, but that
they can be affected by levels of literacy and comprehension, cultural norms and past educational
experience. These may unduly influence people’s perceptions of ‘educational’-type courses. Strong
suggestions were expressed about the need for informality, lots of discussion and socialising. Conversely,
our participants reported that some people did not cope well with the discussion part of the sessions on
the Expert Patients Programme courses as they found them intimidating, especially when required to feed
back on their goal-setting exercises. However, less formal teaching and learning techniques do involve
reflection, discussion and investigation to embed learning, such as ‘problem-based learning’161 and
‘reflective learning’.162
Social, cultural and ethnic grouping
Six of our sample were Bangladeshi. We were able to identify some culturally important issues but we are
not able to say whether or not these are representative of particular ethnic communities, which is why we
have not undertaken different cultural comparisons. The concept of somatisation (absorption and
hypervigilance of pain) is ubiquitous,163 but in the south-east Asian populations physical symptoms are more
legitimate than depressive feelings for visiting a physician.164 Explanations or disease theories can differ
between cultures and background and explanations of disease, healing and diagnoses will vary in their
acceptability. Examples include shamanism, in which illness is explained by spirits and magic, chiropractic, in
which it is explained by misalignment of the spine, psychotherapy, in which it is explained by conflict in the
mind, and ‘new age’ rationale, which is about energy imbalances.165 Understanding different explanations of
disease and accommodating cultural traditions is an important part of self-management, especially if the
culture of care rests within the family. Other more recent qualitative work in Tower Hamlets, focusing on the
pain experience of the first-generation Bangladeshi immigrants, has, however, found remarkable similarities
between this group’s experiences of pain and those found in studies focusing on white British populations.152
There is a paradox of care in these circumstances between offending those who want and need to be seen
to be caring and thus to be perceived, for example, as a good Christian or Muslim and the individual need to
be dependent and self-sufficient. It is difficult for chronic pain patients to self-manage if others around them
continue to care and provide for them.166
Conclusion
From our study the most important factor that appeared to be associated with better coping and improved
quality of life was shifting individual focus away from pain to other activities. However, this was not easy
as chronic pain patients were often very occupied with their pain, which superseded other activities.
Acceptance and self-efficacy appeared to be important factors in the process of positive change and
enhanced quality of life.
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Chapter 5 Outcome measures
Abstract
Aim: To develop a preferred list of patient-centred outcome measures for evaluating self-management
programmes for chronic pain patients with musculoskeletal conditions.
Objectives: To review the literature for valid, reliable and appropriate outcome measures for evaluating the
effects of self-management interventions that match the most important domains emerging from the work
presented in Chapters 2–4 and discuss these with laypeople and pain sufferers to recommend a basket of
appropriate and acceptable measurement tools.
Methods: We selected outcomes by using the data from the previously described systematic reviews to
generate a draft preferred list of outcomes for which to identify patient-centred outcome measures.
By ‘patient-centred’ outcome measures we mean those outcome measures that are the most meaningful,
relevant and important to patients. We carried out a literature review to identify the most commonly used
outcome measures for evaluating self-management interventions for chronic musculoskeletal pain and
consulted patients, laypeople and experts. In the first instance we used the published IMMPACT and MMICS
recommendations. To identify any relevant studies published after these consensus statements were published
we reviewed papers published between 2004 (because the IMMPACT consensus review was published in
January 2005, before the MMICS recommendations) and 2009 (the year the search was conducted) that had
reported or reviewed clinimetric data on outcome measures in our list. We used these to inform three
domains: pain and disability, depression and fear avoidance. When no recent review was identified
(self-efficacy and social support), we carried out a systematic literature search and reviewed the measures’
clinimetrics. The clinimetric criteria applied to the questionnaires were based on published recommendations.
Validated and reliable measures were presented to a panel of eight people (two laypeople, three study team
members, one outcome measure expert, one GP and one psychologist). Data from our pilot study were also
used to inform our decision-making. Consensus was sought for the most appropriate and valid methods.
Results: Seventy-eight questionnaires were considered and tools were chosen to evaluate responses to
self-management interventions. We used these data to inform our final selection of outcome measures.
The primary outcome selected was pain-related disability [subscale of the Chronic Pain Grade (CPG)].
Secondary outcomes were pain intensity (subscale of the CPG), quality of Life [European Quality of Life-5
Dimensions (EQ-5D)], perception of social support [social integration and support domain from the Health
Education Impact Questionnaire (heiQ)], self-efficacy [Pain Self-Efficacy Questionnaire (PSEQ)], pain
acceptance [Chronic Pain Acceptance Questionnaire (CPAQ)], depression and anxiety [Hospital Anxiety and
Depression Scale (HADS)] and the general health question in the 2011 census.
Conclusions: A preferred battery of measures to evaluate responses to self-management courses was
agreed, representing the most important domains to assess relevant outcomes.
Background
The importance of the selection of patient-based outcome measures when designing a clinical trial is well
established.167 Our aim was to develop a preferred list of patient-centred outcome measures for evaluating
self-management programmes for chronic pain in patients with musculoskeletal pain for consideration for
adoption in our pilot study and trial. By ‘patient-centred’ outcome measures we meant those outcome
measures that are the most meaningful, relevant and important to patients. This project was directly
informed by findings and data from Chapters 2–4.
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
63
At the time that we developed this study two international consensus studies had recommended a list of
outcome measures that we considered to be the most informative in selecting our outcome measures.
The MMICS project aimed to improve the quality and completeness of measurement in prospective cohort
studies of the transition from acute to persistent disabling low back pain.31 It involved a collaboration of
teams of back pain experts from 11 countries who had expertise in clinical practice, prospective cohorts,
epidemiology, social sciences and health services. MMICS methodology included identifying preferred
factors predicting back pain progression (using experts) followed by a systematic appraisal of published
reviews and empirical studies of appropriate measurement instruments. Measurement instruments were
assessed for clinimetric properties such as reliability, validity and responsiveness, and for practical
considerations such as length and complexity of language.
The IMMPACT study aimed to develop consensus recommendations for specific measures of each of the
core outcome domains in chronic pain trials.30 The 35 participants were selected on the basis of their
research, clinical or administrative expertise relevant to the design and evaluation of chronic pain treatment
outcomes. Literature reviews of measures of the IMMPACT core outcome domains were carried out
to identify measures that could be used across all chronic pain conditions and that were not specific to
certain types of chronic pain. Again, the measurement tools were clinimetrically assessed and a list of
outcome measures recommended. Although this project drew heavily on these two sources, it was also
designed to address the use of measures that did not appear in these two sets of recommendations.
Objective
The objective of this study was to develop a preferred list of patient-centred outcome measures for
evaluating self-management programmes for chronic pain patients with musculoskeletal conditions.
Methods
We reviewed the literature for valid, reliable and appropriate outcome measures for evaluating the effect
of self-management interventions that matched the most important domains emerging from the
systematic reviews and discussed these with laypeople and pain sufferers to recommend a basket of
appropriate and acceptable measurement tools (costs of instruments and/or copyright issues were not
among the practical aspects considered).
The project progressed through five stages (Figure 7).
In the first instance we consulted two consensus statements on outcomes measures (MMICS31 and
IMMPACT30 recommendations). We then examined reviews published in the previous 5 years of measures
in each specific domain to identify reports of clinimetric quality. In one instance (depression) there were
many candidate measures, all with strong clinimetric properties and a strong evidence base. For this
domain alone, therefore, we conducted a Delphi study.135 A list of 11 measures developed from the
MMICS and IMMPACT recommendations and published reviews was presented to five international
experts in the measurement of depression in pain populations. Experts selected the top two measures from
the preprepared list during an interview (see Appendix 3) and gave their reasons for selection.
When no recent review of instruments to measure a domain had been carried out, original systematic
literature searches were performed to:
(a) ascertain which measures have been previously used in chronic pain research
(b) seek out the psychometric and clinimetric data for the most commonly used measures.
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For the domain of social integration and support we extracted common measures of social support, with
good clinimetric properties, but the research team felt that these failed to capture the main components
described by patients in our qualitative work. We therefore also searched for new, less well-established
measures that seemed to have a better fit with the description of the domain. These, accompanied by
published evidence on clinimetric properties, were presented to the user group.
Finally, all of the candidate instruments were presented at a meeting of experts, including members of the
research team, and external clinicians, experts in outcomes research and patients. As well as clinimetric
quality, ease of use, brevity, acceptability to patients and patient preference were also considered, with a
final preferred list of outcome measures being identified.
SRs and
qualitative study
(see Chapters 2–4)
MMICS IMMPACT
Domains of interest for outcome measurement in chronic musculoskeletal pain  
Only one instrument available > 1 suitable instrument
MMICS/IMMPACT
recommend one
instrument 
NOYES
Review of clinimetrics
on past 2/5 years
(from 2010)?
YES NO
Review/s examined
Decision about
instrument 
Conduct own review
No suitable instrument?
CONSENSUS MEETING
FIGURE 7 Stages of the study. SR, systematic review.
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Results
Selection of domains
The following measurement domains were included after brainstorming and consideration of the
IMMPACT and MMICS recommendations:
l pain and pain-related disability
l pain intensity, interference
l pain catastrophising
l recovery
l depression and anxiety
l health-related quality of life
l perception of social support/social integration
l self-efficacy
l fear avoidance
l coping and acceptance
l patient satisfaction at follow-up
l health-care resource use.
Selection of candidate instruments
We were able to immediately select candidate measurement tools based on the IMMPACT and MMIC
recommendations for the following domains (the tool chosen is given in brackets):
l pain intensity (numerical rating scale)
l pain interference (Brief Pain Inventory168)
l health-related quality of life (either SF-3642 or EQ-5D169)
l recovery (numerical rating scale)
l pain catastrophising (Pain Catastrophising Questionnaire170)
l patient satisfaction at follow-up (the Patient Global Impression of Change171).
For the domain of fear avoidance, the only systematic review in this area looked at fear avoidance and
prognosis in back pain.34 The two main contenders for measuring fear avoidance from this review were the
Tampa Scale of Kinesiophobia172 and the Fear Avoidance Beliefs Questionnaire (FABQ).173 The MMICS
study31 reported a slight advantage for the FABQ if work-related fear is considered important. These
two measures were presented at the expert consensus meeting.
Another immediate selection was based on the fact that there was only one suitable measure for the
domain of pain acceptance: the CPAQ.174
For disability, the MMICS recommendations included only instruments specific to low back pain. The
IMMPACT recommendations included the Brief Pain Inventory. The Brief Pain Inventory, however,
measures both pain and pain-related disability. Furthermore, it is a measure principally designed for
measuring acute pain. For this study we were interested in making a difference to long-term outcomes
and so a measure that measures pain and its impact on just 1 day was not appropriate for our current
purpose. For this reason we carried out a further search to identify measures of chronic pain and chronic
pain-related disability. We identified the CPG as a well-established measure with good clinimetric
properties when used to measure chronic pain and chronic pain-related disability.175 We added this
measure to our potential pool of measures to assess in the pilot study.
For depression, the Delphi study produced conflicting opinions from experts (see Appendix 3). The main
reasons given for endorsing measures were absence of confounding somatic items, brevity and clarity, and
widespread use in research. The consensus was around the use of four depression measures. The HADS176
was thought to be a good candidate, although there was some concern about responsiveness. Reasons for
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using the Beck Depression Inventory (BDI)177 were around compatibility with other studies in our population.
The Center for Epidemiologic Studies Depression (CES-D) scale178 allows international comparisons and
would be a useful measure. Finally, the Patient Health Questionnaire for Depression and Anxiety (PHQ)-4179
was thought to be a useful screening tool. The overall recommendation based on the Delphi study was to
use the HADS as both a baseline descriptor and an outcome measure as the simplest option. The HADS,
CES-D scale and PHQ-4 were presented to the expert consensus meeting for selection of a single measure.
For self-efficacy it was not possible to make a selection of outcome measures based on the MMICS and
IMMPACT guidelines, and we could not identify a recent relevant systematic review. We conducted an
original systematic review for self-efficacy and identified 37 different self-efficacy questionnaires (see
Appendix 3 for methodological details and a description of the results). We selected the two most
commonly used measures (where > 10 articles had used these measures): (1) the Arthritis Self-Efficacy Scale
(ASES)180 with its four variants (for chronic disease and shorter versions) and (2) the PSEQ.181 We searched for
further information on the clinimetric and psychometric properties of these instruments. We reviewed the
clinimetric properties of the questionnaires (full details are provided in Appendix 3). Construct validity was
evident for most measures. There was evidence for content validity for the ASES-20,180 ASES-11183 and
PSEQ181 questionnaires. There was some evidence of test–retest reliability for the ASES-20,180 Chronic
Disease Self-Efficacy Scale-33 (CDSES-33)182 and PSEQ. There was (limited) evidence for responsiveness for
the ASES-20, CDSES-33 and PSEQ.
For perceived social support there were no recommendations from the MMICS or IMMPACT guidelines,
nor were we able to identify a systematic review comparing measures. We carried out a literature search to
identify candidate instruments (see Appendix 3 for the methods and results). There were 30 social support
questionnaires identified in the first broad search and a further nine additional social support measures
identified from specialist text books (see Appendix 3). At this stage we created a reduced list of six
measures that focused on our target population and which included items representing the domains that
we had previously identified, with special emphasis on social (re)integration, while considering the
psychometric properties of the questionnaires (see Appendix 3). Two of these six questionnaires were most
closely aligned with our aims of tapping into use of both health resources and social relationships for social
support. However, we decided to delay a full clinimetric assessment of the questionnaires because we felt
that they did not quite capture our remit in reference to social (re)engagement. It was decided to present
these two measures to the focus group meeting prior to clinimetric assessment.
Consensus meeting
The consensus meeting included five members from the project team (TP, ST, DC, CM and KH) and four
other participants: two clinical psychologists (one from Mile End Persistent Pain Service and one from
Whitechapel Health Centre), one researcher from Patient Reported Outcomes Measurement Group at
Oxford University and one chronic pain patient and lay representative.
The measurement domains discussed and the decisions made with regard to recommending tools are
described in the following sections.
Self-efficacy
The ASES (and its variants)180 and the PSEQ181 were presented. The PSEQ was the final measure selected
because it had the most consistent evidence for reliability, validity and test–retest reliability. It was relevant
for our population and the questions were comprehensive and comprehensible. It was also quick to
administer, with 10 items, and was judged as easy to read, complete and score.
Depression
Findings and comments from the Delphi study were presented to the group, along with the shortlist of
depression measures. The final selected measure was the HADS.176 This was recommended because it has
good clinimetric properties, is widely used and covers depression and anxiety in 14 items. The PHQ-4179
was rejected as it is a screening tool and more detail was needed. The Depression, Anxiety and Positive
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Outlook Scale,184 although good and covering positive outlook, was not widely used. In addition, the
group felt that the HADS also covered positive outlook.
Quality of life
The EQ-5D169 and SF-3662 were potential candidates for this domain. The EQ-5D was chosen because it is
shorter and simpler than the SF-36 and widely recognised and used in economic analysis. However, when
this work was reported to the TSC, we were advised to use both measures in the pilot study.
Coping and fear
The only acceptable tool measuring catastrophic thinking was the Pain Catastrophising Questionnaire.170
However, the group felt that the questions were quite disturbing and our patient representative expressed
concern that some people might find it quite upsetting to complete. The discussion focused on prioritising
the important domains for our target population while reducing the burden by not including too many
measures. On reflection the group decided to exclude the domain of coping and fear, which is partially
covered by the HADS.
Acceptance
The CPAQ174 was selected as it covered two domains independently in one questionnaire: activity
engagement and pain and willingness, that is, engagement and avoidance. There were no other
competing contenders for this domain.
Social support
Two measures were presented to the group members: the Chronic Illness Resources Survey (CIRS)185 and
the Social Support Survey.186 Discussion centred on eliciting the aspects of social (re)engagement. After a
brainstorming session it was decided that the presented social support questionnaires failed to measure
social integration and confidence to socially integrate adequately. We decided to seek guidance from
others by exploring different questionnaires in the wider arena for non-pain health populations that might
measure the construct that we had identified, that is, social integration. After a second search we found a
relatively new measure, the heiQ,187 which included a domain called social integration and support that
measured exactly our area of interest, that is, social engagement and integration in populations exposed to
self-management interventions. Despite it being in the early stages of evaluation, there were no competing
measures and we therefore decided that we would use this domain from the heiQ.
We also asked the group to consider which domain should be used for our primary outcome. An overall
measure of health-related quality of life was deemed to be the most appropriate choice. Such a measure
would synthesise the anticipated effects of our intervention on a wider range of aspects of participants’
lives. The EQ-5D169 was the consensus group’s preferred measure for the primary outcome. The five-level
version of the EQ-5D was developed after our study was designed. When we refer to the EQ-5D we
are referring to what might now be better identified as the EQ-5D-3L. We have, however, used the
nomenclature current at the time that the study was developed.
Conclusion
The measures included in the feasibility study are provided in Table 19. Following the pilot study we
reviewed the performance of the measures before making our final selection (see Chapter 8).
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TABLE 19 Chosen basket of outcome measures
Outcome
measure Description Calculation Score range
CPG
overall175
The CPG overall score is a
composite of the CPG disability
score, the CPG pain intensity
score and the score for another
question assessing the number
of days off usual activities
because of pain
The question assessing the number
of days off usual activities because of
pain has four categories: 0–6 days,
7–14 days, 15–30 days and
≥ 31 days. Categories are assigned
0 points for 0–6 days through to
3 points for ≥ 31 days. CPG pain
intensity is categorised as < 50 vs.
≥ 50 and CPG disability is
categorised as 0 (0–29 points),
1 (30–49 points), 2 (50–69 points) or
3 (70–100 points). An overall
disability score is then formed by
adding the points from the grouped
CPG disability score (range 0–3) to
the points assigned for the number
of days off work (range 0–3), giving
an overall range of 0–6
Grade 0 – pain free: no pain
problems in the last 6 months;
grade I – low pain disability
and low pain intensity:
characteristic pain intensity
< 50 and < 3 disability points;
grade II – low pain disability
and high pain intensity: pain
intensity of ≥ 50 and < 3
disability points; grade III – high
pain disability, moderately
limiting: 3–4 disability points,
regardless of pain intensity;
grade IV – high disability,
severely limiting: 5–6 disability
points
CPG – pain-
related
disability175
This is a composite of three
questions that assess the
participant’s pain-related
disability at present and the
maximum and average intensity
over the past 6 months
Each question is scored on a scale
of 0–10. The final score is the
mean of the three questions,
multiplied by 10
Range 0–100, with higher
scores indicating worse
pain-related disability
CPG – pain
intensity175
This is a composite of three
questions that assess the
participant’s pain intensity at
present and the maximum and
average intensity over the past
6 months
Each question is scored on a scale
of 0–10. The final score is the
mean of the three questions,
multiplied by 10
Range 0–100, with higher
scores indicating worse pain
intensity
EQ-5D169 Quality-of-life measure. This is a
composite of five questions that
ascertain whether the participant
has any problems with mobility,
self-care, performing their usual
activities, pain or discomfort, or
anxiety or depression
Each question has three answers
ranging from ‘no problems’
(scored as 1) to the worst category
(scored as 3)
Perfect health = 1.0. UK norms
for healthy males/females:
40–49 years – 0.89/0.87;
50–59 years – 0.80/0.82188
heiQ187 This is a composite of five
questions that ascertain the
extent to which the participant is
able to enjoy life
Each question has four answers
ranging from ‘strongly agree’
(scored as 4) to ‘strongly disagree’
(scored as 1). The final score is the
sum of the score for each question
Range 5–20, with higher scores
indicating more enjoyment in
life
CPAQ174 This is a composite of 20
questions that ascertain the
participant’s ability to cope with
his or her pain
Each question is scored on a scale
of 0–6, with 0 indicating that the
statement is never true and 6
indicating that the statement is
always true. There are two
subscales: pain willingness and
activities engagement. The
statements in the pain willingness
subscale are reverse scored so
that an answer of ‘always true’
gives a score of 0 and an answer
of ‘never true’ gives a score of 6.
The statements in the activities
Range 0–120, with higher
scores indicating a better ability
to cope
continued
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TABLE 19 Chosen basket of outcome measures (continued )
Outcome
measure Description Calculation Score range
engagement subscale are scored
on a scale of 0–6, with 0 indicating
that the statement is never true
and 6 indicating that the statement
is always true. The final score is the
sum of the score for each question
HADS
depression
score176
This is a composite of seven
questions that ascertain the
extent of the participant’s
depression (these are the even
number questions of the HADS
questionnaire)
Each question has four answers
ranging from not experiencing a
symptom at all, scored as 0, to
experiencing a symptom nearly all
of the time, scored as 3. The final
score is the sum of the score for
each question
Range 0–21, with higher scores
indicating more severe
depression
HADS
anxiety
score176
This is a composite of seven
questions that ascertain the
extent of the participant’s
anxiety (these are the odd
number questions of the HADS
questionnaire)
Each question has four answers
ranging from not experiencing a
symptom at all, scored as 0, to
experiencing a symptom nearly all
of the time, scored as 3. The final
score is the sum of the score for
each question
Range 0–21, with higher scores
indicating more severe anxiety
PSEQ181 This is a composite of 10
questions that ascertain the
participant’s level of confidence
to live a normal life despite his
or her pain
Each question is scored on a scale
of 0–6. The final score is the sum
of the scores for all 10 questions
Range 0–60, with higher scores
indicating higher levels of
confidence
Note: across all of our analyses in phase 2 a decrease in score indicates improvement; this involved us changing the signs of
the scores for those instruments for which an increase in score indicates improvement.
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Chapter 6 Development of the new
self-management intervention
Abstract
Based on evidence from our previous work (see Chapters 2–5) we designed and manualised a psychologically
orientated group course based on principles of CBT with elements covering acceptance, education about
chronic pain, distraction, relaxation, visualisation, posture, social time, encouragement to buddy up and an
introduction to new hobbies and activities. The course was underpinned by social learning theory and the theory
of planned behaviour/reasoned action. The 24 different individual course components/sessions were delivered
over 3 short days (10.00–14.45) with a single 2-hour follow-up session 2 weeks later. Teaching and learning
modalities were varied and included a DVD featuring a medical expert addressing frequently asked questions,
group discussion, role play and exercises. The course, for groups of up to 14 participants, was designed to be
highly interactive and included experiential learning. Courses were facilitated by two trained facilitators: a lay
individual with previous experience of small group facilitation and personal experience of chronic pain and a
health professional with experience of treating people with chronic pain (chiropractor, GP, osteopath,
psychologist or physiotherapist). We also designed a 2-day training programme for potential facilitators.
Introduction
The Medical Research Council (MRC)28 framework for developing and evaluating complex interventions
describes three areas of activity involved in the actual design of an intervention:
1. identifying the evidence base
2. identifying or developing theory
3. modelling processes and outcomes.
We identified the relevant evidence through the systematic reviews reported in Chapters 2 and 3 and the
qualitative study reported in Chapter 4. In this chapter we describe how the findings of these projects,
together with relevant behaviour change theory, influenced the design of the COPERS intervention and our
resulting conceptual model of the intervention. We then describe the intervention to be tested in the pilot
and feasibility studies in detail and conclude by mapping the components of the intervention onto the
behaviour change techniques taxonomy developed by Abraham and Michie and published in 2008189
(the taxonomy has since been further refined but this was the version available when we designed the
intervention). Finally, we describe the training programme we developed to train facilitators to deliver
the intervention in the pilot and feasibility studies.
Summary of the evidence base
The evidence identified from our reviews (see Chapters 2 and 3) indicated that group-based courses
including psychological approaches with education about pain, undertaking activities and developing new
interests were associated with better coping and improved quality of life. We also found that both lay- and
HCP-led courses had some beneficial outcomes. From our qualitative work (see Chapter 4) we found that
participants on courses enjoyed the social element and relaxation training. They had negative reactions to
traditional exercise regimens. Good trainers with good facilitation skills made a difference to participants’
perceptions of courses and were associated with better course attendance. The ideal setting for courses
was somewhere convenient and accessible and, if possible, familiar to participants. Table 20 explains in
more detail how the evidence from Chapters 2–4 informed our course design.
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TABLE 20 Key findings and their influence on course design
Key findings from Chapters 2–4 How these findings influenced course designa
Group delivery appears to be effective (see Chapter 2);
networking with others popular feature of self-management
courses (see Chapter 4)
Group intervention
Most evidence to support professional tutors (see Chapter 2);
mixed professional- and lay-led courses also effective
(see Chapter 2)
Groups to be led by a combination of a lay tutor and a
professional tutor
Medical and community settings both associated with effective
courses (see Chapter 2); convenience of courses important to
participants (see Chapter 4)
Courses to be held in convenient community or health
centre setting
Courses > 8 weeks no more effective than courses < 8 weeks
(see Chapter 2)
Short-duration course
Psychological components commonly used in self-management
interventions for musculoskeletal pain evaluated in RCTs (see
Chapter 2); self-management interventions with psychological
components appear to be more effective than usual care
(see Chapter 2); larger number of different components not
associated with bigger effect sizes compared with usual care
(see Chapter 2)
Principal component of new intervention to be
psychological
Limited evidence to support mind–body therapy components
(see Chapter 2) but relaxation popular with participants (see
Chapter 4)
(Relaxation to be control intervention in the main trial)
Increasing self-efficacy may mediate intervention (see Chapter 3) Course should aim to promote self-efficacy
There was evidence that pain catastrophising and physical
activity can mediate outcome from self-management
(see Chapter 3)
We decided to address this in the intervention
Increasing physical activity may mediate the intervention
(see Chapter 3); patient resistance to concept of exercise but
not general activity (see Chapter 4)
We decided against a large physical activity component
in the course but instead to include taster activities
(possible hobbies)
Depression at baseline may be a predictor for poorer outcomes
(see Chapter 3)
Course covers depression and encourages people who
feel that they may be depressed to discuss this with
their GP. We considered screening people for
depression at baseline and treating depression before
enrolling people on the course but rejected this as we
could not determine a suitable cut-off and many
potential participants had depression
Few other predictors have been identified and no moderators
(see Chapter 3)
Not possible to identify a subpopulation of chronic
musculoskeletal pain patients who might particularly
benefit from the intervention. Course to be offered to
all eligible adult patients
Concerns of attendees about what happens after the course is
completed (see Chapter 4)
Follow-up session at 2 weeks
Loss of activities common in chronic musculoskeletal pain
patients; distraction from pain may be useful (see Chapter 4)
Inclusion of ‘taster’ sessions in the course
Isolation may arise in chronic musculoskeletal pain patients
(see Chapter 4)
Introduction of ‘buddy’ system during the course
a Influences on the main trial are shown in parentheses.
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The aim of the new programme was to facilitate and train people to acquire lifelong skills. We decided to
use psychological, social and physical techniques to change perceptions and feelings about issues that
influence behaviours and to promote accepting, adapting to and coping with life with chronic pain.
Identifying appropriate theories to underpin course design
At the same time as conducting the systematic reviews we searched the literature and spoke to
experts about behaviour change theory and models of persisting pain. We considered psychological
theoretical models and learning and behaviour modification techniques. We drew on social learning
theory190 and cognitive–behavioural theory,191 including psychological flexibility (acceptance and
commitment therapy), that is, the acceptance of internal experiences or things that cannot be changed
countered by behaviour change techniques that are designed to reorientate people towards meaningful
activity.192 We reviewed the theory of planned behaviour and reasoned action193,194 (including emotional
rationalisation) and health belief models.195 Additionally, we looked at attention control techniques160
and techniques to promote posture and balance196 to underpin and inform our intervention. The theories
that we considered were mapped onto the broad components of the intervention arising from the
evidence base.
Social learning theory
Bandura’s10 model of social learning suggests that behaviour is learned through the process of observation
of the environment and the social world to which we are exposed. Bandura identified the importance of
learning from role models and peers. He suggested that imitation and social reactions to those imitations
(positive and negative reinforcement) can influence future behaviour. Our systematic reviews and our
qualitative research also reflected this, with group courses having better outcomes than individual and
remote (web-based) courses and participants recalling other participants who coped well with their pain
(and, conversely, those who coped particularly poorly). We decided that a group approach, in which
participants could learn from each other and try techniques in the company of and with the support of
others, was appropriate.
Theory of planned behaviour/reasoned action
The theory of planned behaviour and reasoned action suggests that a person’s behaviour is determined by
an intention to perform the behaviour, which is based on an individual’s attitude towards the behaviour,
his or her subjective norms and his or her readiness to perform the behaviour (i.e. whether or not the
individual feels that he or she has control and the ability to perform the behaviour).197
Typically, the more favourable the attitude and the subjective norm, and the greater the perceived
control, the stronger the person’s intention to perform the behaviour in question should be. There are
many coping behaviours that those with chronic pain adopt, and these behaviours may be beneficial
or detrimental. Other behaviours that could be advantageous to pain management are not adopted
at all. Raising an individual’s awareness of his or her own behaviour may change attitudes towards
existing behaviours if he or she is exposed to, or becomes aware of, alternative behaviours that may
be beneficial.
We wanted our self-management course to provide an environment that could promote positive attitudes,
challenge and or change inappropriate subjective norms and empower and motivate people to realise that
they have the ability to change.
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Cognitive–behavioural concepts and acceptance
Cognitive–behavioural therapy evolved out of behaviour therapy and cognitive psychology research.
Cognitive therapy has the premise that some behaviours are not simply influenced by rational thoughts
but are also controlled by automatic thoughts.191 In rational emotive therapy, developed by Ellis,198 it was
proposed that once people are made aware of their thoughts and behaviours they can rationalise their
emotions towards them and modify their behaviour accordingly. These two therapies informed the basis
of CBT.
Cognitive–behavioural treatment focuses on individuals’ thoughts, images, beliefs and attitudes
(cognitions) and how these impact on behaviour and emotions. The therapeutic process facilitates
individual reflection on negative patterns of thinking or behaviour that may cause difficulties in living.
Once these behaviours are addressed, this, in turn, is expected to change the way that individuals feel
about their issues. In our study the focus was on pain-related behaviours, thoughts and emotions.
We used the fundamentals of modern CBT, which incorporates problem-solving (identifying problem
behaviours), goal-setting and action planning, to underpin our approach to help individuals raise their
consciousness about how they feel, think and behave towards their pain. Within the action planning stage
we also considered ideas surrounding graded exposure used to overcome fear-avoidant behaviour.173
Modern CBT also encompasses relaxation training, acceptance and commitment therapy, and mindfulness.192
These are known as third-generation behavioural therapies, with the first- and second-generation therapies
being traditional behaviour therapy and CBT. These third-generation therapies focus more on thoughts and
feelings rather than behaviour.199
Acceptance and commitment therapy has six core principles designed to help develop
psychological flexibility:
1. cognitive defusion – learning methods to reduce the tendency to reify thoughts, images, emotions and
memories (in other words when people ‘overvalue/prioritise’ thoughts and images and/or fit and fix
them into misleading mental models)
2. acceptance – allowing thoughts to come and go without struggling with them
3. contact with the present moment – awareness of the here and now, experienced with openness,
interest and receptiveness
4. observing the self – accessing a transcendent sense of self, a continuity of consciousness that
is unchanging
5. values – discovering what is most important to one’s true self
6. committed action – setting goals according to values and carrying them out responsibly.200
Pain catastrophising theory
Pain catastrophising describes a maladaptive thinking/cognitive style often seen in patients with chronic
pain who have associated anxiety and depressive disorders.201,202 It is characterised by the tendency to
magnify the future threat of a predicted pain stimulus, regardless of whether or not it will occur. Chronic
pain patients who catastrophise lose their ability to inhibit pain-related thoughts in anticipation of, during
or following a painful encounter.
Figure 8 illustrates the relationships between the theories that we considered and our desired outcomes.
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Modelling the potential course structure and function
As recommended by the MRC guidelines28 we considered patient pathways through the self-management
programme and the likely action and interaction of the different components with regard to outcomes in
an attempt to model the impact and effect of our intervention.
The first stage of modelling was to consider recruitment. We know that only a proportion of those with
chronic pain will be interested in participating in the study and/or a self-management course (regardless of
research). Once recruited, each participant will be exposed to various components of the intervention with
the aim of affecting thoughts and behaviours to produce the desired outcomes.
Our conceptual model in Figure 8 diagrammatically represents the patients, the components of the
intervention, the factors that may affect the intervention positively and negatively and the outcomes that
we hope to affect. The first column in the model shows the chronic pain population and its potential to be
involved in the study and the potential barriers that may affect uptake.
The model shows the patient pathways through the proposed self-management programme. We
considered the likely action and interaction of the different components (e.g. sessions, materials, suggested
behaviour changes) with regard to outcomes. This involved us elaborating the behaviour change theories
relevant to the new intervention. However, it was not possible to develop any appropriate statistical
models of the action of the intervention because of a lack of published data.
Population
Sample
population
Active elements
of intervention
Change process Outcomes
Chronic pain and
busy (families,
appointments)
Chronic pain too ill
with pain and
comorbidities
Chronic pain and
working
Chronic pain
people willing
Context/external factors that may affect
intervention
• Quality of facilitation
• Comorbidities
• Exposure convenience and access
• Venue convenience and access
• Mobility
• Language fluency
• Dysfunctional group dynamic
Components 
• Education/
   acceptance
• CBT
• Group/social
   interaction
• Active physical
   learning (tasters,
   movement,
   relaxation)
• Communication
• Other (personal
   reflection, summary)
Aim/process
• Change cognitions
• Change behaviour
• Better coping
• Increase activity
• Social engagement
• Reduce anxiety
Outcome and
measures
• Better resource
   use
• Quality of life
• Social activation/
   integration
• Confidence (PSEQ)
• Coping (CPAQ)
• Depression and
   anxiety (HADS)
Chronic pain
not interested
FIGURE 8 Conceptual model.
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Mapping behaviour change techniques to course design
The outcomes that we decided that we might affect with our intervention were function despite pain,
health-care resource use, social engagement, depression, anxiety, self-confidence in managing pain and
coping. After assessing the relevant behaviour change theories we identified individual behaviour change
techniques that might affect our chosen outcomes. We used Abraham and Michie’s189 taxonomy of
behaviour change techniques to describe the techniques that we adopted to promote positive behaviour
change in self-management groups.
Table 21 shows our rationale for mapping and modelling theory to behaviour change techniques and the
methods used by facilitators throughout the courses. Some sessions required facilitators to employ
techniques focusing on providing feedback; other sessions provided instruction to promote behaviour
change; and some sessions allowed participants to try out techniques within the ‘safety’ of the learning
TABLE 21 Theories, therapies and cognitive and behavioural techniques influencing the design of the course
Underlying theories and
therapies Influence on course design
Cognitive and behaviour change techniques
used throughout the course
Biopsychosocial model of medicine:
physiology, psychology and the
social environment and society play
a part in health
Whole course l Plan social support/social change
l Facilitate social comparison
l Barrier identification/problem-solving
l Devise behavioural goals
l Action planning
l Model/demonstrate the behaviour
l Provide information on where and when to
perform behaviour
l Provide instruction on how to perform
the behaviour
l Provide opportunities to devise ways of
performing the behaviour
l Learn where and when to perform
the behaviour
l Learn how to perform the behaviour
l Prompt generalisation of a target behaviour
l Provide information on the consequences of
the behaviour
l Reflect on the consequences of the
behaviour
l Reflect on where and when to perform
the behaviour
l Prompt self-monitoring of the behaviour
l Prompt self-monitoring of the behaviour
outcome
l Review of behavioural goals and outcomes
l Stress management
l Prompt self-talk
l Prompt use of imagery
l Prompt practice
l Emotional control training
l Environmental restructuring
l Communication skills
l Provide feedback
l Prompt focus on past success
l Environmental restructuring
l Teach to use prompts/cues
l Repetition
l Use of follow-up prompts
l Prompt anticipated regrets and setbacks
l Relapse prevention/coping and planning
Acceptance and commitment
therapy: accepting the here and
now and living with it
Pain information; acceptance:
the uninvited guest; relaxation
and mindfulness
Fear avoidance and catastrophising:
pain and fear lead to avoidance
behaviour, which is not always
beneficial
The pain cycle, goal-setting and
action planning
Attention management: keeping
the brain occupied on things other
than pain reduces pain perception
Attention control and
distraction; relaxation, breathing,
visualisation and imagery; taster
sessions (e.g. art)
Social cognitive theory: behaviour
may be influenced by interaction
between personal factors,
environmental factors and own
and others’ behaviour
Group work/discussion,
reflection, listening skills
Cognitive therapy: recognising the
link between thoughts, emotions
and behaviour; theory of planned
behaviour: based on beliefs about
the likely consequences of
behaviour; rational emotive
principles: logical unemotional
rationalisation of events, thoughts,
emotions
Identifying problems, goal-
setting and action planning;
barriers to change – unhelpful
thinking; barriers to change –
reframing negatives to positives;
communicating with your GP;
anger, irritability and frustration:
managing emotion; follow-up –
managing setbacks
Mind–body therapies: muscle
relaxation, biofeedback,
visualisation and mindfulness
techniques
Relaxation and breathing;
relaxation and visualisation;
relaxation and mindfulness of
thoughts
Physical theory and therapies:
Alexander technique for posture
and physical therapy practice of
balancing and stretching
Posture, balance and stretch
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environment and the group. The techniques employed by facilitators were dependent on the needs of the
participants and the groups and therefore were utilised as required in each individual session. No negative
or coercive behaviour change techniques were recommended or used as part of the course.
Overall course design
We appreciated that we would have to consider adult learning theory and a variety of modes of delivery.
Our qualitative research indicated that an informal ‘non-lecture style’ was preferred, with plenty of
opportunities for discussion and socialising. Cognitive and social approaches to behaviour change are often
challenging as they require participants to reflect about themselves and confront issues that they may or
may not be already aware of. Facilitating this process of change and learning requires skill. Facilitators
needed training to motivate participants, actively listen, be non-judgemental, empathise and be patient.
A variety of educational, role-playing and discussion sessions that facilitate the learning and practice of
behavioural change techniques, such as those used in CBT, have been shown to be effective within the
group learning environment in other studies on chronic pain.48,53 A short, intense group intervention has
also been shown to be effective for depression.203
There were two very important messages that we had to convey from the outset: (1) we promised no cure
(to temper expectation and begin the process of acceptance) and (2) self-responsibility and personal action
are important.
Social learning theory takes into account individual ability to learn by experience, either directly or indirectly
through others. This was fundamental to the programme; it was the facilitator’s role to encourage learning
through discussion and self-exploration, and to motivate participants to practise implementing techniques
and use those that they felt might help them.
The theory of planned behaviour and emotional rationalisation are based on feedback from promoting,
praising and practising positive behaviours, thoughts and feelings, to help generate confidence in personal
ability and promote self-confidence. The facilitators and group participants were expected to contribute to
this process.
Figure 9 shows how the course content was constructed and linked to aspects of chronic pain that were
considered important by the people who we interviewed for the study, the theories that we assessed and
the components that showed evidence of benefit.
Figure 10 shows the learning sequence that we adopted; this was informed from our interviews and by
consulting educationalists in the School of Medicine and Dentistry at Queen Mary University of London.
Our interviewees were relatively uninformed about their condition, knowledge about the persisting nature
of pain was unclear and many had not accepted their condition or that there might not be a cure for it.
We proposed to tackle these issues first and then build on the learning to encompass key behavioural
change strategies and coping techniques. The educationalists recommended using a variety of different
teaching techniques and we therefore used videos, didactic education (very little), brainstorming, role play
and practice. We were also keen to make the setting as informal as possible and provide as much social
time as possible.
Key considerations from the evidence influencing course design have already been described; other key
considerations are summarised in Table 22.
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Causes of pain
Diagnosed
dysfunction/pathology
Muscles Joints Brain Social context
Mood and
emotion
Posture and
stretch
Distraction Relaxation CBT
Education and understanding (acceptance)
Communication Activity
FIGURE 9 Mapping pain factors to the course content. Shaded box indicates course content.
Introductions
Understanding pain,
pain education
Acceptance of pain
Appreciating the link
between pain and mood
The pain cycle, understanding pain
behaviour
Doing something about it, coping
strategies and techniques
CBT
Barriers to change
• Unhelpful thinking,
   reframing negativity
Enablers to change
• Problem-solving, 
   goal-setting
• Attention
• Distraction
• Communication
• Relaxation
• Activity
Management strategies
FIGURE 10 Learning sequence.
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The course
We designed a group course to be facilitated by a lay person with chronic pain who had experience in
small group facilitation (e.g. experience as a tutor on the Expert Patients Programme) and a HCP (GP,
psychologist, physiotherapist, chiropractor or osteopath) to be delivered over 3 short days (10.00–14.45)
with a 2-hour follow-up session 2 weeks later. We also designed a 2-day training programme for all
potential facilitators. All courses were to be held in a convenient accessible location for the target
population. A ‘buddying system’ was incorporated into the model.
The components of the course included psychological concepts using cognitive–behavioural approaches to
managing chronic pain (these covered acceptance, attention control, goal-setting and action planning,
recognising unhelpful thinking and behaviours). The course also covered communication skills,
relationships, intimacy, promoting better sleep, education about chronic pain, social time, hobbies and
activities, posture and movement, breathing, relaxation, and visualisation and guided imagery. The course
included a bespoke educational DVD of a pain consultant answering common questions from patients
with chronic pain; this was produced in both English and Bengali (which the Sylheti-speaking Bangladeshi
community also understand).
A summary of the course aims, learning outcomes, rationale and teaching methods is provided in the
following sections and Box 2 (in the box the numbers 1–24 are used to describe the individual sessions or
components of the course).
Day 1: Living with and dealing with pain
l Aims: introduce aims of the course and concept of group work, and increase understanding of pain
and reasons for it; introduce concept of acceptance and no cure; introduce the idea of recognising
different moods and their effects on pain.
l Learning outcomes: know where pain comes from and why we have it and, in chronic pain, why it
persists; the participants should be able to be able to describe why they have persistent pain to
somebody else and be able to identify some of their own beliefs about their pain and identify some
negative thoughts and behaviours, for example when is pain OK/manageable and, when it is at its
worst, how this can relate to mood.
l Teaching methods: group introductions/presentation, facilitated discussion, watching a DVD of
frequently asked questions, pain/mood exercise.
TABLE 22 Other key considerations influencing course design
Consideration How this influenced course design
Adult educationalists advised that to be interesting and
effective the course should employ a variety of media and
modalities, be delivered in 20-minute bites and encourage
experiential learning
Inclusion of role play, filmed material, small group
exercises, exercises for pairs, active listening exercises,
brain storming, etc.
Attrition from self-management courses running over
6–8 weeks known to be a problem
Course was run over 3 days in a single week
Expert professional input may be useful or appealing to
participants
Expert professional input delivered by DVD for economy
Reproducibility and fidelity of the intervention Development of a course manual and training package
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BOX 2 Course schedule
Day 1 sessions
1. Introductions
l Aim: to introduce self succinctly and effectively.
l Rationale: social awareness.
2. DVD on pain education
l Aim: to increase understanding about chronic pain.
l Rationale: introduce idea of acceptance.
Break
3. Acceptance
l Aim: to relate the scenario about the unwanted guest to chronic pain.
l Rationale: introduce idea of acceptance.
Taster activity (pain perception when thoughts not focused on pain).
Lunch break
4. Pain, bearable or not?
l Aim: to start introducing the concept that pain and mood are linked.
l Rationale: pain is not only physiological but also psychological, social and emotional.
5. The pain cycle
l Aim: to explain the pain cycle and understand the process and the unhelpful things that we do that
keep us in that cycle.
l Rationale: behaviour theory and fear avoidance.
Break
6. Posture
l Aim: to promote body awareness, posture and muscle weakness.
l Rationale: evidence for exercise, physical therapy principles, Alexander technique.
7. Relaxation and breathing
l Aim: to reduce muscle tension and introduce breathing as a relaxation technique.
l Rationale: principles of third-generation CBT, mind–body therapies and biofeedback.
Summary of the day
l Aim: reflection and embedding learning.
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Day 2 sessions
8. Reflections from day 1
l Aim: to understand and empathise with the group.
l Rationale: improve bonding and group cohesion, social cognitive theory.
9. Goal-setting and action planning
l Aim: to help participants logically and systematically to identify problems, brainstorm solutions, set goals
and devise action plans as a means of escaping the pain cycle.
l Rationale: based on cognitive–behavioural techniques, change management principles, theory of
reasoned action and theory of planned behaviour.
Break
10. Barriers: unhelpful thinking
l Aim: to introduce ideas about unhelpful thoughts, automatic thoughts and errors in thinking.
l Rationale: recognising errors in thinking can help with realistic assessment and more constructive/
rational views of the world; based on the fundamentals of rational emotive therapy and
cognitive–behavioural principles.
Taster activity.
Lunch break
11. Barriers: reframing ‘cons’ to ‘cans’
l Aim: to identify reasons why people stay in the pain cycle and barriers to change.
l Rationale: based on cognitive–behavioural techniques.
12. Attention control and distraction
l Aim: to learn how to focus the mind away from pain thoughts.
l Rationale: based on attention control and distraction techniques.
13. Making pain more manageable
l Aim: to summarise the techniques learnt so far to manage pain.
l Rationale: embedding learning from the day.
Break
14. Balance and stretch (as day 1).
15. Relaxation and visualisation (as day 1).
Summary of the day (as day 1).
BOX 2 Course schedule (continued)
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Day 3 sessions
16. Reflections from day 2
l Aim: to understand and empathise with the group and ascertain current thoughts.
l Rationale: improve bonding, group cohesion and understanding of learning, social cognitive theory.
17. Communicating with health professionals
l Aim: to reflect on consulting behaviour, promote effective communication and
constructive consultations.
l Rationale: promote effective health-care utilisation; based on theories of reasoned action and
planned behaviour.
Break
18. Listening skills
l Aim: to improve listening and communication skills.
l Rationale: to help with social integration, based on social cognitive theory.
19. Anger, irritability and frustration
l Aim: to identify reasons for negative emotions and implement goal-setting and action planning.
l Rationale: cognitive–behavioural principles.
Taster activity.
Lunch break
20. Stretch
l Aim: to learn how to stretch muscles gently with low risk of injury and pain.
l Rationale: manual therapy.
21. Relaxation and mindfulness of thoughts
l Aim: to learn to apply guided imagery and detach emotion from reality to appreciate ‘the now’.
l Rationale: evidence for focusing attention and separating emotion from sensation: mindfulness.
Break
22. Summary of the course
l Aim: to clarify learning from the past 3 days and introduce the idea of buddying.
l Rationale: embedding learning.
BOX 2 Course schedule (continued)
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Day 2: Doing something about life with pain
l Aim: identify opportunities to change and understand when change is possible and when it is not.
l Learning outcomes: be able to break down issues into manageable chunks and set simple, measurable,
achievable, realistic goals within a suitable time frame; be able to identify negative behaviours and
thoughts and spot errors in thinking.
l Teaching methods: group discussion, self-reflection and practice.
Day 3: Communication and relationships
l Aim: promote effective utilisation of health-care services and improve communication skills.
l Learning outcomes: moderate expectations; communicate effectively.
l Teaching methods: group discussion and role play.
Follow-up at 2 weeks
l Aim: managing setbacks: knowing what to do when experiencing a setback or a flare-up.
l Learning outcomes: improve bonding, group cohesion and understanding of learning;
embedding learning.
Facilitator recruitment and training
The recruitment criteria and training needs for facilitators were obtained from the qualitative study.
We were aware that courses facilitators who were highly regarded were those who managed difficult
participants, included participants to the extent that they were comfortable with, were flexible and knew
the course content well so that they could deviate when necessary and return to issues as appropriate.
Facilitators who had good listening skills, who did not talk too much themselves and who made people
laugh and relax were valued.
We recruited HCPs and laypeople. We recruited HCPs who had a specific interest in and understanding of
chronic pain and we recruited laypeople who had experience of chronic pain and who had previous
tutoring experience.
Follow-up sessions
23. Reflections and narratives
l Aim: to understand and empathise with the group and ascertain current thoughts.
l Rationale: improve bonding, group cohesion and understanding of learning.
Break
24. Managing setbacks
l Aim: to know what to do when experiencing a setback or a flare-up.
l Rationale: cognitive–behavioural principles, attention control and re-embedding learning.
BOX 2 Course schedule (continued)
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The course was designed to deliver:
l facilitation skills training
l trial procedures and protocol training
l course content familiarisation and delivery
l adverse event handling.
The course was spread over 2 days (Saturday and Sunday) and involved didactic education, role play and
practice. Trainees were observed and evaluated throughout the course to assess their understanding,
strengths and weaknesses (the training course structure is provided in Appendix 4).
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Chapter 7 Feasibility study
Abstract
Introduction: In 2010 we conducted a feasibility study to inform us about the COPERS self-management
course, in particular its delivery and content plus the trial procedures, in preparation for a definitive trial.
Method: We designed a pilot RCT with 100 chronic musculoskeletal pain patients randomised 3 : 1 to the
intervention or usual GP care plus an advice leaflet. We included a non-randomised arm in which we
delivered a version of the course translated into Sylheti to Bangladeshi patients not fluent in English.
We used a mixed-methods evaluation including quantitative process information; qualitative feedback from
course participants, facilitators and observers on their experience of the course; and quantitative data
from participant self-report questionnaires at baseline and 3 months’ follow-up.
Results: Systematically identifying eligible participants from GP medical records proved difficult and spurred
us to develop better search strategies for the main trial. Very uneven initial randomisation allocation led us
to abandon the randomised design and offer all participants the intervention. In total, 167 (32%) of 526
potential participants, of whom 343 (65%) were female, expressed an initial interest in participating; 56 of
these (34%) were recruited to the English-speaking courses and 41 (25%) to the Sylheti-speaking courses.
We ran nine courses, six in English and three in Sylheti. Forty-two people attended the English-speaking
courses and 26 attended the Sylheti-speaking courses. Nine facilitators were trained and seven facilitated a
course. We sought written feedback from facilitators and participants and we also carried out 13 in-depth
participant interviews. The course was regarded as beneficial by most participants, with the group
experience being important. Key recommended changes before a definitive trial included:
l better facilitator training
l the provision of clear aims and summaries for each session of the course as well as links
between sessions
l audio-recording of each course to check quality and ‘treatment drift’
l making the outcome questionnaires user friendly and shorter
l adopting the pain-related disability subscale of the CPG as a future primary outcome
l the provision of a more credible control arm
l conducting the main trial only in English.
Conclusion: The feasibility study provided important information on the intervention and its delivery and
on the design and conduct of a definitive trial of the intervention.
Introduction
Having designed the self-management support intervention for chronic musculoskeletal pain (see Chapter 6)
we conducted a feasibility study to test the design of the new intervention and to inform a future definitive
trial of the intervention. We called the intervention COPERS after the name of the study (COping with
persistent Pain, Effectiveness Research into Self-management). The COPERS course aimed to improve the
overall quality of life for people living with chronic pain.
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Objectives
The objectives of the feasibility study were to evaluate the quality and appropriateness of the COPERS
course and the trial processes, including the participant recruitment process, facilitator training, delivery of
the course content and collection of outcome measures, in preparation for the main RCT.
Methods
We proposed a pilot RCT of 100 participants randomised to the intervention or usual GP care plus best
practice patient advice on a 3 : 1 basis favouring the active intervention. In addition to this pilot RCT, to
test the practicality of including participants from a wider range of backgrounds in our main study, we
delivered the intervention separately in both English for the general population and in Sylheti for members
of the Bengali community living in Tower Hamlets (Figure 11).
We used a mixed-methods approach including both qualitative feedback from course participants,
facilitators and observers, and quantitative information from self-report questionnaires and activity data.
We chose randomisation on a 3 : 1 basis to enable us to run at least six to eight courses while testing the
randomisation process and the acceptability of the control arm. This study was not designed to show an
effect of the intervention but to test the feasibility of the intervention and the trial protocols. It was
conducted in Tower Hamlets, London, from January to April 2010.
Recruit participants
Deliver courses
Collect 3-month follow-up
questionnaire data
Team review all data, make
recommendations for main
trial
Recruit and train
facilitators
Randomise 
English-speaking
participants
Book Sylheti-speaking
participants on to a
course
Control Intervention
Collect baseline data
Facilitator log books
Observer notes
Participant course
feedback forms
Participant
interviews
Facilitator focus
group
Recruit recruiting
centres
FIGURE 11 Design of the feasibility study.
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Recruitment
We aimed to recruit participants to the English-speaking courses by targeting patients with chronic pain
who were registered with the local persistent pain service, physiotherapy department or two local general
practices. We selected the community-based pain and physiotherapy services as they reported in excess of
1000 new chronic pain patients per year. We also involved general practices as clinicians estimated that
around 10% of GP consultations in Tower Hamlets were for chronic pain.204 One of the general practices
was chosen because around 90% of patients were Sylheti speaking (in other local practices the equivalent
figure was around 50%).
Recruitment of participants
Participant recruitment is key to any successful trial. We reviewed six studies that had also recruited
participants to trials of group interventions for musculoskeletal pain (Table 23). Their mean uptake rate
from invitations was 8.8%; we aimed for an uptake of around 10%.
Participant identification and participant recruitment materials
We anticipated inviting approximately 600 patients with chronic pain to participate in the feasibility study.
We estimated a 60% response rate (around 360 people) based on previous studies that we have
conducted and expected that around one-third of these would accept the invitation to participate,
resulting in around 120 potential participants. Of these, we anticipated that about 10% would not be able
to commit to the study or would not meet our inclusion criteria.
We asked the clinical staff at recruiting centres to search their computerised medical records to identify
eligible patients. At this point we realised that there was no easy way to identify people with chronic pain
from the patient electronic records in general practice using condition terms and/or Read codes, such as
low back pain and OA combined with recent consultations for pain. This led to a separate study to explore
the best way of identifying patients relevant to our trial.206 We also encouraged face-to-face invitations at
all recruitment sites as we anticipated that the personal interaction and authentication of the course by a
HCP/patient adviser would increase interest (see Chapter 4). Potential participants were identified and
reviewed by their clinician according to the inclusion and exclusion criteria described later in this chapter.
Those deemed likely to be eligible were invited to participate in the trial by their clinic or general practice
by letter. With the letter they also received a participant information leaflet and a consent to approach
form to complete and return to the study team if they were interested in joining the study (the final
versions of these documents as used in the main trial are contained in Appendix 6). We translated
participant recruitment materials into Bengali script for the Bangladeshi participants (see Appendix 5).
In addition, one of the recruiting general practices employed a bilingual patient advisor advocate who was
able to translate and explain the information to any less literate Bangladeshi patients living with chronic
pain identified for the study. Reminder invitation letters were sent after 10 days.
TABLE 23 Trial uptake data
Study Country
Pain
condition Setting
Duration
of course
(weeks)
Number
invited
Number
recruited
Uptake
rate (%)
Bernaards 200698 The Netherlands Upper limb Occupational 24 8000 466 5.8
Johnson 200754 UK Lower back Community 6 2068 234 11.3
Lamb 201053 UK Lower back Community 6 9744 701 7.2
Moore 200083 USA Lower back Medical 3 2582 226 8.8
UK BEAM Trial
Team 2004205
UK Lower back Community 6 11,341 1334 11.8
Von Korff 199877 USA Lower back Medical 4 3292 255 7.7
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Sylheti-speaking groups
In addition to the English-speaking courses (proposed pilot RCT), we proposed three additional courses
conducted in the Sylheti language for Bangladeshi participants. We ran separate Sylheti courses for male
and female participants. The Bangladeshi community has a written language, Bengali, and a spoken
language, Sylheti. Depending on the level of education potential participants may or may not have been
able to read and understand the Bengali script but all could understand and speak Sylheti. Participants
recruited to the Sylheti-speaking courses were not included in the randomisation process but were enrolled
directly onto the courses. We were particularly keen to explore how this course could be made available to
the Bangladeshi community of Tower Hamlets (where many of the study team were based), who, in
common with other South Asian groups living in the UK, have a high prevalence of chronic musculoskeletal
pain.153 Delivering the course in a language other than English provided the specific experience needed to
inform a decision for the main trial on whether to present all courses in English or to also offer the
programme in minority languages.
Consent
The study team telephoned interested patients and spoke to them about the study to check that they were
eligible and ensure that they had enough information. We were also able to establish language fluency
during this initial telephone contact. If potential participants were still interested in the study, we attained
informed verbal consent to participate and assigned them a study number. We then asked them to
complete the baseline questionnaire and sign the study consent form and return both documents to the
study team in the Freepost envelope provided. Another member of the COPERS team, fluent in Sylheti,
made the initial contact telephone calls to interested Bangladeshi participants and sent out the consent
form and questionnaire (Sylheti-speaking participants were given both a Bengali script and an English
version of the questionnaire).
Participant inclusion criteria
l Adults (aged > 18 years) with a diagnosis of chronic non-specific musculoskeletal pain.
Participant exclusion criteria
l Not fluent in spoken English (except for Bangladeshi participants eligible for the Sylheti-
speaking course).
l Serious comorbidity such as cancer and not in remission.
l Poorly controlled major psychological illness.
l Terminal illness.
l Unaddressed or poorly controlled addiction to drugs or alcohol or other substance misuse.
l Inability to give valid consent.
Randomisation
On receipt of the signed study consent form the English-speaking participants were randomised to either
the intervention or the control group. An independent statistician based at the Pragmatic Clinical Trials
Unit (PCTU) at Queen Mary University of London performed the randomisation using minimisation,
with gender as a minimisation factor, in a ratio of 3 : 1 favouring the intervention. Participants were then
telephoned by the study team and informed of their allocation. Those randomised to the intervention
group were enrolled on the earliest available convenient course and asked to complete a baseline
questionnaire prior to the course. The Bangladeshi participants were not randomised but booked on to
courses directly.
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The intervention
The structure of the course and the rationale for its design are described in Chapter 6.
We aimed to book courses on alternating days when possible, for example Monday, Wednesday and
Friday, in easily accessible, familiar and local places, with a large room, kitchen and toilet facilities.
The course content was modified to be culturally appropriate for the local Bangladeshi population but
remained as similar in design and structure as possible to test whether or not our approach was directly
transferable to this particular ethnic group. The modifications included single-sex courses and avoiding a
clash with Friday prayers.
Training facilitators to deliver the intervention
We recruited HCPs (chiropractors, GPs, osteopaths, psychologists and physiotherapists) and laypeople with
chronic pain and experience of facilitating and/or teaching to deliver the intervention. Training took place
over 2 days and consisted of familiarisation with the course content and structure, facilitation skills and
trial procedures.
Control arm
Participants randomised to the control arm of the study received usual GP care plus best practice advice in
the form of a 20-page booklet called The Pain Toolkit, developed by Frances Cole and Pete Moore.207
We asked the control participants to refrain from attending any self-management courses for the duration
of the study but encouraged them to contact their local Expert Patients Programme after the COPERS
follow-up period had elapsed.
Data collection
We collected both quantitative and qualitative data as part of the feasibility study. Quantitative data
included questionnaire-based self-reported outcomes and participant feedback. Qualitative data included
observational field notes from the courses, free response questions from participant feedback forms,
a focus group with team members and COPERS facilitators, and in-depth interviews with some of
the participants.
Questionnaire for self-reported outcomes
Questionnaire-based self-reported outcomes were collected at baseline (just prior to randomisation) and
3 months after randomisation. We collected data from the Bangladeshi participants before the beginning
of each course and 3 months after the course. The questionnaires were returned to the study team using
reply-paid envelopes. Reminder letters and telephone calls were used to contact those who failed
to respond.
We used the basket of outcome measures identified in Chapter 5. These were:
l pain intensity using a 0–10 numerical rating scale
l pain extent using a pain manikin drawing
l heath-related quality of life using the EQ-5D169
l self-efficacy using the PSEQ181
l anxiety and depression using the HADS176
l coping and acceptance using the CPAQ174
l in addition, following a TSC meeting decision we used the SF-36.208
At baseline we also collected self-reported demographic data: date of birth, gender, living arrangements
(alone or with others), language fluency, ethnicity,209 employment status and education level, duration
of pain and location of pain (the final questionnaires used in the main trial are in Appendix 6).
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Facilitator log books
Each facilitator (two per course) was required to complete a structured log book. Facilitators were asked to
reflect and comment on the following for each session/component of the course:
l engagement of participants in the process
l level of understanding shown by participants
l types of questions asked
l displays of discordance/expressed difficulties/dysfunctional elements
l group dynamics
l personal reflections and suggestions for improvements.
The facilitators returned their completed log books to the study team after each course was finished.
Observer field notes
Each course was observed by a member of the study team and notes were taken and prepared in a
structured format for each session on:
l the facilitation process
l the content generated
l the types of questions asked
l displays of discordance/expressed difficulties/dysfunctional elements
l the level of understanding shown
l group dynamics/engagement of trainees in the process
l personal reflections and suggestions for improvements.
Participant feedback questionnaires
Participants on the English-speaking courses were asked how satisfied they were, on a 5-point scale,
with aspects of the course, together with some free-response questions (Box 3).
Questionnaires were handed out to participants by the course observers at the end of each course and
questionnaire completion was optional and anonymous.
Participant interviews
Purposive sampling was used to identify participants to approach for interview. We invited a mix of
genders and ages (≤ 40 years or > 40 years) and those who had good or poor attendance or who had
chosen not to attend the course at all. The topic guide for the in-depth interviews was generated by the
study team and aimed to cover:
l the invitation process (recruitment and marketing)
l randomisation (reasons for attending)
l the baseline questionnaire
l course content
l course duration and facilities
l the group process (‘buddying’ and mix of participants)
l facilitation
l post-course changes and activities.
All interviews were recorded and written up but were not transcribed verbatim.
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Data analysis
Questionnaire for self-reported outcomes
The output from the baseline questionnaire was used to produce summary statistics on demographics and
outcome measures for both the randomised participants and the Bangladeshi participants.
Facilitator feedback and observer data
Data collected from the observer notes, the facilitator focus group and facilitator log books were
combined. Two members of the study team familiarised themselves with the data to identify themes
and subthemes.
Participant data
Response rates and mean scores were calculated for the participant feedback questionnaire items. The
qualitative data from the participant feedback questionnaire and the participant interviews were analysed
using a framework approach.154 Two researchers reviewed the data independently to derive a framework
of themes and subthemes.
These data were used to inform the facilitator focus group and modifications to the course and the
trial processes.
BOX 3 Participant feedback questionnaires
Quantitative questions
On a scale of 0–5, with 0 indicating least satisfied and 5 indicating most satisfied, how satisfied were you with
the following:
l the course today?
l the teaching methods used?
l the handouts?
l the facilitators?
l the group discussions process?
l the amount of time for socialising?
l the amount of time spent on each topic?
l the taster session?
l the facilities?
l the amount of information given?
Qualitative questions
l Name three things that you learned were important to you.
l What parts of the course did you enjoy the most and why?
l What parts of the course did you least enjoy and why?
l How relevant was the course content to you?
l Comments about facilitation.
l Suggestions for improvements.
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Results
Recruitment sources and participant identification
Recruitment and delivery of the intervention took place over 9 months (February to October 2010). We
identified 526 potential participants, of whom 32% (n = 167) expressed an initial interest in participating.
Of these, 42% (n = 70) were allocated a study ID number and sent a questionnaire and consent form to
participate in the English-speaking study, and 24% (n = 40) were enrolled into the Sylheti-speaking
feasibility study, representing an overall 21% recruitment rate (Table 24).
Reasons for declining to take part were:
l a preference for ‘physical’ treatment such as physiotherapy or injections
l inability to get time off work, especially for teachers
l inability to attend because of childcare issues
l language barriers (English fluency not sufficient to take part in a group process).
Consenting participants were randomised using minimisation with a 60 : 40 female/male split expected
and a 3 : 1 ratio in favour of the intervention. However, we abandoned allocation to the control arm
as the initial randomisation sequence was top heavy with control participants and did not yield sufficient
participants in the intervention arm to fill the first prebooked course. We continued to run the
randomisation sequence and eventually the randomisation sequence was as expected overall. We modified
our randomisation strategy for the main study to include randomly permuted blocks to ensure that a
steady flow of participants was randomised to the active intervention.
We ran nine courses in total starting in the last week of March 2010 and continuing to mid-July 2010,
with around seven participants on each course. There were six mixed-gender English-speaking courses, one
Sylheti-speaking male course and three Sylheti-speaking female courses. Fifty-six participants [n = 30/56
(54%) female participants] were booked onto the English-speaking courses. Fourteen participants (25%)
did not attend any sessions. Four participants attended day 1 only and 38 attended ≥ 2 days (Table 25).
TABLE 24 Source of participants
Recruitment source
Number of invitations
(letter or face to face)
Reminder
letters
Initial
interest
Enrolled
Allocated study
ID number
Booked onto
Sylheti course
Pain service 423 342 124 59 26
GP 1 68 5 24 0 12
GP 2 23 19 12 7 2
Physiotherapy 12 0 7 4 1
Total 526 366 167 70 41
TABLE 25 Recruitment and attendance day 1
Participants Number contacted
Total number booked on a
course (% of those contacted)
Attendance at day 1 (% of
those approached/booked)
English-speaking females 228 30 (13) 23 (77)
English-speaking males 134 26 (19) 19 (73)
Sylheti-speaking females 115 34 (30) 22 (65)
Sylheti-speaking males 46 7 (15) 4 (57)
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Four male participants attended the Sylheti-speaking course, with three attending ≥ 3 days. The first
Sylheti-speaking female course had 20 participants booked but four (20%) did not attend any sessions.
Of the remaining 16 participants all attended at least 2 days. The second Sylheti-speaking female course
had 14 participants booked but eight (57%) did not attend any sessions.
There were 10 participants on the English-speaking courses who were not from a white British/Irish ethnic
group and who spoke English with varied fluency. They coped with the course but those who were not
very fluent did struggle to maintain full involvement with the discussions, often preferring to listen rather
than talk.
There were more female than male participants interested in being part of the study (75 females vs. 34 males),
particularly for the Sylheti-speaking group (33 females vs. 7 males) (Table 26). The mean number of
participants attending each English-speaking course was seven and the mean number of participants
attending each Sylheti-speaking courses was nine. The median age range of participants was 41–50 years
(see Table 26).
Questionnaire for self-reported outcomes
Of 56 potential participants allocated a study ID number and booked on a course, 48 (86%) returned
usable baseline questionnaire and study consent forms. The response rate at 3 months was 52% (n = 25).
Of 41 Bangladeshi participants booked onto courses, 18 (44%) returned their baseline questionnaire and
three (7%) retuned their follow-up questionnaire.
The participants found the questionnaire extremely difficult to complete because it was long and repetitive;
this was particularly so for the Bangladeshi group. We provided assistance and extra time prior to the
courses being run to help participants complete the questionnaire but participants and the assistants found
the task arduous and slow. Table 27 shows that, despite providing the questionnaire in both English and
standard Bengali to the Bangladeshi group, more English questionnaires were returned. Our qualitative
work explained that help to complete the questionnaire was often given by participants’ children who
were fluent in English and but who did not read Bengali.
There was a high proportion of missing data in the participant questionnaires, meaning that the data
should be interpreted with caution (Table 28). At baseline, differences in employment were seen between
the groups, with few of the Bangladeshi group being employed and the majority of responders being
TABLE 26 Age and gender of those allocated study IDs
Age (years)
Sylheti speaking English speaking
Male Female Male Female
≤ 20 0 0 0 0
21–30 0 1 0 2
31–40 2 9 7 5
41–50 3 8 6 17
51–60 0 13 7 12
61–70 0 2 3 4
71–80 2 0 3 0
≥ 81 0 0 1 2
Total 7 33 27 42
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TABLE 27 Questionnaire completion: Sylheti-speaking courses
Course
Questionnaires
sent
Questionnaires
returned
(response rate, %)
Returned
in English
Returned
in Bengali
Fully
completed
(completion
rate, %)
Partially
completed
(completion
rate, %)
Baseline
B1 4 3 (75) 0 3 0 3
B2 16 6 (38) 5 1 3 3
B3 6 6 (100) 5 1 1 5
Total 26 15 (58) 10 5 4 (27) 11 (73)
Follow-up
B1 4 0 (0) 0 0 0 0
B2 16 2 (13) 2 0 2 0
B3 6 0 (0) 0 0 0 0
Total 26 2 (8) 2 0 2 (100) 0 (0)
TABLE 28 Participant characteristics at baseline
Characteristic Sylheti speaking (N= 26), n (%) English speaking (N= 48), n (%)
Employment
Employed 1 (4) 13 (27)
Family/home keeper 8 (31) 5 (10)
Retired 1 (4) 8 (17)
Unable to work because of ill health 4 (15) 17 (35)
Unemployed 3 (12) 5 (10)
Missing 9 (35) 0 (0)
Education
None 3 (12) 1 (2)
Until < 12 years 4 (15) 0 (0)
Until 13–16 years 4 (15) 18 (38)
Until 17–19 years 1 (4) 9 (19)
Until ≥ 20 years 2 (8) 18 (38)
Still a student 0 (0) 2 (4)
Missing 12 (46) 0 (0)
Support
Living alone 0 (0) 17 (35)
Living with others 6 (23) 27 (56)
Missing 20 (77) 4 (8)
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female home/family carers. The other between-group difference related to education: 7/14 (50%) of the
Bangladeshi participants who supplied data on age completing education had either no formal education
or were educated only to the age of 11 years, compared with 2% of the English-speaking group.
The mean scores for pain extent, intensity, depression and social integration were similar between the
groups at baseline (Table 29). EQ-5D, anxiety, self-efficacy and coping showed differences between
the groups, indicating worse states in the Bangladeshi group. This is consistent with other evidence from
Tower Hamlets.153
At follow-up, overall, almost all mean outcomes showed a tendency towards improvement but, when
confined to those for whom we had longitudinal data, as anticipated, no statistically significant changes in
scores were seen in these pilot data (see Table 29).
Recruitment and related issues are summarised in Table 30. These issues were identified from feedback
from the facilitators and from observations by the study team. Detailed feedback data are provided in
Appendix 5.
TABLE 29 Summary baseline and follow-up questionnaire data
Outcome
Baseline English
speaking (n= 43),
mean score (SD)
Baseline Sylheti
speaking (n= 26),
mean score
Follow-up English
speaking (n= 22),
mean score (SD)
CPG pain intensity (scale 0–10)a 6.7 (2.1) 7.7 6.3 (2.2)
CPG pain extent (scale 0–13)b 4.6 (2.4) 5 –
EQ-5D scorec 0.23 (0.4) 0.12 0.31 (0.4)
PSEQ score (scale 0–60)d 22.5 (12.7) 25.4 30.2 (13.1)
HADS anxiety score (scale 1–21)e 11.3 (4.1) 12.7 10.2 (3.8)
HADS depression score (scale 1–21)e 9.4 (3.8) 9.3 8.8 (4.1)
CPAQ score (scale 0–120)f 46.7 (17.3) 41.9 54.1 (18.02)
heiQ score (scale 5–20)g 12.8 (3.1) 12.4 13.1 (3.5)
a 10 =worst pain imaginable.
b 13 = all over pain.
c Perfect health = 1.0; UK norms for healthy males/females: age 40–49 years = 0.89/0.87; age 50–59 years = 0.80/0.82.188
d 60 = completely confident.
e 0–7 ‘normal’, 8–10 borderline, 11–21 ‘abnormal’.
f 0= not coping at all.
g Higher scores indicate a better social life.
TABLE 28 Participant characteristics at baseline (continued )
Characteristic Sylheti speaking (N= 26), n (%) English speaking (N= 48), n (%)
Pain
Duration > 4 years 13 (50) 36 (75)
Duration < 4 years 4 (15) 11 (23)
Missing 9 (35) 1 (2)
Mean extent (out of 13 sites) 5 sites (n= 18) 5 sites (n= 47)
Mean intensity (out of 10) 7.7 (n= 18) 7.0 (n = 44)
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TABLE 30 Recruitment and outcome data collection issues
Process Issues identified Potential solutions
Recruitment sources
and patient
identification
Time-consuming to secure collaborations with
recruitment sources allowing for approvals
Allow time for recruitment of recruitment sources
Recruitment sources did not yield enough
participants
Do not target all recruitment sources at the same
time – phased recruitment; try to estimate number
of participants expected compared with actual and
flag up deficits early – allow for exclusions; boost
recruitment by advertising in non-GP sites (e.g. local
adverts in waiting rooms, pharmacy posters)
More potential participants yielded from
medical record searches than expected
Construct more specific search strategies for
medical record systems to target the most
appropriate participants
Fewer participants yielded from secondary care
registers than expected
GPs/clinicians too busy to screen lists of
potential participants generated from medical
record searches
Ensure participating GPs/clinicians are given
enough time to check patient lists against
exclusion criteria
GP/clinic staff did not have dedicated resources
to perform the searches of their record systems
or have time to produce the mail-merge
invitation letters and post the packs
Recruit a research assistant and allocate time to
perform the initial searches of patient records
to identify suitable participants and also to
prepare the invitation packs and reminder letters
Difficulty in finding a patient advocate who
had time to assist in the recruitment of
non-English-speaking participants
Provide specific funding for a patient advisor/
advocate to help in face-to-face or over the
telephone recruitment for non-English-speaking
participants
Randomisation and
course booking
Freepost envelopes were sometimes delayed
compared with stamped envelopes
Allow time for post office processing of the
Freepost service
Need time to receive baseline questionnaire
back prior to course dates
Allow at least 4 weeks for participants to return
their baseline questionnaire and consent form;
allow 2 months between the participant
invitation mail-out and course booking
Control group It was difficult to ‘sell’ the control arm of usual
care and an educational leaflet to potential
participants
Provide a more credible control arm to motivate
people to take part
Randomisation Individual randomisation by minimisation
yielded an unpredictable sequence of
allocations
Use the block randomisation method to ensure
that enough participants are allocated to the
intervention to run a course
Cultural adaptation Courses running on a Friday precluded the
male Muslim population because they were
attending prayer
Choose alternative day to Friday
Data collection Questionnaire fatigue an issue Shorten questionnaire
Response rate from non-English-speaking
participants particularly poor
Use English-speaking population to test effectiveness
to optimise the amount of data collected
Low questionnaire response rate generally Incentivise return with vouchers
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Table 31 shows the number of respondents recording each satisfaction score for each question. Overall,
the average response rate was 72%.The mean overall satisfaction score was high (4.3). There was little
variation in overall scores; however, the ranges indicate that there was less satisfaction with time allocated
for discussion, socialising and each topic. At least four people found the ‘taster’ unsatisfactory.
Participant interviews and feedback
The emergent themes and subthemes arising from the free response questions in the course feedback
questionnaires related to knowledge and learning, course content, relevance to self, facilities and course
structure and duration. These issues were also summarised and repeated in the participant interviews.
Sample
We approached 18 course participants who were potentially exposed to the intervention for interview; five
declined [reasons included work commitments (n = 2); having an operation; bereavement; and ‘no time’]
and we therefore interviewed 13 participants, including four males. Three interviews were conducted in
Sylheti and the remainder were conducted in English. Four researchers conducted the interviews; all were
members of the study team.
Themes
We organised the data into 12 themes: clarity of aims, motivation, positive aspects, negative aspects,
learning, social interaction, effect of others, repercussions/outcomes post course, suggested changes,
facilitation, ‘buddying’, course material; these themes are detailed in Appendix 6. There was no need to
conduct second-order analysis to interpret the data in greater depth as the aim of the evaluation was to
find out what modifications needed to be carried out to the intervention programme.
In summary, participants wanted not only the aims of course made clearer but also the rationale for
each session. Participants greatly valued the social interaction and wanted more time for informal
interaction. They valued good facilitation, which was seen as good group control, that is, managing
TABLE 31 Satisfaction scores for each question
How satisfied were
you with the . . .?
Level of satisfaction from least to most (0–5)
Number of questionnaires
receiveda
Mean
score0 1 2 3 4 5
Course today – – 3 7 30 46 86 4.4
Teaching methods – – – 12 26 46 84 4.4
Handouts – – 1 14 33 38 86 4.3
Facilitators – – 1 4 21 61 87 4.6
Group discussions – 1 – 6 26 52 85 4.5
Time for socialising 1 2 5 13 26 36 83 4.0
Time on each topic – 2 7 13 26 37 85 4.0
Taster session – 1 3 11 22 42 79 4.3
Facilities – – 2 10 24 50 86 4.4
Information given – – 2 6 27 50 85 4.5
Mean score 4.3
a Course participants were asked to complete a questionnaire on each of the 3 main days of the course, but often did not
do this.
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difficult people and situations; this had implications for facilitator training. Different participants
preferred different sessions but they really liked the relaxation sessions and requested audio-recordings
of the scripts used. ‘Buddying’ was wanted by some and not others and those interviewed strongly
recommended that it be left up to individuals in the groups to identify other participants to ‘buddy up’
with if they so wished.
Study team meeting for modifications and changes
Two study team meeting sessions were conducted because of the number of data, one for facilitator/
observer feedback and one for participant feedback. The recommendations from the study team meetings
are provided in Table 32.
Overall summary of the results of the feasibility study
The process evaluation of the feasibility study gave clear indications of areas for improvement for the main
RCT. The key areas are summarised as follows:
l The feasibility study demonstrated that it is feasible and acceptable to translate and deliver the
intervention in another language; however, it also demonstrated that it was not feasible to collect
sufficient outcome data from the non-English-speaking Bangladeshi population. The main trial should
be conducted only among people fluent in English (but the results could probably be extrapolated to
non-English-speaking people).
l A credible control is required to encourage participants to enter into a definitive trial. Usual care and a
pain education booklet were not sufficient to attract participants.
l More time was required to secure recruitment sites. A phased approach would assist in the planning of
recruitment to courses, along with recruitment monitoring against an expected rate per source to flag
up problems early in the study.
l A more specific search strategy needed to be developed for general practice medical record systems to
find suitable participants. GPs do not have time to look through lists of hundreds of patients. General
practices may need assistance from the study team in performing the searches and preparing invitation
packs and reminder letters.
TABLE 32 Recommendations from the study team meetings
Facilitator/observer feedback Participant feedback
Course content:
l introduce variation in learning methods
l reorder pain cycle content so positive at the end
l simplify cognitive behavioural sessions
l use participant examples more
l remove sleep management session and
incorporate as a problem-solving example
l provide handouts
l CD for relaxation
l keep tasters (change photography)
l remove buddying, keep informal
Facilitation:
l make aims clearer
l summarise each session
l use links
l more training on dealing with difficult people
l pair inexperienced with experienced
Trial process:
l make trial more user friendly
l make control more credible
l change Freepost address label
l provide weekend courses
Course content:
l refer to diagnosed pain conditions more
l include cortical and descending pathway information
l link rationale for each session to pain experience and causes
l course duration appropriate
l withdraw intimacy session
l more discussion time
Facilitation:
l more facilitation skills training
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l At least 8 weeks should be allowed between posting out participant invitation letters and the start of a
local course to allow time for potential participants to complete and return the baseline questionnaire
and complete the enrolment process.
l A block system for randomisation would ensure that groups of participants are randomised in sufficient
numbers to provide enough participants for a course.
l The questionnaire was too long.
l Good facilitators, and hence good facilitator training, were absolutely key to the successful delivery of
the intervention and the retention and satisfaction of course participants.
Consideration of our outcome measures and choice of a primary outcome
measure for the main trial
It is usual in trials of treatment for chronic painful disorders to see a substantial improvement between
baseline and follow-up in the control arm.210,211 This is because of a combination of two factors. First, the
natural history of the disease is to improve as people will be more likely to be motivated to join a trial if
they are in a period of relatively more severe pain; chronic musculoskeletal pain tends to wax and wane
over time. Second, one would expect to see some regression to the mean in the results for any outcome
measure, irrespective of any change in the underlying disorder. That the EQ-5D169 did not identify this
expected change in our pilot study gave the study team serious concerns that it would not be sufficiently
responsive to any change in participants’ underlying disorder. The team therefore considered that an
alternative primary outcome was needed. The closest measure in the portfolio that we had evaluated (see
Chapter 5) was the pain-related disability component of the CPG. This is a disorder-specific outcome that is
directly related to overall quality of life. It has much greater disorder-specific clinical relevance than other
measures in our portfolio. For this reason the study team chose to use the pain-related disability subscale
of the CPG as the primary outcome in the main trial.
Results in the context of other research
Past research on self-management courses has shown that self-management can have small effects on
self-efficacy14 and that group approaches can benefit participants. The group process encourages active
involvement, cheering successes and offering and receiving advice and support.49 Our findings support the
‘power’ of the group process as an active part of learning and behaviour change. Self-efficacy seems to
enable and contribute to and/or evolve out of the group process. Participants could be empowered either
by those who were seemingly worse off than themselves or by those who appeared to be proactive
and/or worthy role models. We also found in our systematic review (see Chapter 2) that group-based
self-management programmes provided more beneficial effects for participants than remote or individually
delivered programmes.
Providing a meaning for learning about the complex interactions between the body, pain, mind and
emotions, be it internal (via self) or external (via others), was observed in participants who went on to
illustrate examples of better coping strategies. Heightened self-awareness potentially could lead to
hypervigilance or, conversely, self-awareness could promote coping strategies that related to personal life
situations and were therefore more meaningful to the participant.
Cognitive–behavioural approaches for pain management have been systematically reviewed48 and found to
be effective for short-term pain relief. However, it is still unclear which types of cognitive approaches or
which elements of the cognitive approaches are more effective than others. Based on our interview data
we postulate that self-reflection on unhelpful behaviours and goal-setting have most impact on change.
These elements of CBT are often linked with plans to carry out activities in the future; if these plans are
carried out they can have an impact on physical and mental health. Other systematic reviews conclude
that exercise (any type) is beneficial for persistent non-specific pain.33 In the COPERS programme we
encouraged activity as opposed to exercise to avoid raising existing negative cognitions about exercise, but
ironically the posture and stretch sessions were very well received despite us trying to avoid the concept of
exercise as much as we could.
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Strengths and limitations
We specifically sought to deliver the intervention in a language other than English to a minority ethnic
group. This research had its origins in a collaboration with Social Action for Health, a Tower Hamlets-based
community organisation that seeks to promote health and well-being in the Bengali community of Tower
Hamlets. Social Action for Health had identified the management of chronic musculoskeletal pain as a
community priority. We had also demonstrated the higher prevalence of chronic musculoskeletal pain in
first-generation Bengali migrants living in Tower Hamlets153 and were aware of the issues through our
clinical work. Developing a programme to help this group was therefore a priority for both us and our
patient partners.
The large Bengali community in Tower Hamlets meant that it was plausible to develop and a deliver an
intervention tailored to this group. This information is locally important. However, we cannot necessarily
extrapolate from these findings to other minority ethnic groups or establish how practical it might be
to deliver such a programme in areas that do not have the same dominant minority ethnic group.
Nevertheless, we have for the first time demonstrated that such an intervention is deliverable to such
groups. We had no a priori expectation that this experience would not be transferable to other ethnic
groups living in the UK.
Our evaluation was designed to gather information about the COPERS course and its content to determine
whether or not any improvements needed to be made and how to improve delivery. We systematically
collected data from participants, observers and facilitators. The data were gathered and analysed by
different team members to try and avoid bias in interpretation; however, some bias may have occurred.
We demonstrated that it was feasible to deliver the COPERS course in Sylheti, that the courses were
acceptable to participants and that there was a relatively low rate of attrition. However, this pilot showed
that it would be very difficult to determine the effectiveness of the Sylheti language course in a definitive
effectiveness trial because most participants were unwilling or unable to complete questionnaires
administered by post. An alternative would be to formally evaluate English-language courses for those
fluent in English of all ethnicities and extrapolate the data to non-English-language courses. Delivering
courses in multiple languages poses an issue in ethnically diverse areas because there is no one dominant
language group; however, it is feasible in areas with predominantly one ethnic group, as we have shown.
There is also the additional problem that some of our outcome measures have not been validated in
other languages.
Recommended changes
The changes required to the COPERS course were not major changes. The suggestions for change could
be categorised into three main areas: changes to the course content, changes to processes and changes to
facilitator training. We believed that many of the issues that the participants flagged would be avoided by
better facilitator training. The facilitator training course was therefore modified and run closer to the
start of the courses; when this was not possible we decided to provide ‘top-up’ training to refamiliarise
facilitators with the techniques and course material. Facilitators who wanted top-up training would be able
to observe other courses and receive individual coaching on a one-to-one basis from the study team (in
practice, two facilitators out of 39 (5%) requested additional training and observed a course). Additionally,
we would endeavour to always pair a new facilitator with an experienced COPERS facilitator. We also
needed to provide a more credible control. Relaxation does not have medium- to long-term effects on pain
severity48 but our participants really enjoyed this element of the course. Relaxation can be carried out in
groups or alone and so we decided to use this as part of our control as it has limited clinical effects and
does not involve any interaction with others.
The use of observer notes for each course was useful to check for ‘treatment drift’ and fidelity. The
observers also helped to debrief the facilitators after each day. An audio-recording of each course was
used to check quality and ‘treatment drift’ in the main trial.
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Conclusions
We demonstrated that it was feasible to deliver the COPERS course in a non-English-speaking population.
However, because of the difficulties experienced with filling courses in multiple languages and collecting
outcome data, there was an argument for conducting the main trial in English first and, if effective, then
either simply extrapolating the results directly to non-English-speaking groups or perhaps evaluating the
intervention in a true implementation study in these groups.
The qualitative evaluation of the feasibility study illustrated that the COPERS course was regarded as
beneficial by most participants; however, ways to improve the course were suggested. As a result the
course content was modified, the aims were made clearer and summarising and linking between sessions
were incorporated as essential deliverables for each session. High-quality facilitation appeared to be the
key to a successful course and therefore effective training for facilitators was prioritised.
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Chapter 8 Phase 1: development of the
intervention – discussion
Principal findings from phase 1
In phase 1 of this programme of work we carried out the substantial background work required to prepare
for delivering a definitive trial of a self-management approach to managing chronic musculoskeletal pain.
Following this we developed:
l systems for recruiting our population of interest
l an active intervention grounded in the best available evidence that was acceptable to participants,
manualised and deliverable to a wide range of people living with chronic pain
l an acceptable, manualised training programme to train facilitators to deliver the intervention
l a credible and acceptable control treatment
l a carefully selected package of outcome measures.
This put us in the best possible position to answer our original research question: ‘Does a self-management
support programme improve outcomes for people living with chronic musculoskeletal pain?’.
The evidence
Group-delivered courses that had HCP input had better outcomes than other types of courses and longer
courses did not appear to provide additional benefits over shorter courses. We found mixed evidence
for the effectiveness of different proposed components of the intervention package. Courses with a
psychological component, however, had more evidence of beneficial effects than those without
psychological components and increasing the number of components did not appear to improve course
effectiveness. We proposed that this indicated that other factors related to the group process, such as
socialisation, may be as important as the content in the success of self-management courses.
Our qualitative work with chronic pain patients who had participated in courses also indicated that they
gained benefit from the social aspects of courses and learning from others, as well as the need to focus
their attention on things other than pain. People who had accepted their pain and had personal coping
strategies that enabled them to lead fulfilling lives were most positive about their experience of pain
management courses.
The psychological theories that we reviewed supported our qualitative study findings and underpinned the
structure and content of the course. The theory underpinning the decisions to include a variety of sessions
and behavioural change techniques worked well within the group learning environment; this has also
shown to be effective in other studies of chronic pain.48,53
Informed by the available theoretical and empirical evidence we developed a brief group intervention to be
delivered jointly by a HCP and a lay expert.
The course
The course ran over 3 days in 1 week with a top-up session 2 weeks later. The target attendance was
10–12 participants.
The learning sequence that we adopted enabled each session to build on the previous session and in many
cases the participants were able to predict the next phase of learning in advance. The learning and flow of
information was pitched at a level at which participants could follow the structure and understand the
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content. This was shown in the daily feedback sheets that asked participants what they had learned: their
learning mapped well onto the learning objectives.
In our feasibility study we demonstrated that the course was feasible, acceptable to participants and
deliverable in a NHS context. Participants were positive about the course and the content appeared to be
meaningful to them. Attrition was very low over the 3 main days: participants attended on average 85%
of the course. Attrition has been reported as an issue in other trials. In one such trial of an Expert Patients
Programme run over a 6-week period (intervention arm n = 313), one-quarter of participants failed to
attend any session, only 60% were considered to have completed the course (attending at least four of
the six sessions) and only one-third attended all six sessions.15
We tested the feasibility of the intervention in a non-English-speaking Bangladeshi population. In Tower
Hamlets in east London 32% of the community are of Bangladeshi origin,212 with some not speaking
English or not speaking English well. The prevalence of chronic pain in the Bangladeshi population (arrived
in UK after the age of 14 years) is higher than that in the white British and British Bangladeshi population
living in Tower Hamlets, at around 75% compared with around 50%.153 We demonstrated that the
intervention can be delivered in Sylheti to a group who may find services hard to access. Although we
could not collect validated participant-reported outcomes, our evidence from interviews and feedback
from the courses indicated that the participants valued the courses and appreciated the effort made to
accommodate their needs, for example running single-sex courses. From a national perspective the ethnic
distribution varies, supporting our decision to run the trial in two areas. The non-white population in
London makes up about 40% of the total population, whereas in the West Midlands it is around 17%.212
In the census 8% report that English is not their main language and of these 21% do not speak English
well (this equates to 1.7% of the total English and Welsh population).213 Our experience running the
non-English speaking courses was that they were feasible and well received but it was hard to recruit
sufficient people onto the courses to make them viable and hard to collect outcome data, which may
affect the analysis and sample size required for the main trial (attrition and incomplete data).
The facilitation and group process may have optimised the learning process as discussion embedded
participant thinking. All of the course evaluation material suggested that good facilitation skills were
crucial for positive participant perception. Comprehensive facilitator training was essential for courses to
run effectively. We found that it was possible to train both laypeople and non-psychologists to facilitate
the courses and deliver the cognitive–behavioural approach that we had developed. The facilitator training
included four components: facilitation skills training, course content familiarisation and practice, trial
management protocols and evaluation.
Delivery styles varied, indicating a need to embed fidelity assessment from the outset to measure both
adherence and the competence of those delivering the intervention. Measuring whether or not an
intervention has been delivered as efficiently and effectively as possible has been advocated by others;214,215
however, published reports of fidelity assessment, or the methods used to perform it, are sparse.
We found that the course withstood the inexperience of our facilitators in delivering an entirely new
course; the content in terms of the discussions, information and handouts was robust enough to make an
impression regardless of delivery style. We recommended that inexperienced personnel be partnered with
experienced personnel in the main trial.
Recruitment and participants
Recruitment to the feasibility study was challenging; the conversion rate from invitation to course
attendance was lower than we had hoped (approximately 13% of those invited) but was in line with other
studies of this nature recruiting patients from primary care with chronic conditions.53,83,98 Nevertheless,
we had sufficient interest from patients to run nine courses and this demonstrated a demand for learning
about non-pharmacological approaches to managing pain. Procedures for future recruitment need to be
enhanced by increasing the number of invitations sent and devising and testing a comprehensive and
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inclusive electronic search strategy for patients with chronic pain. To address this need we developed and
tested an electronic patient record search strategy using repeat prescription data for chronic pain-related
medication, musculoskeletal Read codes and contact within the last 3 months.206
In our feasibility study participants reported poor quality of life, low self-efficacy to manage their chronic
pain, relatively high levels of social isolation, poor coping skills and a tendency towards anxiety and
depression. This is consistent with the findings of a European survey carried out in 2005216 that asked
respondents about the impact that pain had on their daily lives. In total, 32% reported that they were no
longer able to work outside the home or attend social activities and 21% reported having a diagnosis of
depression as a result of having chronic pain (24% in the UK); thus, our secondary outcome measures
need to reflect these health and social states.
We noted the levels of depression and considered whether depression should be addressed with patients
prior to, or in conjunction with, attending these types of courses.
The control
The pilot study indicated that the control arm needed to have more credibility; there was little motivation
for people to join the trial if they perceived that they would receive no added benefit, that is, usual care.
Our systematic review illustrated that mind–body approaches (mostly relaxation) may have some short-term
beneficial outcomes but did not produce medium- or long-term benefits and this has also been shown by
other reviews of relaxation.217,218 Our qualitative work indicated that participants really enjoyed this part of
the course that they attended and so we decided that if there was little evidence for effectiveness but
positive appeal for relaxation this may be an incentive for recruiting people into the trial who might
otherwise decline.
Strengths and weaknesses
We designed a novel approach to analyse the effectiveness of courses by content and characteristics by
looking at interventions with and without prespecified components and characteristics. Although many
studies were available, some subgroups had few data available and the conclusions drawn were tentative.
However, looking at all of the studies, and the data indicating beneficial outcomes, we were able to
identify characteristics and components that seemed to elicit better effects than others. This allowed us to
translate the findings directly into our intervention design, enabling us to put together an evidence-based
intervention at a level of detail that included content and delivery style.
A byproduct of our predictor, mediator and moderator study was that we found that there was no
consensus about methodological standards for mediator studies. We carried out an additional expert
consensus study that informed and enhanced our systematic review.135 Additionally, we also tested and
piloted an electronic search strategy for identifying chronic pain patients.206 The strategy that we devised is
applicable to other conditions but would need further testing. We involved patients in the selection of
outcome measures but, in retrospect, as was pointed out by one of our reviewers at the end of the entire
programme, we would have liked more patient involvement in this process. Following the recommendations
in MRC guidance,28 as part of the feasibility phase of the project we started to design and develop a
methodology for rigorously and systematically assessing and measuring the fidelity of our intervention
delivery from the outset,207 so that the assessment was embedded into the training, delivery and
implementation of the intervention. Importantly, we were able to demonstrate that we could deliver the
course in Sylheti for the Bangladeshi community of Tower Hamlets. We were not able to include this group
in the main trial; nevertheless, showing that the course can be simply translated and delivered to another
ethnic group indicates that our findings are likely to be generalisable to other non-English-speaking groups
in the UK. We suggest that running a parallel non-randomised arm of the study for groups who may find
services hard to access may be a sustainable and credible option for researchers to demonstrate the
generalisability of an intervention for groups who cannot be included in a randomised comparison.
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
105
Findings in relation to other studies
Optimal self-management of chronic pain can be achieved by addressing the reasons surrounding
acceptance, negative cognitions and behaviour change to enhance quality of life. The course that we
proposed is theoretically driven by behavioural approaches and techniques to address the emotional,
psychological and social aspects of living with chronic pain. The Expert Patients Programme and the
Chronic Disease Self-Management Programme are two interventions that have gone partway towards
addressing the issues of living with chronic pain. In these programmes weekly sessions are held over
6 weeks, which has implications for attendance.15 Our short intensive intervention appeared to overcome
this problem because there was less scope for ‘life’ events to occur over the duration of a week,
preventing attendance.
Our framework had a strong emphasis on utilising specific behaviour change techniques such as goal-
setting and tailored education to address health beliefs. Our model is delivered to groups and addresses
issues surrounding social integration. Our approach creates the opportunity for social support and
integration shown to be important to this population and is likely to be more cost-effective than
individually delivered programmes. We structured some group sessions to formally address and facilitate
behaviour change through the application of well-established psychological theories, principally social
cognitive theory.
Cognitive–behavioural therapy and the Expert Patients Programme have shown some evidence of effectiveness
for improving function and pain and quality of life and self-efficacy.13,14,53 Cognitive–behavioural approaches
are typically delivered by HCPs and the Expert Patients Programme by laypeople. Our research shows that
courses delivered by HCPs have a more beneficial impact on pain-related outcomes, whereas lay-led courses
have a more beneficial impact on self-efficacy. Using both may optimise the potential for effectiveness but
perhaps reduce cost–utility; this will need testing in the trial.
Conclusions
The MRC guidance for developing complex interventions28 enabled us to develop and test an evidence-based
and theory-informed pain self-management course.219 The process enhanced the intervention and gave the
study team confidence in the modified intervention and trial procedures and processes necessary to run
efficiently a full effectiveness and cost-effectiveness RCT.
The development phase of this study was comprehensive and thorough. Funding external feasibility or pilot
studies has many ‘hidden’ benefits that may help ensure the success of large expensive trials. The feasibility
study gave the team knowledge and experience and on-the-job training to deliver the intervention and run
the trial. In addition, we were able to use existing contacts and peer networks and create new contacts
and networks to help recruit general practices and use our already-trained facilitators to deliver the courses
at the standard that we wanted.
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Chapter 9 Randomised controlled trial of the
clinical effectiveness and cost-effectiveness of
the COPERS intervention: methods
Abstract
In part II of this report we describe how we tested the clinical effectiveness and cost-effectiveness of our
self-management programme in a large RCT.
Aim
To establish the effectiveness and cost-effectiveness (expressed as the cost–utility) of the new
self-management intervention (COPERS) for patients with chronic musculoskeletal pain when added to
usual care plus a relaxation CD of simple relaxation exercises.
Study objective
To test the clinical effectiveness of a self-management course for chronic pain and usual care compared
with usual care plus an education leaflet and a CD of simple relaxation exercises with respect to (1) the
primary clinical outcome of pain-related disability and (2) the secondary outcomes: anxiety, depression,
coping skills, chronic pain acceptance, social integration, self-efficacy, being prescribed analgesics and
being prescribed weak and strong opioid drugs.
Methods: effectiveness study
Figure 12 illustrates the recruitment process and the different stages of the trial. This was a two-arm RCT
with a follow-up period of 12 months to assess participant outcomes.
Ethical approval
The study was approved by the Cambridgeshire Ethics Committee on 18 March 2011 (reference no. 11/EE/046).
Additional ethical approval was obtained to give participants unconditional £5 high-street shop vouchers
with the 6- and 12-month questionnaires and, on the advice of the TSC, to add questions about non-NHS,
pain-related personal costs at 12 months (7 October 2011). We sought further approval for additional
questions at 12 months enquiring about attendance at other similar or pain-related courses, new hobbies or
activities undertaken and any psychological help participants may have sought during the trial period
(August 2011–July 2012).
Recruitment
Recruitment of recruiting centres
The study was conducted in two areas: inner east London (Tower Hamlets, City and Hackney and Newham
Primary Care Trusts, which were coterminus with their respective London boroughs) and the Midlands
(Warwickshire and Coventry Primary Care Trusts). Thus, the COPERS study population included residents of
deprived inner-city areas and those living in affluent urban, suburban and rural settings.
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Assisted by the primary care research networks in London and the Midlands we invited all general practices
in both areas to recruit participants. We also invited intermediate and secondary care pain clinics,
rheumatology services and musculoskeletal physiotherapy services to recruit participants. Interested
practices and services signed a study agreement form and were reimbursed for all costs associated with
recruiting patients.
GP practices
Electronic record
searches
Potential participants screened by a
clinician according to eligibility criteria.
Eligible patients sent invitation pack
Participant completes
‘consent to approach’ form
Study team gives participant more
information and checks eligibility
according to criteria
Face-to-face
consultations
Adverts in waiting
rooms
Secondary care pain clinics and
physiotherapy units
Interested eligible participants are allocated a unique site-specific study
ID and sent cover letter about trial, participant information sheet,
trial consent form and baseline questionnaire
Follow-up
Self-efficacy questionnaire only 12 weeks
All outcomes, 6 and 12 months
Health records checked, 12 months
Patient returns questionnaire and trial
consent form
Study team telephones participant. Baseline questionnaire checked and
consent is validated. Participant is randomised using live online system and
informed of allocation. GP is informed of participant enrolment
Intervention: self-management
plus usual care
Participant booked on course.
Participant receives ‘Pain
Toolkit’ and relaxation CD
when course complete
Participant sent relaxation
CD with instructions and
‘Pain Toolkit’
Control: usual care, ‘Pain Toolkit’ and
relaxation CD
Participants sends ‘consent to
approach’ form or contacts study 
team by telephone or e-mail
FIGURE 12 Recruitment process and different stages of the trial.
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Recruitment of participants
Participants were recruited in three ways:
l searches of general practice/service electronic patient records
l clinician referrals during face-to-face consultations (GPs, pain physicians, rheumatologists
or physiotherapists)
l through posters displayed in clinics advertising the study.
Recruitment of participants from general practice
Each practice designated a key contact to liaise with the study team. The contact was given a standard
operating procedures booklet for the study and was responsible for maintaining the master list of those
approached securely within the practice. The electronic searches were conducted by practice staff with the
support of the study team. No single computer code for a diagnosis of chronic musculoskeletal pain is
routinely used in primary care and so we developed a new search strategy to identify potential study
participants. Full details of the development of our general practice search strategy and its rationale are
described elsewhere.206 In summary, during extensive consultation and piloting of searches we noted the
different coding and prescribing ‘cultures’ in individual practices. Therefore, there was no definitive final
search and each search was tailored to the individual practice but constructed using the same principles.
Whenever possible searches followed three stages:
l Stage 1. We selected patients who were aged ≥ 18 years and who were registered with the general
practice and had consulted within the previous 6 months.
l Stage 2. Within the population identified in stage 1 we searched for repeat prescribing information for
a variety of drugs associated with chronic pain including low-dose tricyclic antidepressants, strong and
weak opioids, non-steroidal anti-inflammatory drugs (NSAIDs), pregabalin and gabapentin. We chose
the drugs most commonly prescribed within each individual practice and excluded opiates more
commonly used in palliative care (e.g. slow-release morphine).
l Stage 3. We searched the population identified in the first two stages by high-order Read
(classification) codes for low back pain, back pain, OA and fibromyalgia and/or other codes commonly
used by the practice staff for musculoskeletal conditions.220
This strategy generated a list of potential participants, who were screened by their GP for suitability to
ensure that no vulnerable people were approached (see inclusion and exclusion criteria). From previous
searches and test runs we estimated that this search would yield around 5% of the registered patients,
which is consistent with the National Pain Audit finding that 6.4% of the population have chronic pain
(the exact figure varies by definition of chronic pain).221
General practices sent all screened potential participants an invitation letter to the trial from each patient’s
own GP. These were placed in preprepared envelopes that contained a consent to approach form, a
patient information leaflet and a Freepost envelope for returning the consent to approach form to the
study team. The general practices sent a postal reminder letter 10–14 days later if the study team had not
received a response. The general practices provided us with an anonymised list of all of the patients invited
into the study, which described only gender, age and ethnicity (if available).
General practitioners were also able to recruit patients directly into the study by offering an information
pack or the study contact telephone number during a consultation. In addition, we placed posters about
the study in practice waiting areas. This served as both a prenotification for participants approached by
post or during a consultation and an opportunity for people to self-refer into the study. Those who wanted
to refer themselves into the study could obtain information packs from the practice reception or by
telephoning the study team.
We recruited from general practices in three waves, within sublocalities, to ensure that we had a sufficient
flow of randomised participants living near enough to attend the intervention courses. At the time of the
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initial telephone contact with the study team potential participants were informed of the date and location
of the course that they would attend if randomised to the active intervention. Completion of the baseline
questionnaire and consent form could be deferred if a potential participant was unable to attend the next
available course.
Recruitment of participants from other services
Recruitment processes in other services followed a similar general approach to that in general practices but
we did not design a specific computer search for these services. When a service had a suitable electronic
record identifying patients consulting for chronic musculoskeletal pain invitation packs were posted by the
service with a covering letter signed by the treating clinician. Otherwise patients were recruited directly by
the treating clinician or through self-referral.
Consent and withdrawal
We obtained participant consent in two stages. First, we sought consent for the study team to receive
contact details to allow an approach (the consent to approach form). Second, on enrolment to the trial
participants provided informed consent, including consent to access routine NHS records. Full details of the
study procedures around consent are available in Appendix 6.
Participants were free to withdraw from the study at any time and without explanation; on formal
withdrawal from the study we ceased to collect further questionnaire data but, when possible, we asked
participants if we could still collect patient record data at 12 months. If we could not contact participants
we assumed that this permission was withdrawn as well.
Inclusion criteria
l People aged ≥ 18 years with musculoskeletal pain of > 3 months’ duration.
l Available to participate in an intervention course if randomised to the intervention arm.
l The IASP17 defines chronic pain as that which has persisted beyond normal tissue healing time, usually
interpreted as 3 months. Causes/types of pain included, but were not restricted to, OA, back pain,
chronic widespread pain and fibromyalgia.
Exclusion criteria
l Unable to give informed consent.
l Not fluent in English.
l Life expectancy of < 6 months.
l Presence of chronic pain arising from active malignant disease.
l Presence of inflammatory arthritis such as rheumatoid arthritis.
l Presence of a serious comorbidity that was more disabling than chronic pain.
l Poorly controlled serious mental health illness that would make it difficult to participate in
the intervention.
l Misusing substances to an extent that would make it difficult to participate in the intervention.
We excluded people living with chronic pain arising from malignant disease because this requires specific
management. However, chronic pain in people living with or beyond cancer may arise from non-malignant
causes and such patients were eligible for our study.
We restricted the study to those who were fluent in spoken English for practical reasons:
l The interactive, participatory nature of the intervention meant that it was unsuitable for delivery
through an interpreter or advocate.
l Our systematic review (see Chapter 3) identified that lack of fluency in the language of the programme
was associated with lack of clinical effect.
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l The only language other than English that was sufficiently common to consider running courses in the
study recruitment areas was Sylheti. We piloted delivering the intervention in Sylheti and found
that it was not feasible to include a Sylheti language stream in the evaluation of the intervention
(see Chapter 7).
l The validity and reliability of the outcome measures translated into languages other than English have
not always been established.
People with serious mental health problems or substance abuse problems were able to join the study.
They were excluded only if their GP, or other screening clinician, judged that their current problems were
so severe that they were likely to cause difficulties within the group sessions or if patients themselves felt
that this might be the case.
Randomisation
The randomisation ratio between the intervention and control arms was 1.33 : 1 (see Sample size for an
explanation). Randomisation was overseen and implemented by the PCTU at Queen Mary University of
London. Participants were randomised after the study team had received signed informed consent and the
completed baseline questionnaire. Strict allocation concealment was maintained through the use of
Sheffield University’s Clinical Trials Research Unit’s web-based, real-time, randomisation programme,222
which was accessed by the study team while on the telephone to participants to avoid having to call them
again. Randomisation was performed using random permuted blocks stratified by site of recruitment, with
randomly varying block lengths of seven and 14. All randomisations were logged using an online audit trail
of use according to each user ID.
Interventions
The active intervention
The intervention was a group-based facilitated learning course about chronic pain. The course had
24 distinct components (also called sessions) covering various aspects of pain education and pain
management. At the end of the 3-day course participants received the same relaxation CD and self-help
booklet as those in the control arm.
We aimed to include around 12 participants per course. The minimum number of participants required for
a course to take place was eight and the maximum was 16. When a course was undersubscribed prior to
the course running those registered were offered alternative courses. Our target was that all participants
randomised to a course should start the course within 8 weeks of randomisation; whenever possible
participants were recruited onto the next available course. This was not always possible when participants
were booked on a course but were subsequently unable to attend; we gave participants a choice of up to
three dates or venues.
Recruiting and training intervention course facilitators
Courses were led by two facilitators, a HCP and a lay person. We recruited facilitators from a variety
of sources:
l HCPs. Relevant HCPs included chiropractors, GPs, occupational therapists, osteopaths, physiotherapists
and psychologists. Press releases were issued to professional magazines explaining that we were
seeking people who might be interested in becoming study facilitators. We also used our own peer
networks to recruit facilitators. Interested people submitted their curriculum vitae to the study team
and were interviewed by telephone. The recruitment criteria were experience with chronic pain
patients, articulate, empathic, having an interest in the psychological aspects of health care and
available to run at least two courses.
l Lay facilitators. Lay facilitators were recruited through an internet self-management news site
[www.self-management.org.uk (accessed 2010)] and community interest companies providing expert
patient self-management programmes. Interested people sent their curriculum vitae to the study team.
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The recruitment criteria for lay facilitators were interest and experience in facilitating self-management
or self-help groups, current or past personal experience of chronic pain and available to run at least
two courses.
Applicants meeting the recruitment criteria were invited to a local joint 2-day training course for lay and
professional facilitators. We invited the trained and experienced facilitators from the pilot study to
participate and paired these more experienced facilitators with the newly trained facilitators to optimise
delivery of the intervention.
The training course covered the course content, how to facilitate, dealing with difficult situations and what
to do if an adverse event occurred. During the course facilitators were required to demonstrate that they
were good listeners, empathic, flexible, able to encourage equal participation, able to encourage laughter,
able to manage difficult people and able to summarise sessions and put the course content into a chronic
pain context. Those who were evaluated by the study team as competent by structured observation
throughout the course and after a brief written ‘test’ at the end of the training were asked to facilitate
future intervention courses.
The control intervention
Those in the control arm received usual care and a copy of The Pain Toolkit booklet,207 a relaxation CD and
instructions for relaxation. During the study period 2011–12 The Pain Toolkit booklet was a free resource
for people with chronic pain distributed by the Department of Health; from 2009 to 2012, 250,000 copies
of the toolkit were distributed to health services. Because of its wide availability it can be viewed as a
component of good usual care. Control participants also received a simple relaxation pack in the form of
an audio CD with instructions for use and the rationale for the benefits of relaxation (see Appendix 6).
Participants were asked to practise the techniques on the CD every day for at least 3 weeks (the same
duration as the intervention) and as much as they liked thereafter. Both The Pain Toolkit booklet and the
relaxation pack were posted to control patients following randomisation.
Quality control and fidelity of intervention delivery
To promote fidelity of intervention delivery the first day of each course was observed by a member of the
study team experienced in delivering the intervention. In the case of first-time facilitators or facilitators who
expressed a lack of confidence the course was observed in its entirety. When necessary, immediate
feedback was given to facilitators during breaks in the course and at the end of each day, enabling them
to modify and improve their performance.
Our assessment of the actual fidelity of delivery of the intervention is described in detail elsewhere223 and
in Chapter 10. In summary, every course was audio-recorded. After all the courses had been delivered a
random selection of audio-taped sessions was chosen for formal evaluation of fidelity. The evaluators used
a checklist to record adherence to structure and content and facilitator competence.
Outcome measures
The rationale for our final choice of outcome measures is described in detail in Chapters 5 and 7.
All selected outcome measures were used with approval and licence when required.
Primary outcome measure
Our primary outcome was pain-related disability as measured using the pain-related function subscale of
the CPG175 at 12 months post randomisation. This measure has three items, each scored from 0 to 10, that
assess the extent to which the participants’ pain has, in the previous 6 months: (1) interfered with their
ability to perform their daily activities; (2) changed their ability to take part in recreational, social and family
activities; and (3) changed their ability to work. The pain-related disability score is the mean score for these
three items multiplied by 10 and is recorded on a scale from 0 to 100, with higher scores indicating worse
pain-related disability.
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Secondary outcome measures
l CPG pain-related disability subscale175 at 6 months post randomisation.
l CPG pain intensity subscale175 at 6 and 12 months post randomisation.
l HADS depression subscale176 at 6 and 12 months post randomisation.
l HADS anxiety subscale176 at 6 and 12 months post randomisation.
l EQ-5D169 at 6 and 12 months post randomisation.
l PSEQ181 at 12 weeks and 6 and 12 months post randomisation.
l CPAQ174 at 6 and 12 months post randomisation.
l heiQ social integration subscale187 at 6 and 12 months post randomisation.
l Census global health question209 at 6 and 12 months post randomisation.
l Total defined daily dose (DDD) consumed of psychotropic drugs up to 12 months post randomisation.
l Total DDD consumed of analgesics (including all opioids and other central nervous system drugs) for
pain up to 12 months post randomisation.
l Total DDD consumed of weak opioids up to 12 months post randomisation.
l Total DDD consumed of strong opioids up to 12 months post randomisation.
l Proportion of participants using weak opioids at 12 months post randomisation (defined as having
received a prescription for a weak opioid up to 12 weeks before the 12-month follow-up date).
l Proportion of participants using strong opioids at 12 months post randomisation (defined as having
received a prescription for a strong opioid up to 12 weeks before the 12-month follow-up date).
Additional baseline data collected
In addition, at baseline we collected:
l demographic data from participants, that is, age, gender, ethnicity
l pain duration
l living arrangements
l language fluency
l age at completion of education
l employment status.
Additional data collected at 6 and 12 months
Private health-care use was collected at 6 and 12 months:
l number of and money spent on non-NHS consultations (including complementary and
alternative consultations)
l type and number of and money spent on tests and investigations
l type of and money spent on medicines
l type of and money spent on devices and aids
l overnight admissions/stays in private hospitals
l money spent on support and help at home as a result of pain.
Additional data collected at 12 months
We also collected data about other activities and interests undertaken in the last year to test whether or
not participants were inspired to undertake other similar courses to help and/or manage their pain better.
We asked about:
l attendance on other similar courses
l psychological services accessed
l hobbies and interests undertaken on a regular basis
l regular relaxation undertaken.
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At 12 months the study team also collected data from participants’ general practice records for the
12 months post randomisation on:
l number and type of comorbidities
l number of consultations (doctor and nurse consultations and other face-to-face, telephone and home visits)
l hospital admissions
l referrals to outpatient services
l tests and investigations
l all medications prescribed (in addition we collected data on all medications prescribed in the 3 months
prior to randomisation).
We also collected secondary care information from the Secondary Uses Service (SUS) database.224
Schedule of data collection
Participants received follow-up questionnaires by post at 12 weeks and 6 and 12 months post
randomisation. Based on our systematic review225 (see Chapter 3), we hypothesised that improving
self-efficacy was the principal mediator of the expected benefits from a self-management intervention.
Improving self-efficacy was a key aim for the COPERS intervention. To ensure that we had evidence for any
effect that our intervention had on this hypothesised mediator we sent participants the PSEQ at 12 weeks.
At baseline and 6 and 12 months we collected all of our primary and secondary outcomes from
participants. We sent a postal reminder after 2 weeks if no response was received. If there was still no
response we collected the primary clinical outcome and the EQ-5D data needed for the health economic
analysis by telephone. We sent participants a £5 high-street shop voucher that was redeemable in multiple
stores with their 6- and 12-month questionnaires to encourage a response. The vouchers were given on a
non-conditional basis. This expression of appreciation has been shown to improve questionnaire return
rates, with a systematic review reporting that ‘the odds of response were more than doubled when a
monetary incentive was used (odds ratio 2.02; 95% confidence interval 1.79 to 2.27) and almost doubled
when incentives were not conditional on response (1.71; 1.29 to 2.26)’.226
At 12 months we collected health-care activity data from participants’ medical records for the 12 months
post randomisation and the 3 months prior to randomisation for our health economic analyses.
Figure 13 illustrates the data collected at each time point and how the data were collected.
Analysis of drug data
Medications used over a 15-month period were collected from participants’ medical records. We extracted
drug names and strength used plus quantity and dates prescribed. We used the Prescription Cost Analysis
(PCA) database227 to attach a cost to each individual preparation used. Using the World Health
Organization (WHO) DDD228 for each drug we generated the number of days of each medication used
organised by British National Formulary (BNF) chapter and subchapter.229 The WHO does not provide DDDs
for topical NSAIDs or rubefaciants and so we used a previously published report to define these.56
The total DDD consumed for each drug was defined as:
Total DDDDrugA = (strengthMedA × quantityMedA)=DDDMedA. (2)
The total DDD for a group of medications (e.g. the total DDD for opioids) was the sum of the total DDD
for each drug within that medication group (e.g. each drug that was considered an opioid). For example,
if there were three opioid drugs (drugs A, B and C), the total DDDopioid was defined as:
Total DDDopioid = total DDDDrugA + total DDDDrugB + total DDDDrugC. (3)
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The DDD (used in the denominator of the calculation for the total DDD) was determined in the first
instance using the WHO register, then by precedent in other trials56,230 and then by clinician consensus.
For compound drugs, for example co-codamol, we separated out the components (paracetamol and
codeine) and worked out the DDD for each component drug.
Medication outcomes
We considered the following outcomes:
l Total DDD consumed of psychotropic drugs up to 12 months post randomisation.
l Total DDD consumed of all analgesics up to 12 months post randomisation.
l Total DDD consumed of weak opioids up to 12 months post randomisation (codeine, dihydrocodeine
and meptazinol, as defined by BNF paragraph 4.7.2229).
l Total DDD consumed of all NSAIDs (oral and topical combined) up to 12 months post randomisation.
l Total DDD consumed of all central nervous system drugs for neuropathic pain up to 12 months
post randomisation.
l Total DDD consumed of strong opioids up to 12 months post randomisation (all opioids prescribed
other than the ones listed above as weak, as defined by BNF paragraph 4.7.2229).
Calculations were based on BNF subchapters 4.1 and 4.3 for psychotropic drugs, BNF paragraph 4.7.2
for opioids and BNF paragraphs 4.7.1, 4.7.2 and 4.7.3 and paragraphs 10.1.1, 10.2.2 and 10.3.2 for
analgesics including opioids229 (Table 33). These are drugs used for treating chronic pain. We excluded all
drugs administered as injections but included topical preparations, patches and liquids.
Baseline data collection (self-report via questionnaire)
General health, pain duration, CPG, EQ-5D, pain self-efficacy, CPAQ, HADS,
heiQ, age, gender, ethnicity, employment status, education status
12-week data collection (self-report via questionnaire)
Pain self-efficacy questionnaire
6-month data collection (self-report via questionnaire)
CPG, EQ-5D, general health, pain self-efficacy, CPAQ, HADS, heiQ, private
health-care use
12-month data collection (self-report via questionnaire)
CPG, EQ-5D, general health, pain self-efficacy, CPAQ, HADS, heiQ, private
health-care use, other interests
12-month NHS resource-use data collection
Extracted from participant primary care patient electronic health record
Extracted from secondary user services data records
FIGURE 13 Follow-up data collection.
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Adverse event reporting
An adverse event was defined as any untoward physiological or psychological occurrence in a subject to
whom the intervention or control intervention was administered.
We defined serious adverse events as:
l death
l life-threatening events
l events necessitating hospitalisation
l events resulting in persistent or significant disability or incapacity
l events otherwise considered medically significant by the chief investigators.
Minor adverse incidents, for example a participant being tearful and distressed during a session, were
logged and fed back to the study team by the end of the course.
If a course participant experienced an adverse event the facilitators were required to notify the study manager
and, if necessary, the chief investigators immediately. The study team would then inform the Research Ethics
Committee and the sponsor if, in the opinion of the chief investigators, the event was serious and (1) related
to the COPERS intervention or (2) unexpected and possibly related to the COPERS intervention.
Details of any adverse events were recorded and stored in the trial master file.
TABLE 33 Pain-related drugs
Drugs
BNF
CommentsChapter Subchapter Paragraph
Psychotropic 4. Central nervous
system
4.1 Hypnotics and
anxiolytics
4.1.1 Hypnotics Not chloral and derivatives,
clomethiazole or
antihistamines4.1.2 Anxiolytics
4.3 Antidepressant
drugs
4.3.2 Monoamine oxidase
inhibitors
4.3.3 Selective serotonin
reuptake inhibitors
4.3.4 Other antidepressant
drugs
Analgesic 4.7 Analgesics 4.7.1 Non-opioid analgesics 4.8.1 Gabapentin and
pregabalin feature as
antiepileptics but also
feature in 4.7.3 Neuropathic
and functional pain. For this
analysis 4.3.1 Tricyclic
antidepressants are included
in paragraph 4.7.3
4.7.2. Opioid analgesics
4.7.3 Neuropathic and
functional pain
10. Musculoskeletal
and joint diseases
(exclude steroids,
DMARDs)
10.1 Drugs used in
rheumatic diseases
and gout
10.1.1 NSAIDs Exclude aspirin; no steroids
10.2 Drugs used in
neuromuscular
disorders
10.2.2 Skeletal muscle
relaxants
10.3 Drugs for the
relief of soft tissue
inflammation
10.3.2 Rubefacients and
other topical antirheumatics
Not enzymes
DMARD, disease-modifying antirheumatic drug.
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Sample size
The sample size calculation was based on detecting a SMD of 0.3 in pain-related disability between the
intervention group and the control group, with 80% power and at a 5% significance level. This effect size
was commensurate with the largest change seen in a systematic review of Expert Patients Programmes14
and also with the sort of change effected by interventions for other chronic pain syndromes, such as low
back pain, on any continuous outcome measure. An initial sample size calculation indicated that we would
require data on 350 subjects (175 in each group). We inflated the sample size because of the possibility of
a ‘clustering’ effect in the group intervention arm and chose a ratio between intervention participants and
control participants to maximise statistical efficiency.231 Using an intracluster correlation coefficient (ICC) of
0.1 and assuming an average of nine individuals in each group (from an average of 13 individuals recruited
to each group, with a 30% loss to follow-up) meant that 480 individuals were needed, with 275 in the
intervention group and 205 in control the control group (ratio of 1.33 : 1 between the intervention group
and the control group). Allowing for this very conservative estimated 30% loss to follow-up we originally
sought to randomise 685 participants (391 intervention participants and 294 control participants).
Previous research221 and electronic record searches in the pilot study indicated that around 5% of adults on
GP registers consult with chronic musculoskeletal pain. Based on our pilot study we estimated that 10% of
these may be interested in participating in the trial and around half of these would be recruited into the trial.
Around 80% of the population consists of adults aged > 18 years [www.statistics.gov.uk (accessed
19 April 2016)]. This meant that to recruit 685 participants we needed a population base of around 342,000
registered patients, assuming that 80% (approximately 274,000) would be adults. Of these, 5% would be
identified from searches as having chronic pain (n = 13,700), of whom around 10% might express an
interest in participating in the study (n = 1370). Half of these might be recruited and enrolled (n = 685).
Using an average total practice list size of 7000, this equates to around 49 practices. We estimated that we
would recruit between 12 and 14 patients per practice.
Blinding and protection from bias
All baseline data were collected by self-completed questionnaire prior to randomisation. After allocation,
however, it was impossible to blind participants to treatment allocation because of the nature of the
intervention. General practices and clinicians were informed of their patients’ enrolment into the trial but
not their treatment allocation, although participants were free to divulge this information to their
clinicians. We felt that this information in itself would have little impact on their care. Outcome data were
collected using a participant-completed postal questionnaire. Complete blinding of the research team was
not possible because of the need to manage course attendance and the unbalanced randomisation.
Whenever possible we blinded the research team to treatment allocation during outcome data collection,
for example, for those who did not return their questionnaire after the second reminder, primary outcome
data and the EQ-5D instrument were collected over the telephone by research personnel blind to
treatment allocation using a set script, asking participants not to divulge their allocation prior to collecting
their data. To achieve this blinding London staff contacted Midlands patients and vice versa. Patient record
data, such as GP consultations, hospital admissions and drug usage, were extracted by personnel blind to
treatment allocation. All data were coded according to participants’ study ID and notes were anonymised
as much as possible by clinical staff at the practices.
Data management
All data were managed in line with Queen Mary University of London’s PCTU standard operating
procedures and were subject to review by PCTU staff audit and the Data Monitoring and Ethics
Committee. All electronic participant data were stored in encrypted and/or password-protected files in a
secure environment. A database was designed to manage the data input to ensure consistency of practice
and coding, with a built-in audit trail that enabled us to track all entries and changes. Regular audit and
double-checking of all primary outcome data was conducted to ensure the accuracy of data entry and a
further random 10% of all data were double entered.
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Statistical analysis
Our statistical analysis plan has been published elsewhere.232 We briefly summarise the analytical approach
used here.
The main analysis for each outcome followed ITT principles, meaning that all participants with a recorded
outcome were included in the analysis233 and were analysed according to the treatment group to which
they were randomised.
All analyses accounted for clustering by course in the intervention arm,234,235 Participants in the control arm
(who did not attend courses) acted as their own cluster (i.e. we analysed the data as if each participant in
the control arm belonged to a ‘course’ in which he or she was the only member).
Site of recruitment (London or Midlands), age, gender and HADS depression score at baseline were
included as covariates in each analysis.236–239 Additionally, for continuous outcomes (CPG pain-related
disability, CPG pain intensity, PSEQ, HADS anxiety, HADS depression, CPAQ, heiQ and EQ-5D), the
outcome measured at baseline was included in the analysis. Continuous covariates (age, HADS depression
score at baseline) were assumed to have a linear relationship with the outcome.
Analysis of the primary outcome
The primary outcome (CPG pain-related disability at 12 months) was analysed using a mixed-effects linear
regression model with ‘course’ as a random effect. Restricted maximum likelihood was used. The model
included site of recruitment, age, gender, HADS depression score at baseline and CPG pain-related
disability at baseline as covariates.
All participants who completed at least one of the three questions that form the CPG pain-related
disability score at either 6 or 12 months were included in the analysis. Participants who did not fill out any
portion of the CPG pain-related disability score at either 6 or 12 months were excluded from the analysis.
Multiple imputation (MI)240 was used to account for participants who had an observed outcome at
6 months but who were missing the outcome at 12 months, as well as participants who completed some
but not all of the questions on the CPG pain-related disability scale at 12 months. Imputation was
performed using REALCOM-IMPUTE version 1.0.20 (University of Bristol, Centre for Multilevel Modelling;
www.bristol.ac.uk/cmm/software/realcom/).241
Twenty imputations were performed and the results were combined using Rubin’s rules.240 Only
participants who were to be included in the analysis were included in the imputation model. Imputation
was performed separately within each study arm. The imputation model included the three questions that
form the CPG pain-related disability score at baseline and 6 and 12 months as well as site of recruitment,
age, gender, the HADS depression score at baseline and employment status (employed or in full-time
education vs. not employed or in full-time education) (14 variables in total). In the intervention arm,
multilevel imputation was performed, with ‘course’ included in the imputation model as a random effect.
Missing data in any of the covariates to be adjusted for in the analysis (site of recruitment, age, gender,
HADS depression score at baseline, CPG pain-related disability at baseline) were accounted for using the
same MI model as above.
Sensitivity analyses for the primary outcome
We performed three sensitivity analyses242 for the primary outcome to assess the robustness of the results
to other methods of accounting for missing data. The first sensitivity analysis involved specifying a different
imputation model than that used in the primary analysis and the last two sensitivity analyses involved
reanalysing the primary outcome using two approaches that are not based on MI.
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Sensitivity analysis 1
We determined which baseline covariates are associated with loss to follow-up and included them in the
imputation model. The analysis model was the same as above except for the inclusion of additional
covariates in the imputation model.
Sensitivity analysis 2
We performed a complete case analysis in which all participants who did not complete all components of
the CPG pain-related disability scale at 12 months were excluded from the analysis. The analysis model
was the same as above except that missing baseline covariates were replaced using mean imputation.
Sensitivity analysis 3
We analysed the three components that form the CPG pain-related disability score at 12 months rather
than the CPG pain-related disability score itself. This was carried out by performing a multivariate analysis
in which each of the three components of the 12-month score was included in the model as an outcome
(i.e. each participant had three outcomes). A three-level mixed-effects model was used, with random
effects for ‘course’ and participant. Treatment–question interactions were included, allowing the treatment
effect to vary for each of the three components. An overall treatment effect for CPG pain-related disability
at 12 months was estimated using the lincom function in Stata version 14 (StataCorp LP, College Station,
TX, USA) to combine the treatment estimates from the three separate components. As above, missing
baseline covariates were replaced using mean imputation.
Participants with no completed follow-up data
The primary analysis assumed that the excluded participants (those not completing any questions on the
CPG pain-related disability questionnaire at both 6 and 12 months) were missing at random (i.e. they were
missing based on the covariates included in the analysis model). To assess the robustness to departures
from this assumption, the primary outcome was assessed under a range of missing not at random
scenarios. This was carried out using the formula ΔΔ = Δprimary + Y1P1 – Y2P2, where Δ is the treatment
effect under the missing not at random scenario, Δprimary is the treatment effect from the primary analysis,
Y1 and Y2 are the assumed mean responses for participants with missing data in treatment groups 1 and 2,
respectively, and P1 and P2 are the proportion of participants who were excluded from the analysis in
groups 1 and 2, respectively. The standard error for Δ was assumed to be approximately equal to the
standard error for Δprimary. Y2 varied between 10, 25, 50, 75 and 90 and, for each value of Y2, Y1 was set to
Y2 – 10, Y2 and Y2 + 10. For example, for Y2 = 25, Y1 varied between 15, 25 and 35.
Redefinition of the primary end point
The primary outcome was a composite of three questions. The first question (Q1) assessed to what extent
the participant’s pain had interfered with daily activities in the previous 6 months. This was assessed on a
scale of 0–10, with higher scores indicating more interference. The last two questions assessed to what
extent the participant’s pain had changed their ability to take part in (1) recreational, social and family
activities (Q2) and (2) work (Q3). Both of these questions were measured on a scale from 0 to 10, with
higher scores indicating more extreme change.
For the last two questions, higher change scores are meant to represent a higher negative change;
however, it is possible that some participants might have misinterpreted this and recorded a high score to
indicate a large positive change. We therefore performed a sensitivity analysis by redefining the outcome
for participants whose scores indicated that they might have misinterpreted the intended direction of the
questions relating to change.
For participants with a score of ≤ 2 for Q1 (indicating very little interference in daily activities) and a score of
≥ 8 for either Q2 or Q3 (intending to indicate an extreme negative change in their ability to take part in social
activities or to work), we assumed that the participant had misinterpreted the intended direction of the scale
for Q2 or Q3 (as it is inconsistent for the pain to have had very little interference in daily activities and for there
to have been an extreme negative change in the participant’s ability to take part in activities or work). We
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therefore rescored Q2 or Q3 based on a reverse scale (i.e. a score of 10 was rescored as 0, 9 was rescored as
1, 8 was rescored as 2, etc.). We reanalysed the outcome using the same method as for the main analysis.
Subgroup analyses for the primary outcome
Subgroup analyses were performed for the primary outcome (CPG pain-related disability at 12 months).
All subgroup analyses were performed using the same analysis model as for the primary outcome but also
included the subgroup of interest and a treatment–subgroup interaction. Interaction tests were considered
significant at the 5% level. No correction was made for multiple tests.
The following a priori subgroups were assessed:
l non-pain related:
¢ comorbidities: three or fewer compared with more than three comorbidities, including
musculoskeletal comorbidities
¢ living arrangements: living alone compared with living with others
¢ baseline self-efficacy: PSEQ score of 0–20 (not likely to be confident) compared with 21–39
(more likely to be confident and to self-manage) compared with ≥ 40 (confident)
¢ socioeconomic status (based on the Index of Multiple Deprivation 2010243), calculated from
participant postcodes via a geographical information system: lower social class (less than observed
median in data) compared with higher social class (equal to or greater than observed median in data)
l pain related
¢ pain duration: 0–12 months compared with 13 months to 4 years compared with ≥ 5 years
¢ baseline pain intensity: CPG intensity score of 0–3 (low) compared with 4–7 (medium) compared
with 8–10 (high)
¢ baseline pain-related disability: CPG disability score of 0–3 (low) compared with 4–7 (medium)
compared with 8–10 (high)
¢ baseline depression: HADS depression score of < 11 compared with ≥ 11.
Analysis of secondary outcomes
Chronic Pain Grade pain-related disability at 6 months
This outcome was analysed using the same methods as for CPG pain-related disability at 12 months.
Chronic Pain Grade pain intensity, Hospital Anxiety and Depression Scale anxiety
and depression and Health Education Impact Questionnaire at 6 and 12 months
These outcomes were analysed using the same methods as for CPG pain-related disability at 6 and
12 months.
Pain Self-Efficacy Questionnaire at 6 and 12 months
We had prespecified in the statistical analysis plan that this outcome would be analysed using the same
methods as for CPG pain-related disability at 6 and 12 months, except that the individual components of
the PSEQ score at 12 weeks were also included in the imputation model. However, we were unable to
perform the imputations because too many variables with missing data were included in the
imputation model.
Therefore, rather than including the individual components of the PSEQ at baseline, we tried to include the
overall score at baseline in the imputation model (setting scores to missing if participants had any missing
components). However, there were still too many variables with missing data in the imputation model and
the imputations did not work.
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We therefore tried using mean imputation to replace missing baseline scores with the overall mean PSEQ
score at baseline. This allowed us to include the baseline PSEQ score in the imputation model as an
auxiliary variable (as it contained no missing data) rather than as a variable with missing data that needed
to be imputed. This method allowed the imputations to proceed and so was the basis for the analyses of
the PSEQ at 6 and 12 months.
Chronic Pain Acceptance Questionnaire at 6 and 12 months
We prespecified in the statistical analysis plan that this outcome would be analysed using the same
methods as for CPG pain-related disability at 6 and 12 months, with the exception that we would include
only the individual questions for CPAQ at 6 and 12 months in the imputation model and include the full
CPAQ score at baseline (leading to 41 variables rather than 60). For participants who were missing the
CPAQ score at baseline, we used mean imputation. However, we were unable to perform the imputations
because too many variables with missing data were included in the imputation model.
To reduce the total number of variables, we combined the individual components into pairs, leading to
10 pairs of two components at each time point. For example, if Q1, Q2, . . ., Q20 are the 20 individual
questions that form the overall CPAQ score at any time point, we generated 10 pairs as:
P1 = Q1 + Q2, P2 = Q3 + Q4, . . ., P10 = Q19 + Q20. (4)
We set P to missing if either of the Qs involved was missing. We then included the Ps in the imputation
model at 6 and 12 months, reducing the total number of variables from 40 to 20. This method allowed
the imputations to proceed and so was the basis for the analyses of the CPAQ at 6 and 12 months.
European Quality of Life-5 Dimensions at 6 and 12 months
The EQ-5D was analysed using the same analysis model as for the primary outcome (i.e. mixed-effects
linear regression model with ‘course’ as a random effect, adjusted for site of recruitment, age, gender,
HADS depression score at baseline and EQ-5D at baseline).
All participants who fully completed the EQ-5D at either 6 or 12 months were included in the analysis.
EQ-5D scores with missing components were regarded as completely missing.
Multiple imputation was used to account for participants who were missing the outcome at either 6 or
12 months. The MI strategy was the same as that for the primary and other secondary outcomes, except
that, instead of imputing the individual components of the EQ-5D score, we imputed the whole score.
Census global health question at 6 and 12 months
This outcome was analysed using a mixed-effects ordered logistic regression model with ‘course’ as a
random effect. Site of recruitment, age, gender, HADS depression score at baseline and the outcome at
baseline were included as fixed covariates.
All participants who completed the census global health question at either 6 or 12 months were included
in the analysis.
Multiple imputation was used to account for participants who were missing the outcome at either 6 or
12 months. The MI strategy was the same as that for the primary and other secondary outcomes, except
that we imputed the whole score (as there are no individual components).
Total defined daily doses up to 12 months post randomisation for psychotropic drugs,
drugs for pain, weak opioids and strong opioids
These outcomes were analysed using a mixed-effects linear regression model with ‘course’ as a random
effect. Restricted maximum likelihood was used. The model included site of recruitment, age, gender,
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HADS depression score at baseline and total DDD in the 3 months before randomisation as covariates.
All participants who had data on total DDD up to 12 months post randomisation were included in the
analysis. Mean imputation was used for missing baseline covariates.
Proportion of participants using weak opioids and strong opioids at 12 months
post randomisation
These outcomes were analysed using a mixed-effects logistic regression model with ‘course’ as a random
effect. The model included site of recruitment, age, gender, HADS depression score at baseline and weak
or strong (depending on outcome) opioid use at baseline (defined as a prescription for weak or strong
opioids in the 12 weeks before randomisation) as covariates. All participants who had data on whether or
not they had had a weak/strong opioid prescription at 12 months were included in the analysis.
Adherence-adjusted analyses
The primary complier average causal effect (CACE) analysis for each outcome was adjusted for all of the
baseline covariates included in the primary analysis models, namely site of recruitment, age, gender and
HADS depression score at baseline and the corresponding outcome at baseline. As a sensitivity analysis we
also conducted CACE unadjusted analyses. We assumed:
l that randomisation was a valid instrument for treatment received
l that the intervention was not available outside the trial
l the stable unit treatment value assumption
l monotonicity
l that exclusion restriction assumptions hold.
We used two-stage least-squares estimation on the multiply imputed data.
We predefined four levels of adherence (or exposure) to the intervention: none; low adherence – less than
seven sessions (≤ 1 day); medium adherence – eight to 16 sessions; and adherent – ≥ 17 sessions
attended. Day 1 included seven sessions, day 2 included eight sessions, day 3 included seven sessions and
the follow-up included two sessions. We defined ‘compliers’ as those who attended at least half of the
course (i.e. those present for at least 12 of the 24 course components).
Ethical considerations
There were few ethical concerns with this study. To maintain patient confidentiality only the clinical staff
and primary care research network were able to search clinical records and invite suitable patients to
participate. Research staff provided guidance and advice when needed and when confidentiality could be
maintained. Only potential participants who had provided their contact details to the research team were
approached. Patients received one reminder letter if they did not respond.
The risks to the participants in this study were low; however, the study team was aware that the course
could trigger emotional reactions. We therefore ensured that the facilitator training course trained
facilitators in distress management. Each course had two facilitators so if any participant became unduly
distressed he or she was helped by a facilitator who, if necessary, and with the participant’s agreement,
withdrew the participant from the group and helped him or her until he or she was ready to return to
the group, go home or seek further help from a more suitable HCP. Under no circumstances was a
participant left alone while distressed. If the facilitators felt that a participant was a danger to him- or
herself or others, they sought permission to contact the participant’s GP or take him or her to an
emergency department.
We ensured that another member of the study team was always available by mobile phone for the
duration of any course should any emergency advice be needed.
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Methods: health economic analysis
For the economic analysis we adopted a NHS perspective spanning primary, secondary and intermediate
health-care sectors, given that the poor reporting of out-of-pocket expenses made it difficult to reflect
a wider societal perspective. Economic evaluation followed the National Institute for Health and Care
Excellence (NICE) Guide to the Methods of Technology Appraisal 2013.244
Microcosting of the intervention
A microcosting of the self-management course for primary care patients with chronic musculoskeletal pain
included a bottom-up construction of the costs associated with setting up and delivering the programme.
The course running costs included salaries, room rental, course materials, facilitators’ travel expenses and
administration costs. The cost of training facilitators included salaries and travel expenses (for both trainers
and facilitators), room rental, course materials and administration costs. Courses were run in multiuse
settings and the same daily rate was used for all venues. Trainers and facilitators were paid a fixed fee
per session. Assumptions used in the microcosting are summarised in Appendix 6. The costs of the
intervention were estimated as a cost per course and a cost per participant. Costs associated with usual
care included the costs of the pain education booklet and the relaxation CD.
Cost of the intervention per participant
The estimated cost of the intervention per participant was based on the number of participants enrolled on
the courses. The average cost per participant was estimated with and without the costs of staff training.
The average cost of the intervention for each region (London and the Midlands) is reported without
training, given that the two centres shared training costs. Sensitivity analyses were conducted using the
minimum and maximum number of participants who could be enrolled on each course.
Use of health-care resources by participants
Service use data (all providers) were collected for each participant from GP electronic records at the 12-month
follow-up. In addition, information about prescribed medication over the 3-month pre-randomisation period
was requested to account for possible differences in baseline prescribing between the intervention group and
the control group. To obtain these data, practices produced a printout of all prescriptions issued over a
15-month period for each participant. These data were then manually entered into a master database for
analysis by product name and strength. This allowed both allocation of costs and the calculation of the
number of days each medication was prescribed. Data relating to secondary care use over the 12 months
since randomisation were downloaded from the SUS database224 after 15 months. This allowed for a
3-month ‘lag’ in the availability of SUS data. The primary care data included consultations, prescriptions,
tests and investigations, and referrals to community care. Consultations included contacts with GPs, nurses,
health-care assistants and other health professionals such as specialist nurses, physiotherapists, psychologists,
counsellors, pharmacists, phlebotomists, dietitians, etc. Contacts with GPs and nurses also included telephone
consultations, out-of-hours services and home visits. Referrals to community care included rehabilitation
programmes, exercise programmes, community mental health teams, community diabetes teams and other
health professionals. Secondary care services included inpatient stays, outpatient appointments and accident
and emergency (A&E) admissions.
Cost of health-care services
Individual-level resource use data were combined with unit costs to calculate the total cost of health
service use for each participant. Primary care consultations and referrals to community care were costed
using the Unit Costs of Health and Social Care 2012.245 Unit costs that were not available in this source
were supplemented with costs from the National Schedule of Reference Costs 2011–2012.246 Tests and
investigations were costed using the National Schedule of Reference Costs 2011–2012, direct access
diagnostic and pathology services.246 The unit costs and assumptions used for costing primary health-care
services is shown in Appendix 6.
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Prescriptions were analysed using the PCA database 2011–12.227 Some items, however, were missing in this
database, whereas others had no cost per item. Costs missing in the PCA database were supplemented with
costs from other sources, including the BNF,229,247 the NHS Drug Tariff,248 the Monthly Index of Medical
Specialities249 and UK retailers’ price lists.250–252 The flow chart depicting the costing process is shown in
Appendix 6. Briefly, prescription items that were not found in the PCA database were first checked for
spelling. If costs were not identified after the spelling check, they were taken from the BNF edition
62 published in 2011229 or from the BNF website in September 2013.247 If costs were missing in the BNF, they
were sourced from the NHS Drug Tariff, the Monthly Index of Medical Specialties or retailers’ price lists (for
items other than drugs). Items missing in all of the above sources were substituted with alternative items from
the PCA database that contained the same active ingredients/strengths. Generic products were selected when
possible. Pack size was considered when indicated. When pack size was not indicated, the smallest pack size
was assumed. For items that were included in the PCA database but for which there were no costs, the cost
per item was taken from the BNF edition 62.229 Costs missing in the BNF edition 62229 were supplemented
with costs from the BNF 2013.247 Costs obtained from UK retailers were used without value-added tax.
The costs of secondary health-care services used by participants were downloaded as part of the SUS
database, and were used to cost the services received by participants due to the difficulties encountered in
matching the SUS data set to unit cost databases. When costs were not provided, the National Schedule of
Reference Costs 2011–2012246 was used. Outpatient costs were matched by specialty code. The average
unit costs (all NHS trusts) were used given insufficient information about the type of outpatient appointment
(consultant led/non-consultant led, face to face/non-face to face) provided by SUS. Inpatient and A&E
department costs were matched by the Healthcare Resource Group (HRG) code. The average HRG costs
(all NHS trusts) were used because of a lack of information about inpatient stay (elective/non-elective, short
stay/long stay) provided by the SUS. A&E department costs were assumed to be ‘not leading to admitted’.
Health-related quality of life
Health-related quality of life was measured using the EQ-5D at baseline and 6 and 12 months’ follow-up.
The EQ-5D is recommended by NICE244 and aims to measure the extent of problems across the domains of
mobility, self-care, usual activities, pain/discomfort and anxiety/depression using three levels of severity
(no problems, moderate problems and severe problems). The EQ-5D domain scores were converted to a
preference-based score using a tariff derived from members of the general public.253 EQ-5D scores at the
three time points (baseline, 6 months and 12 months) were then aggregated to estimate the total
quality-adjusted life-years (QALYs) for each participant over the 12-month period. More information about
QALY calculation is provided in the following section.
Data analysis
Data analyses were conducted using Microsoft Excel® 2012 (Microsoft Corporation, Redmond, WA, USA)
and Stata 12.1.254 The base-case cost-effectiveness analysis was conducted for the ITT population on the
imputed data set using a multilevel model (MLM). Sensitivity analyses were conducted using a generalised
linear model (GLM) and a seemingly unrelated regression (SUR) model. The secondary analyses were
performed on the non-imputed data set using a GLM, SUR and MLM. Per-protocol analysis was conducted
on the imputed data set using a MLM. Subgroup analyses included participants with different levels of
compliance and exposure to treatment. Additional subgroup analysis excluded participants with high
service use costs (top 5%). All subgroup analyses were conducted on the imputed data set using a MLM.
The intervention and follow-up period lasted for 12 months only so a discount factor of 1 was applied to
the costs and benefits following standard discounting practice.255
Missing data
The number of missing items in the health economics data set was analysed at baseline and 6 and
12 months’ follow-up. The proportion of missing data was reported for consultations, prescriptions,
investigations, referrals to community care, secondary care service use data and the EQ-5D. Baseline data
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were collected for prescriptions (3 months pre-randomisation) and the EQ-5D. There were two types of
missing data within the EQ-5D data set: missing items within a measure and missing measures at a
particular time point (baseline or 6 or 12 months’ follow-up). EQ-5D data were considered missing if there
were no data for at least one descriptive domain as this precludes calculation of total QALYs. Only data
missing at a particular time point were imputed for the EQ-5D. Within GP records and the SUS database
there was only one type of missing data, that is, when data were missing at a particular time point for all
items. The aggregate costs were therefore imputed for primary and secondary care services.
Use of health-care resources by participants
The use of health-care services by participants from the intervention and control groups was analysed in
quarters and over the entire duration of the trial. The number of contacts for each participant was extracted
from the GP and SUS databases and arranged into quarters starting from the randomisation date.
The following categories together accounted for approximately 95% of all primary care consultations:
contacts with GPs (surgery and telephone), nurses (surgery and telephone) and health-care assistants
(surgery). The category ‘other specialists’ included contacts with specialist nurses, physiotherapists,
psychologists, counsellors, pharmacists, phlebotomists, dietitians and other health professionals, which
together accounted for < 5% of all primary care contacts. It had been anticipated that the intervention
would predominantly affect the use of primary care services, such as GP and nurse consultations. Other
categories included in the resource use analysis were investigations, referrals to community care, inpatient
stays, outpatient appointments and A&E admissions.
Cost of health-care services
The use of health-care services by participants from the intervention and control groups was analysed in
quarters and over the entire duration of trial. Unit costs were assigned to each service category and
multiplied by the number of contacts. Differences in costs between the intervention group and the control
group, with 95% CIs, were estimated for consultations, investigations, prescriptions, referrals to
community care, outpatient attendances, inpatient stays and A&E admissions.
Quality-adjusted life-years
The total QALYs over the 12-month period were estimated using the area-under-the-curve method.
Two formulae for the area-under-the-curve calculation were compared: trapezoidal and Simpson’s rules.256
The trapezoidal rule assumes that data for different time points (baseline and 6 and 12 months’ follow-up)
are connected by a straight line, whereas Simpson’s rule applies a quadratic polynomial function (i.e. a
parabola). Depending on the direction of QALY changes over time in the intervention and control groups,
these methods may produce different incremental QALYs. The trapezoidal method was chosen as the
more conservative method as Simpson’s method would potentially overestimate the difference in QALYs
between the intervention group and the control group.
Imputations
Missing data for costs and QALYs were imputed using a MI procedure in Stata 12.1. Missing data were
assumed to be missing at random. Patterns of missing data were not found to be related to patient
characteristics. Imputed data included total primary care costs, total secondary care costs, baseline
prescription costs and EQ-5D scores at baseline and 6 and 12 months’ follow-up. For each missing
category five data sets were imputed.257 Participants were excluded from imputations if they had more
than one missing time point for the EQ-5D. We used a single-level imputation procedure as ICCs for both
costs and QALYs were very low (< 0.001, 5–17 participants per cluster). Single-level imputations were
carried out using the Stata chained imputation procedure.258 Given the skewed distributions of cost and
QALY data we used the predictive mean matching imputation method, which has been recommended for
skewed distributions.259 Covariates included in the imputation were age, gender, site of recruitment
(London or Midlands), course and HADS depression score at baseline. Participants in the control arm were
considered in the analysis as their own cluster (course).
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Cost-effectiveness analysis
In the cost-effective analysis we assessed the incremental changes in costs and QALYs in the intervention
group compared with the control group (a cost–utility analysis). In the base-case analysis, costs and QALYs
were analysed using a mixed-effects linear regression model with ‘course’ as a random effect. Covariates
included in the model as fixed effects were age, gender, site of recruitment, treatment group, EQ-5D score at
baseline, prescription cost at baseline and HADs depression score at baseline. Sensitivity analyses were
conducted using a GLM and a SUR model. SUR assumes that costs and QALYs are drawn from a bivariate
normal distribution.260 Covariates included in the GLM were age, gender, site of recruitment, course, treatment
group, EQ-5D score at baseline, prescription cost at baseline and HADS depression score at baseline. The SUR
model included regression equations for costs and QALYs, each regressed on the above variables.
The outcomes of the cost–utility analyses were an incremental cost-effectiveness ratio (ICER) and the
probability of the intervention being cost-effective at the NICE threshold of £30,000 per QALY gained. The
ICER was estimated as the difference in mean total costs between the intervention group and the control
group divided by the difference in mean QALYs between the intervention group and the control group.
A parametric approach was then used to address the uncertainty around ICER point estimates for the
imputed data set.261 Briefly, this method involved calculating the net monetary benefit (NMB) for each
participant at different willingness-to-pay (WTP) thresholds,245 having first controlled for covariates using a
MLM, GLM or SUR model. We then used Rubin’s rule240 to estimate the mean and standard error of the
NMB for the intervention and control groups. The incremental net benefit (INB) was estimated for
each WTP threshold (i.e. mean INB =mean NMB control –mean NMB intervention) and a normal
distribution was assigned to the INB based on patient-level data. The probability of the intervention being
cost-effective was estimated using 10,000 random samples from the above distribution.
Sensitivity analyses were conducted using the non-imputed data set (complete case analysis). Only
participants with a complete health economics data set were included in this analysis. The ‘complete’ data
set included EQ-5D data at baseline and 6 and 12 months’ follow-up, and resource use costs for primary
and secondary care over 12 months. Total costs and QALYs were analysed using a mixed-effects linear
model. Sensitivity analyses were conducted using a GLM and a SUR model. The non-parametric bootstrap
method was used to address the uncertainty around the ICER point estimates. The probabilities of the
intervention being cost-effective were estimated using both bootstrap and INB approaches.
The primary cost-effectiveness analysis was conducted on an ITT basis. Subgroup analyses were conducted
using the per-protocol population. Additional subgroup analyses included participants with different rates
of compliance and exposure to the intervention. Compliers were defined as individuals who attended
12–17 sessions and non-compliers were defined as those who attended ≤ 11 sessions. Full exposure to the
intervention assumed 17 sessions, moderate exposure 9–16 sessions and no exposure eight sessions or
fewer. The moderate-exposure subgroup was excluded from the cost-effectiveness analysis because of the
small number of participants (n = 23).
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Chapter 10 Fidelity
Abstract
Introduction: The fidelity of intervention delivery is crucial in any consideration of the results of the
intervention. Fidelity has many components but this study was concerned with the fidelity of intervention
delivery (intervention integrity), which was influenced by both the adherence of facilitators to the course
content and their competence (or skill) in delivering the intervention.
Aim: To assess how well the COPERS intervention was delivered during the trial by measuring the
adherence and competence of the facilitators delivering the intervention.
Methods: We identified seven of the 24 course components (or sessions) that we considered to be the
most important in terms of effecting participant behaviour change. All of the courses were audio-recorded
and intervention integrity was assessed by examination of the recordings of these seven components.
Checklists to capture adherence and competence systematically were designed. Researchers also gave an
overall impression rating for intervention delivery. We randomly selected four of the seven components
on each of the 31 courses. Using the appropriate checklist one evaluator listened to each recorded
component in its entirety and rated adherence, competence and overall impression. We checked the
intra- and inter-rater reliability.
Results: Intra- and inter-rater reliability were excellent for adherence, very good for competence and less
good for overall impression. Adherence was very good or excellent across the courses with competence
being more variable across the courses, being excellent for some sessions and less good for others.
The overall impression measure proved to be challenging to use and the data were difficult to interpret.
Conclusions: Overall, the results suggested that the COPERS course was delivered competently and
as intended.
Background
Complex interventions such as the COPERS intervention are recognised in MRC guidance28 as having varied
and challenging issues in terms of their design, evaluation and implementation. This guidance recognises
that intervention fidelity is underevaluated. Intervention fidelity is defined as the use of methodological
strategies to monitor and enhance the reliability and validity of behavioural programmes.214
The construct of ‘intervention fidelity’ originated from concerns about the ‘treatment integrity’ of
psychotherapeutic interventions expressed in the 1980s and 1990s.262–264 The monitoring, measurement
and assessment of intervention fidelity is important as it has been demonstrated that fidelity is a mediator
of study outcomes.265–268 For example, when interventions lack impact, this may reflect implementation
failure rather than genuine ineffectiveness. One of the potential explanations for the small effect sizes
generally seen in studies of self-management support14 may be the lack of intervention fidelity, but this is
rarely reported.
In the last 20 years the notion of intervention fidelity has become increasingly differentiated and
multilayered.269–271 There is an ongoing debate about how core elements of fidelity should be defined and
measured264,272 and a recognition of the need for reliable fidelity measurement instruments.273 There is
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little consensus about the key elements that contribute to intervention fidelity, possibly because it is a
multidimensional construct.268 Some authorities have identified five domains of fidelity:
1. study design
2. training
3. intervention delivery, defined as the monitoring and assessment of behaviours at the point of
intervention delivery
4. intervention receipt by participants
5. intervention enactment, defined as the extent to which participants apply the skills learned in their
daily lives.215,269
However, intervention enactment may be considered an outcome measure rather than an indicator of
fidelity. Here we focus on the domain of intervention delivery or integrity.
The effectiveness of complex interventions may also be dependent on the ‘skills’ of those delivering them.
‘Skills’ can be characterised by the separate, but related, constructs of adherence and competence:214
l adherence – the extent to which the intervention is delivered in the way that it was intended to be
delivered (as per protocol and/or design)
l competence – the level of ‘skill’ demonstrated by those delivering an intervention; this may include the
ability to respond appropriately to a wide variety of contextual cues.
Competence is less likely to be assessed than adherence. This may be a reflection of the debate
surrounding the definition of competence and ‘skill’,263 the methodological difficulties surrounding the
monitoring and measurement of competence274 and the significant expenditure of time and resources
required to collect and analyse competence data.263
Aim
The overall aim of the fidelity study was to assess how well the COPERS intervention was delivered by
measuring the adherence and competence of the facilitators delivering the intervention.
Methods
Setting and data collection
The research team identified seven of the 24 course components (or sessions) that they considered to be
the most important in terms of effecting participant behaviour change (Table 34). These components
focused on participant education and theoretically driven behaviour change techniques and strategies in
contrast to other components, which encouraged social interaction, relaxation and postural awareness.
All of the courses were audio-recorded and intervention integrity was assessed by examination of the
recordings of the components listed in Table 35.
Developing the intervention integrity measures
We used the monitoring and assessment tools from three previously published trials to inform the
development of the COPERS measures.53,275,276 The learning outcomes outlined in the COPERS facilitator
training course manual helped to design a provisional set of criteria to measure adherence and
competence. To develop the measures we used a two-stage pilot testing process.
Our adherence measure was designed to assess the delivery of key elements of each component as
described in the facilitators’ manual. The generic competence measure was designed to determine the
extent to which the facilitators created an environment in which participants could share their experiences
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and learn new skills. An overall impression score was designed to reflect the extent to which the aims and
objectives of the component were achieved and how the material was received by the group.
We tested a variety of scoring systems for adherence, competence and the overall impression score.
We found that each method of assessment had its own strengths and weaknesses. Numerical scales and
Likert scales seemed, intuitively, to be more suitable for measuring degrees of competence but they had
low levels of intra- and inter-rater reliability. Frequency methods of assessment were resource intensive and
time-consuming, had low levels of intra- and inter-rater reliability and were challenging to verify from
audio recordings only. Dichotomous response categories (such as yes/no, present/absent or occurred/did
not occur), when used to evaluate adherence items, were time efficient and had high intra- and
inter-rater reliability.
The research team revised and amended the evaluation forms. The final agreed measures consisted of
component-specific adherence forms, a generic competence form and an ‘overall impression’ scoring sheet
(see Appendix 7).
The option to transcribe the audio recordings was unrealistic because of the volume involved and potential cost;
evaluators were therefore asked to provide supportive quotations and or comments to justify their ratings.
Data analysis and presentation
Adherence measurement
The adherence form consisted of items that reflected the occurrence or non-occurrence of an event.
Component-specific items, relating to the key elements prescribed in the COPERS facilitators’ manual,
formed the basis of the assessments. The team added a third response of ‘unsure’ for cases when an item
was unclear. The evaluation forms allowed the assessors to add explanatory notes if necessary to justify the
categories chosen [these categories were ‘yes’, element occurred/was delivered (2 points); ‘no’, element
did not occur/was not delivered (0 points); and ‘unsure’ (1 point)].
The number of adherence items evaluated for each component varied (Table 35). To ensure that all scores
from the components were standardised to a consistent scale we summed the ‘raw scores’ for each
component and divided them by the total number of items for that component. For example, component
TABLE 34 Components evaluated for fidelity of intervention delivery
Component Component description
Component 2 (day 1): pain information Participants watched a DVD aimed at educating them about chronic
pain and introducing them, through facilitated discussion, to the notion
of acceptance of their pain
Component 3 (day 1): acceptance Participants were asked to consider a scenario about an uninvited/
unwanted guest as a metaphor for their pain
Component 5 (day 1): the pain cycle Groups were introduced to the pain cycle and the varied and individual
emotions and behaviours that may perpetuate that cycle
Component 9 (day 2): identifying problems,
goal-setting and action planning
Groups were introduced to strategies to enable them to systematically
identify problems, brainstorm creative solutions, set goals and devise
strategies to escape the pain cycle
Component 10 (day 2): barriers to change –
unhelpful thinking
Groups were encouraged to consider that reflexive, automatic thinking
patterns may prevent individuals from achieving their goals
Component 11 (day 2): barriers to change –
reframing negatives to positives
Participants were asked to consider what they were able to do rather
than what they were unable to do
Component 12 (day 2): attention control and
distraction
Participants were introduced to techniques that might enable them to
focus their minds away from thoughts about pain
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2 (pain information) had six adherence items with a maximum ‘raw’ score of 12 (6 × 2). The total
aggregate six-item score for this component was divided by 6. Thus, a maximum (100%) score was 2 and
a minimum score was zero.
Competence measurement
A competence evaluation form was designed to evaluate all of the course components. This generic measure
consisted of items related to the extent to which the facilitators introduced the aims/rationale of each
component, the success or failure of the facilitators to generate group discussion and individual disclosure,
whether or not the facilitators consolidated and summarised the participant learning at the conclusion of
each component and whether or not the facilitators linked that learning to other components in the course.
Assessment was scored as ‘yes’/demonstrated (2 points), ‘no’/not demonstrated (0 points) and ‘unsure’
(1 point). The scores were also standardised by dividing the maximum ‘raw’ score of eight by the number of
items (i.e. four); thus, the maximum score was 2 and the minimum score was zero.
Overall impression rating
We used an overall general impression rating scale ranging from 1 to 4, anchored at 1, ‘did not go well’,
and 4, ‘excellent’.
As the scores were not normally distributed, the median and 25th and 75th percentiles are presented.
Selection and assessment of components
We used a random sampling grid to select four of the seven selected components from each course. Using
the appropriate evaluation form one evaluator listened to each recorded component in its entirety and
rated adherence, competence and overall impression. A number of components could not be analysed
because of equipment failure, facilitator error, incomplete recording or poor sound quality; evaluators were
instructed to substitute that component with the next available selected component from that course.
Three members of the COPERS research team (DE, TM, KH) evaluated/assessed the audio recordings.
Intra-/inter-rater reliability
A total of 10% of the assessed component recordings were tested for intra- and inter-rater reliability.
Of this sample, a purposive sample of 10% of the evaluations that reflected a range of scores was used to
assess both intra- and inter-rater reliability. For inter-rater reliability each reviewer was asked to code a
session that had already been coded (they were blinded to the initial reviewer’s scores). For intrarater
reliability a period of at least 2 weeks between the first and the second evaluations was adopted.
We calculated the percentage agreement for each item rated on the evaluation forms.
Results
In total, 31 COPERS courses were delivered, 14 in London and 17 in Warwick. A total of 122 individual
COPERS components were assessed (see Table 35) amounting to approximately 71 hours of intervention.
Because of missing recordings two London courses were assessed on three rather than four components;
all Warwick courses were assessed on four components.
Intra-/inter-rater reliability
Intrarater reliability was measured using assessments from 16 COPERS components consisting of 94
adherence item scores, 64 competence item scores and 16 overall impression scores. Intra-rater reliability
was 91% for adherence items, 76% for competence items and 69% for overall impression scores.
Fifteen COPERS components were used to measure inter-rater reliability, consisting of 95 adherence item
scores, 71 competence item scores and 15 overall impression scores. Inter-rater agreement was 80% for
adherence items, 67% for competence items and 54% for overall impression scores.
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Adherence
Both COPERS study centres achieved the maximum overall course delivery adherence score (median 2.00);
however, there were some component score variations (Table 36). The lowest levels of adherence were
observed for component 10 (unhelpful thinking) [median 1.67, interquartile range (IQR) 1.67–2.00] and
component 2 (pain information) (median 1.75, IQR 1.42–2.00).
Competence
Competence scores exhibited higher levels of variability than adherence scores (Table 37). The overall
median course delivery competence score for both COPERS centres was 1.50 (IQR 1.25–2.00). In Warwick
the highest level of competence was for component 11 (reframing negatives to positives) (median 1.75,
IQR 1.25–2.00) and the lowest for component 12 (attention control and distraction) (median 1.13, IQR
TABLE 36 Overall adherence scores for London and Warwick
Component
Warwick
median
25th–75th
percentile
London
median
25th–75th
percentile
Warwick/London
median
25th–75th
percentile
2: Pain information 1.67 1.50–2.00 1.83 1.33–2.00 1.75 1.42–2.00
3: Acceptance 2.00 1.92–2.00 2.00 1.67–2.00 2.00 1.83–2.00
5: The pain cycle 2.00 1.75–2.00 2.00 2.00–2.00 2.00 2.00–2.00
9: Identifying problems, goal-
setting and action planning
2.00 2.00–2.00 2.00 1.91–2.00 2.00 2.00–2.00
10: Barriers to change –
unhelpful thinking
1.67 1.67–1.67 1.92 1.62–2.00 1.67 1.67–2.00
11: Barriers to change –
reframing negatives to
positives
1.70 1.60–2.00 2.00 2.00–2.00 2.00 1.60–2.00
12: Attention control and
distraction
2.00 1.67–2.00 2.00 1.83–2.00 2.00 1.67–2.00
Overall course adherence
score
2.00 1.67–2.00 2.00 1.83–2.00 2.00 1.67–2.00
TABLE 37 Overall competence scores for London and Warwick
Component
Warwick
median
25th–75th
percentile
London
median
25th–75th
percentile
Warwick/London
median
25th–75th
percentile
2: Pain information 1.50 1.13–2.00 2.00 1.25–2.00 1.75 1.25–2.00
3: Acceptance 1.50 1.38–2.00 1.25 1.00–2.00 1.50 1.00–2.00
5: The pain cycle 1.63 1.50–2.00 2.00 1.56–2.00 1.88 1.50–2.00
9: Identifying problems, goal-
setting and action planning
1.50 1.00–2.00 1.25 1.06–1.88 1.50 1.00–2.00
10: Barriers to change –
unhelpful thinking
1.50 1.50–2.00 1.38 1.00–1.56 1.50 1.00–1.81
11: Barriers to change –
reframing negatives to
positives
1.75 1.25–2.00 1.50 1.06–2.00 1.63 1.25–2.00
12: Attention control and
distraction
1.13 1.00–1.88 1.25 1.00–1.63 1.13 1.00–1.63
Overall course competence
score
1.50 1.31–2.00 1.50 1.00–2.00 1.50 1.25–2.00
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1.00–1.88). In London the highest level of competence was observed for component 5 (the pain cycle)
(median 2.00, IQR 1.56–2.00) and the lowest also for component 12 (attention control and distraction)
(median 1.25, IQR 1.00–1.63).
Overall impression scores
The median overall impression score for all courses was 3.00 (IQR 2.00–3.00). There was some component
score variability (Table 38). Component 12 (attention control and distraction) had an overall median
impression score of 2.00, reflecting the low facilitator competence scores for this component. Component
11 (reframing negatives to positives) had a similarly low overall median impression score of 2 (IQR
2.00–3.25), although this component was delivered with the maximum score for adherence (median 2.00,
IQR 1.60–2.00) and with good levels of competence (median 1.63, IQR 1.25–2.00).
Discussion
The aim of this study was to develop a methodology and assess the level of intervention integrity achieved
during the delivery of the COPERS self-management course in a RCT setting. Overall, the results suggested
that the COPERS course was delivered competently and as intended. We were satisfied that intervention
fidelity was acceptable and therefore that the results of the intervention are a reflection of an intervention
that was delivered well.
As has been pointed out by others, this work suggests that effective adherence in complex interventions
may involve not only the delivery of prescribed ‘surface’ content but also adherence to essential but
non-content-related ‘core’ theoretical/structural elements.270 Component 10 (unhelpful thinking) in the
COPERS programme illustrates the challenges in defining adherence in complex interventions. This
component was intended to help participants recognise and change patterns of automatic negative and
self-limiting thoughts. The COPERS manual outlined the informational content of this component and the
structure, sequence, timing and mode of delivery of the various elements to be used by the facilitators.
To deliver this component as prescribed, a high level of adherence to both ‘surface’ content and ‘core’
elements was required. Component 10 had a relatively low adherence score, which was primarily caused
by the facilitators’ difficulty in maintaining the complex structure of the component rather than a failure to
deliver the prescribed content.
TABLE 38 Overall impression scores for London and Warwick
Component
Warwick
median
25th–75th
percentile
London
median
25th–75th
percentile
Warwick/London
median
25th–75th
percentile
2: Pain information 3.00 2.00–3.00 3.00 3.00–4.00 3.00 3.00–3.00
3: Acceptance 3.00 2.00–3.00 3.00 3.00–4.00 3.00 2.50–3.00
5: The pain cycle 3.00 3.00–4.00 3.00 2.25–4.00 3.00 3.00–4.00
9: Identifying problems, goal-
setting and action planning
3.00 2.00–3.00 2.50 2.00–3.75 3.00 2.00–3.00
10: Barriers to change –
unhelpful thinking
2.50 2.00–3.00 3.00 2.75–3.25 3.00 2.00–3.00
11: Barriers to change –
reframing negatives to
positives
2.00 2.00–3.25 2.50 2.00–3.75 2.00 2.00–3.25
12: Attention control and
distraction
2.50 2.00–3.00 2.00 1.00–3.00 2.00 1.75–3.00
Overall course impressionistic
score
3.00 2.00–3.00 3.00 2.00–4.00 3.00 2.00–3.00
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Component 10 also demonstrated that the constructs of adherence and competence are complex and
may be seen to overlap. Competence, defined as the skilful delivery of content, implies some level of
adherence. However, adherence, defined as the extent to which content is or is not delivered, does not
imply any degree of skill or competence. High levels of content adherence may be associated with a
mechanistic, inflexible or unresponsive delivery style and therefore with low levels of competence.263
However, within component 10, facilitator ‘failure’ to order the component content as prescribed, that is,
low structural adherence, was directly related to low levels of competence. Component content designed
to promote group participation, if poorly sequenced or timed, resulted in a didactic/mechanistic delivery
style that inhibited rather than encouraged group disclosure and discussion.
Seemingly low levels of adherence may not necessarily be associated with poor intervention delivery. In
component 2 (pain information), some facilitators deviated from the prescribed content of the manual (and
were by definition non-adherent) but these deviations could be reinterpreted positively as the facilitators
had responded to individual or group need or intervention receipt. Some of the facilitators reframed
questions and subtly changed delivery from the prescribed content in the manual but they still achieved
the component’s overall aims and objectives. This may be a demonstration of high levels of facilitator
competence despite them being rated as non-adherent.270 There is, as yet, little empirical work that
demonstrates the conditions that may influence adaptation or reinvention or whether, and in what
circumstances, these deviations from prescribed protocol may enhance outcomes or decrease effectiveness.
The monitoring and assessment of competence within the COPERS study illustrated the difficulties
associated with its measurement. Competence can be considered as a complex construct that includes the
ability to establish collaborative relationships and form alliances with participants277 through the use of
responsive tailoring of programme content,276 the pacing of delivery278 and the use of positive verbal and
non-verbal behaviours.279
The findings from the COPERS study support the view that competence is considered to be more
contextually and/or externally or environmentally dependent than adherence. The greater variability in the
competence scores than in the adherence scores reflects, in part, the diversity of facilitator skills required to
deliver the COPERS programme and the recognised practical and methodological difficulties in measuring
what may seem to be a subjective concept.215,263
For example, facilitators were required to encourage participant reactions, elicit individual narratives and
generate group discussion and debate. They were also required to deliver complex component structures,
introduce their groups to new knowledge and skills and make the components individually relevant to
‘real-world’ situations, often while managing difficult situations, people and emotions. The COPERS study
demonstrated how competence and effective course delivery may be influenced and moderated by
many factors such as positive or negative individuals and/or groups, component content, facilitator and
cofacilitator teamwork and skill, issues related to the use of computer hardware and software, the venue,
the distribution of handouts, the use of flip charts, the co-ordination and organisation of group activities,
feedback and time management. Experience also influences competence; we noted that our facilitators
improved with each course that they conducted. Our ratings might also reflect the inexperience of the
facilitators who were delivering a new initiative.
The overall impression measure was, in part, designed to reflect some of the ‘non-facilitator-determined’
factors not evaluated by the adherence and competence measures. This subjective measure assessed
the extent to which the delivery of each component achieved its specific aims and was consistent
with the goals of the wider programme. The overall impression measure proved to be challenging to
use and the data difficult to interpret. Evaluators found it relatively straightforward to assess a component
as either ‘excellent’ or ‘did not go well’ but the consistent use of the intermediate scores was problematic.
The relationship between the level of adherence and competence, and the overall impression score was
difficult to determine but generally low overall impression scores seemed to be associated with deficiencies
in assessed competence rather than low levels of adherence.
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Limitations
We tested only 10% of samples for both intra- and inter-rater reliability; although this sample size may be
considered relatively small by some, it was felt to be reasonable and feasible, and indeed represented a
higher degree of feasibility checking than has been reported in many other studies.
We used audio recordings to evaluate the components but it is doubtful if sound recordings alone can
capture the subtleties of facilitator competence involving non-verbal behaviours and the dynamics of both
facilitators and individual and group interactions. The component-specific adherence measures were
designed to assess the fundamental requirements of course delivery; however, the use of a generic
competence measure may not have reflected the range of skills required to deliver the various
components. The absence of standardised definitions and the lack of valid and reliable measures of
adherence and competence made assessments of the impact of either on outcomes difficult. There is a
need for more empirical work to clarify how the findings from psychotherapeutic research may be applied
to other similar interventions and populations free of mental health issues.278
Conclusions
Complex interventions pose significant challenges for developing practical methods for assessing
‘treatment integrity’. Generic adherence and competence criteria seem inadequate to encompass the full
complexity of interacting elements that occur in behaviour change interventions. The robust monitoring
and assessment of treatment integrity requires the systematic collection of appropriate data, the
formulation of programme- and component-specific measures and the comprehensive training of
assessors. The explicit manualisation of programmes and their component competencies is necessary to
ensure robust evaluation. We have proposed one model of assessing adherence and competence and
demonstrated its use in a large pragmatic RCT. We recognise, however, that more work is necessary to
develop valid, resource-efficient methods of evaluating intervention integrity. We are confident that the
COPERS intervention was delivered with high levels of adherence and good levels of competence and that
the programme aims were largely achieved. We therefore anticipate that our outcome data will not be
influenced by poor intervention delivery.
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Chapter 11 Randomised controlled trial of the
clinical effectiveness and cost-effectiveness of
the COPERS intervention: results
Recruitment
Recruitment of recruiting centres
We invited all of the general practices in our study areas (n = 282) to participate in the trial. We approached
practices using the NIHR primary care research networks; we also used our own peer networks. Practices were
paid service support costs to compensate them for the time spent on the study. We recruited 12 out of 141
(9%) practices in east London and 13 out of 141 (9%) practices in Warwick. Reasons given by general
practices for not participating in the trial included lack of time or resources and/or that many of their
registered patients with chronic pain did not speak fluent English. The practices that we recruited were based
in areas with a wide range of deprivation (from the lowest to the second highest decile for deprivation) but
generally all had very high Quality and Outcomes Framework scores (which might be a marker of good clinical
care or organisation). We also recruited two secondary care pain services (one in London and one in Warwick)
and one community musculoskeletal service in London to identify patients for the trial.
Recruitment of participants
Recruitment took place between August 2011 and July 2012. The total number of patients registered at the
25 recruited general practices was 223,425, of whom 8138 (3.6%) were identified by our searches.
Screening by practice clinical staff led to 2278 (28.0%) of these patients being excluded. The remaining
5878 patients were invited by post to participate and 531 (9.0%) of these joined the study (recruitment rate
2.4/1000 registered patients). This represents a conversion rate from those identified by our searches of
6.5% (Table 39 and Figure 14). Although our approach was identical in both areas the proportion of
potential participants approached by general practices who joined the study was higher in the Midlands
(11%) than in London (7%). This may reflect the differences in socioeconomic and demographic factors
between the two areas.
We recruited an additional 167 participants from secondary and intermediate care services. The Warwick
centre was unable to provide the number of patients approached. A total of 2865 people attending the
pain service or the musculoskeletal physiotherapy service in east London were identified from the service
databases. Clinical staff excluded just 31 (1.1%) of these and 2834 (98.9%) were invited by their clinicians
to join the study. In total, 150, or 5.2% of those originally identified, agreed to participate in the study.
Five people in Warwick (and none in London) referred themselves to the trial giving a final total of 703
participants, with 383 participants recruited from Warwick and 320 recruited from London (see Figure 14).
To ensure that all of our intervention participants received the group intervention as intended it was
important that every intervention patient was recruited to a group with at least eight participants.
This meant that we had to recruit 18 participants more than our target of 685 participants. This necessary
‘over-recruitment’ was approved in advance by the TSC and the Research Ethics Committee.
As part of recruitment, general practices and secondary/intermediate services sent a total of 8712 letters
inviting patients to join the trial. In response the trial offices received around 1500 informal telephone
enquiries about the trial. Those callers who dropped out at this point could not meet the requirements to
join the study, for example they could not take time off work to complete the course, they were no longer
interested once the study had been explained to them or they did not meet our inclusion criteria; in
London, this was principally because of a lack of fluency in English.
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TABLE 39 Recruitment to the study from general practices
General
practice
Practice characteristics
Identified,
n
Excluded by
practice, n
Invited,
n
Enrolled,
n
List
size, n
Deprivation decilea
(1=most deprived)
QOF scorea
(out of 1000)
1 16,927 4 997.2 599 376 223 9
2 14,984 6 990.4 1058 211 847 60
3 14,147 5 984.9 390 30 360 36
4 14,000 1 962.1 546 34 512 6
5 12,600 8 961.9 568 285 283 50
6 12,500 9 997 218 83 135 21
7 12,190 2 990.1 602 439 163 12
8 12,181 1 995.7 312 74 238 22
9 12,051 4 986.4 309 87 222 11
10 10,878 8 988.7 372 104 268 38
11 10,500 5 917.6 428 254 174 33
12 10,000 8 983.9 375 44 331 40
13 9200 4 997.3 404 37 367 28
14 8300 1 962.7 350 10 340 26
15 8107 3 991 281 41 240 26
16 7300 1 982.4 166 6 160 7
17 7059 5 959.3 143 36 107 14
18 5700 1 961.9 300 37 263 24
19 5500 5 985.3 291 11 280 36
20 4300 2 889.5 38 0 38 6
21 3496 2 997.3 143 36 107 8
22b 3093 5 988.6 0 0 0 3
23 3000 3 995.9 51 0 51 7
24 2900 2 951.7 175 25 150 8
25 2512 4 982.6 19 0 19 0
Total
London
97,584 – – 3365
(3.4%)
825
(24.5%)
2540
(75.5%)
170
(6.7%)
Total
Midlands
125,841 – – 4773
(3.8%)
1453
(30.4%)
3338
(69.9%)
361
(10.8%)
Overall
total
223,425 – – 8138
(3.6%)
2260
(27.8%)
5878
(72.2%)
531
(9.0%)
QOF, Quality Outcomes Framework.
a Source: http://fingertips.phe.org.uk/profile/general-practice/ (accessed 20 April 2016).
b Practice resource changes meant that the site did not complete the full recruitment process.
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A total of 1026 people returned a consent to approach form or contacted us directly and met our inclusion
criteria. These people were then sent a baseline questionnaire and a trial consent form. Of these, 323 people
declined to join the study (Figure 15). Reasons for this included:
i. They could not commit or no longer wanted to commit to the course or the relaxation programme
(unavailable because of holiday, work or family commitments; did not like being in groups or with
strangers; too difficult to get to venues; did not think that they would benefit from being in the trial;
had done other similar things in the past; or were no longer interested).
ii. They had other more serious comorbidities and/or scheduled hospital visits.
iii. They were not fluent in English.
Secondary/
intermediate care
services (London)
General practices
(n = 223,425)
Excluded by
practice
(n = 2260) (28%)
Identified in search
(n = 8138) (4%)
Approached
(n = 5878) (82%)
No reply
(n = 7642) (87%)
Not interested
(n = 66) (1%)
Declined
participation
(n = 323)
(31% of 1026
interested)
Expressions of interest
(n = 1026)
(12% of 8712
approached)
Randomised
(n = 703)
(69% of 1026
interested)
Intervention
(n = 403) (57%)
Control
(n = 300) (43%)
Approached
(n = 2834) (99%)
Identified in search
(n = 2865)
Excluded by
service
(n = 31) (1%)
Secondary care and
self-referral
(Warwick)
(n = 22)
FIGURE 14 Recruitment flow chart.
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Assessed for eligibility
(n = 1026) (interested, screened 
as eligible and allocated study ID)
Allocated to control
(n = 300)
• Did not receive allocated intervention, n = 0
• Withdrawn, n = 6 (no longer interested, n = 1;
   other commitments, n = 5)
12 weeks
(n = 242) (81% response from 300)
• Lost to follow-up,a n = 0
• Withdrawn, n = 6 (no longer interested n = 4,
   disliked CD n = 1, death n = 1)
• Non-responder, n = 46
6 months
(n = 262) (87% response from 300)
• Lost to follow-up,a n = 2
• Withdrawn, n = 2 (no longer interested, n = 1;
   disliked CD, n = 1)
• Non-responder, n = 2
12 months
(n = 263) (88% response from 300)
• Lost to follow-up,a n = 0
• Withdrawn, n = 1 (no longer interested, n = 1)
• Non-responder, n = 22
Analysed primary outcome
(n = 278)
Excluded from analysis owing to no 
follow-up data
(n = 22)
Allocated to intervention
(n = 403)
• Did not receive allocated intervention, n = 57
• Withdrawn, n = 10 (illness, n = 2; no longer
   interested, n = 5; other commitments n = 3)
12 weeks
(n = 348) (86% response from 403)
• Lost to follow-up,a n = 1
• Withdrawn, n = 0
• Non-responder, n = 44
6 months
(n = 363) (90% response from 403)
• Lost to follow-up,a n = 1
• Withdrawn, n = 8 (other commitments, n = 4;
   no longer interested, n = 3; disliked 
   questionnaire, n = 1)
• Non-responder, n = 21
12 months
(n = 358) (89% response from 403)
• Lost to follow-up,a n = 2
• Withdrawn, n = 4 (no longer interested, n = 3;
   terminal cancer, n = 1)
• Non-responder, n = 21
Analysed primary outcome
(n = 374)
Excluded from analysis owing to no 
follow-up data
(n = 29)
Excluded
(n = 323)
• Not meeting inclusion criteria, n = 34
• Declined to participate/could not attend, 
   n = 179
• Other reasons, n = 110 (including 
   non-responders)
FIGURE 15 Consolidated Standards of Reporting Trials flow diagram. Total analysed is for primary outcome only.
a, Loss to follow-up (moved or changed telephone number).
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Description of invitees
Practices provided anonymous demographic data on 6182 (71%) of the 8712 people whom they invited
to participate in the trial (not all practices were able to supply these data). The proportion of women
invited was the same in each site (64%). The overall mean age was 59 years (range 18–101 years), but the
mean age in Warwick (67 years) was higher than that in London (52 years). Describing the ethnicity of
those invited was hampered by a lack of data. Of the 3151 invitees for whom ethnicity was recorded,
2122 (67%) were white British or European and 1029 (33%) were Asian or African (Table 40). The
difference in ethnicity recording and reporting between east London and the Midlands might represent an
underestimation of the proportion of white British/European invitees.
Baseline characteristics of study participants
Of those recruited, 67% were female; the mean age was 60 years (range 19–94 years) and 81% were
white British. Age and gender were similar between those recruited and those invited (with available data).
Table 41 provides baseline characteristics of all participants.
There were no important differences in baseline characteristics between the intervention arm and the
control arm (Table 42). Just over half of the participants [381/703 (54%)] had completed formal education
TABLE 40 Characteristics of patients invited into the trial (n= 6182, 71% of invitees)
Site Female, n (%)
Age (years),
mean (range)
Ethnicity, n (%)
White British,
mixed or European
Asian or African
or mixed Unknown
London (N= 3187) 2025 (64) 52 (18–95) 1029 (32) 971 (30) 1187 (37)
Warwick (N = 2995) 1911 (64) 67 (19–101) 821 (27) 83 (3) 2091 (70)
Total (N = 6182) 3936 (64) 59 (18–101) 1850 (30) 1054 (17) 3278 (53)
TABLE 41 Baseline characteristics: all participants
Characteristics All participants (n= 703)
Age (years), mean (range) 59.9 (19.3–94.4)
CPG pain-related disability score, mean (SD) 63.3 (25.1)
CPG pain intensity score, mean (SD) 71.3 (16.3)
PSEQ score, mean (SD) 31.0 (13.9)
CPAQ score, mean (SD) 56.6 (20.1)
HADS depression score, mean (SD) 7.4 (4.1)
HADS anxiety score, mean (SD) 9.2 (4.6)
hEIQ score, mean (SD) 13.9 (3.5)
EQ-5D score, mean (SD) 0.40 (0.34)
Comorbidities, median (range) 2 (0–8)
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TABLE 42 Baseline characteristics in the intervention arm and the control arm
Characteristics
Control
(N= 300), n (%)
Intervention
(N= 403), n (%)
Number of participants
with missing data
(control, intervention)
Age (years), mean (SD) 59.4 (13.8) 60.3 (13.5) 0, 0
Male 98 (33) 132 (33) 0, 0
Lives alone 101 (34) 143 (36) 4, 6
Ethnicity
White 239 (80) 325 (81) 0, 0
Black 36 (12) 53 (13)
Asian 20 (7) 13 (3)
Mixed 5 (2) 9 (2)
Other 0 (0) 3 (1)
Self-rated English language fluency
Fluent 259 (86) 341 (85) 0, 0
Good 36 (12) 56 (14)
Below average 3 (1) 6 (1)
Poora 2 (1) 0 (0)
Age at which formal education ended
No formal education received 4 (1) 1 (< 1) 0, 0
≤ 12 years 0 (0) 1 (< 1)
13–16 years 153 (51) 222 (55)
17–19 years 66 (22) 68 (17)
≥ 20 years 66 (22) 102 (25)
Still in full-time education 3 (1) 3 (1)
Other 8 (3) 6 (1)
Employment status
Employed, including self-employed
(full- or part-time)
78 (26) 91 (23) 0, 0
Unemployed and looking for work 10 (3) 20 (5)
Still in full-time education 3 (1) 1 (< 1)
Unable to work because of long-term sickness 62 (21) 86 (21)
Looking after home/family 14 (5) 23 (6)
Retired from paid work 132 (44) 175 (43)
Other 1 (< 1) 7 (2)
Time kept from usual activities because of pain in the past 6 months
0–6 days 84 (28) 136 (34) 3, 3
7–14 days 49 (16) 72 (18)
15–30 days 57 (19) 71 (18)
≥ 31 days 107 (36) 121 (30)
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TABLE 42 Baseline characteristics in the intervention arm and the control arm (continued )
Characteristics
Control
(N= 300), n (%)
Intervention
(N= 403), n (%)
Number of participants
with missing data
(control, intervention)
State of health
Very good 17 (6) 27 (7) 0, 0
Good 100 (33) 138 (34)
Fair 130 (43) 159 (39)
Bad 45 (15) 63 (16)
Very bad 8 (3) 16 (4)
Duration of pain
0–3 months 4 (1) 1 (< 1) 0, 0
4–12 months 10 (3) 15 (4)
13 months–2 years 43 (14) 45 (11)
3–4 years 45 (15) 55 (14)
5–6 years 40 (13) 49 (12)
7–10 years 50 (17) 81 (20)
> 10 years 108 (36) 157 (39)
CPG overall
0 0 (0) 0 (0) 3, 5
1 18 (6) 30 (8)
2 66 (22) 99 (25)
3 81 (27) 123 (31)
4 132 (44) 146 (37)
CPG pan-related disability score, mean (SD) 63.8 (24.4) 62.9 (25.7) 0, 1
CPG pain intensity score, mean (SD) 70.9 (15.3) 71.5 (17.0) 1, 1
PSEQ score, mean (SD) 30.6 (14.1) 31.2 (13.8) 0, 5
CPAQ score, mean (SD) 55.3 (19.1) 57.5 (20.7) 7, 15
HADS depression score, mean (SD) 7.5 (4.0) 7.4 (4.2) 3, 2
HADS anxiety score, mean (SD) 9.3 (4.7) 9.2 (4.6) 3, 3
HADS depression score
0–7 159 (54) 217 (54) 3, 2
8–10 74 (25) 95 (24)
11–21 64 (22) 89 (22)
heiQ score, mean (SD) 13.8 (3.4) 14.0 (3.6) 5, 3
EQ-5D score, mean (SD) 0.39 (0.34) 0.41 (0.34) 1, 1
Number of comorbidities, median (IQR) 3 (2–4) 2 (2–3) 21, 32
continued
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at or below the age of 16 years and only 169 out of 703 (24%) were in any form of employment, with
148 out of 703 (21%) unable to work because of long-term sickness and another 307 out of 703 (44%)
being retired from work. In the previous 6 months nearly half of the participants [341/703 (49%)] had
been prevented from engaging in their usual activities for ≤ 14 days because of their pain and 356 of 703
(51%) had been prevented from engaging in their usual activities ≥ 15 days because of their pain. In total,
40% (282/703) described their current health as good or very good at baseline (this compares with 83%
of adults in Tower Hamlets, 83% in Hackney, 83% in Newham, 85% in Warwickshire and 81% in
Coventry in the 2011 census280). Most of the participants had had pain for at least 3 years (85%), with
38% reporting pain for > 10 years.
Mean (SD) anxiety and depression scores on the HADS instrument at baseline were 9.2 (4.6) and 7.4 (4.1),
respectively. The mean value exceeded the usual cut-off for caseness for anxiety (≥ 8) and was close to
that for depression (≥ 8).176 Overall, health utility as assessed by the EQ-5D instrument (commonly
interpreted as quality of life) was very low, with a mean (SD) score of 0.4 (0.34). The median number of
comorbidities (determined from primary care records) was two (range 0–8).
Overall, this was a group of with a high rate of medication use. Many individuals were taking multiple
analgesic medications, meaning that a substantial minority were taking more than one DDD of analgesic
medication per day. Similarly, it is notable that a substantial minority were prescribed no analgesic
medication in the 3 months prior to randomisation. It is noteworthy that just under one-quarter (23%)
were being prescribed strong opioids at baseline.
Overall attendance on the course was excellent, with little evidence of attrition; on average, participants
attended 85% of the course.
TABLE 42 Baseline characteristics in the intervention arm and the control arm (continued )
Characteristics
Control
(N= 300), n (%)
Intervention
(N= 403), n (%)
Number of participants
with missing data
(control, intervention)
Total amount of drugs taken above the DDD in 3 months prior to randomisation, expressed in units of DDD
Psychotropic, median (IQR) 0 (0–0) 0 (0–0) 4, 3
Weak opioids, median (IQR) 0 (0–7) 0 (0–8) 4, 3
Strong opioids, median (IQR) 0 (0–0) 0 (0–0) 4, 3
Analgesics (including opioids, non-opioids,
NSAIDs and other CNS drugs and oral and
topical preparations), median (IQR)
44 (0–136) 49 (0–140) 4, 3
Drugs taken orally for neuropathic pain, median
(IQR)
0 (0–7) 0 (0–0) 4, 3
NSAID analgesics (both oral and topical),
median (IQR)
0 (0 –44) 0 (0–56) 4, 3
Proportion of participants prescribed weak opioids 76 (26) 107 (27) 4, 3
Proportion of participants prescribed strong opioids 72 (24) 90 (23) 4, 3
CNS, central nervous system.
a When we spoke to people on the telephone their language skills were suitable; however; they rated themselves as poor
on the baseline questionnaire.
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Retention and follow-up rates
We obtained primary outcome data from 621 (88%) participants at 12 months. At 6 and 12 months’
follow-up 6% and 5% of responders, respectively, provided only primary outcome and quality of life
(EQ-5D) data (Table 43).
A comparison of the characteristics of those retained in the study and the characteristics of those not
included in the primary analysis is provided in Table 44. In general, the two groups were remarkably
similar, the one exception being that people living alone were over-represented among those lost to
follow-up (51% vs. 33%).
Delivery of the intervention
Recruitment and training of facilitators
We identified 30 potential facilitators, 14 HCPs and 16 laypeople, who attended one of three 2-day
training courses. Twenty-four (80%) of these were both available to deliver the course and assessed as
being competent to deliver it. Eleven HCPs and 13 laypeople delivered courses; this included two members
of the study team who delivered sessions on 10 courses when no other experienced qualified HCP
was available.
The mean age of the HCPs delivering the intervention was 44.3 years (range 34–59 years), seven (64%)
were female and the mean duration of practice was 13 years (range 3–29 years). They included one
chiropractor, three osteopaths, four physiotherapists and three psychologists. All courses were facilitated
by at least one experienced facilitator who had delivered the intervention before.
The mean age of the lay facilitators was 55 years (range 33–71 years), 10 (77%) were female and all had
personal experience of living with chronic pain. The mean number of years of small group facilitation
experience was 4 years (range 0–10 years); two had a background in teaching but considered that they
had no previous facilitation experience of this nature. The characteristics of the facilitators are provided in
Table 45. Overall, the median number of courses delivered was one (range 1–6) for the lay facilitators and
three (range 1–5) for the HCPs.
TABLE 43 Response rates by site and follow-up period
Site Enrolled, n
Sent 6-month
questionnaire, n
All
responders, n
Telephone
responders (CPG and
EQ-5D only), n (%)
Response
ratea (%)
Response
rateb (%)
6 months
London 320 307 275 30 (11) 90 86
Warwick 383 364 350 6 (2) 96 91
Total 703 671 625 36 (6) 93 89
12 months
London 320 303 271 22 (8) 89 85
Warwick 383 363 350 7 (2) 96 91
Total 703 666 621 29 (5) 93 88
a Denominator = number sent the 6-month questionnaire.
b Denominator = number enrolled.
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TABLE 44 Characteristics of responders and participants lost to follow-up
Characteristics Responder (N= 652), n (%) Lost to follow-upa (N= 51), n (%)
Age (years), mean (SD) 60.2 (13.4) 56.8 (16.0)
Male 215 (33) 15 (29)
Living alone 218 (33) 26 (51)
Ethnicity
White 523 (80) 41 (80)
Black 83 (13) 6 (12)
Asian 30 (5) 3 (6)
Mixed or other 16 (2) 1 (2)
Fluent in or good at English 642 (98) 50 (98)
Age at which formal education ended
≤ 12 years 6 (1) 0 (0)
13–19 years 472 (72) 37 (73)
≥ 20 years or still in full-time education or other 174 (27) 14 (27)
Employment or in full-time education 157 (24) 16 (31)
Time kept from usual activities because of pain in past 6 months
0–14 days 318 (49) 23 (45)
≥ 14 days 328 (51) 28 (55)
State of health
Very good, good or fair 530 (81) 41 (80)
Bad or very bad 122 (19) 10 (20)
Duration of pain
0–2 years 106 (16) 12 (24)
3–6 years 171 (26) 18 (35)
≥ 7 years 375 (58) 21 (41)
CPG pain-related disability score, mean (SD) 63 (25) 69 (26)
CPG pain intensity score, mean (SD) 71 (16) 76 (16)
PSEQ score, mean (SD) 31 (14) 26 (13)
HADS depression score, mean (SD) 7.4 (4.0) 8.6 (4.6)
HADS anxiety score, mean (SD) 9.2 (4.6) 9.9 (5.1)
CPAQ score, mean (SD) 57 (20) 51 (19)
heiQ score, mean (SD) 14.0 (3.5) 12.8 (3.6)
EQ-5D score, mean (SD) 0.41 (0.34) 0.34 (0.37)
Number of comorbidities, mean (SD) 2.7 (1.4) 2.6 (1.3)
a Lost to follow-up refers to participants who were excluded from the primary analysis for CPG pain-related disability at
12 months because they did not complete any CPG pain-related disability questions at either 6 or 12 months.
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TABLE 45 Characteristics of the course facilitators
Facilitator Site
Age
(years) Gender Ethnicity Type
HCP profession/
experience
Years of
professional
experience
(HCP) or
facilitation
(lay)
Number of
courses
facilitated
1a London 60 M White British HCP Osteopath 5 5
2a London 48 F White British HCP Osteopath 14 5
3a London 50 M White British Lay EPP accreditation 4 3
4a London 34 M Bangladeshi Lay EPP accreditation 3 3
5 London 35 F British
Pakistani
HCP Psychologist
(BABCP)
9 2
6a London 36 M White British HCP Osteopath 9 2
7 London 41 F Indian Lay EPP accreditation 7 2
8a London 49 M White British HCP Chiropractor 25 1
9 London 37 F White British HCP Clinical
psychologist
14 1
10 London 36 M White British HCP Clinical
psychology
assistant
3 1
11 London 64 F British
Pakistani
Lay EPP accreditation 4 1
12 London 55 F White British Lay EPP accreditation 7 1
13 London 53 F White British Lay EPP accreditation 0 1
14a London 69 F White British Lay Ex-nursing tutor 30 1
15 London 42 F Black
Caribbean
Lay EPP accreditation 9 1
16 Warwick 53 F Other white Lay EPP accreditation 4 6
17 Warwick 53 F White British HCP Physiotherapist 29 5
18 Warwick 61 F White British Lay EPP accreditation 7 5
19 Warwick 37 F White British HCP Physiotherapist 9 4
20 Warwick 51 F White British HCP Physiotherapist 20 4
21 Warwick 72 M White British Lay EPP accreditation 5 4
22 Warwick 53 F White British HCP Physiotherapist 7 2
23 Warwick 69 F White British Lay Ex-teacher 0 1
24 Warwick 57 F British
Bangladeshi
Lay CDSMP
certification
1 1
BABCP, British Association for Behavioural & Cognitive Psychotherapies; CDSMP, Chronic Disease Self-Management
Programme; EPP, Expert Patients Programme; F, female; M, male.
a Took part in the pilot study.
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Courses run and attendance
Thirty-one courses were held in total, 14 in London and 17 in Warwick. The average number of
participants booked on each course was 14 (London, n = 15; Warwick, n = 13) and the average number
who attended on day 1 was 11 (London, n = 11; Warwick, n = 11) (Tables 46–49). Courses were delivered
in accessible venues near the recruitment sites including community centres, hospitals, university premises
and a hospice. The mean duration from randomisation to attending a course was 42 days (range
1–168 days).
TABLE 46 Phase I, September 2011–December 2011: course venues, facilitators and participants
Course Venue Facilitator
Number enrolled
(target 16)
Attended day 1
(% of enrolled)
Attendance rate
(average number of
sessions/24 × 100) (%)
L01 University Osteopath and lay
person
13 9 (69) 82
L03 Community
hospital
Osteopath and lay
person
12 7 (58) 71
L04 Hospice
community
centre
Osteopath and lay
person
14 10 (71) 88
L05 General practice Osteopath and lay
person
14 11 (79) 90
L06 Hospice
community
centre
Psychologist and
lay person
17 13 (76) 87
L07 University Chiropractor and
lay person
14 13 (93) 83
W04 Community
centre
Physiotherapist and
lay person
10 10 (100) 95
W06 Community
centre
Physiotherapist and
lay person
12 12 (100) 91
W07 Community
centre
Physiotherapist and
lay person
10 9 (90) 93
Overall 116 94 (81) 86
London 84 63 (75) 84
Warwick 32 31 (97) 92
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TABLE 47 Phase II, January 2012–March 2012: course venues, facilitators and participants
Course Venue Facilitator
Number enrolled
(target 16)
Attended day 1
(% of enrolled)
Attendance rate
(average number of
sessions/24 × 100) (%)
L08 Hospice
community
centre
Psychologist and lay
person
16 8 (50) 70
L09 Community
hospital
Osteopath and lay
person
16 12 (75) 65
L10 Community
hospital
Osteopath and lay
person
17 11 (65) 84
L11 Community
hospital
Psychologist and lay
person
16 10 (63) 91
L12 University Osteopath and lay
person
14 10 (71) 98
W08 Community
centre
Physiotherapist and
lay person
16 11 (69) 99
W09 Community
centre
Physiotherapist and
lay person
16 13 (81) 90
W10 Community
centre
Physiotherapist and
lay person
15 11 (73) 89
W13 Community
centre
Physiotherapist and
lay person
15 11 (73) 96
W14 Community
centre
Physiotherapist and
lay person
16 16 (100) 70
W15 Community
centre
Physiotherapist and
lay person
16 14 (88) 65
W16 Hotel conference
centre
Osteopath and lay
person
16 13 (81) 84
Overall 189 140 (74) 91
London 79 51 (65) 98
Warwick 110 89 (81) 99
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Adverse events
No serious adverse events occurred as a result of the study. Twenty-one incidents resulted in emotional
upset, which was dealt with at the scene by the facilitators or later after follow-up contact with one of the
study managers. One person in the control arm of the study died but the death was not related to
the study.
TABLE 48 Phase III, April 2012– July 2012: course venues, facilitators and participants
Course Venue Facilitator
Number enrolled
(target 16)
Attended day 1
(% of enrolled)
Attendance rate
(average number of
sessions/24 × 100) (%)
L13 Hospice
community
centre
Osteopath and lay
person
17 10 (59) 93
L14 Community
hospital
Osteopath and lay
person
16 12 (75) 80
L15 University Osteopath and
psychologist and lay
person
17 14 (82) 74
W18 Community
centre
Osteopath and lay
person
16 16 (100) 93
W19 Community
centre
Physiotherapist and
lay person
14 8 (57) 55
W20 Community
centre
Physiotherapist and
lay person
9 6 (67) 69
W21 Community
centre
Physiotherapist and
lay person
11 10 (91) 60
W23 Community
centre
Physiotherapist and
lay person
12 11 (92) 85
W24 Community
centre
Physiotherapist and
lay person
5 5 (100) 98
W25 Community
centre
Physiotherapist and
lay person
11 10 (91) 84
Overall 128 102 (80) 80
London 50 36 (72) 82
Warwick 78 66 (85) 78
TABLE 49 Phases I–III: course venues, facilitators and participants
Course Number enrolled Attended day 1 (% of enrolled)
Attendance rate
(average number of
sessions/24 × 100) (%)
Overall 433 336 (78) 86
London 213 150 (70) 83
Warwick 220 186 (85) 88
COPERS INTERVENTION: RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
150
Course adherence
Fifty-seven initial course non-attendees were booked onto a further course/courses, but most of these
failed to attend any subsequent courses. Overall, 67 (17%) of those randomised to the intervention did
not attend any course. The reasons given for not attending any course were that participants felt too
unwell, had a preference for the control arm, had work commitments, had family issues, had been
bereaved or considered the venues or times of courses offered unsuitable. Tables 46–49 show the number
of courses that were run, the number of participants booked on the courses, the number attending on
day 1 and the mean number of sessions attended per course per participant. There were 24 sessions/
components on the course and overall the mean attendance broken down by sessions attended was 86%
(20–21 sessions).
Overall, 282 (70%) intervention participants achieved our predefined criterion of adherence (≥ 17 sessions
attended), whereas we considered 95 (24%) non-adherent to the intervention as they attended eight
sessions or fewer. If we dichotomise participants into compliers and non-compliers based on our predefined
criterion of attendance at more than half the course (at least 12 sessions), 76% were compliant. Attendance
was consistently better in Warwick than in London (Table 50).
Primary outcome analyses
We included 652 participants in the analysis of the primary outcome of pain-related disability as determined
by the CPG [278/300 (93%) control, 374/403 (93%) intervention]. Pain-related disability did not differ
between groups at 12 months [intervention mean (SD) 52.9 (28.0) vs. control mean (SD) 53.3 (28.8);
difference (intervention vs. control) –1.0, 95% CI –4.9 to 3.0] (Table 51). The results were similar at 6 months.
This effectively excludes any possibility of a worthwhile effect on our primary outcome; the limit of the
95% CI is 0.22 SDs of its baseline value, well within our prespecified clinically importance benefit of 0.3 SDs.
All sensitivity analyses for the primary outcome showed similar results.
Secondary outcomes: questionnaire items
The results for the secondary outcomes (except for the census global health question and the drug data) at
6 and 12 months’ follow-up are shown in Table 51. Self-efficacy (PSEQ score: difference 2.3, 95% CI 0.6 to
4.1), anxiety (HADS anxiety score: difference –0.7, 95% CI –1.3 to –0.2), depression (HADS depression score:
difference –0.7, 95% CI –1.2 to –0.2), pain acceptance (CPAQ score: difference 3.4, 95% CI 1.3 to 5.5) and
TABLE 50 Compliance and levels of adherence to the intervention by site
Exposure London, n (%) Warwick, n (%) Both, n (%)
Adherent (≥ 17 sessions) 115 (63) 167 (76) 282 (70)
Moderate adherence (9–16 sessions) 16 (9) 10 (5) 26 (6)
Non-adherent (≤ 8 sessions) 52 (28) 43 (20) 95 (24)
Total 183 (100) 220 (100) 403 (100)
Complier (≥ 12 sessions) 130 (71) 175 (80) 305 (76)
Non-complier (≤ 11 sessions) 53 (29) 45 (20) 98 (24)
Total 183 (100) 220 (100) 403 (100)
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social integration (heiQ score: difference 0.6, 95% CI 0.1 to 1.0) were all significantly better in the
intervention group than in the control group at 6 months’ follow-up.
At 12 months’ follow-up the differences favouring the intervention were sustained for depression (difference
–0.7, 95% CI –1.2 to –0.2) and social integration (difference 0.8, 95% CI 0.4 to 1.2) and, although no
longer statistically significant, the results for self-efficacy (difference 1.4, 95% CI –0.2 to 3.1) and anxiety
(difference –0.4, 95% CI –0.9 to 0.1) tended to favour the intervention. The improvement in pain acceptance
seen in the intervention group at 6 months was no longer present by 12 months (difference –0.8, 95% CI
–3.0 to 1.4). Of the questionnaire items, only pain intensity (CPG pain intensity score at 6 months: difference
TABLE 51 Main results for primary and secondary outcomes
Outcome Control (n= 300), mean (SD) Intervention (n= 403), mean (SD) Treatment effecta (95% CI)
CPG pain-related disabilityb
6 months 54.3 (26.7) 53.2 (25.7) –1.2 (–4.8 to 2.4)
12 months 53.3 (28.8) 52.9 (28.0) –1.0 (–4.9 to 3.0)
CPG pain intensityc
6 months 64.3 (19.4) 65.0 (18.8) 1.0 (–1.5 to 3.6)
12 months 64.4 (20.1) 63.5 (20.3) –0.9 (–3.7 to 1.9)
PSEQ scored
6 months 32.7 (15.0) 35.5 (14.0) 2.3 (0.6 to 4.1)
12 months 33.4 (15.1) 35.4 (14.1) 1.4 (–0.2 to 3.1)
HADS anxiety scoree
6 months 9.1 (4.8) 8.2 (4.7) –0.7 (–1.3 to –0.2)
12 months 8.4 (4.5) 8.1 (4.5) –0.4 (–0.9 to 0.1)
HADS depression scoree
6 months 7.0 (4.4) 6.3 (4.1) –0.7 (–1.2 to –0.2)
12 months 6.9 (4.6) 6.2 (4.3) –0.7 (–1.2 to –0.2)
CPAQ scoref
6 months 59.2 (19.7) 64.4 (20.0) 3.4 (1.3 to 5.5)
12 months 74.0 (14.4) 73.1 (15.1) –0.8 (–3.0 to 1.4)
heiQ score
g
6 months 14.3 (3.6) 14.9 (3.3) 0.6 (0.1 to 1.0)
12 months 14.1 (3.6) 14.9 (3.5) 0.8 (0.4 to 1.2)
EQ-5D scoreh
6 months 0.41 (0.35) 0.46 (0.34) 0.03 (–0.01 to 0.08)
12 months 0.45 (0.35) 0.46 (0.34) 0.00 (–0.04 to 0.04)
a Treatment effects are defined as a difference in means (Intervention vs. control) for all outcomes.
b 10 =worst pain imaginable.
c 13 = all over pain.
d 60 = completely confident.
e 0–7 ‘normal’, 8–10 borderline, 11–21 ‘abnormal’.
f 0= not coping at all.
g Higher scores indicate a better social life.
h Perfect health = 1.0; UK norms for healthy males/females: age 40–49 years = 0.89/0.87; age 50–59 years = 0.80/0.82.188
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1.0, 95% CI –1.5 to 3.6) and EQ-5D score (at 6 months: difference 0.03, 95% CI –0.01 to 0.08) were not
significantly better in the intervention group at either 6 or 12 months.
Table 52 shows the treatment effect sizes expressed as SMDs at 6 and 12 months using the adjusted SDs
for centre, age, gender, baseline depression score and baseline value of the outcome.
Responses to the census global health question are summarised in Table 53. This table presents the results
based on available data; those who did not provide data are not included. There was no difference
between groups at either 6 or 12 months (odds ratio for being in a higher category at 6 months 1.09,
95% CI 0.77 to 1.54; odds ratio at 12 months 1.07, 95% CI 0.77 to 1.51).
TABLE 52 Treatment effects expressed as adjusted SMDs
Outcome Treatment effect (95% CI)a
CPG pain-related disability score
6 months –0.06 (–0.24 to 0.12)
12 months –0.04 (–0.22 to 0.13)
CPG pain intensity score
6 months 0.07 (–0.10 to 0.24)
12 months –0.06 (–0.23 to 0.12)
PSEQ score
6 months 0.25 (0.07 to 0.43)
12 months 0.15 (–0.02 to 0.32)
HADS anxiety score
6 months –0.24 (–0.41 to –0.06)
12 months –0.13 (–0.30 to 0.03)
HADS depression score
6 months –0.25 (–0.44 to –0.06)
12 months –0.22 (–0.39 to –0.06)
CPAQ score
6 months 0.27 (0.08 to 0.45)
12 months –0.03 (–0.20 to 0.13)
heiQ score
6 months 0.25 (0.06 to 0.43)
12 months 0.32 (0.16 to 0.49)
EQ-5D score
6 months 0.13 (–0.03 to 0.29)
12 months 0.01 (–0.16 to 0.17)
a Effect sizes were calculated by dividing the treatment effect and the confidence limits by the estimated residual SD from
the analysis model adjusted for centre, age, gender, baseline HADS depression score and baseline value of the outcome.
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Secondary outcomes: prescribed medicines
Differences in prescribed medicines between the groups at 12 months’ follow-up, expressed as DDD, are
presented in Table 54. Intervention arm patients were prescribed significantly more DDDs of weak opioids
in the 12 months following randomisation than those in the control arm, amounting to a difference of
18 days of medication at WHO standard dosing (95% CI 5 to 32 days). The proportion of intervention arm
participants taking weak opioids at 12 months also tended to be higher than that in the control group,
although the difference was not statistically significant (the odds of taking weak opioids was increased by
39% in the intervention arm, 95% CI 10% fewer to 114% more).
Overall, intervention patients received considerably more analgesics than control arm patients in the
12 months after randomisation (98 DDDs, 95% CI 17 to 178 DDDs). However, there was no evidence of
any difference in the prescription of strong opioids between study arms (–1 DDD, 95% CI –12 to 11 DDDs)
nor in the proportions of those receiving strong opioids at 12 months (the odds of taking strong opioids
was increased by 4% in intervention arm, 95% CI 41% fewer to 85% more).
TABLE 53 Responses to the census global health question at baseline and 6 and 12 months’ follow-up
Response
Baseline, n (%) 6 months, n (%) 12 months, n (%)
Control Intervention Control Intervention Control Intervention
Very good 17 (6) 27 (7) 11 (5) 20 (6) 8 (3) 14 (4)
Good 100 (33) 138 (34) 81 (34) 121 (35) 84 (34) 130 (38)
Fair 130 (43) 159 (39) 100 (42) 144 (42) 115 (47) 144 (42)
Bad 45 (15) 63 (16) 39 (16) 46 (13) 32 (13) 40 (12)
Very bad 8 (3) 16 (4) 7 (3) 11 (3) 6 (2) 14 (4)
Total 300 (100) 403 (100) 238 (100) 342 (100) 245 (100) 342 (100)
TABLE 54 Total amount of drugs prescribed as DDD in the 12 months post randomisation and proportion of
participants using opioids at 12 months post randomisation
Type of drug
Control
(n= 258a)
Intervention
(n= 350a)
Treatment effectb
(95% CI)
DDD in 12 months post randomisation, median (IQR)
Psychotropics 0 (0–21) 0 (0–28) –12 (–30 to 6)
Weak opioids 0 (0–36) 0 (0–64) 18 (5 to 32)
Strong opioids 0 (0–22) 0 (0–24) –1 (–12 to 11)
Analgesics (including opioids and other CNS drugs) 232 (45–551) 295 (57–648) 98 (17 to 178)
Proportion of participants using opioids at 12 months post randomisation, n (%)
Weak opioids 59 (23) 103 (29) 1.39 (0.90 to 2.14)
Strong opioids 64 (25) 82 (23) 1.04 (0.59 to 1.85)
CNS, central nervous system.
a A total of 258 participants (86%) in the control arm and 350 (87%) participants in the intervention arm had drug
prescription data available and were included in the analysis.
b Treatment effect represents a difference in means for DDD outcomes at 12 months and an odds ratio for opioid use
outcomes at 12 months.
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Mediator analysis
The mediation analysis examining the potential role of self-efficacy at 12 weeks as a mediator is not
presented because of the lack of effect seen on our primary outcome.
Preplanned subgroup analyses for the primary outcome
The results of our preplanned subgroup analyses for the primary outcome of CPG pain-related disability at
12 months are presented in Table 55. There is no evidence to support the intervention being more effective
in those who live alone, who have four or more comorbidities or who have a lower socioeconomic status.
There was a suggestion of a non-significant tendency for those with a shorter pain duration to show more
benefit in terms of the primary outcome; however, interpretation is difficult as this subgroup analysis is
hampered by the small number of participants as the vast majority of participants had long-standing pain.
There was no evidence that treatment effects differed across subgroups.
No trend was seen in the association between pain-related self-efficacy and the primary outcome;
however, there was an (inconclusive) suggestion that the effect size might be greatest in the group with
an intermediate level of baseline self-efficacy.
Finally, there was a suggestion that those with a HADS depression score highly indicative of the likelihood
of depression (scores of ≥ 11) may have shown a much greater improvement in pain-related disability at
12 months but, again, the numbers are relatively small and this finding is not statistically significant.
Compliers average causal effects
As a secondary analysis, the CPG pain-related disability, CPG pain intensity, PSEQ, HADS anxiety, HADS
depression, CPAQ, heiQ and EQ-5D scores at 12 months were reanalysed to obtain a CACE of treatment,
using our prespecified definition of ‘compliers’ (those who attended at least half of the course).
These analyses were performed on the same participants as the corresponding ITT analyses, so, for example,
the CACE of the primary outcome excluded all participants who did not complete any CPG pain-related
disability questions at 12 months and we assumed that the excluded participants were missing at random.
The CACE for the primary outcome of pain-related disability as determined by the CPG did not differ
between treatment groups at 12 months (difference –1.0 intervention vs. control, 95% CI –5.9 to 3.9).
This again excludes our prespecified worthwhile benefit of 0.3 SDs of the baseline score.
Only depression (HADS depression score –0.9, 95% CI –1.5 to –0.3) and social integration (heiQ score 1,
95% CI 0.5 to 1.5) were significantly better in the intervention group than in the control group at
12 months’ follow-up among the compliers.
Treatment effects on primary and secondary outcomes estimated from CACE adjusted and unadjusted
analyses at 12 months’ follow-up are shown in Table 56.
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TABLE 55 Results of the preplanned subgroup analyses for the primary outcome (CPG pain-related disability at
12 months)
Subgroup
Control,
number
included in
analysis
Intervention,
number
included in
analysis
Control,
mean (SD)
Intervention,
mean (SD)
Treatment effect
(95% CI)
p-value for
interaction
Non-pain related
Comorbidity
0–3 192 269 50.2 (29.2) 50.6 (27.7) –0.6 (–5.1 to 4.0) 0.72
≥ 4 76 90 59.8 (26.8) 57.8 (28.0) –2.1 (–9.4 to 5.3)
Living arrangements
Living with
others
185 239 52.4 (28.1) 50.9 (28.0) –0.1 (–4.9 to 4.8) 0.60
Living alone 89 129 54.5 (30.8) 56.9 (27.4) –2.2 (–8.9 to 4.5)
PSEQ score
0–20 72 83 71.7 (22.5) 72.8 (23.6) 0.5 (–7.0 to 7.9) 0.78
21–39 121 184 56.5 (23.2) 54.6 (24.2) –2.2 (–7.6 to 3.3)
40–60 85 103 34.0 (29.1) 34.6 (25.9) 0.4 (–6.4 to 7.1)
Socioeconomic status
Lower 136 197 52.0 (29.3) 48.5 (27.3) –2.4 (–7.8 to 3.0) 0.42
Higher 142 177 54.6 (28.4) 57.9 (28.1) 0.8 (–4.7 to 6.2)
Pain related
Pain duration
0–12 months 13 13 40.0 (30.3) 31.8 (29.4) –5.5 (–23.5 to 12.6) 0.88
13 months
to 4 years
80 93 51.7 (29.2) 51.3 (26.6) –1.7 (–8.9 to 5.4)
≥ 5 years 185 268 54.9 (28.5) 54.5 (28.1) –0.8 (–5.5 to 3.8)
CPG pain intensity score
0–3 4 17 45.0 (42.6) 21.6 (20.1) –22.5 (–47.9 to 2.8) 0.24
4–7 186 219 47.1 (28.1) 46.1 (25.8) –1.0 (–5.8 to 3.8)
8–10 87 138 66.7 (25.3) 67.4 (25.1) –0.2 (–6.6 to 6.3)
CPG pain-related disability score
0–3 51 70 31.7 (27.6) 33.3 (27.4) 0.5 (–8.1 to 9.1) 0.60
4–7 138 187 51.1 (26.1) 48.4 (23.7) –2.8 (–8.2 to 2.5)
8–10 89 117 69.8 (23.8) 71.5 (23.6) 1.1 (–5.6 to 7.8)
HADS depression score
0–10 222 291 49.0 (28.7) 49.0 (27.4) –0.2 (–4.6 to 4.2) 0.44
11–21 56 83 70.6 (22.5) 67.1 (25.7) –3.8 (–12.0 to 4.4)
Notes: Participants with missing baseline values of the subgroup were excluded from the analysis for all subgroup analyses
apart from those for CPG pain-related disability and HADS depression. The numbers included in each subgroup are
approximate for CPG pain-related disability and HADS depression as these variables were included in the MI model.
Therefore, participants with a missing baseline value for CPG pain-related disability or HADS depression were included in
the analysis; however, it is unclear which of the subgroups they belong to.
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Participant exposure to other similar non-trial interventions
To make some assessment of performance bias, we collected data on participation in courses and activities
other than the COPERS course during the 12-month follow-up period (Table 57). There were a
considerable number of missing data, making interpretation of the data difficult. Overall, few respondents
had attended any other courses and there appeared to be no differences in the proportions attending
these courses between the groups. Reported practice of regular relaxation appeared to be somewhat
higher in the control arm than in the intervention arm, with 32% of respondents in the control arm saying
that they practised daily relaxation, compared with 21% in the intervention arm, and 26% of respondents
in the control arm saying that they practised relaxation every week, compared with 18% in the
intervention arm.
TABLE 56 Results from adjusted and unadjusted CACE analyses at 12 months
Outcome Adjusted treatment effect (95% CI) Unadjusted treatment effect (95% CI)
CPG pain-related disability score –1.0 (–5.9 to 3.9) –0.6 (–6.8 to 5.5)
CPG pain intensity score –1.0 (–4.4 to 2.4) –0.6 (–5.0 to 3.7)
PSEQ score 1.7 (–0.3 to 3.7) 2.7 (–0.4 to 5.9)
HADS anxiety score –0.5 (–1.1 to 0.1) –0.4 (–1.4 to 0.5)
HADS depression score –0.9 (–1.5 to –0.3) –0.8 (–1.7 to 0.2)
CPAQ score –1.0 (–5.3 to 3.3) –0.7 (–5.4 to 4.0)
heiQ score 1.0 (0.5 to 1.5) 1.1 (0.3 to 1.8)
EQ-5D score 0.00 (–0.05 to 0.05) 0.01 (–0.07 to 0.09)
TABLE 57 Participation in courses and activities other than the COPERS course during the follow-up period
Other activity/courses
Control
(N= 300), n (%)
Intervention
(N= 403), n (%)
Number of participants with
missing data (control, intervention)
Courses or activities attended during the follow-up period outside of the COPERS trial
Pain management 20 (9) 26 (9) 86, 109
Expert Patient Programme/
self-management course
9 (4) 11 (4) 96, 118
Other wellness or well-being
courses
15 (7) 15 (5) 96, 114
Return to work courses 7 (4) 9 (3) 101, 116
Frequency of practising relaxation and/or meditation during the follow-up period
Daily 75 (32) 66 (21) 69, 82
Weekly 59 (26) 59 (18)
Monthly 14 (6) 21 (7)
Rarely 56 (24) 93 (29)
Never 27 (12) 82 (26)
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Changes from baseline
Our primary outcome decreased (i.e. improved) within both the control arm and the intervention arm
between baseline and 6 months’ follow-up [mean (SD) difference between baseline and 6 months: control
–8.8 (23.0), intervention –9.3 (23.3)] and these decreases were sustained at 12 months’ follow-up (Figure 16).
CPG pain intensity followed a similar pattern. Indeed, all of the questionnaire variables improved to some
extent between baseline and 6 months in both arms of the study and these improvements were sustained,
but not generally increased, at 12 months. The one exception to this was the improvement in pain
acceptance as measured by the CPAQ. In both study arms this appears to have improved a great deal in the
second half of the follow-up period [mean (SD) difference between baseline and 6 months: control 3.0 (12.1),
intervention 5.4 (14.6); between baseline and 12 months: control 17.2 (20.7), intervention 14.3 (22.7)]
(Table 58).
Post hoc analyses
As a result of the finding that mean levels of depressive symptoms were high at baseline we looked at the
proportion of participants who might be depressed at each time point. We examined two cut-off points:
a HADS depression score of ≥ 8, which is the most sensitive and specific cut-off for possible depression,
and a HADS depression score of ≥ 11, which is often considered to be a cut-off for probable depression.281
In total, 169 out of 698 (24%) participants scored 8–10 and 153 out of 698 (22%) participants scored
≥ 11 on the HADS depression subscale.
The statistically significant sustained reduction in depressive symptoms seen in the intervention group
prompted us to conduct an exploratory post hoc subgroup analysis to assess whether or not the treatment
differed between those who were depressed at baseline and those who were not depressed at baseline
(HADS depression score 0–7 vs. 8–21). We hypothesised that the reduction in depressive symptoms had
arisen in those who were likely to have been depressed at baseline and we also wanted to ascertain that
people who were not depressed at baseline did not suffer psychologically through exposure to the
intervention. This post hoc analysis revealed that the improvement in depressive symptoms seen in the
intervention arm was indeed concentrated in those who were depressed at baseline, whereas those who
were not depressed at baseline experienced no overall change in HADS depression score at 12 months
(p-value for interaction = 0.004) (Table 59). Moreover, the SMD among those depressed at baseline was
–0.50 (95% CI –0.74 to –0.25), which is highly likely to be clinically relevant.282
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FIGURE 16 Reduction in pain-related disability over the 12-month trial period.
COPERS INTERVENTION: RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
158
TABLE 58 Mean (SD) change from baseline within each study arm at 6 and 12 months’ follow-up
Outcome Control Intervention
Number of participants
(control, intervention)
CPG pain-related disability score
6 months –8.8 (23.0) –9.3 (23.3) 261, 356
12 months –9.1 (26.4) –9.5 (26.1) 261, 355
CPG pain intensity score
6 months –6.5 (16.2) –5.4 (15.8) 241, 337
12 months –6.1 (17.2) –7.2 (17.7) 245, 341
PSEQ score
6 months 1.9 (10.6) 3.2 (11.0) 240, 338
12 months 2.2 (10.7) 3.3 (10.6) 244, 334
HADS anxiety score
6 months –0.1 (3.2) –0.7 (3.4) 234, 333
12 months –0.5 (3.2) –0.9 (3.5) 242, 338
HADS depression score
6 months –0.3 (2.9) –0.9 (3.0) 238, 339
12 months –0.3 (3.1) –1.0 (3.4) 242, 339
CPAQ score
6 months 3.0 (12.1) 5.4 (14.6) 228, 321
12 months 17.2 (20.7) 14.3 (22.7) 227, 323
heiQ score
6 months 0.3 (2.5) 0.7 (2.7) 238, 337
12 months 0.1 (2.7) 0.7 (2.8) 234, 340
EQ-5D
6 months 0.02 (0.29) 0.04 (0.28) 255, 359
12 months 0.04 (0.29) 0.04 (0.28) 258, 353
TABLE 59 Subgroup analysis of HADS depression score at 12 months by HADS depression score at baseline
(0–7 vs. 8–21)a
HADS depression
score at baseline
HADS depression score at 12 months, mean (SD)
Treatment effect
(95% CI)
p-value for
interactionControl Intervention
Original scale
0–7 4.2 (3.0) 4.0 (3.0) 0.0 (–0.7 to 0.6) 0.004
8–21 9.4 (4.8) 8.2 (4.7) –1.5 (–2.3 to –0.8)
SMD
0–7 – – –0.01 (–0.23 to 0.21) –
8–21 – – –0.50 (–0.74 to –0.25)
a A total of 625 participants were included in the subgroup analysis: 348 patients with a HADS depression score of 0–7
(n= 148 usual care, n = 200 intervention) and 277 patients with a HADS depression score of 8–21 (n= 113 usual care,
n= 164 intervention).
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Sensitivity analyses
All of the sensitivity analyses produced similar results to those of the primary analysis and demonstrated
that the primary outcome results were robust (Table 60 and Figure 17).
The y-axis in Figure 17 shows the treatment effect for the CPG pain-related disability score at 12 months
(e.g. a value of –2 indicates that the mean CPG disability score was 2 points less in the intervention group
than in the control group). The x-axis shows the assumed CPG disability score in participants in the control
group who were lost to follow-up (e.g. a value of 10 indicates that we set the average CPG disability score
for participants in the control arm who were lost to follow-up to 10). In sensitivity analysis 1 we set the
CPG disability score for participants in the intervention arm who were lost to follow-up to 10 points less
than the score for participants in the control arm (e.g. if the value on the x-axis was 10, this would indicate
that participants in the control arm who were lost to follow-up had a CPG disability score of 10 and
participants in the intervention arm who were lost to follow-up had a CPG disability score of 0). In
sensitivity analysis 2 we set the CPG disability score for participants in the intervention arm who were lost
to follow-up to 10 points more than the score for participants in the control arm (e.g. if the value on the
x-axis was 10, this would indicate that participants in the control arm who were lost to follow-up had a
CPG disability score of 10 and participants in the intervention arm who were lost to follow-up had a CPG
disability score of 20).
TABLE 60 Sensitivity analyses for CPG pain-related disability at 12 months
Analysis Treatment effect (95% CI)
Main analysis –1.0 (–4.9 to 3.0)
Complete case analysis –0.9 (–4.9 to 3.1)
Multivariate analysis –0.1 (–5.5 to 5.2)
Different imputation model –1.1 (–5.1 to 2.9)
Redefinition of primary outcome –1.1 (–5.0 to 2.9)
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FIGURE 17 Sensitivity analysis for CPG pain-related disability at 12 months (assuming that missing data are missing
not at random).
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The primary analysis excluded all participants who did not complete any CPG pain-related disability
questions at either 6 or 12 months. This analysis assumed that the excluded participants were missing at
random, that is, the reason that these participants’ data were missing was based on variables that were
included in the analysis (e.g. that older participants with a high baseline CPG pain-related disability score
were more likely to be excluded from the analysis).
In the sensitivity analyses in Figure 17 we have made different assumptions regarding participants who
were excluded from the analysis to assess how robust the primary analysis results are to departures from
the missing at random assumption. Specifically, the analyses have assumed that the excluded participants
were missing not at random, that is, the reason that these participants’ data were missing was actually
based on their CPG pain-related disability scores at 6 and 12 months (e.g. participants with a higher CPG
disability score at 6 and 12 months were more likely to be excluded from the analysis).
Figure 17 indicates that the results of the primary analysis for CPG pain-related disability are robust to
departures from the missing at random assumption (i.e. even if the missing data from participants who
were lost to follow-up were missing not at random, this would not alter the conclusions from our
main analysis).
Health economics
Microcosting of the COPERS intervention
In total, 31 courses were delivered across two centres over the duration of the trial (14 in London and
17 in the Midlands). Each course consisted of three 1-day sessions delivered during 1 week and a 2-hour
follow-up session delivered 2 weeks later. Each course was conducted by two specially trained facilitators.
Facilitators were recruited from NHS staff (off-duty time) and self-employed health-care specialists.
Facilitator costs included a daily fee of £100 plus £40 travel costs per person. Administrator costs
associated with booking the venue, allocating facilitators and arranging the sessions were £20 per hour
(14 hours per course). Courses were run in community, primary care, hospital and university premises.
Meeting rooms were hired at £100 per day for 3.5 days (3-day course and half-day follow-up session).
Each participant was supplied with an educational DVD (£1.20 each), a relax pack including an education
booklet and a CD (£1.17 each), and printed handouts (£1.21 each). Facilitators were recruited by team
members who were paid £20 per hour (2 hours per recruit). On recruitment, facilitators attended a 2-day
training course run by two members of the research team. Trainers were paid £200 per day plus £20 travel
expenses. Facilitators were paid £100 per day for attending the training course and £10 per day towards
travel expenses. Facilitators were provided with DVDs, relax packs (including a pain education booklet and
a CD) and training manuals. In total, 35 facilitators (divided into two groups) were trained.
Table 61 summarises the direct costs of delivering the 31 courses. The total cost of the intervention was
£62,888, of which £48,184 was the cost of running the course and £14,704 was the cost of training
the facilitators.
More than two-thirds of the total running cost was accounted for by staff-related costs, which included
salaries (£32,463) and travel expenses (£2480). The majority of facilitators were freelancers paid a fixed fee
(£100) to run a session. The salary cost for this group does not include any additional employment costs.
The salary cost of the course administrator (university employee) included a fixed fee of £20 per hour plus
24% salary on-costs (employer’s pension and National Insurance contributions). Organisation overheads
were not included and London multipliers were not used.
The second highest category of costs was venue costs. Rooms were hired at a flat rate of £100 per day
(£350 per course). The total cost of venues over the duration of the programme, including hospitality
costs, was £11,470.
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TABLE 61 Course costs
Component Cost per course (£) Total cost (£)
Course running costs
Salary
Facilitators 700.00 21,700.00
Administrator 347.20 10,763.20
Subtotal (salary) 1047.20 32,463.20
Facilitators’ travel 80.00 2480.00
Course materials
DVD 16.80 520.80
Relax packs (including CD) 16.38 507.78
Handouts 16.94 525.14
Facility 350.00 10,850.00
Hospitality 20.00 620.00
Consumables 7.00 217.00
Subtotal (course) 1554.32 48,183.92
Training costs
Salary
Trainers 992.00 1984.00
Facilitators 3600.00 7200.00
Administrator (recruitment of facilitators) 1562.40 3124.80
Subtotal (salary) 6154.40 12,308.80
Trainers’ travel 80.00 160.00
Facilitators’ travel 360.00 720.00
Course materials
DVD 24.00 48.00
Relax packs (including CD) 23.40 46.80
Manuals 180.00 360.00
Facility 200.00 400.00
Hospitality 320.00 640.00
Consumables 10.00 20.00
Subtotal (training) 7351.80 14,703.60
Total cost of intervention 62,887.52
Cost per participant (including training) 145.24
Cost per participant (excluding training) 111.28
COPERS INTERVENTION: RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
162
Course materials and other consumables (e.g. letters and stamps) accounted for only a small proportion of
the total running costs (£1771). Costs presented in this category reflect the direct costs incurred by the
programme. Training costs were shared between the two centres and included all costing items described
above: salaries (trainers, facilitators and administrator), travel, venue, course materials, etc. (see Table 61).
Given that trainers were university employees, 24% salary on-costs were added to a fixed pay rate of £200
per day. The total cost of training was £420 per facilitator and £14,704 per whole programme.
Costs associated with providing usual care for primary care patients with chronic musculoskeletal pain
included the costs of a pain education booklet and a relaxation CD (£1.17 each).
Cost of the intervention per participant
Our base-case estimations of the cost of the intervention per participant were based on the
following assumptions:
l The cost of the intervention per participant was calculated by dividing the total cost of the intervention
by the total number of participants enrolled on the courses across the two centres. Sensitivity analysis
considered the maximum and minimum number of participants per course, observed in the trial.
l The quantity of training materials was based on the average number of participants per course.
Sensitivity analysis considered no wastage of course materials.
l Training was included in the calculation of the average cost per participant across the two centres.
The cost per participant for each centre was presented without training costs, given that centres shared
training courses.
Different costing scenarios for the cost of the intervention per participant are shown in Table 62. The
average number of participants per course across the two centres was 14 (London n = 15, Warwick
n = 13). The minimum number of participants enrolled on a course was five and the maximum was 17.
The total cost of the course per participant across the two centres was £145.24 with training and
£111.28 without training. The cost without training was £102 for London and £120 for Warwick. In the
cost-effectiveness analyses we used a conservative estimate of £145.24 per participant.
Two costing scenarios were considered to address the uncertainty around the number of participants
enrolled on the course and the use of course materials. Given the maximum (n = 17) and the minimum
(n = 5) number of participants enrolled on the courses, the minimum cost per participant including training
was £120 and the maximum cost including training was £389. Based on the actual number of participants
TABLE 62 Cost of the intervention per participant
Costing scenario
Number of participants
per course
Cost per
participant (£)
All centres, including training 14 145.24
All centres, excluding training 14 111.28
London, excluding training 14 102.16
Warwick, excluding training 14 120.11
London, excluding training, no wastage 15 102.43
Warwick, excluding training, no wastage 13 119.79
Minimum number of participants, all centres, including training 5 389.38
Maximum number of participants, all centres, including training 17 120.05
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at each centre (in contrast to the average number across the two centres), we estimated that the recycling
of course materials had only a very small impact on the total cost per participant (< £1) because of the low
cost of the course materials (see Tables 61 and 62).
Use of health-care resources by participants
The use of health-care resources by participants was analysed at 12 months post randomisation. The analyses
of contacts with primary and secondary health-care services by participants in the intervention and control
groups are summarised in Table 63. To assess any changes in resource use over time we looked at the use of
health-care services in 3-month periods, which is summarised in Table 64. Given that the intervention may
affect the use of primary care resources by participants, in particular consultations with GPs or practice nurses;
these categories are shown separately from other service use data in Table 64.
Over 12 months, participants in both the intervention group and the control group had, on average,
12 consultations with primary care, three investigations/tests, four outpatient appointments and less than
one referral to community care, inpatient stay or A&E admission. The average number of prescriptions over
12 months was 50 and 52 per participant for the intervention and control groups, respectively. There were
no significant differences between the groups in the use of health-care resources for any category
(see Table 63).
Quarterly analyses of resource use did not find any statistically significant changes in the number of
health-care contacts in either group over the duration of the trial (see Table 64). Consultations with GPs
and nurses (both surgery and telephone) and health-care assistants (surgery) accounted for almost 95% of
all primary care contacts, with consultations with all other specialists accounting for < 5%. The numbers
of contacts were not significantly different between the groups at any time period.
We also collected information about the use of private care including:
l number of and money spent on non-NHS consultations (including complementary and
alternative consultations)
l type and number of and money spent on tests and investigations
l type of and money spent on medicines
l type of and money spent on devices and aids
l overnight admissions/stays in private hospital
l money spent on support and help at home as a result of pain.
TABLE 63 Use of health-care services by participants (average number of contacts)
Service Intervention, mean (SD) Control, mean (SD)
Difference
in means 95% CI
Primary care sector (intervention, n= 370; control, n= 276)
Consultations 12.32 (11.12) 12.80 (12.50) –0.48 –2.31 to 1.35
Investigation 3.35 (3.09) 3.43 (3.32) –0.07 –0.58 to 0.43
Prescriptions 49.62 (48.77) 51.71 (55.01) –2.09 –10.19 to 6.01
Referrals to community care 0.40 (0.71) 0.38 (0.72) 0.02 –0.09 to 0.13
Secondary care sector (intervention, n= 383; control, n = 291)
Outpatient 4.08 (5.12) 4.32 (6.52) –0.24 –1.15 to 0.67
Inpatient 0.65 (1.43) 0.55 (1.04) 0.11 –0.08 to 0.29
A&E 0.57 (1.21) 0.57 (1.29) 0.01 –0.19 to 0.20
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However, the private care costs were not well reported given that participants preferred not to answer
questions about their personal expenses. Therefore we did not use these data in the health
economics analysis.
Cost of health-care services
Resource use data were combined with unit costs to calculate the cost of health-care services for each
quarter and over 12 months. The total costs of the health-care services used by participants are
summarised in Table 65. The largest proportion of costs was associated with inpatient stay (approximately
£1000 per participant). The next highest cost categories were prescriptions (approximately £580), followed
by consultations (approximately £540) and outpatient appointments (approximately £480 per participant).
There were no differences in the number of referrals to community care between the intervention group
and the control group (see Table 63), although the participants from the intervention group were referred
to more costly community rehabilitation programmes. Consequently, the mean referral costs for
community care were higher for the intervention group (mean costs of £117 and £75, respectively),
although this difference was not statistically significant. The breakdown of the costs of service use by
TABLE 64 Health-care service use per participant
Service
Number of contacts, mean (SD)
Intervention group Control group
3 months 6 months 9 months 12 months 3 months 6 months 9 months 12 months
Primary care
GP surgery 1.87
(1.94)
1.84
(1.84)
1.94
(2.05)
1.76
(2.22)
1.81
(1.79)
1.84
(1.91)
1.95
(1.98)
1.83
(1.80)
GP telephone 0.32
(0.83)
0.40
(0.99)
0.41
(1.30)
0.35
(0.98)
0.31
(0.72)
0.38
(1.03)
0.36
(0.99)
0.42
(1.13)
Nurse surgery 0.45
(1.06)
0.48
(1.02)
0.52
(1.57)
0.66
(1.59)
0.68
(2.29)
0.46
(0.92)
0.60
(1.51)
0.67
(1.64)
Nurse
telephone
0.06
(0.29)
0.04
(0.26)
0.04
(0.27)
0.04
(0.19)
0.08
(0.56)
0.09
(0.72)
0.08
(0.86)
0.07
(0.49)
Health-care
assistant
0.13
(0.41)
0.11
(0.39)
0.14
(0.60)
0.13
(0.42)
0.15
(0.51)
0.11
(0.47)
0.14
(0.52)
0.12
(0.40)
Other
specialistsa
0.15
(0.55)
0.14
(0.54)
0.18
(0.65)
0.15
(0.67)
0.18
(0.70)
0.17
(0.62)
0.17
(0.58)
0.16
(0.65)
Investigations 0.79
(1.24)
0.82
(1.20)
0.84
(1.23)
0.91
(1.33)
0.86
(1.32)
0.79
(1.19)
0.82
(1.31)
0.95
(1.45)
Prescriptions 13.43
(12.50)
12.86
(12.18)
14.32
(13.50)
14.03
(13.26)
14.39
(13.61)
14.55
(14.05)
15.34
(14.65)
15.93
(16.24)
Referrals to
community
care
0.10
(0.33)
0.11
(0.34)
0.09
(0.30)
0.10
(0.36)
0.09
(0.30)
0.08
(0.33)
0.11
(0.35)
0.09
(0.32)
Secondary care
Inpatient 0.12
(0.35)
0.16
(0.56)
0.21
(0.68)
0.16
(0.50)
0.13
(0.45)
0.15
(0.44)
0.11
(0.38)
0.15
(0.51)
Outpatient 0.98
(1.66)
1.00
(1.58)
1.06
(1.75)
1.04
(1.67)
1.06
(2.06)
1.09
(2.30)
1.16
(2.13)
1.01
(1.77)
A&E 0.13
(0.50)
0.16
(0.48)
0.18
(0.53)
0.10
(0.38)
0.13
(0.42)
0.17
(0.61)
0.12
(0.37)
0.14
(0.51)
a GP out of hours, NHS walk-in service, home visits, specialist nurse, physiotherapist, psychologist, counsellor, pharmacist,
phlebotomist, dietitian, etc.
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quarters is shown in Table 66. There was no significant difference in the cost of health-care services
between the intervention group and the control group for any category of primary or secondary care or
any time period.
Missing data and multiple imputations
The complete health economics data set was obtained for 540 participants (intervention, n = 319; control,
n = 221), 77% of all trial participants. Information about the completeness of the health economics data
set is summarised in Table 67. The proportion of missing data varied from 3% to 24% for different
data categories. The highest proportion of missing data was for baseline prescriptions, followed by the
EQ-5D and primary care contacts.
The baseline characteristics of participants with complete and incomplete data are summarised in Table 68.
This table demonstrates that participants with missing data had lower health-related quality of life and
higher depression scores at baseline than participants with complete data. Among participants with
complete data, those in the intervention group had a higher mean baseline EQ-5D score, whereas among
participants with incomplete data those in the control group had a higher mean baseline EQ-5D score.
Among participants with complete data, those in the intervention group had a lower mean baseline HADS
depression score, whereas among participants with incomplete data those in the control group had
a lower mean baseline HADS depression score. However, none of these reported differences was
statistically significant.
To address bias associated with missing data, MIs were conducted for 107 participants (intervention,
n = 53; control, n = 54). MIs were conducted for primary and secondary care costs (12 months post
randomisation), baseline prescriptions (3 months pre randomisation) and EQ-5D score (baseline and 6 and
12 months post randomisation). The 3-month pre-randomisation data were used for baseline adjustment
in the sensitivity analyses. The complete baseline prescription data were obtained for 561 participants
(intervention, n = 332; control, n = 229). MIs were conducted for 86 participants (intervention, n = 40;
control, n = 46). The final number of participants in the imputed data set was 647 (intervention, n = 372;
control, n = 275). This corresponds to 92% of the total number of participants in the trial and 99% of the
trial population included in the statistical analyses of the primary outcome. The comparison of the imputed
and complete data sets is shown in Table 69. Figure 18 shows the cost-effectiveness planes for the
complete case and imputed data sets, generated using a non-parametric bootstrap.
TABLE 65 Summary of health-care costs for the intervention and control groups
Service
Intervention,
mean (SD) (£)
Control,
mean (SD) (£)
Difference
in means (£) 95% CI (£)
Primary care sector (intervention, n= 370; control, n= 276)
Consultations 539 (462) 541 (428) –2 –70 to 66
Prescriptions 576 (873) 585 (878) –9 –143 to 126
Investigation 56 (85) 52 (92) 4 –10 to 17
Referrals to community care 117 (607) 75 (383) 42 –34 to 118
Secondary care sector (intervention, n= 383; control, n = 291)
Outpatient 484 (587) 476 (750) 8 –96 to 113
Inpatient 1044 (2701) 1000 (3021) 45 –395 to 484
A&E 61 (129) 64 (166) –3 –26 to 20
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TABLE 67 Completeness of the health economics data set
Service
Baseline, n (%) 6-month follow-up, n (%) 12-month follow-up, n (%)
Intervention Control Intervention Control Intervention Control
Consultations NA NA 370 (92) 276 (92) 370 (92) 276 (92)
Prescriptions 332 (82) 229 (76) 350 (87) 258 (86) 350 (87) 258 (86)
Investigations NA NA 370 (92) 276 (92) 370 (92) 276 (92)
Referrals NA NA 370 (92) 276 (92) 370 (92) 276 (92)
SUS data NA NA 383 (95) 291 (97) 383 (95) 291 (97)
EQ-5D 402 (100) 299 (100) 360 (89) 256 (85) 354 (88) 259 (86)
NA, not applicable.
TABLE 66 Cost of health-care service use per participant
Service
Cost, mean (SD) (£)
Intervention group Control group
3 months 6 months 9 months 12 months 3 months 6 months 9 months 12 months
Primary care
GP surgery 108.63
(112.53)
106.59
(106.68)
112.71
(118.71)
102.21
(128.85)
105.07
(103.77)
106.54
(110.80)
112.85
(114.74)
105.91
(104.44)
GP telephone 7.72
(19.94)
9.54
(23.86)
9.79
(31.29)
8.37
(23.44)
7.39
(17.30)
9.04
(24.68)
8.52
(23.83)
10.00
(27.19)
Nurse surgery 10.03
(23.44)
10.56
(22.54)
11.52
(34.61)
14.62
(35.11)
15.12
(50.60)
10.16
(20.22)
13.28
(33.48)
14.72
(36.16)
Nurse
telephone
0.61
(2.95)
0.39
(2.69)
0.44
(2.79)
0.39
(1.96)
0.78
(5.71)
0.90
(7.41)
0.78
(8.82)
0.71
(5.01)
Health-care
assistant
1.32
(4.31)
1.13
(4.05)
1.46
(6.25)
1.38
(4.42)
1.59
(5.32)
1.17
(4.85)
1.43
(5.43)
1.21
(4.18)
Other
specialistsa
3.79
(17.09)
4.01
(19.56)
6.78
(33.13)
5.01
(32.83)
3.89
(17.98)
3.40
(15.56)
3.83
(19.59)
2.63
(11.66)
Investigations 13.10
(34.53)
13.15
(42.69)
12.97
(36.34)
16.67
(40.48)
12.06
(37.94)
13.05
(38.97)
13.50
(38.52)
13.74
(48.25)
Prescriptions 153.53
(243.66)
149.70
(231.06)
162.78
(240.24)
168.23
(254.68)
159.25
(229.74)
164.80
(240.45)
174.82
(268.06)
181.87
(251.09)
Referrals to
community
care
37.03
(288.00)
29.38
(253.48)
13.26
(144.30)
36.94
(285.43)
15.12
(153.40)
6.68
(31.20)
28.18
(237.88)
24.61
(235.31)
Secondary care
Inpatient 206.79
(1006.36)
199.35
(935.18)
320.43
(1193.87)
318.12
(1523.05)
244.97
(1584.35)
331.96
(1663.91)
213.61
(951.03)
209.65
(1022.30)
Outpatient 109.68
(178.62)
123.71
(207.27)
126.20
(206.14)
124.44
(200.35)
121.02
(255.63)
119.62
(229.96)
127.45
(255.25)
107.51
(192.15)
A&E 13.76
(49.62)
16.37
(53.19)
18.02
(53.98)
12.68
(47.02)
15.93
(56.15)
19.54
(74.05)
13.42
(42.21)
15.11
(59.96)
a GP out of hours, NHS walk-in service, home visits, specialist nurse, physiotherapist, psychologist, counsellor, pharmacist,
phlebotomist, dietitian, etc.
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TABLE 68 Baseline characteristics of participants with complete and incomplete data
Parameter
Complete data (intervention
n= 319, control n= 221)
Incomplete data (intervention
n= 84, control n= 79)
Intervention,
mean (SD)
Control, mean
(SD)
Intervention,
mean (SD)
Control, mean
(SD)
Baseline EQ-5D score 0.4301 (0.3298) 0.4014 (0.3321) 0.3164 (0.3733) 0.3617 (0.3546)
HADS depression score 7.24 (4.05) 7.31 (3.92) 8.11 (4.49) 8.02 (4.13)
Age (years) 61 (13) 61 (12) 57 (14) 54 (17)
Gender (%) Male 33,
female 67
Male 30,
female 70
Male 32,
female 68
Male 41,
female 59
Site of recruitment (%) London 41,
Warwick 59
London 39,
Warwick 61
London 61,
Warwick 39
London 63,
Warwick 37%
TABLE 69 Comparison of complete and imputed data sets
Parameter
Complete data set Imputed data set
Intervention,
mean (SD)
Control, mean
(SD)
Intervention,
mean (SD)
Control, mean
(SD)
Baseline prescription cost (£) 154 (252) 176 (253) 148 (273) 161 (257)
Baseline EQ-5D score 0.4313 (0.3298) 0.4014 (0.3321) 0.4132 (0.3380) 0.3970 (0.3381)
6-month follow-up EQ-5D score 0.4678 (0.3353) 0.4096 (0.3461) 0.4511 (0.3452) 0.4102 (0.3542)
12-month follow-up EQ-5D score 0.4700 (0.3354) 0.4491 (0.3423) 0.4529 (0.3492) 0.4445 (0.3551)
Primary care cost (£) 1267 (1343) 1317 (1232) 1286 (1407) 1285 (1271)
Secondary care cost (£) 1453 (2545) 1605 (3449) 1614 (3126) 1469 (3213)
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FIGURE 18 Cost-effectiveness planes depicting 5000 bootstrapped estimates generated from complete case data
and one imputed data set.
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Health-related quality of life
Complete EQ-5D data (baseline and 6 and 12 months’ follow-up) were obtained for 298 participants in
the intervention group and 205 participants in the control group. Health-related quality of life was low in
the studied population compared with the UK national norms for the EQ-5D.188 At baseline, the mean total
EQ-5D scores were 0.41 for the intervention group and 0.40 for the control group. The difference
between the two groups was not statistically significant (Table 70). Over the duration of the trial there was
an increase in health-related quality of life in both groups. However, at 6 months the increase in the mean
EQ-5D score in the intervention group was greater than that for the control group. Consequently,
participants in the intervention group spent, on average, more time in a higher health state than
participants in the control group. This resulted in higher mean total QALYs for the intervention group
(0.44) than the control group (0.42) (see Table 70).
Cost-effectiveness analysis
The results of the primary cost-effectiveness analysis for the imputed and complete case data sets are
shown in Tables 71 and 72, respectively. The base-case cost-effectiveness analysis was conducted for the
ITT population on the imputed data set using a multilevel mixed-effects model (see Table 71). The mean
total cost was higher in the intervention group than in the control group (£2955 and £2767, respectively).
The difference in mean costs was £188 (95% CI –£125 to £501). Total QALYs were higher in the
intervention group (0.4475) than in the control group (0.4150). The difference in mean QALYs was
0.0325, which is equivalent to approximately 12 quality-adjusted days. This difference was not statistically
significant because of the wide CIs (95% CI –0.0074 to 0.0724). The ICER point estimate was £5786 per
QALY. The probability of the intervention being cost-effective at the NICE threshold of £30,000 per QALY
was 87%. Figures 19 and 20 show the cost-effectiveness planes generated using bootstrapping of one
imputed data set and the cost-effectiveness acceptability curve derived from five imputed data sets using a
parametric approach to represent uncertainty, respectively (see the methods section). Sensitivity analyses
conducted using the SUR model and GLM generated higher ICERs (£8995 and £9582, respectively), and
lower probabilities of being cost-effective (80% and 79%, respectively) than the MLM (see Table 71).
TABLE 70 Mean EQ-5D scores in the intervention and control groups over 12 months
Assessment Intervention, mean (SD) Control, mean (SD)
Difference
in means 95% CI
Non-imputed
Baseline (intervention n= 371,
control n = 274)
0.4139 (0.3368) 0.3976 (0.3376) 0.0163 –0.0364 to 0.0691
6-month follow-up
(intervention n= 360, control
n= 256)
0.4572 (0.3391) 0.4067 (0.3493) 0.0505 –0.0046 to 0.1057
12-month follow-up
(intervention n= 354, control
n= 259)
0.4590 (0.3448) 0.4506 (0.3459) 0.0083 –0.0471 to 0.0638
Imputed (intervention n = 372, control n = 275)
Baseline 0.4132 (0.3380) 0.3970 (0.3381) 0.0162 –0.0366 to 0.0690
6-month follow-up 0.4511 (0.3452) 0.4102 (0.3542) 0.0409 –0.0133 to 0.0952
12-month follow-up 0.4529 (0.3492) 0.4445 (0.3551) 0.0084 –0.0470 to 0.0638
Total QALYs 0.4421 (0.3058) 0.4155 (0.3083) 0.0266 –0.0213 to 0.0745
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Complete case analyses were conducted for reference purposes only (see Table 72). The mean total costs
for complete case were lower in the intervention group than in the control group; however, these
differences were not statistically significant. The differences in mean QALYs between the intervention
group and the control group were higher in the complete case analysis than in the imputed data analysis.
The complete case analysis produced dominant ICERs as the intervention was less costly and more effective
than the control. The probability of the intervention being cost-effective varied from 92% for unadjusted
data to 97% for adjusted data. The results of the complete case analysis should be interpreted with
caution because of potential bias associated with excluding non-responders from the analysis.
A secondary cost–utility analysis was conducted using the per-protocol population (Table 73). We excluded
from the analysis 51 participants from the intervention group who, although randomised to the
intervention group, did not receive any intervention. MIs were performed for this data set. Imputed data
were analysed using the mixed-effects linear model. The difference in mean costs between the intervention
group and the control group was £141, the difference in mean QALYs was 0.0351 and the ICER point
estimate was £4033 per QALY. The probability of the intervention being cost-effective at £30,000 per
QALY was 91%.
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FIGURE 20 Cost-effectiveness acceptability curve estimated using the INB method from five imputed data sets
adjusted using the mixed-effects linear model.
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FIGURE 19 Cost-effectiveness plane showing 5000 bootstrapped estimates generated from one imputed data set
adjusted using the mixed-effects linear model.
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Table 73 also summarises the results of the cost-effectiveness analyses for subgroups of participants with
different levels of compliance and exposure to treatment. Analyses were conducted using the mixed-effects
model. Between-group differences in cost were lower, and between-group differences in QALYs higher,
among participants with high levels of compliance (≥ 12 sessions) than among those with low compliance
(< 12 sessions). The ICER point estimate was £3493 for the high compliance subgroup and £24,896 for the
low compliance subgroup. The probabilities of being cost-effective were 94% and 54%, respectively.
Similar analyses were conducted for subgroups with different levels of exposure to treatment (see Table 73).
Participants who attended 17 sessions (full exposure) had a lower mean total cost and higher mean total
QALYs than participants who attended eight or fewer sessions. A small number of participants attended
9–16 sessions (n = 23). Cost–utility analyses were not conducted because of the small size of this subgroup.
The ICER point estimates were £2396 for participants with high exposure and £29,631 for those with an
exposure of eight or fewer sessions. The probabilities of the intervention being cost-effective in these
subgroups of participants were 99% and 50%, respectively.
We also conducted a subgroup analysis excluding the ‘high-cost’ participants. The top 5% of participants
with total costs > £12,000 were excluded (intervention group, n = 19; control group, n = 13). Removing
high-cost participants did not significantly affect the results of the cost-effectiveness analysis compared
with the base case. The ICER was £4326 per QALY and the probability of the intervention being
cost-effective was 92%.
In summary, our cost–utility analyses demonstrated that the intervention was more costly and more effective
than the control. However, the differences in costs and QALYs were small and not statistically significant.
The results of the analyses were robust to different analytical models. The mixed-effects linear model
(accounting for clustering effects) produced better cost-effectiveness results than a SUR model and GLM.
The results of the probabilistic analysis indicated that the intervention has a high probability (> 79%) of
being cost-effective compared with usual care for patients with chronic pain. Subgroup analysis suggested
that the intervention is more likely to be cost-effective in participants with a high compliance rate.
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Chapter 12 Phase 2: evaluating the COPERS
intervention – discussion
Summary and discussion of the principal findings
Our carefully designed evidence-informed chronic pain self-management intervention (COPERS) was relatively
cheap to deliver at £111.28 per participant (excluding facilitator training costs), had a good uptake (336/403,
83%) with little attrition (85% of sessions attended) and was delivered as intended. The intervention had no
impact on our primary outcome of pain-related disability at 12 months or on pain-related disability at
6 months. However, at 6 months’ follow-up the intervention led to improved psychological well-being
compared with the control with regard to all of our psychological measures: anxiety, depression, chronic pain
acceptance and pain-related self-efficacy. Across all of these outcomes the effect sizes were modest and their
individual clinical importance is unclear. These beneficial effects appeared to be attenuated at 12 months
except for depressive symptoms, which remained lower in the intervention group than in the control group.
Social integration, as measured by the heiQ, was also significantly improved in the intervention group
compared with the control group at both 6 and 12 months. Again, the effect size appeared to be modest
but, as with depressive symptoms, there was no evidence of any attenuation at 12 months.
Pain intensity, as measured by the CPG pain intensity subscale, was not influenced by the intervention and
nor was the overall response to the census global health question. The treatment group received
significantly more analgesic medication and more weak opioids than the control group in the 12 months
following the intervention but there was no difference in the prescription of strong opioids or psychotropic
medication between the two groups. The intervention did not have any consistent pattern of effect on
health service use: those in the intervention group had slightly few primary care and outpatient
consultations and investigations; however, they had slightly more inpatient admissions. None of these
differences approached conventional statistical significance. This resulted in an overall increase in base-case
health-care costs in the intervention group of £188, that is, £76.72 more than the acquisition cost of the
intervention. This does not support the notion that improved self-management reduces health-care costs.283
These results proved robust in extensive sensitivity analyses and using different analytical approaches.
Both the intervention group and the control group improved between baseline and follow-up; the
observation that there are improvements in both intervention and control groups over time is well recognised
in intervention studies for chronic musculoskeletal pain.210,211 This probably reflects the fluctuating course of
chronic musculoskeletal pain, with people joining studies during periods of worsening symptoms.210
We cannot exclude the possibility that, in this population, our control intervention may have had a
beneficial effect or that those randomised to the control group consequentially sought additional care.
However, the key component of our control intervention (relaxation) was selected because it had not been
shown to be effective and The Pain Toolkit booklet is already a standard part of care. Our health service
activity data do not support the notion that we have underestimated any treatment effects because of
changed care-seeking behaviour. Any such effects are very unlikely to be of sufficient magnitude to
change our overall conclusions.
There was a small gain in health utility of approximately 0.033 QALYs (12 quality-adjusted days) in the
intervention group compared with the control group in our study. By way of comparison, the national
evaluation of the Expert Patients Programme estimated that the programme generated 0.02 QALYs
(approximately 7 quality-adjusted days) compared with usual care.15 An evaluation of the Improving Access
to Psychological Therapies (IAPT) demonstration sites, which compared the IAPT programme with usual
care, found that the IAPT programme was associated with a gain of 0.013–0.014 QALYs (approximately
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5 quality-adjusted days).284 Thus, the QALY gain from the COPERS intervention is at least as good as that
of comparable interventions already in common use.
Our cost–utility analyses demonstrated that the COPERS intervention is more costly and more effective than
usual care. Our base-case analysis generated an ICER of £5786 per QALY with an 87% probability of the
intervention being cost-effective at a threshold of £30,000 per QALY (see Table 71). The probability
of the intervention being cost-effective was higher in the per-protocol population (91%) and in subgroups
with high rates of compliance and exposure to the intervention (92–99%; see Table 73). This demonstrates
that the COPERS programme is highly likely to be cost-effective compared with current care for people living
with chronic musculoskeletal pain, with a cost per QALY that falls well within the usual NICE threshold
range of £20,000–30,000 per QALY. Although the health gain observed in the COPERS study is typical of
that of many patient self-management programmes, it is an extremely cost-effective intervention.15,285–288
The findings of a long-term effect on depression are striking. Our exploratory post hoc analyses examined
this further. Nearly half of our participants [322/703 (46%)] met criteria for possible depression at baseline.
There was a clinically important sustained improvement in depressive symptoms at 12 months among
these participants. The SMD in this group (–0.50, 95% CI –0.74 to –0.25) was of a similar size to that
reported in Cochrane reviews of exercise for depression (–0.62, 95% CI –0.81 to –0.42)289 and tricyclic
antidepressants in primary care (–0.49, 95% CI –0.67 to –0.32).290 Our observed effect size exceeds that
found in an individual patient data meta-analysis of selective serotonin reuptake inhibitors for mild/
moderate depression (0.11, 95% CI −0.18 to 0.41) or severe depression (0.17, 95% CI −0.08 to 0.43).291
Other reviews have found similar modest effect sizes from selective serotonin reuptake inhibitors; for
example, Kirsch et al.292 quote 2004 NICE guidance defining a SMD of 0.50 or a drug/placebo difference
of 3 points on the scale as a threshold for clinical significance. However, it should be noted that studies
focusing primarily on depression usually adopt different outcome measures from the one used in this
study, (typically the 21-item Hamilton Rating Scale for Depression,293 which is completed by the researcher
following a clinical interview and observation of the patient, or the 21-item participant-completed BDI177).
The commonly intractable nature of chronic pain was evident by the duration of pain experienced by
COPERS participants. Our participants were predominantly older (mean age 60 years, range 19–94 years)
women (67%). Our study population had a high level of morbidity and disability at baseline: EQ-5D scores
were low compared with UK national norms188 and below those reported in studies of patients with other
serious chronic conditions.294 Participants’ mean HADS depression and anxiety symptom scores were high
compared with norms for the general UK population [3.68 (SD 3.07) and 6.14 (SD 3.76), respectively281].
Compared with clinical populations with life-threatening illnesses, mean HADS depression and anxiety
scores were similar to those found in patients with non-operable lung cancer [7.22 (SD 5.16) and 7.20
(SD 5.25), respectively] but better than those found in patients with end-stage chronic obstructive
pulmonary disease [10.18 (SD 3.95) and 11.44 (SD 4.76), respectively].295 In total, 46% of the COPERS
study population met criteria for possible depression on the HADS and nearly half of these (22% of the
overall study population) were above the higher HADS threshold for probable depression; the equivalent
UK norm figures are 7.8% and 2.9%, respectively.281
General practice consultation rates (including doctor, nurse and any other health professional face-to-face or
telephone contact in general practice) among the COPERS study population were very high, with the
intervention and control group participants having a mean (SD) of 12.32 (11.2) and 12.80 (12.50) consultations
in the 12-month follow-up period, respectively. This compares with 2008 data showing an average of around
three general practice consultations per year for registered male patients aged 45–64 years and an average of
four consultations per year for similarly aged women.296 That one-quarter of our participants were using strong
opioids gives some measure of the difficulties faced in managing their pain. This is a particularly striking
observation because the COPERS study was run in localities with low opioid use compared with the rest of
England; all participating primary care trust’s opioid prescribing rates were below regional and national median
rates (Knaggs R, University of Nottingham, personal communication).
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None of our prespecified moderator analyses achieved, or even approached, conventional statistical
significance. This is to be expected in a trial powered on main effects rather than on interactions. Indeed,
for a study of this nature in which there was no main effect, identifying a subgroup in which there was a
large positive effect would inevitably mean commensurate harm in the rump of the trial population. It
might be that these middle groups are worth targeting as key variables are more susceptible to
meaningful change.
As we achieved a positive long-term effect on depression, the effect of the intervention in just those with
depression at baseline is of greater interest post hoc than it was a priori. One would not expect a substantial
improvement in depressive symptoms in those who were not depressed at baseline. It is reassuring that our
post hoc analyses confirmed this and that we have not harmed those who were not depressed (see Table 59).
The apparent effect size in the depressed group and the p-value for interaction are impressive. However, one
cannot apply these findings in practice. There remains the possibility that this apparently statistically significant
interaction may be no more than a chance finding because of multiple comparisons. Furthermore, it would
not be possible to implement the COPERS intervention ‘as is’ because half of the participants were not
depressed. The group dynamic might be radically different if only those with depression at baseline joined the
group and the whole ethos of the intervention would change to a treatment for depression, in which case
there are established psychological treatments for depression. Implementing the COPERS intervention just to
help those with depression and including the whole population of those living with chronic pain, many of
whom would not themselves gain any benefit, might be questionable.
Results in context
Once the COPERS analysis was completed we updated our original systematic review for the effectiveness
of self-management interventions for chronic musculoskeletal pain. We reran our original searches to
identify all studies published up to September 2013. When appropriate, we extracted outcome data and
added these to our original meta-analyses. Finally, we added in the COPERS trial results (Table 74).
TABLE 74 Summary of total effect sizes by outcome and follow-up interval including the studies from the
updated review
Outcome
Follow-up
(months)
Review January 1994–April
2009 Review January 1994–September 2013
Total n
participants
(number of
studies)
Effect size
(95% CI)
Total n
participants
(number of
studies)
Effect size
(95% CI)
Including COPERS
results
Pain intensity 4–8 3911 (20) –0.25
(–0.38 to –0.12)
6038 (32)a –0.29
(–0.38 to 0.20)
–0.28
(–0.37 to 0.19)
> 8 3332 (18) –0.18
(–0.28 to 0.07)
5104 (25)a –0.18
(–0.26 to 0.10)
–0.17
(–0.25 to 0.10)
Physical
function
< 4 2453 (19) –0.26
(–0.40 to 0.12)
4093 (26) –0.31
(–0.44 to 0.18)
4–8 3759 (18) –0.15
(–0.23 to 0.07)
5546 (28)a –0.19
(–0.25 to 0.13)
–0.18
(–0.23 to 0.12)
> 8 2482 (13) –0.12
(–0.20 to 0.04)
3980 (19)a –0.14
(–0.22 to 0.06)
–0.13
(–0.21 to 0.05)
Quality of life 4–8 399 (2) –0.11
(–1.05 to 0.82)
665 (4) –0.14
(–0.55 to 0.27)
–0.13
(–0.40 to 0.15)
> 8 170 (1) –0.50
(–0.80 to 0.19)
170 (1) –0.50
(–0.80 to 0.19)
–0.24
(–0.70 to 0.21)
continued
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Overall, despite our efforts to develop and test a more effective intervention, the effect sizes found with the
COPERS intervention across a range of domains were broadly similar to those found in previous research.
That in a large well-conducted study with a low risk of bias we found similar results to those found in
multiple smaller studies lends credence to the notion that these are ‘true’ estimates of effect sizes.
Strengths of the study
A key strength of this study is that its pragmatic design means that our results directly relate to the
real-world setting.297 Another of its principal strengths lies in the robustness of the results. The study was
adequately powered and recruited to target and attrition of follow-up data was very low. The statistical
analysis plan was written and published before data were unblinded or any analysis was undertaken.
We used MI to reduce bias, conducted extensive sensitivity analyses and adopted different analytical
approaches to test the robustness of our statistical and economic analyses.
The study was designed and conducted to minimise bias: strict allocation concealment was maintained and
usual health-care providers were aware that participants had joined the study but were not informed of
their allocation arm. The intervention was delivered by trained facilitators who in the main were completely
uninvolved in the collection or evaluation of study data; however, throughout the delivery of the
intervention experienced members of the study team codelivered 10 of the 31 courses with new
inexperienced facilitators. All outcome data collected by telephone were collected by researchers unaware
of the allocation arm of the participants and a script was used asking respondents not to reveal their
allocated treatment. Primary care patient record data were extracted by trained personnel blind to the
TABLE 74 Summary of total effect sizes by outcome and follow-up interval including the studies from the
updated review (continued )
Outcome
Follow-up
(months)
Review January 1994–April
2009 Review January 1994–September 2013
Total n
participants
(number of
studies)
Effect size
(95% CI)
Total n
participants
(number of
studies)
Effect size
(95% CI)
Including COPERS
results
Self-efficacy 4–8 1214 (7) –0.29
(–0.44 to 0.14)
2030 (10) –0.25
(–0.34 to 0.17)
–0.24
(–0.32 to 0.16)
> 8 1701 (7) –0.25
(–0.35 to 0.15)
2173 (8) –0.23
(–0.31 to 0.14)
–0.20
(–0.28 to 0.13)
Depression 4–8 597 (4) –0.25
(–0.47 to 0.03)
1899 (12)a –0.26
(–0.38 to 0.13)
–0.24
(–0.35 to 0.13)
> 8 641 (3) –0.04
(–0.26 to 0.18)
1516 (7)a –0.20
(–0.44 to 0.03)
–0.20
(–0.38 to 0.01)
Anxiety 4–8 451 (3) –0.28
(–0.56 to 0.00)
878 (6) –0.14
(–0.31 to 0.03)
–0.16
(–0.28 to 0.04)
> 8 50 (1) –0.28
(–0.84 to 0.27)
553 (3) –0.41
(–0.58 to 0.24)
–0.28
(–0.51 to 0.06)
Social
function
4–8 286 (4) –0.19
(–0.61 to 0.22)
931 (8)a –0.24
(–0.40 to 0.09)
–0.22
(–0.34 to 0.11)
> 8 205 (2) 0.19
(–0.09 to 0.47)
922 (6)a –0.11
(–0.26 to 0.05)
–0.15
(–0.27 to 0.02)
a Includes studies with two intervention arms viable for the comparison. Therefore, the number of studies shown
contributing to the plot is inflated by n + 1 and the total number of participants shown contributing to the plot is
inflated by double counting of the control arm. A sensitivity analysis in the previous systematic review showed that
removing these multiarm studies made no difference to the results and so they have been kept in.
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allocation arm of participants. All questionnaire data, secondary care service use data and primary care
record data were entered, checked and cleaned before any unblinding. All primary outcome data were
double entered and checked and a further 10% random selection of other data were double entered and
checked; accuracy was high, aided by sophisticated database construction limiting errors. Study
participants were ethnically diverse (indeed our participants were more ethnically diverse than the UK
overall) and lived in localities ranging from those characterised as very affluent to those characterised as
very deprived. Our feasibility study indicated that the intervention could be successfully delivered in
languages other than English and was acceptable to a non-English-speaking ethnic group. The study
successfully identified the right patients – those significantly disabled by their chronic pain – as evidenced
by their high levels of disability and morbidity at baseline. This population also consumed a considerable
amount of health-care resources, including strong opioids. Thus, this is a highly appropriate group in which
to study complex, non-pharmacological interventions such as the COPERS intervention, directed at
improving health outcomes and potentially reducing health-care resource use.
The intervention tested was evidence informed and underpinned by behaviour change theory – the strengths
in the design and nature of the intervention are described in the discussion to Chapter 8. In addition, the
COPERS intervention was relatively cheap and, if successful, could plausibly be implemented within the NHS.
Both the feasibility study and the main trail suggest that it was highly acceptable to participants.
The fidelity of intervention delivery in trials of complex interventions has not been routinely considered
until recently14 but its importance has recently been underlined by the WISE (Whole System Informing
Self-management Engagement) study, in which the failure of a complex, whole-system self-management
support intervention may have arisen from a failure to implement the intervention as intended.298 Our study
included a detailed and comprehensive assessment of the fidelity of intervention delivery223 (see Chapter 10)
and so we can be confident that the intervention tested here was delivered as intended. We intended the
COPERS groups to include around 14 participants and we achieved this with the exception of just one course.
We were able to show a sustained effect of the intervention on our key target mediator, self-efficacy,
indicating that the intervention worked as intended. That these changes failed to result in the desired
effect on our primary outcome suggests that this is not, on its own, a sufficient change to result in
changes in pain-related disability, but there may be other important unmeasured mediators that we were
unable to investigate.
Limitations of the study
Our choice of primary outcome might be considered a limitation. Although we had identified pain-related
disability as determined by the CPG as one of our preferred potential outcome measures (see Chapter 5),
we did not use this as the primary outcome in the feasibility study (see Chapter 7). In designing the study
we wished to move beyond the existing evidence that consistently showed benefits for intermediate
outcomes such as self-efficacy without showing improvements in clinically relevant outcomes. In our
development work we considered different candidate measures for our clinically relevant primary outcome.
The mixture of disorders included in the trial meant that a generic outcome measure was needed. We had
originally considered using the EQ-5D. In the feasibility study, however, it was clear that this was not
sufficiently responsive to change from baseline for it to be a suitable outcome. For this reason we chose a
measure with a narrower focus on pain-related disability (the main trial data confirmed that the EQ-5D
was unresponsive to the intervention). Our choice of which pain-related disability outcome measure to use
was constrained by the necessity of choosing an instrument suitable for pain at different musculoskeletal
sites. The CPD pain-related disability subscale had been used with positive results in other studies of
chronic pain populations, suggesting that it was an appropriate choice and sensitive to change.53,83 Indeed,
as anticipated from previous studies,208,210 CPG scores fell by more than one-third of a SD between baseline
and 6 months (and then remained at similar levels at 12 months) in both the intervention arm and the
control arm, suggesting that it is sensitive to change.
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Another potential limitation of our study might have been our inclusion of a relaxation CD and leaflet along
with usual care in the control arm. Our pilot study had demonstrated that recruiting people to trials in which
one arm is usual care might be difficult and other researchers have described the possibility of ‘resentful
demoralisation’, when patients with a strong preference for one arm of a study are assigned to the other
arm.299 To maximise recruitment and, perhaps, reduce the risk of resentful demoralisation we chose to add a
very simple relaxation package to our control intervention (this package was also given to treatment arm
patients at the end of the COPERS course). We chose the relaxation package because our systematic review
(see Chapter 2) had suggested that, although relaxation was popular, it was unlikely to have an effect on our
primary outcome of pain-related disability. A 2006 systematic review found that progressive muscle
relaxation (the technique provided in our control arm) reduced chronic pain but in the two studies that
reported longer-term follow-up the effect on pain was not sustained at 3 or 6 months.300 However, one of
the most important effects of our intervention was on the secondary outcome of depression and there is
systematic review evidence that relaxation may improve participant-reported depression.301 Moreover, there
is a suggestion from the 12-month questionnaire that control arm patients might have practised regular
relaxation more frequently than intervention arm patients, although the data are difficult to interpret
because of poor response rates to the questions. (The questions were at the end of the questionnaire and
we assumed that most missing responses meant that people did not practise any relaxation.) Thus, there is
the possibility that the control arm intervention diminished the apparent effect of our intervention on
depression and, by extension, potentially on our other secondary psychological outcomes. It might be argued
in favour of our choice of control that, even if the relaxation CD had some efficacy, we would want to be
able to demonstrate that our intervention was superior to such a simple (and very slightly effective)
intervention. Control and intervention arm participants also received a copy of The Pain ToolKit booklet but
we have already explained that we consider this to be good usual care (see Chapter 9).
The ethnic mix of our participants was not nationally representative (COPERS trial: 80% white, 13% black,
5% Asian; England and Wales: 86% white, 3.4% black, 7.5% Asian302). Unusually, we achieved an
over-representation of minority ethnic groups compared with national norms. This reflects our decision to
recruit in a very ethnically diverse locality. Nevertheless, our recruited population might still not have been
representative of the ethnic mix of the communities from which we were recruiting. The overall uptake of the
offer to join the study by patients recruited from primary care was low and differed between east London
(6.7%) and the Midlands (10.8%), leading to concerns about the generalisability of the study and the feasibility
of implementing the intervention (if it were successful). However, because of the nature of our electronic
search many of the people identified for invitation from primary care records may not have been eligible.
Even if invitees were eligible, it is not clear how inviting participants to participate in a research project, in
which they are not guaranteed to receive an intervention and have to initiate contact with researchers
themselves (data protection necessitated that they were invited by their GP, not the research team), relates to
offering patients an intervention outside a research setting as part of usual care. Uptake (when reported) is
generally low in studies of self-management. Overall, the low uptake seen in our study suggests that, although
we can be confident that our results apply to the group included, we are less confident about extrapolating
these results to the wider chronic pain population. These uptake rates are, however, comparable with those in
other studies recruiting from primary care.53,56,83 That the clinical course of low back pain is similar in RCTs and
cohort studies provides some reassurance that the results from a trial of this nature do reflect real life.210 The
high levels of depressive symptoms seen in the COPERS study population are interesting in this context because
there is evidence from other chronic conditions that depressed patients are less likely to participate in group
self-management support and more likely to drop out.303 If this is also true for chronic pain it suggests that
levels of depressive symptoms could be even higher in eligible patients who did not participate in our study.
In common with other studies of self-management14 the majority of participants in our study were female
(67%). A 2014 Cochrane review of self-management in OA included 29 studies and reported that overall
68% of participants were female13 [our chronic pain patients were younger (mean age 60 years) than those
in the OA review (mean age 65 years)]. It is not clear why women are more attracted to self-management
interventions than men although, in general, more women than men report chronic pain. In a previous study
we found that the relative risk of women having chronic widespread pain was 1.3 (95% CI 1.2 to 1.4).59
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We originally wanted to identify subgroups who were most likely to benefit from a pain self-management
intervention. In our systematic review (see Chapter 3) we failed to identify any groups who might benefit
more than others and so we directed the intervention at all adult chronic musculoskeletal pain patients
who met our inclusion criteria. Prespecified subgroup analyses (see Chapter 11) failed to identify any group
in whom our primary outcome was significantly improved (although there was a suggestion that those
with less intense pain and a shorter duration of pain and those with neither high nor low self-efficacy
at baseline might benefit the most) but these analyses lacked statistical power. Thus, the issue of
subgrouping remains unaddressed.
Strengths and limitations in relation to other studies
Measuring a primary outcome at 12 months’ follow-up is a strength of our study; most other studies of
self-management in general, and of chronic pain self-management in particular, consider shorter follow-up
periods.13,14 Including self-efficacy among our choice of outcome measures is another strength. Although
we regard increasing self-efficacy as a process outcome, it has been advocated as an important outcome
that often goes unmeasured in studies of chronic pain self-management.13
Our intervention was successful compared with other self-management support interventions. A recent
RCT of the Arthritis Self-Management Programme in Australia, which also aimed to look at a real-world
setting, was terminated because of a lack of enthusiasm from potential referrers and patients.297 In
contrast to our study, which principally recruited patients with very longstanding musculoskeletal pain from
primary care, the Australian study recruited patients with knee and hip OA from secondary care, including
private hospitals.
The results of the economic evaluation demonstrate that the COPERS self-management course is a
relatively inexpensive intervention, with an average acquisition cost of approximately £145 per person,
including staff training (see Chapter 11). This is a little over half of the cost of a year’s supply of duloxetine
at a dose of 60 mg per day (£268.80),304 which is recommended for use for either fibromyalgia or knee
OA.305,306 It also compares favourably to the cost of the Expert Patients Programme, which is estimated to
cost £250 per patient.15 The estimated cost per participant for the COPERS course is also much lower than
the average cost of £599 per patient for the IAPT programme283 (another study estimated that the cost of
the IAPT programme per patient varied from £493 for low-intensity therapy to £1416 for high-intensity
therapy307). Several factors suggest that the cost per person would be lower should the COPERS
intervention become widely available. The first factor relates to training: although the training of facilitators
in the trial was conducted by university staff, wider adoption of the intervention would be likely to reduce
costs through using experienced facilitators in a training role. The second factor relates to venue costs: the
COPERS team had to hire premises but courses could be delivered in NHS/primary care settings if the
intervention were more widely adopted. Therefore, our cost estimate of £145 per participant per course
may be regarded as conservative.
The COPERS intervention is not a true CBT intervention. However, it was never our intention to deliver
CBT as such; we intended only to deliver an intervention informed by some of the principles of a
cognitive–behavioural approach.
Meaning of the study: possible mechanisms and implications
for clinicians or policy-makers
Our original conceptual model, adapted to include our revised primary outcome (Figure 21), suggested
that we would influence a variety of outcomes. In fact, we influenced only the psychological outcomes
and social integration and support, and a sustained effect at 12 months was seen only for depression and
social integration and support. In other words, our psychologically based group intervention had marked
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psychological effects that were concentrated in those who were depressed at baseline, but did not appear
to affect health-care resource use or disability. We are not in a position to say with certainty what the
active elements of the intervention were for certain but it seems likely that these were the psychologically
orientated components and the effect of being in a group of peers.
Implications
Overall, for patients with chronic pain, this rigorous, well-designed and well-conducted study suggests that
we now know the limitations of self-management support interventions for chronic musculoskeletal pain.
First, the study demonstrates that research studies of these interventions appeal to a limited number of a
particular type of chronic pain patient: those who are older, those who are likely to be retired or not
working and predominantly female patients. Even if they are not representative of chronic pain patients as
a whole, there may be merits in targeting this group as we also know that these patients are likely to be
significantly disabled by their pain and have high levels of anxiety and depression, may well be on strong
opioids, will be taking a lot of prescribed medications, attend their GP very frequently and have a long
history of pain. Moreover, the feasibility study for the COPERS intervention showed that the intervention
can actually be applied to a lot of other groups, for example the Sylheti-speaking group in Tower Hamlets
could complete the intervention with the Bengali DVD, even though it was not feasible to include them in
the main trial because of difficulties with collecting outcome data.
Second, the outcomes of these interventions appear to be modest and predominantly psychological. Such
interventions do not appear to have a marked, if any, effect on health-care resource use, at least within
Population
Sample
population
Active elements
of intervention
Change process Outcomes
Chronic pain and
busy (families,
appointments)
Chronic pain too ill
with pain and
comorbidities
Chronic pain and
working
Chronic pain
people willing
Context/external factors that may affect
intervention
• Quality of facilitation
• Comorbidities
• Exposure convenience and access
• Venue convenience and access
• Mobility
• Language fluency
• Dysfunctional group dynamic
Components 
• Education/
   acceptance
• CBT
• Group/social
   interaction
• Active physical
   learning (tasters,
   movement,
   relaxation)
• Communication
• Other (personal
   reflection, summary)
Aim/process
• Change cognitions
• Change behaviour
• Better coping
• Increase activity
• Social engagement
• Reduce anxiety
Outcome and
measures
• Pain-related
   disability
• Better resource
   use
• Quality of life
• Social integration
   and support
• Confidence (PSEQ)
• Coping (CPAQ)
• Depression and
   anxiety (HADS)
Chronic pain
not interested
FIGURE 21 The COPERS contextual model.
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the first 12 months. However, there is a strong suggestion in our post hoc analyses that this type of
intervention may be very effective in the subgroup of chronic pain patients with depression with no
deleterious effects on those who were not depressed at baseline.
Although some commissioners may interpret the modest effects of the COPERS intervention as justification
not to fund this type of self-management support for chronic pain patients, the COPERS intervention is
feasible and safe, can be delivered to large numbers of people, is evidence based and leads to levels of
improvement that are at least as good as those seen with other similar interventions and meets NICE
criteria for cost–utility. We suggest that the COPERS intervention could be a substitute for other less
well-evidenced and more expensive chronic pain management programmes. Its potential role in the
management of depression in chronic pain patients merits further research.
Research recommendations
Our work suggests that there is a need to address the following research questions (presented in order
of importance).
Research questions related to chronic musculoskeletal pain
1. What can be done to improve the disability experienced by patients with chronic musculoskeletal pain?
2. Does the COPERS intervention have a role in the management of chronic pain patients with mild to
moderate depression? Is it more effective and acceptable than alternative non-pharmacological
treatments for depression in this population? Our post hoc analyses strongly suggest that this is an
effective treatment for depression in this population. Nevertheless, this is based on a mixed clientele
joining the groups. As the group dynamic may be different if only people with depression join the
groups, it cannot be promoted as an intervention for this population. A new trial is needed to target
this population and focus on depression. It may be appropriate to use a depression outcome that is
more responsive to change than the HADS.
3. Could self-management interventions delivered before chronic musculoskeletal pain has become very
longstanding be more effective than those delivered after the individual has experienced years of
chronic pain? Would they be acceptable to patients? Would they have the potential to alter the disease
trajectory and long-term outcomes?
Research questions related to methodology
1. Should complex interventions have single outcome measures? Work is needed to explore the
interpretation of the results of trials of complex interventions in which multiple outcomes are reported.
In common with many complex interventions, the COPERS intervention had multiple facets that might
affect different outcomes in different ways. The traditional model whereby paramount importance is
given to the primary outcome is well established. In this model any apparently important benefits in
secondary outcomes are no more than hypothesis generating. A further full trial with these as the
primary outcome would be needed to confirm the findings. This approach leads to a hazard that
important beneficial effects, in our case a reduction in depressive symptoms, might be discarded as a
chance finding when, in fact, it may be an important positive result. Research in this area may consider
how such findings should be considered within the trial and also when data pooling.
2. Are large RCTs the best way to evaluate novel, complex, non-pharmacological interventions? There is a
large opportunity cost in developing and testing interventions of this nature. The risk of harm from such
interventions is small and a negative trial is unlikely to dissuade others from implementing similar
intervention packages. Once we put the results of the COPERS trial into context they made little
difference to the estimates of effects of such interventions on a wide range of outcomes and so our
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study has, arguably, not added to the evidence base commensurately with its size. Although a positive
trial would support implementation it would strictly support the implementation only of the package
tested. In reality, it is variants of the proven intervention that are delivered. For example, few
physiotherapy departments offer more than six sessions for people with low back pain, whereas NICE
guidance,129 based on the available evidence, suggests up to 12 sessions. This is in contrast to trials of
pharmacological interventions in which fully understanding the benefits and harms of a particular
preparation is critical. It may be worthwhile for the research community to explore whether or not other
approaches might generate ‘good enough’ data to inform policy and practice across a wider range of
topic areas for the same research cost.
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Appendix 2 Systematic review of predictors,
mediators and moderators
Search strategies for the review
MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations (via Ovid)
1. PATIENT EDUCATION AS TOPIC/
2. (patient$ adj (educat$ or train$ or teach$ or instruct$ or skill$ or participat$ or involv$)).ti,ab.
3. (expert adj patient).ti,ab.
4. SELF CARE/
5. SELF EFFICACY/
6. (self adj (manage$ or care or improve$ or develop$ or help or monitor$)).ti,ab.
7. (support adj group).ti,ab.
8. ((computer or internet or web or telephone or online) adj base$).ti,ab.
9. ((group or clinician or lay or volunteer or professional or expert or advisor or consultant or peer or
tutor or educator) adj (led or run)).ti,ab.
10. or/1-9
11. CHRONIC DISEASE/ and PAIN/
12. MUSCULOSKELETAL DISEASES/ and PAIN/
13. LOW BACK PAIN/ or FIBROMYALGIA/ or NECK PAIN/ or SHOULDER PAIN/ or OSTEOARTHRITIS/
14. ((chronic or persistent or long-term or wide-spread or recurrent or non-specific or musculoskeletal)
adj pain).ti,ab.
15. ((lower back or knee or neck or shoulder or hip or thoracic) adj pain).ti,ab.
16. osteoarthriti$.mp. or (osteo$ adj2 pain).ti,ab.
17. (osteoarthriti$ or (osteo$ adj2 pain)).ti,ab.
18. or/11-17
19. 10 and 18
EMBASE (via Ovid)
1. PATIENT EDUCATION/
2. (patient$ adj (educat$ or train$ or teach$ or instruct$ or skill$ or participat$ or involv$)).ti,ab.
3. (expert adj patient).ti,ab.
4. SELF CARE/
5. SELF CONCEPT/
6. (self adj (manage$ or care or improve$ or develop$ or help or monitor$)).ti,ab.
7. (support adj group).ti,ab.
8. ((computer or internet or web or telephone or online) adj base$).ti,ab.
9. ((group or clinician or lay or volunteer or professional or expert or advisor or consultant or peer or
tutor or educator) adj (led or run)).ti,ab.
10. or/1-9
11. CHRONIC PAIN/ and MUSCULOSKELETAL DISEASE/
12. MUSCULOSKELETAL PAIN/
13. SPINAL PAIN/ or LIMB PAIN/ or FIBROMYALGIA/ or NECK PAIN/ or SHOULDER PAIN/
or OSTEOARTHRITIS/
14. ((chronic or persistent or long-term or wide-spread or recurrent or non-specific or musculoskeletal)
adj pain).ti,ab.
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
235
15. ((lower back or knee or neck or shoulder or hip or thoracic) adj pain).ti,ab.
16. osteoarthriti$.mp. or (osteo$ adj2 pain).ti,ab. [mp=title, abstract, subject headings, heading word,
drug trade name, original title, device manufacturer, drug manufacturer name]
17. (osteoarthriti$ or (osteo$ adj2 pain)).ti,ab.
18. or/11-17
19. 10 and 18
PsycINFO (via Ovid)
1. CLIENT EDUCATION/
2. (patient$ adj (educat$ or train$ or teach$ or instruct$ or skill$ or participat$ or involv$)).ti,ab.
3. (expert adj patient).ti,ab.
4. SELF MANAGEMENT/
5. SELF EFFICACY/
6. (self adj (manage$ or care or improve$ or develop$ or help or monitor$)).ti,ab.
7. (support adj group).ti,ab.
8. ((computer or internet or web or telephone or online) adj base$).ti,ab.
9. ((group or clinician or lay or volunteer or professional or expert or advisor or consultant or peer or
tutor or educator) adj (led or run)).ti,ab.
10. or/1-9
11. MUSCULOSKELETAL DISORDERS/ and CHRONIC PAIN/
12. BACK PAIN/ or FIBROMYALGIA/
13. ((chronic or persistent or long-term or wide-spread or recurrent or non-specific or musculoskeletal)
adj pain).ti,ab.
14. ((lower back or neck or knee or thoracic or shoulder or hip) adj pain).ti,ab.
15. (osteoarthriti$ or (osteo$ adj2 pain)).ti,ab.
16. or/11-15
17. 10 and 16
Health Information Resources (www.nlh.nhs.uk) (Cumulative Index to
Nursing and Allied Health Literature, Allied and Complementary
Medicine Database)
1. (self AND (manage* OR help OR improve* OR care OR monitor* OR develop*)).ti,ab
2. (support group).ti,ab
3. (patient* AND (educat* OR train* OR teach* OR instruct* OR skill* OR participat* OR involv*)).ti,ab
4. (expert patient).ti,ab
5. ((computer OR internet OR web OR telephone OR online) AND base*).ti.ab
6. ((group OR clinician OR lay OR volunteer OR professional OR expert OR advisor OR consultant OR peer
OR tutor OR educator) AND (led OR run)).ti,ab
7. OR (1-6)
8. (((chronic OR persistent OR long-term OR wide-spread OR recurrent OR non-specific OR
musculoskeletal OR thoracic) AND pain)).ti,ab
9. ((lower back OR neck OR knee OR shoulder OR spinal OR shoulder OR hip) AND pain).ti,ab
10. (osteoarthriti* OR (osteo* AND pain)).ti,ab
11. OR (8-10)
12. 7 AND 11
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The Cochrane Library (Cochrane Database of Systematic Reviews, Database
of Abstracts of Reviews of Effects and Cochrane Central Register of
Controlled Trials)
(self NEAR/1 (manage* OR help OR improve* OR care OR monitor* OR develop*)) OR support group OR
(patient* NEAR/1 (educat* OR train* OR teach* OR instruct* OR skill* OR participat* OR involv*)) OR
expert patient* (computer OR internet OR web OR telephone OR online) OR ((group OR clinician OR lay
OR volunteer OR professional OR expert OR advisor OR consultant OR peer OR tutor OR educator) NEAR/1
(led OR run)) in Title, Abstract or Keywords
AND
(((chronic OR persistent OR long-term OR wide-spread OR recurrent OR non-specific OR musculoskeletal
OR thoracic) NEAR/1 pain)) OR ((lower back OR neck OR knee OR shoulder OR spinal OR shoulder OR hip)
NEAR/1 pain) OR osteoarthrit* in Title, Abstract or Keywords
Web of Science (Social Sciences Citation Index)
((self SAME (manage* OR help OR care)) OR “support group” OR (patient* SAME (educat* OR train* OR
teach* OR instruct* OR skill*)) OR “expert patient” OR ((group OR clinician OR lay OR volunteer OR
professional OR expert OR peer OR tutor OR educator) SAME (led OR run))) in Topic
AND
(((chronic OR persistent OR long-term OR wide-spread OR recurrent OR non-specific OR musculoskeletal
OR thoracic) SAME pain) OR ((lower back OR neck OR knee OR shoulder OR spinal OR shoulder OR hip)
SAME pain) OR osteoarthri*) in Topic
Meta-regression
To examine the impact of moderator variables, we used meta-regression analyses for the outcomes listed
in Table 75. Age and gender were chosen as the moderators to assess as these are the most frequently
reported demographics and we included at least six studies that reported these moderators for each
outcome. All calculations were performed using Stata 11.
TABLE 75 Number of studies for each outcome by each follow-up period
Outcome
Short term
(< 4 months), n
Medium term
(4–8 months), n
Long term
(> 8 months), n
Pain intensity 26 20 18
Physical/functional capability 19 18 13
Self-efficacy 12 7 7
Depression 13 4 3
SF-36 general mental health 9 5 4
Global health status 8 7 5
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There were few observations for some outcomes when considering only one time point. In addition,
modelling each time point separately gave rise to multiplicity, increasing the type 1 error substantially.
Therefore, the different time points were collapsed giving one average effect size to represent the different
time points per outcome. Results from the meta-regression were considered statistically significant if
p < 0.05, marginally significant if p < 0.10 and non-significant if p > 0.10. p-values between 0.05 and 0.10
were noted in light of potential type 2 errors as a result of the limited number of effect sizes in some of
our pooled effect size calculations.32
Table 76 presents the results for the meta-regression analyses with age and gender as moderators. Gender
was not associated with effect sizes for pain intensity, physical/functional capability, self-efficacy and
depression. Gender was marginally significantly associated with effect sizes for SF-36 general mental health
and global health status (all p < 0.10), suggesting a positive association between effect sizes for these
outcomes, that is, that self-management interventions favoured samples that included a lower percentage
of males. Age was also marginally significantly associated with effect sizes for physical/functional capability
and self-efficacy (all p < 0.10), suggesting a positive association between effect sizes for these outcomes,
that is, that self-management interventions favoured younger samples.
Heterogeneity
Study heterogeneity was generally in the mild to moderate range (I2 = 13.27–61.16%). Of the 12 comparisons,
none exceeded 65%; five exceeded 50%, suggesting moderate to high levels of heterogeneity; four fell
between 25% and 50%, suggesting low to moderate levels of heterogeneity; and three fell below 25%,
suggesting low levels of heterogeneity and a high concordance between studies.
TABLE 76 Meta-regression analyses with age and gender as moderators
Measure Studies, n Moderator Adjusted R2 (%) I2 t p-value 95% CI
Pain intensity 39 Gender –12.17 47.66 –0.20 0.840 –0.0062 to 0.0051
Physical/functional
capability
27 Gender –3.57 51.84 –0.58 0.560 –0.0084 to 0.0047
Self-efficacy 17 Gender –20.19 32.36 –0.44 0.732 –0.0115 to 0.0082
Depression 16 Gender –18.67 24.23 –0.64 0.533 –0.0108 to 0.0058
SF-36 general mental
health
11 Gender 35.48 51.60 1.86 0.095 –0.0021 to 0.0214
Global health status 14 Gender 13.50 59.06 2.12 0.065 –0.0003 to 0.0230
Pain intensity 39 Age 20.70 43.09 –1.61 0.116 –0.0114 to 0.0121
Functional capability 28 Age 28.27 45.84 1.86 0.074 –0.0008 to 0.0164
Self-efficacy 17 Age 46.56 17.32 1.98 0.060 –0.0004 to 0.0165
Depression 16 Age 42.30 13.27 1.62 0.156 –0.0025 to 0.0144
SF-36 general mental
health
11 Age 35.35 53.17 1.47 0.176 –0.0082 to 0.0317
Global health status 14 Age 12.72 61.16 1.29 0.223 –0.0085 to 0.0402
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Meta-regression results
Meta-regression                                       Number of obs  =      
39 
REML estimate of between-study variance               tau2           =  
.01926 
% residual variation due to heterogeneity             I-squared_res  =  
47.66% 
Proportion of between-study variance explained        Adj R-squared  = -
12.17% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
 PerCentMale |  -.0005626   .0027746    -0.20   0.840    -.0061845    
.0050593 
       _cons |   -.234762   .0820146    -2.86   0.007    -.4009394   -
.0685847 
----------------------------------------------------------------------------
-- 
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FIGURE 46 Pain intensity, sex and effect size.
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Meta-regression                                       Number of obs  =      
39 
REML estimate of between-study variance               tau2           =  
.01184 
% residual variation due to heterogeneity             I-squared_res  =  
43.09% 
Proportion of between-study variance explained        Adj R-squared  =  
20.70% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
     Ave_Age |   .0053627   .0033299     1.61   0.116    -.0013842    
.0121097 
       _cons |  -.5428533   .1938214    -2.80   0.008    -.9355727    -
.150134 
----------------------------------------------------------------------------
-- 
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FIGURE 47 Pain intensity, age and effect size.
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Meta-regression                                       Number of obs  =      
27 
REML estimate of between-study variance               tau2           =  
.02572 
% residual variation due to heterogeneity             I-squared_res  =  
51.84% 
Proportion of between-study variance explained        Adj R-squared  =  -
3.57% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
 PerCentMale |  -.0018458   .0031869    -0.58   0.568    -.0084092    
.0047177 
       _cons |  -.1692657   .0984468    -1.72   0.098    -.3720207    
.0334894 
----------------------------------------------------------------------------
-- 
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FIGURE 48 Physical/functional capability, sex and effect size.
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Meta-regression                                       Number of obs  =      
28 
REML estimate of between-study variance               tau2           =  
.01661 
% residual variation due to heterogeneity             I-squared_res  =  
45.84% 
Proportion of between-study variance explained        Adj R-squared  =  
28.27% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
     Ave_Age |   .0077655   .0041768     1.86   0.074    -.0008202    
.0163511 
       _cons |  -.6485839   .2433096    -2.67   0.013    -1.148714   -
.1484539 
----------------------------------------------------------------------------
-- 
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FIGURE 49 Functional capability, age and effect size.
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metareg SummaryES PerCentM, wsse(SummarySE_ES) mm 
 
Meta-regression                                       Number of obs  =      
17 
Method of moments estimate of between-study variance  tau2           =  
.01428 
% residual variation due to heterogeneity             I-squared_res  =  
32.36% 
Proportion of between-study variance explained        Adj R-squared  = -
20.19% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
 PerCentMale |  -.0016184   .0046446    -0.35   0.732    -.0115181    
.0082813 
       _cons |  -.2908392   .0900272    -3.23   0.006    -.4827277   -
.0989507 
 
Ef
fe
ct
 s
iz
e
0 10 20 30 40
Percentage male
– 0.8
– 0.6
– 0.4
– 0.2
0.0
0.2
Prediction interval
CI
Linear prediction
Summary effect size
FIGURE 50 Self-efficacy, sex and effect size.
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
243
metareg SummaryES Ave_Age, wsse(SummarySE_ES) mm 
 
Meta-regression                                       Number of obs  =      
17 
Method of moments estimate of between-study variance  tau2           = 
.006351 
% residual variation due to heterogeneity             I-squared_res  =  
17.32% 
Proportion of between-study variance explained        Adj R-squared  =  
46.56% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
     Ave_Age |   .0080561   .0039525     2.04   0.060    -.0003684    
.0164806 
       _cons |  -.7776062   .2358272    -3.30   0.005     -1.28026   -
.2749525 
----------------------------------------------------------------------------
-- 
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FIGURE 51 Self-efficacy, age and effect size.
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Meta-regression                                       Number of obs  =      
16 
Method of moments estimate of between-study variance  tau2           =  
.01211 
% residual variation due to heterogeneity             I-squared_res  =  
24.23% 
Proportion of between-study variance explained        Adj R-squared  = -
18.67% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
 PerCentMale |  -.0024756   .0038725    -0.64   0.533    -.0107813    
.0058302 
       _cons |   -.123099   .1006789    -1.22   0.242    -.3390337    
.0928357 
----------------------------------------------------------------------------
-- 
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FIGURE 52 Depression, sex and effect size.
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Metareg SummaryES Ave_Age, wsse(SummarySE_ES) mm 
 
Meta-regression                                       Number of obs  =      
16 
Method of moments estimate of between-study variance  tau2           =  
.00589 
% residual variation due to heterogeneity             I-squared_res  =  
13.27% 
Proportion of between-study variance explained        Adj R-squared  =  
42.30% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
Ave_Age |   .0059301   .0039536     1.50   0.156    -.0025494    .0144097     
 cons |  -.5070137   .2324535    -2.18   0.047    -1.005577   -.0084506  
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FIGURE 53 Depression, age and effect size.
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Meta-regression                                       Number of obs  =      
14 
Method of moments estimate of between-study variance  tau2           =  
.05279 
% residual variation due to heterogeneity             I-squared_res  =  
59.06% 
Proportion of between-study variance explained        Adj R-squared  =  
13.50% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
 PerCentMale |   .0113429   .0053389     2.12   0.055    -.0002895    
.0229753 
       _cons |  -.4725985   .1315918    -3.59   0.004    -.7593125   -
.1858845 
----------------------------------------------------------------------------
-- 
0 20 40 60
Percentage male
Ef
fe
ct
 s
iz
e
– 1.0
– 0.5
0.0
0.5
1.0
Prediction interval
CI
Linear prediction
Summary effect size
FIGURE 54 General health score, sex and effect size.
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Meta-regression                                       Number of obs  =      
14 
REML estimate of between-study variance               tau2           =  
.07286 
% residual variation due to heterogeneity             I-squared_res  =  
61.16% 
Proportion of between-study variance explained        Adj R-squared  =  
12.72% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
     Ave_Age |   .0117597   .0091412     1.29   0.223    -.0081573    
.0316767 
       _cons |  -.9141217   .5073514    -1.80   0.097    -2.019545     
.191302 
----------------------------------------------------------------------------
--
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FIGURE 55 General health score, age and effect size.
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
248
Meta-regression                                       Number of obs  =      
11 
REML estimate of between-study variance               tau2           =  
.04834 
% residual variation due to heterogeneity             I-squared_res  =  
51.60% 
Proportion of between-study variance explained        Adj R-squared  =  
35.48% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
   SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
 PerCentMale |   .0096764   .0051961     1.86   0.095    -.0020781    
.0214309 
       _cons |   -.501659   .1634463    -3.07   0.013    -.8714002   -
.1319179 
----------------------------------------------------------------------------
-- 
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FIGURE 56 General mental health, sex and effect size.
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Meta-regression                                       Number of obs  =      
11 
REML estimate of between-study variance               tau2           =  
.04844 
% residual variation due to heterogeneity             I-squared_res  =  
53.17% 
Proportion of between-study variance explained        Adj R-squared  =  
35.35% 
With Knapp-Hartung modification 
----------------------------------------------------------------------------
-- 
  SummaryES |      Coef.   Std. Err.      t    P>|t|     [95% Conf. 
Interval] 
-------------+--------------------------------------------------------------
-- 
    Ave_Age |   .0158437   .0107781     1.47   0.176    -.0085381    
.0402255 
      _cons |  -1.073206   .5653125    -1.90   0.090    -2.352032    
.2056193 
----------------------------------------------------------------------------
--
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FIGURE 57 General mental health, age and effect size.
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Appendix 3 Clinimetric study of outcome
measures
Measures of depression in pain populations
Measure Description Advantages Limitations
HADS176 14 items, seven for depression
and seven for anxiety
Designed for people with
physical problems, commonly
used, short, good
psychometrics, responsive in our
population, cut-points exist
One item (feeling slowed
down) may reflect pain
DAPOS184 11 items, five for depression,
three for anxiety and three for
positive outlook
No somatic items, designed and
validated in a chronic pain
population, positive outlook
dimension, a potentially useful
subgroup, short, psychometrics
OK, responsive in our population
No cut-points, not commonly
used
BDI177 24 items, subgrouped into
affect, cognitive and somatic
items
Very commonly used Contaminated by somatic
items, quite depressing,
developed for psychiatric
population so may lack
sensitivity in less depressed
groups
Zung Depression
Inventory308
24 items, similar to the BDI Used in pain populations,
designed and validated in back
pain
Contaminated by somatic items
CES-D178 20 items, similar to BDI in
structure
Very commonly used, good
psychometrics
Contaminated items
SF-36 mental
health309
Five-item subscale, mixture of
anxiety and depression items
Very common, good
psychometrics, short if only
those five items used
GHQ-12310
(psychological)
12 items, a mixed bag
representing distress
Very common, properties OK,
has been used in our population
Cut-points exist but they are
very low: our entire population
would become a case
PHQ-4179
(depression and
anxiety)
Two items on each Short More screening than
evaluation of mood
PHQ-9179 Nine items Commonly used in our
population, cut-points exist
Some items may reflect pain:
‘Moving or speaking so slowly
that other people could have
noticed or being so fidgety or
restless that you’ve been
moving around a lot more than
usual’
HSCL-20311 20 items Overeating, poor appetite and
sexual interest items may
reflect pain
EQ-5D depression
and anxiety
subscale312
Three items, simple
self-classification as ‘very’,
‘moderate’ or ‘not’
Essential for health economic
analysis
Not sensitive, does not
distinguish between depression
and anxiety
DAPOS, Depression, Anxiety and Positive Outlook Scale; GHQ-12, General Health Questionnaire 12; HSCL-20, Hopkins
Symptom Checklist-20.
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Self-efficacy systematic review methodology and results
Inclusion criteria
l Studies were included if they were a published in a peer-reviewed journal and included adults with
pain as a result of either chronic musculoskeletal disorders or chronic disease.
l Studies that included some clinimetric or psychometric evaluation of the most commonly used
self-efficacy and social support measures identified in the first search.
Search strategy for self-efficacy
1. Self-efficacy adj4 (scale or inventory or instrument or measure* or assess* or outcome).ti.ab
2. Self-efficacy.ti.ab
3. QUESTIONNAIRES/.ti.ab
4. OUTCOME ASSESSMENT (HEALTH CARE)/ti.ab
5. PSYCHOMETRICS/.ti.ab
6. 3 OR 4 OR 5
7. 2 AND 6
8. 1 OR 7
9. CHRONIC DISEASE/ and PAIN/
10. MUSCULOSKELETAL DISEASES/ and PAIN/
11. LOW BACK PAIN/ or FIBROMYALGIA/ or NECK PAIN/ or SHOULDER PAIN/ or OSTEOARTHRITIS/
12. ((chronic or persistent or long-term or wide-spread or recurrent or non-specific or ongoing or
musculoskeletal) adj pain).ti,ab.
13. ((lower back or knee or neck or shoulder or hip or thoracic) adj pain).ti,ab.
14. Osteoarthriti* or (osteo* adj2 pain).ti,ab.
15. 9 OR 10 OR 11 OR 12 OR 13
16. 8 AND 14
The most commonly used measures (ASES180 plus variants and PSEQ313) from the first search were selected
for clinimetric evaluation. The names of these measures were used in the second search:
1. Arthritis self-efficacy or Chronic Disease self-efficacy or Stanford self-efficacy or Pain self-efficacy
or PSEQ
2. Test Reliability/ or exp Psychometrics/ or exp Test Validity/ or exp Test Interpretation/
3. Validity or reliability or development or consistency or responsiveness or interpretability or psychometrics
or clinimetrics
4. 1 AND (2 or 3)
Clinimetric assessment
Clinimetric assessment was planned for the most commonly used measures obtained from both of the
searches. To evaluate the clinimetrics of the questionnaires a checklist was used based on criteria developed in
a former study.314 The following information was extracted: name of the questionnaire, target population,
domains measured, number of scales, number of questionnaire items; number of response options, range of
scores, time to administer, ease of scoring and study population used in the clinimetric study.
Validity
Content validity here refers to the degree to which the items within a research instrument represent the
domain of measurement. If a positive rating for readability and comprehension of the items was given by
the studied population and/or experts, content validity was achieved.
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The internal consistency of a questionnaire was rated as satisfactory when the Cronbach’s alpha was
between 0.70 and 0.90 for each subscale (if more than one)315 and when the dimensional structure of the
questionnaire was assessed by factor analysis or principal components analysis.
Construct validity refers to when a questionnaire demonstrates its ability to identify or measure the
variables or constructs that it proposes to identify or measure. Construct validity is adequate when studies
show correlations of the evaluated measure with other measures that the tool is hypothesised to be
related to.
For floor and ceiling effects to be judged as adequate, authors were required to provide sufficient
information regarding the distribution of scores.
Reproducibility (test–retest reliability)
This was evaluated as adequate if the interclass correlation coefficient was calculated and was > 0.70.
The use of Pearson correlation coefficients to estimate test–retest reliability was viewed as doubtful.
An adequate assessment of the agreement of the questionnaire was the calculation of the 95% limits of
agreement (the kappa coefficient or the standard error of measurement was viewed as an adequate
measure of agreement).
Responsiveness
The aim here was to measure whether or not the questionnaire can measure change in the measurement
domain in association with an intervention of some kind. If change scores were calculated and these were
associated with changes in a reference measure that was based on predefined hypotheses then the
measurement tool was given adequate responsiveness status.
Interpretability is when information is given that describes or explains a quantitative score obtained on a
test. This information could be presented in various ways: (1) the authors had presented a minimal
clinically important difference (MCID); (2) a report of means and SDs of patients scores before and after
treatment; (3) comparative data on the distribution of scores in relevant subgroups; (4) information on the
relationship of scores to well-known functional measures or to clinical diagnosis; or (5) relating changes in
disability score to patients’ global ratings of the magnitude of change they have experienced. At least two
of these types of information were needed for a positive rating of interpretability to be assigned.
Results
The electronic searches identified 1520 references, which were downloaded to an EndNote bibliographic
database (version X2, Thomson Reuters, CA, USA). A search through the references within the EndNote
database for the term ‘self-efficacy’ in either the title or the abstract resulted in 224 references being
retained. Thirty-eight dissertations were then removed and 21 studies were excluded as they did not
fit the inclusion criteria (chronic pain population including musculoskeletal conditions); in addition,
three references were books and so these were removed. Of the 162 references remaining, five were
discussion/review articles (data were extracted from three of these) (Table 77).
We identified the two most commonly used measures (> 10 articles had used these measures): (1) ASES-11
with its four variants (for chronic disease and shorter versions)180 and (2) PSEQ-5.313 We searched for
further information on the clinimetric and psychometric properties of these instruments.
The second search identified a further 21 articles for the ASES and its variants. The authors of this test
were contacted for unpublished data and we were referred to the following website for psychometric
data, where a further three references were retrieved [http://patienteducation.stanford.edu/research/
(25 April 2016)]. For the PSEQ-specific search, a further 20 articles were located. Three of these articles
were relevant plus an additional eight studies identified from the reference lists of these papers.
A description of these questionnaires and their properties is presented in Table 78.
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TABLE 77 Studies that featured psychometric evaluation of self-efficacy scales
Study Measure Description of psychometric evaluation
Baheiraei 2005316 Osteoporosis Self-Efficacy Scale317 Psychometric properties of the Persian version of
the scale
Horan 1998317 Osteoporosis Self-Efficacy scale317 Development and evaluation
Barlow 1997183 ASES180 Reliability and validity of the scale in British people
with arthritis
Lomi 1992318 ASES, Swedish version Evaluation of a Swedish version of the ASES with
respect to factor structure and reliability on
rheumatology and chronic pain patients
Mueller 2003319 ASES,180,320 Validation of the ASES short-form scale
Nicholas 2007181 PSEQ313 Reliability and validity in a low back pain population
Sarda 2007321 PSEQ313 The translation of the PSEQ into Portuguese. The
Brazilian version of the PSEQ had a high concordance
with the original version
Lim 2007322 PSEQ313 Chinese version322 Reliability and construct validity
Shin 2001323 Exercise Self-Efficacy Scale190 Reliability, face validity and factor analysis of the scale
in a Korean population with chronic diseases
Anderson 1995324 Chronic Pain Self-Efficacy Scale (CPSS)324 Development and initial validation in chronic pain
patients
Barlow 2000325 Parent’s Arthritis Self-Efficacy (PASE)325 scale Development and validation
Bursch 2006326 Child Self-Efficacy Scale – parent and child
version326
Reliability and validity tested
Gard 2005327 Motivation for Change questionnaire327 Development and reliability
Gibson 1996328 Spinal Function Sort Measure329 Reliability and validity tested
Sandborgh 2008330 Pain Belief Screening Instrument (PBSI)331 Reliability and validity tested
Vlaeyen 1990332 Liste des Cognitions de la Douleur332 Development of the scale
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Content validity
Information regarding the content validity of the questionnaires is summarised in Table 79.
For perceived social support there were no recommendations from the MMICS31 or IMMPACT30 guidelines,
nor were we able to identify a systematic review comparing measures. We carried out a literature search to
identify candidate instruments. Items were selected by experts and patients for four of the questionnaires
(PSEQ, ASES-20, CDSES-33 and ASES-11). Readability and comprehensibility were assessed in two
questionnaires (PSEQ and ASES-11). Factor analysis and principal components analysis demonstrated the
presence of factors for the ASES-20 (two factors), ASES-11 (two factors) and PSEQ (one factor). Internal
consistency was studied in all of the questionnaires and Cronbach’s alpha ranged from 0.76 to 0.94 and
was given a positive rating if it was > 0.70.315 Therefore, content validity was most explored for the
ASES-20, ASES-11 and PSEQ questionnaires. Item reduction and confirmatory factor analysis were carried
out only for the ASES-20.
Construct validity
Construct validity was demonstrated for all measures except for the CDSES-6 through correlations of the
self-efficacy measures with various outcomes. Hypotheses were given regarding expected relationships,
although these were not always directional. Outcomes were depression, psychological well-being, reported
pain and fatigue, positive effect, pain-related disability and pain coping strategies among the ASES scales.
PSEQ scores were correlated with depression, anxiety, unhelpful coping strategies, pain ratings, somatic
focusing and perceived capacity for work-related tasks (Table 80).
Information regarding floor/ceiling effects was available only for the ASES-8 and CDSES-33. Both
questionnaires were free from floor effects, although minimal ceiling effects were reported for the
CDSES-33. Such information was missing for the ASES-20, ASES-11, CDSES-6 and PSEQ.
Reproducibility
Test–retest reliability was assessed for three out of the six questionnaires (ASES-20, CDSES-33 and PSEQ)
(Table 81). Time intervals between test administrations were between 9.4 days and 16.3 weeks.
Test–retest correlations ranged from 0.68 to 0.88 across the three questionnaires. Pearson’s product
correlations were used to assess test–retest reliability; however, the ICC is thought to be a more
appropriate test of retest–reliability.
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TABLE 80 Construct validity of the self-efficacy questionnaires
Questionnaire
Construct validity
Hypothesis (Main) results FCE Study size, n
ASES-20180 Yes – self-efficacy will be
related to present health
status and future health
status (non-directional)180
Pearson’s correlations
were used. Baseline FSE
with baseline pain
(r = –0.29), disability
(r = –0.76) and depression
(r = –0.16). Baseline OSE
with baseline pain
(r = –0.27), disability
(r = –0.25) and depression
(r = –0.44). Baseline PSE
with baseline pain
(r = –0.29), disability
(r = –0.21) and depression
(r = –0.33).180 Predictive
and concurrent validity
also presented
97180
ASES-11180 Concurrent validity was
examined through
Pearson product–moment
correlations of the ASES
scores with demographic
variables, physical status,
psychological status and
social well-being (no
directional hypotheses).
Congruence between
specific arthritis
self-efficacy and
generalised self-efficacy
beliefs was predicted,
although the strength
was expected to be
modest (hypotheses).
The predictive abilities of
the two subscales of the
ASES were examined
using hierarchical
regression analyses with
psychological well-being
(depression and positive
affect) as the dependent
variable (no directional
hypotheses)
Greater self-efficacy
results were associated
with decreased physical
functioning (in study 2
only). Greater self-efficacy
beliefs tended to be
associated with less
reported pain and less
fatigue. The strongest
patterns of associations
were in the expected
directions, with
correlation coefficients
ranging from 0.30 to
0.61 for depression and
from 0.25 to 0.63 for
positive affect. Greater
self-efficacy beliefs were
associated with more
positive psychological
well-being.183 A consistent
pattern of positive
association was found
between the ASES other
symptoms subscale and
the Generalised
Self-Efficacy Scale.183
The ASES other symptoms
subscale was influential in
predicting depression
(CES-D) and positive
affect (B= –0.31,
p = 0.024 and B= –0.34,
p = 0.006, respectively).
The ASES pain subscale
was less predictive of
depression or positive
affect183
Study 1 53,
study 2 145,
study 3 66,
study 4 80183
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TABLE 80 Construct validity of the self-efficacy questionnaires (continued )
Questionnaire
Construct validity
Hypothesis (Main) results FCE Study size, n
ASES-8180 Yes – self-efficacy will be
associated negatively with
pain, disability and
depression (clear
hypotheses)
Controlling for age,
gender and pain intensity,
self-efficacy was
associated significantly
and negatively with
pain-related disability
(r = –0.29, p< 0.001),
pain (r = –0.34,
p< 0.001) and depressive
symptoms (r = –0.49,
p≤ 0.001) and positively
with use of pain coping
strategies (particularly
task persistence, r = 0.48,
p< 0.001)338
The scale showed no floor
effects (no one had the
lowest possible score) and
minimal (1.4%) ceiling
effects in the sample338
140 chronic
pain patients338
CDSES-33182 In addition to the item
convergence and
discriminant validity tests
conducted as part of the
multitrait scaling analyses,
construct validity was
examined by evaluating
correlations among self-
efficacy measures and
their corresponding
behaviour or outcome to
ensure that self-efficacy
was not highly correlated
with the corresponding
measure180
The absolute magnitude of
the correlations between
self-management
behaviours and self-efficacy
to perform the behaviours
ranged from 0.01 to 0.41.
Therefore, the scales were
sufficiently independent of
the actual behaviours that
they can be viewed as
distinct scales. The
absolute magnitude of the
correlations between
health outcomes and
self-efficacy to achieve the
outcomes ranged from
0.14 to 0.75. The largest
correlation was between
self-efficacy for managing
depression and three of
the psychological scales:
depressive symptoms
(–0.75), CES-D depression
(–0.68) and psychological
well-being/distress (0.72).
However, multitrait scaling
analysis in which these
items were included
showed that the items in
these scales were
discriminating sufficiently
well to be used as distinct
measures. The remaining
correlations were of less
concern, falling below
0.65182
No floor or ceiling effects
were observed182
1130182
continued
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TABLE 80 Construct validity of the self-efficacy questionnaires (continued )
Questionnaire
Construct validity
Hypothesis (Main) results FCE Study size, n
CDSES-6333
PSEQ313 Validity was assessed by
examination of the
relationships between the
PSEQ and validated
measures of constructs
that would be expected
to have different types
of relationship with
self-efficacy.181
Self-efficacy theory
would predict a strong
relationship between the
PSEQ and measures of
activity181 (expected
negative correlations with
higher medication usage,
pain coping strategies,
pain-related activities and
pain beliefs). Positive
correlations would be
expected with coping
strategies (for active
approaches) and negative
correlations with passive
approaches (these authors
had hypotheses)
Pearson product–moment
correlations between the
PSEQ and the other
assessment measures
were examined. Because
of the large number of
intercorrelations, only
correlations of r > 0.40
and p< 0.001 were
considered significant.
As expected, significant
negative correlations were
obtained between the
PSEQ and total number
of medications used,
impact of pain on daily
life (SIP-self-rated and
SIP-significant-other-
rated), mood (BDI, STAI)
and unhelpful coping
strategies and beliefs
(catastrophising subscale
of the CSQ, the PBQ)
(between r = –0.45 and
r = –0.60). Also as
expected, significant
positive correlations were
obtained between the
PSEQ and active coping
strategies measured
(ignoring pain, coping
self-statements and
increasing activity)
(between r = –0.45 and
r = –0.60). In contrast, no
significant correlations
were found between the
PSEQ and measures of
pain and somatic focusing
(average pain ratings,
MPQ subscales or MSPQ),
but all were in the
negative direction, as
expected181 (all r > 0.40,
p > 0.001).311 In a study
with CLBP patients there
were high correlations
between PSEQ scores and
perceived capacity for
work-related tasks,
as well as another
self-efficacy measure
(r = 0.78 and 0.63,
respectively)328
Westmead
sample 103;
tertiary referral
pain centre
(RNSH) sample
1306
CLBP, chronic low back pain; CSQ, Coping Style Questionnaire; FCE, floor/ceiling effect; FSE, self-efficacy for physical
function; MPQ, McGill Pain Questionnaire; MSPQ, Modified Somatic Perception Questionnaire; OSE, self-efficacy for other
symtoms; PBQ, Pain Beliefs Questionnaire; PSE, self-efficacy for pain management; RNSH, Royal North Shore Hospital;
SIP, Sickness Impact Scale; STAI, State Trait Anxiety Index.
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Responsiveness
The responsiveness of three of the questionnaires (ASES-20, CDSES-33 and PSEQ) was evaluated in five
studies (Table 82). Hypotheses were provided in all of the studies except for that by Burckhardt et al.339
regarding specific changes in self-efficacy in association with the intervention (note that a change was
explored in Nicholas et al.,313 not predicted). No data on responsiveness were found for the other three
questionnaires (ASES-11, ASES-8, CDSES-6). The best way to analyse responsiveness is through receiver
operating characteristic curve analysis and no study used this technique.
Interpretability
Interpretability data were provided for three of the questionnaires (ASES-20, CDSES-33 and PSEQ) across
seven studies (see Table 82). Baseline and post means were given for all three questionnaires; however,
scores for relevant subgroups were described only for the PSEQ. MCIDs were not reported for any of the
self-efficacy measures and there were no interpretability data available for the other three questionnaires
(ASES-11, ASES-8 and CDSES-6).
Systematic review of social support measures in chronic pain
populations with clinimetric properties
Search strategy for social support measures
The main aspects of social support that we wanted to measure were (1) friends and family and
(2) health-care resources.
The studies in Table 83 either refer to psychometric evaluation of social support scales or are the actual
psychometric studies.
Table 84 provides a description of additional measures of social support extracted from specialist texts.
Finally, Table 85 provides a list of measures that fitted most closely to our aims.
TABLE 81 Reproducibility of the self-efficacy questionnaires
Questionnaire Test–retest reliability
Time interval
between tests Study size, n
ASES-20180 The test–retest correlations (r) were 0.75 for pain self-efficacy, 0.84
for functional self-efficacy, 0.68 for other self-efficacy and 0.88 for
the total score334
16.3 weeks334 CLBP 59180
ASES-11180
ASES-8180
CDSES-33182 Test–retest reliability coefficients (r) ranged from 0.82 to 0.89
(method not specified)182
10 days182
CDSES-6333
PSEQ313 Carried out with Pearson correlations and analysis of chance.
The test–retest correlation (r) from baseline to 3 months was 0.73
(p < 0.001). The mean scores for the two occasions were 26.7
(SD 12.5) and 26.9 (SD 12.6), respectively (i.e. no significant
change). Interestingly, similar findings were reported by Williams
199670 with a waiting-list control group of mixed chronic pain
patients (n = 31) tested 12 weeks apart. In that study, in which
patients [mean age 51.1 (SD 10.7) years; mean pain duration 7.2
(SD 6.6) years; mean BDI 16.6 (SD 6.5); mean pain severity (0–100)
67.9 (SD 22.3)] continued with whatever treatments their doctors
had prescribed, the mean (SD) PSEQ score at baseline was 26.3
(10.8) and at 12 weeks was 26.7 (6.2); again, no significant
change was found (as well as no change in pain or disability)313
3 months 245 chronic
pain patients
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TABLE 83 Psychometric studies for social support questionnaires
Study Measure Description of psychometric evaluation
Ahlstrom 2002344 Swedish version of the Ways of Coping
Questionnaire; 6/66 items focus on ‘seeking
social support’
Some psychometrics presented
Bell 1982345 Social Support Index Reliability and validity reported in Orth-Gomer
and Unden346
Bennett 2001347 Social Support Survey186 Reliability and validity has been established in
previous research
Berkman 1979348 Social Network Index Reliability and validity reported in Orth-Gomer
and Unden346
Blazer 1982349 Social support scale Reliability and validity reported in Orth-Gomer
and Unden346
Broadhead 1982350 Broadhead questionnaire Reliability and validity reported in Orth-Gomer
and Unden346
Cohen 1985351 Interpersonal Support Evaluation List (ISEL) Reliability and validity reported in Orth-Gomer
and Unden346
Da Costa 2000352 Short version of the Social Support
Questionnaire (SSQ-6)
The SSQ-6 is psychometrically sound
Da Costa 2006353 Social Support Questionnaire (SSQ) Sarason
1987354 was used to assess perceived
satisfaction with social support
The SSQ is psychometrically sound and includes
six items measuring satisfaction with social
support, Sarason 1987354
Dean 1981355 The Instrumental-Expressive Social Support Scale Reliability and validity reported in Orth-Gomer
and Unden346
Doeglas 1996356 The Social Support Questionnaire (SSQ) consists
of two parts: the Social Support Questionnaire
for Transactions (SSQT) and the Social Support
Questionnaire for Satisfaction with the
supportive transactions (SSQS)374
Yes
Eakin 2007357 Spanish version of the CIRS357 Validation
Edwards 2009358 Social Support Survey186 Reliability and validity has been established in
other studies. Designed for chronically ill
patients
Esteve 2005359 The Vanderbilt Pain Management Inventory
(VPMI) has a seeking social support scale
(identified through confirmatory FA)
Some psychometrics presented (reliability)
Evers 2002360 Social functioning in the past 6 months was
measured with the IRGL social functioning
scales
Good reliability and validity demonstrated
elsewhere
Franks 2004361 The Norbeck Social Support Questionnaire
(NSSQ)362
Reliability and validity demonstrated elsewhere
Funch 1986363 Social support scale Yes, reliability and validity
Garcia-Campayo
2007364
The Norbeck Social Support Questionnaire
(NSSQ)362
Reliability and validity demonstrated elsewhere
Gard 2005327 Social support is one of the scales in the
Motivation for Change Questionnaire327
Development and reliability
Glasgow 2005365 CIRS185 Cross validation and sensitivity to intervention
data
Glasgow 2000185 CIRS185 Psychometrics presented
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TABLE 83 Psychometric studies for social support questionnaires (continued )
Study Measure Description of psychometric evaluation
Henderson 1980366 Interview Schedule for Social Interaction (ISSI) Reliability and validity reported earlier, in this
review
Hesselink 2004367 Perceived social support was measured using a
standardised 12-item questionnaire, the Social
Support List – Interactions (SSL12-I), measuring
‘everyday social support’, ‘social support in
problem situations’ and ‘esteem support’368
Cronbach’s alpha given for the present study
Marhold 2002369 Obstacles to Return-to-Work Questionnaire
(ORQ). One scale identified by Confirmatory
Factor Analysis as ‘social support at work’
Development and validation
McCormack 2008370 Resources and Support for Self-Management
(RSSM) questionnaire
Development and validation
McFarlane 1981371 Social relationship scale Reliability and validity reported earlier, in this
review
Raleigh 1994372 A scale in the Multidimensional Hope Scale
measures social support
Development and evaluation; reliability and
validity
Savelkoul 2001373 Action-directed coping and coping by seeking
social support were measured with two
subscales of a short version of the Utrecht
Coping Questionnaire
Reliability and validity reported elsewhere as
acceptable
Sherbourne 1991186 Social Support Survey186 Development and evaluation
Suurmeijer 1995374 The Social Support Questionnaire (SSQ) consists
of two parts: the Social Support Questionnaire
for Transactions (SSQT) and the Social Support
Questionnaire for Satisfaction with the
supportive transactions (SSQS)
Development and validation
Tan 2001375 The Chronic Pain Coping Inventory (CPCI) has
65 items that measure 11 coping strategies that
patients might use to cope with or manage
their chronic pain.376 One of the strategies
measured is seeking social support
Psychometric data available elsewhere
Tan 2005377 The CPCI has 65 items that measure 11 coping
strategies that patients might use to cope with
or manage their chronic pain.376 One of the
strategies measured is seeking social support
Further validation of the CPCI
Thompson 1993378 Short version of the Social Support
Questionnaire (SSQ-6)
Discriminant validity. Adequate reliability and
validity shown elsewhere
Trief 1995379 Social Support Questionnaire (SSQ)354 Discriminant validity
Weir 1996380 Social support was measured using the
Duke-UNC Functional Social Support
Questionnaire381
Validity established elsewhere
Yu 2004382 Psychometric testing of the Chinese version of
the Medical Outcomes Study Social Support
Survey (MOS-SSS-C) against the Chinese version
of the Multidimensional Perceived Social
Support Survey
Yes, psychometric evaluation of this scale
IRGL, Impact of Rheumatic Disease on General Health and Lifestyle.
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TABLE 84 Additional social support measures from specialist texts
Social support measure What it measures Length Comments
Inventory of Socially
Supportive Behaviours
(ISSB)383
Types of support: emotional,
instrumental, information appraisal
and socialising
40 items/
10 minutes
Not designed to provide information
on the people who provided
resources or appraisal of the support
Arizona Social Support
Interview Schedule (ASSIS)383
Measures several aspects of social
support plus identifies social
support network membership and
satisfaction with social support
15–20
minutes
Interview
Perceived social support from
family and friends384
Perceived social support 8 minutes Does not cover health care
Social Network Scale (SNS)385 Network size, number of people
respondent feels close to, number
of relatives in network and network
density
8 items Does not cover health care
Lubben Social Network Scale
(LSNS)386
Social network scale for use with
older people
10 items Does not cover health care
Family Relationship Index387 Social support within the family ? Does not cover health care
Social Support Appraisals
Scale (SS-A) and Social
Support Behaviours Scale
(SS-B)388,389
Social support from family and
friends
? Does not cover health care
Network typology: the
Network Assessment
Instrument390
Classifies a person into a network
type
8 questions Those administering the questions
need to go on a training course
Weinert and Brandt391 – part 2
of the Personal Resource
Questionnaire392
Family and social support 25-item
Likert scale
Lengthy
TABLE 85 Reduced list of measures based on mapping our aims onto the test
Measure Description Comment
Social Support Survey186 21 items Measures both social and health
support (n= 4 studies)
Chronic Pain Coping Inventory (CPCI)376 8-item scale Only measures social interaction
(n= 2 studies)
CIRS185 65 items (there is a 22-item version) Lengthy and impractical. Shorter
22-item version includes social and
health support (n = 3)
Norbeck Social Support Questionnaire362 9 items Interview
Social Support Questionnaire for
Transactions (SSQT) and the Social
Support Questionnaire for Satisfaction
with the supportive transactions (SSQS)374
23 items Interview
Social Support Questionnaire (SSQ)354 27 items/15 minutes (also a
short-form version including
6 items)
Does not cover health care
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Appendix 4 Development of the new intervention
Facilitator training course: outline
Saturday
Time Content
09.30–10.00 Introduction to selves and course
Evaluation sheets
1-minute introductions
10.00–10.30 Background to project
Group facilitation (flip chart difficulties and what to do)
Course overview and explanations
10.30–10.45 Day 1 – the course
Session 1: rules of group (practice facilitation, generate rules, use flip chart)
Exercise group facilitation: ice-breaker with dominant person
10.45–11.30 Session 2: pain education DVD, discussion, DVD, discussion
Break
11.40–11.45 Explain about lunch and tasters
11.45–12.00 Session 3: the unwanted guest (someone to read and facilitate)
12.00–12.15 Session 4: discuss pain – bad and not so bad (describe session only)
12.15–12.30 Session 5: pain cycle – show diagram. Allocate a facilitator, discuss why stay in cycle, make a list of
unhelpful behaviours (including depression list). Ask group how to escape from cycle. Show diagram
12.30–12.45 Depressive symptoms – read out
Lunch
13.30–14.00 Distress and suicidal intent (allocate facilitator and answer question). Go through protocol and questions
14.00–14.15 Session 6: posture (trainer to show)
14.15–14.30 Session 7: relaxation (allocate someone to read script)
14.30–14.35 Evaluation forms – end of day
14.35–14.45 Day 2 – session 8: reflections (allocate facilitator to carry out this)
14.45–15.15 Session 9: depressive symptom list, problems, brainstorm solutions, goals, actions (separate and carry out
group discussions)
Break
15.30–16.00 Session 10: pros and cons (allocate facilitator). Choose a con and reframe it
Brainstorm reasons that stop us doing things
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Sunday
Time Content
09.30–10.00 Session 11: errors in thinking
Scenario 1: allocate person to read out statement, group to discuss it and why illogical and then try and
reframe it
Go through unhelpful thinking (based on session 10 discussions)
Read scenario 2. Allocate facilitator to enable group to identify unhelpful ways of thinking
10.00–10.20 Session 12: carry out exercises 1 and 3 (trainer)
10.20–10.35 Session 13: allocate facilitator to brainstorm ways to manage pain
10.35–10.45 Recap posture from last session and carry out balancing (trainer)
10.45–11.00 Breathing, relaxation and visualisation (allocate)
Break
11.10–11.20 Session 16: reflections and feedback (allocate or skip if time short)
11.20–11.30 Session 17: run through and ask questions (trainer)
11.30–12.15 Session 18: role plays (assign parts), discuss each (allocate facilitators)
12.15–12.45 Session 19: listening skills (trainer to lead)
Lunch
13.30–13.45 Session 20: sleep (allocate facilitator to generate ideas for solving sleep problems)
13.45–14.00 Session 21: intimacy – trainer to lead and discuss with them (can leave out if they wish)
14.00–14.20 Session 22: anger and frustration (allocate facilitator to read and lead discussion and to ask: ‘when was the
last time you had fun?’)
14.20–14.30 Session 23: stretches (trainer to lead brief run through)
14.30–14.45 Session 24: mindfulness explanation and practice relaxation
14.45–15.00 Go through buddying idea, mention contract, suggest participants buddy up
15.00–15.15 Follow-up
15.15–15.30 Evaluation of the course, debrief, choose course dates
APPENDIX 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
268
Appendix 5 Feasibility study
Bengali questionnaire
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Feedback from facilitators and participants
Facilitator and observer feedback on the intervention
Session
Observer/facilitator notes/facilitator
focus group Study team discussion
Introduction l Egg timer works well
l Provide reading material at the start
l Simplify aims and define better
l Nerves of facilitators evident
l High levels of participant input from
the start
l Mixed participant expectations;
some negative
l More time for talking about health beliefs
and acknowledgement of current
medical treatments
l Clearly communicate aims
l Challenge negative expectations at the start
l Continuous slideshow of previous
participants’ quotations in the background
DVD l Consider those with specific diagnoses
causing pain
l Denervation conflicts with message
on DVD
l Most groups identified with Charlie
and Lisa
l Leave out ‘Where does Charlie’s pain
come from?’
l Do not read out background scenario
l Make the DVD shorter, just keep the
pain pathway
l Change questions used for discussion, e.g.
‘How do you feel about consultant saying
there’s no cure?’
l Show Charlie going to a course
l Use positive quotations from real people at
the end
l More about cortical/cerebral involvement
(e.g. the limbic system and emotion,
e.g. happiness)
l Educate facilitators to answer questions
about medical treatments (denervation)
l Acknowledge specific causes of
pain (osteoporosis)
Unwelcome guest l Often taken literally/be upfront
about analogy
l When prompted analogy works well
l Do this before lunch on first day
l Change ‘unwelcome’ to ‘uninvited’?
l Often misperceived until the penny drops
l Anticipation of medical treatment
undermines acceptance process
l Change analogy to gatecrasher at a party
l Get facilitators to focus on pain
Pain/mood l Aim of pain/mood diary not clear – better
as flip chart?
l Literacy issues for Bengali group
l Prompting for things other than weather
and environmental factors
l Pain/mood diary not always used; could
leave out
l Jenny’s holiday not always used but still
required as backup
l Hard concept to embed pain/mood
relationship (may need different method)
l Get rid of pain/mood diary as it
encourages hypervigilance
l Keeping bearable or not linking pain
to emotions
l Do this as buzz groups and feedback
Pain cycle l Move depressive symptoms or spend less
time on it
l Pain cycle works well; people resonate
with concept
l Facilitators must take care not to spend too
long on presentation; more
discussion needed
l Pain cycle is very powerful and works
very well
l Reorder to (1) things that keep you in the
cycle, (2) depressive symptoms list and
(3) things that move you out of the cycle
l Need clearer instructions for facilitators
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Session
Observer/facilitator notes/facilitator
focus group Study team discussion
Stretching, movement,
posture
l More of it
l Well received
l Some participants had difficulty standing
up to perform exercises because of
limited mobility
l Adapt to include seated postures too
l Provide handouts for exercise
Relaxation
visualisation
l Well received
l Provide a recording in CD or MP3 format
l Need to remind participants why this is
useful for pain
Reflections l Get all members of the group to
present feedback
l Works well and by the follow-up groups
virtually unfacilitated
l Good for embedding concepts and going
over content
l Good for motivation
l Role models evolve and emerge here
l Follow-up session had the worst
attendance
CBT l For all sessions, make the aim clearer and
put in the context of pain. Laypeople are
very important in these sessions
l Reorder the sessions: (1) unhelpful
thoughts, (2) barriers to change – reframing
cons to cans and (3) goal-setting
CBT: goal-setting l More time needed for this
l Simplify whole process, especially
‘SMART’ goal exercise (consider
language/literacy)
l Use an example generated by group (or
as backup, ‘I can no longer walk to the
shops to do my own shopping’)
l Small groups work well with more
unfacilitated interaction
l Choose sleep as the example for
goal-setting in small groups
CBT: pros and cons
and barriers
l Clarify aim
l Too much material in this session – move
unhelpful thoughts into session 11
l Overall pros and cons work well – lots
of content
l Reframing the group’s cons to cans
works well
l Carry out only one reframing
CBT: unhelpful
thoughts
l Start session with unhelpful thoughts list
l Simplify unhelpful thoughts list (consider
language/literacy)
l Use an example that relates to pain or
group’s own example
l Too much material – move/remove
reframing (slide 17)
l Important material – worked well
l ABCDE checklist not used; no time really
l Use negative statements from
participants more effectively as examples
of unhelpful thoughts
l Use laminated cards of unhelpful thoughts
for prompting throughout and use in game
to identify the unhelpful thoughts in a
scenario in two groups
l Get participants to give examples of
unhelpful thoughts
CBT: attention control l Move to before lunch to help with
food analogy
l Need to use humour with this session
l Clarify aim – emphasise ‘Don’t think
about pain’
l Works well when penny drops
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Session
Observer/facilitator notes/facilitator
focus group Study team discussion
CBT: coping strategies l Physical examples remembered frequently
l Sometimes takes a lot of prompting
l Application of these skills not so clear
l Worked well for some groups
Communication:
GP consulting
l Not always relevant (not all frequent
GP attendees)
l Distinction between role plays not always
immediately obvious
l Shifting focus to what GP hears and what
the GP can do really important
l Facilitators should have extra guidance to
help them to focus the session on GPs’
point of view
l Merge this session with role play
Communication:
role play
l Generally worked well providing the
‘acting’ was good
l Make role play optional/backup
l Obtain a real example from the group
Communication:
listening skills
l Instructions need to be crystal clear
l Worked well for most
l Get facilitator to apply to other
relationships (friends, etc.)
l Change the word topic to hobbies –
something you like doing or used to
like doing
Communication:
intimacy
l Some in the groups are single
l Worked better for some groups
than others
l Disclosure uncomfortable
l Unsure if this session works well
l Delete
Communication:
anger
l Situation taken literally – aim not clear –
emphasise contrast in scenarios
l Act as role play instead?
l Worked well on the whole
l Group and course fatigue at this point
sets in
l Delete if short of time as not perceived as
crucial to the learning about pain
Sleep l Lots of content generated
l Often addressed at different stages
throughout the course so facilitators
consolidate information
l Rushed?
l Delete session but use as an example for
goal-setting
Tasters l Make aim clear?
l On the whole well received but must
keep them voluntary
l Keep in but perhaps make them less
physical (e.g. problem-solving, team games)
Buddying up l Often rushed and process confused
l Ad hoc
l Not much feedback
l Improve process by providing a venue
l Have cross-fertilisation between groups
l Online forum
l No contract. Keep informal
Other general
suggestions
l More variation in learning modes – small
groups, games
l Have something positive to take home on
the first day
l Do something practical on the first day
l Make structure clearer
l What about core content and peripheral
content that can be dropped if necessary?
l Make course longer because there is too
much content
ABCDE, A= activating event, B= beliefs, C = consequences, D= disputing and E = effects; SMART, Smart, Achievable,
Relevant and Timed goals.
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Facilitator and observer feedback about processes and training
Session Observer/facilitator notes/facilitator focus group Study team discussion
Facilitation
process
l Need to draw out quiet people
l Laughter really useful
l Informal atmosphere helps (especially getting up
whenever felt like it for tea and coffee)
l Examples very useful
l Need to set scene otherwise purpose unclear
l Need for summarising to end sessions and link into
new ones
l Summarising helps put things into context
l Let group self-regulate
l Need to keep referencing and linking back to
concepts previously covered
l Preparation important
l Harder to facilitate small groups
l Assess learning process as you go along
l Must be a minimum group size
l Start off as didactic teaching then relax into
group process
l Facilitators need to believe in the content
l Allow facilitators to eject very difficult participants
l Pair inexperienced with experienced
l Ensure that facilitators prepare together beforehand
l Summarise at end of each day – what have
you learnt?
l More signposting, more linking
Facilitation
training
l Training required for controlling dominant people
going off topic
l Need for more facilitator training to improve
confidence
l Train facilitators to be more flexible
l Facilitators need to be more familiar with
CBT materials
l Facilitators need confidence
l See an experienced facilitator in action (DVD)
l Obtain expertise in dealing with difficult situations
l Observe a course beforehand
l Experiential learning time
l The current training course is only content based
l Longer training required and partner
less-experienced tutors with
experienced tutors
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Emergent themes from participants’ feedback questionnaires
Q11: If you can, name three things you learned today that are important
to you
Themes Illustrative quotations
Social aspects
This was a recurrent theme. The social
aspect was beneficial to different
participants in different ways: the group
experience, pain-specific interaction,
several types of communication
(e.g. family, health professionals) and
the activities-based social interaction
there are people in the same situation as me
Day 1, E7
The social interaction between pain
participants enabled group members to
learn from each other’s coping strategies
Other people’s experiences can help me, meeting others in pain and
discussing experiences and methods
Day 1, E7
Knowledge and learning
Participants valued three areas in
particular, the mind–body and therapy
components, the CBT components and
the pain education (DVD)
Reminded distraction/absorption is something that can put pain in
background rather than foreground
Day 1, E1
I’ve learnt how to cope/change negative thinking about myself in relation
to other people. (The unhelpful thoughts checklist is very useful here.)
Day 1, E1
The pain education covered general
information about pain pathways, the
link with mood and the limited impact
that medicine has on chronic pain. Most
participants found this useful; however,
some found the content too simplistic
and others found it too complex and the
DVD did not cover diagnosed conditions
very well
That acceptance of my pain is crucial
Day 2, E1
overcoming difficulties by acceptance
Day 1, E1
Mood
This theme was linked to pain education.
Participants liked pain and mood being
linked together. Several participants
grasped the idea and wrote it on the
evaluation form as a learnt theme. This
suggested that the concept being taught
was memorable
mood and pain go together
Day 1, E4
mood effects pain
Day 1, E1
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Question 12: What parts of this course today, if any, did you enjoy or value
the most? Please tell us why it was valuable for you
Themes Illustrative quotations
Discussion/social interaction
Participants related personal accounts of
how they manage their pain; they found
that this was a very valuable aspect for
group members
Discussing other people’s pain relief methods and what helps others that
will also work for me. Just meeting other people who are similar to me
Day 1, E1
Participants appreciated that they were
not alone and could seek ways of
relieving themselves from their pain
group discussion, sharing, listening to people’s experience
Day 1, E7
Relating learning to self/personal experience
Relating the content taught in the course
to personal experience was valuable for
some participants who were able to
relate things to themselves
planning/setting goals. This will help me with changing my life/become
more active
Day 2, E7
Participants were able to recognise
methods of helping themselves. This
demonstrated their willingness to take
away what they had learnt and try to
implement it
how to sleep. I picked a few points to use. No sleep and pain has been
a big issue for me
Day 3, E2
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Question 13: What parts of this course today, if any, did you least enjoy?
Please tell us why
Themes Illustrative quotations
Social content
Participants mentioned a number of
different contents that were less
valuable. The intimacy session was
mentioned by a few participants. It is
difficult to know whether this is because
they believed the content was irrelevant
or because the discussion was awkward
for some
talking about sex although I seemed to be the only one contributing.
Was quite embarrassed afterwards
Day 3, E4
Disruption
Dominant group members were deemed
to be disruptive to the group. Facilitators
need to be aware of dominant/disruptive
participants who steer away from the
session topic and steer the group back
into discussion or close off discussion to
continue the session. Poor facilitation
skills resulted in lost time and alienating
participants
the cross talking. This group is easily distracted onto irrelevant topics
Day 2, E2
Poor timing
For some participants, the course
appeared to be too short. They felt that
this resulted in the course content being
taught briefly and presented in a rushed
manner
I found it a bit rushed due to the fact it has to be crammed into 3 days
Day 1, E1
Many participants wanted a longer
course. The timing allocated to each
session was an issue too
too much time spent on personal histories
Day 1, E2
Disclosure discomfort
Not all participants liked disclosing
information about themselves. For those
who were shy about speaking out in
a group, the discussions were
nerve-racking for them
Introducing myself, not at ease with strangers but a good ice breaker
Day 2, E3
Lack of personal relevance
The need for personal relevance was
important for engaging participants in
the course and optimising interest
some of the points made did not seem relevant
Day 1, E3
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Q14: Do you feel that the content was relevant and applicable to you?
In what ways could relevance and applicability be improved?
Themes Illustrative quotations
Cause of pain
Some participants felt that there should
be more focus on known causes of pain.
Some were quite sure of their own
explanation for their pain and were
resistant to learning
I still find my pain is purely from over-activity and not mood
Day 2, E7
Applicability of content
A variety of responses with many people
identifying with the scenarios in the
video and others feeling that they were
not in enough pain or that pain was
more specific from a particular diagnosis
Wondered if I was slightly here under false pretences as not in serious
pain all day every day
Day 1, E1
Yes, very relevant. Charlie in the video was me
Day 1, E7
Relevance of learning from others (sharing)
Most enjoyed learning from others I really, really got a lot out of the other participants and would have
loved to spend more time in facilitated discussion
E1, Day 2
Q15: Do you have any comments about facilitation?
Themes Illustrative quotations
Listening, communication and empathy
Participants highlighted the need for
facilitators to be attentive and responsive
towards participants. The importance
of receiving participants well and
responding to them accordingly, with
understanding, reinforced the skills
required as a facilitator. Facilitators need
to deliver information to participants and
listen to and counsel them
They are very good; they listen and respond appreciatively to everyone
Day 2, E6
Tutors’ backgrounds
For a few courses there were lay tutors
who had experienced chronic pain.
Participants picked up on this
Both are good communicators and it helps that they are also pain
sufferers so we are not being lectured
Day 1, E1
People management
An important characteristic that
facilitators need to attain is good people
management. Handling dominant
participants and off-topic discussions is
vital for good facilitation as this can
cause annoyance among other group
participants
It was quite good. There was one attendee who took up a bit too much
time talking and I think he could have been managed slightly more
assertively by the facilitators
Day 3, E4
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Question 16: Suggestions
Themes Illustrative quotations
Whole course/structure
Suggestions for the course included
comments on the course length. Many
participants mentioned that the course
was too short
That perhaps longer need to be spent on the topics and 3 long days for
people with chronic pain is not ideal. Maybe session every morning over
1 week
Day 2, E1
For those who found the course
beneficial and interesting, there was a
desire for the course duration to be
extended
whilst it was relevant and applicable, in a few weeks I will probably
forget it. To maintain the benefits, further sessions at regular spaced out
intervals would be helpful
Day 1, E6
Discussion/social interaction
The course provided a social platform for
the participants. The theme social
interaction/discussion emerged in many
answers and illustrated the influence on
the participants
Only encouraging more people to open up during discussion time, maybe
moving around the room and asking people individually – start in a
different position each time obviously within time frames
Day 3, E1
Flexibility (individual participant needs)
There was a desire for course content to
be personalised for participants to
optimise relevance
Most of the day was about back trouble but I also have knee trouble and
would have liked the course to touch on other areas of pain
Day 1, E1
Content
Participants wanted more exercise. They
liked the practical side to the course,
which included relaxation/breathing and
stretching and posture exercises
If they can arrange more exercises handouts for the standing and
posture, balance and movement, stretching exercises would be helpful
Day 2, E3
Themes from the participant interviews
Themes Illustrative quotations
Clarity of aims
Overall, the aims were not clear I do not know what the aim was
E2
I did not know what to expect
Non-attender
Motivation
The main reason for attending the
course was out of curiosity. Indifference
characterised responses
I thought I’d give it a try
E3
I wanted to learn and see how I can cope with my pain
E3
I did not see much benefit for myself
Non-attender
Positive aspects
The participants did learn from the DVD
but they took away different things
it’s [pain] not damaging, but just more pain not damage
E1
Actually that video was brilliant, that guy was me
E4
Others commented on the unwelcome
guest, listening skills session, the pain
cycle, goal-setting, breathing and
exercise, movement and the hand
massage
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
297
Themes Illustrative quotations
Negative aspects
Sitting down for long periods, disclosure
was too intense, the DVD was too much
like school, the DVD talked about
unknown pain not diagnosed conditions,
the timing and work, the relevance of
the tasters, too rushed, too chaotic, the
relevance of photography
I did not see the relevance of photography
B2
it was not well thought through, it was chaotic
E3
the course was pressurised, we moved on too quickly
E1
Learning
Overall, participants felt that they needed
time to embed their learning
you can forget your pain if your mind is occupied by something
B2
I still have pain but I’m learning to deal with it
E4
Social interaction
The discussion, meeting people and
learning from others was by far the most
strongly talked about aspect of the
course. However, courses needed
sufficient people (six or more) and good
facilitation to let everyone talk and to be
informal
we are all in it together, we did not have to pretend about our pain
E2
It’s a forum to talk about pain without burdening other people who do
not understand
E4
I was not the odd one out
E1
everyone offered suggestions, we learned from each other
B2
we all self-helped, we came a component of one, instead of individuals
E2
Effect of others
Negative, disruptive and dominant
participants needed to be controlled by
the facilitators
I felt overwhelmed by the intellectuals in the group
E3
I know I’m not alone, there are others suffering like me
B3
he was so bad I felt sorry for him, he made me feel better
E3
I would not have come if it had been mixed gender
B2
Repercussions/outcomes from the course
Some reported no changes since the
course; however, others reported that
they had either gone back to work or
were renegotiating working hours. One
group had organised a trip and others
had implemented action plans and goals.
Distraction and relaxation techniques had
been used since the course
the course has not changed me at all
E3
it put me on a path
E2
I’m not moaning so much
E2
It’s changed my life, every day I set my self a new goal like a
new exercise
E4
I thought all that stuff was mumbo jumbo and nonsense but that
relaxation technique was good
E4
I’m working from home now
E4
I now go to work
E3
I do stuff despite my pain, I’m not panicking as much
E1
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Themes Illustrative quotations
Changes suggested
These included extra time, less time,
evenings and weekend courses for
working people, more information prior
to and during the course, more follow-up,
better and clearer aims, changing the
DVD so less didactic, more time spent on
exercise and lifestyle advice such as
financial advice
Facilitation
Good facilitation meant good ‘control’ of
the group – managing conversation,
disruption, etc. Laughing, joking and
anecdotes were appreciated along with
informality
the facilitators have to let everyone speak
E3
discussion could have been controlled a bit more
E2
Buddying
Buddying did not always work but there
were examples of when it worked really
well
I did not get a chance to get one person’s number
E3
we all wrote our names down on a piece of paper
E2
we have kept in touch
E2
Material
Although there were requests for more
material, there was not much evidence
from the interviewees that they referred
to it afterwards
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Appendix 6 Methods
Costing the intervention
TABLE 86 Assumptions used for costing the COPERS intervention
Item Assumptions
Number of participants The base-case costing scenario was based on the average number of participants enrolled on
the course across the two centres (London and Midlands). Sensitivity analyses were conducted
for each centre as well as for the minimum and maximum number of participants enrolled on
the course
Facilitator costs Facilitators were paid a fixed fee per session. Consequently, given that facilitators were either
self-employed or conducted the courses during their free time, on-costs (pension and National
Insurance contributions) were not included. The analysis assumed no overheads
Administrator costs Costs were determined using a fixed daily rate; estimations include 24% salary on-costs
(pension and National Insurance contributions).245 The analysis assumed no overheads
Trainer costs Costs were determined using a fixed daily rate; estimations include 24% salary on-costs
according to 1. The analysis assumed no overheads
Facility costs Courses were run in multiuse settings. The same daily rate was used for all venues. The analysis
assumed no overheads
Course running costs It was assumed that the cost of course materials (relax packs, DVDs and handouts) depended
on the number of participants. Other costs (facility, hospitality, facilitators’ fees and travel) were
assumed to be independent of the number of participants enrolled. The base-case costing
scenario included some wastage of course materials. Sensitivity analyses were conducted
assuming no wastage of course materials
Health economic costs
TABLE 87 Unit costs used for costing consultations
Costing item Unit cost (£) Cost of contact (£) Assumption Reference
Acute medicine
ambulatory
assessment unit
106 106.00 Non-24-hour A&E/casualty
department: not leading to
admitted. Average cost of HRG
codes B01Z, VB02Z, VB03Z, VB04Z,
VB05Z, VB06Z, VB07Z, VB08Z,
VB09Z and VB11Z246
Community
pharmacy
69 11.50 Duration of contact
10 minutes
Per hour of patient-related activities
including qualifications (p. 172)245
Counselling 59 59.00 Per consultation (p. 53)245
Dietitian 34 28.33 Duration of contact
50 minutes
Per hour including qualifications
(p. 216)245
Dispensing assistant 25 4.17 Clinical support
worker, duration of
contact 10 minutes
Per hour of patient-related work
(p. 179)245
GP surgery 58 58.00 Per-patient contact lasting
17.2 minutes, excluding direct care
staff costs, with qualification costs
(p. 183)245
continued
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TABLE 87 Unit costs used for costing consultations (continued )
Costing item Unit cost (£) Cost of contact (£) Assumption Reference
GP telephone 24 24.00 Per telephone consultation lasting
7.1 minutes, excluding direct care
staff costs, with qualification costs
(p. 183)245
Health-care
assistant telephone
21 5.25 Clinical support
worker, duration of
contact 15 minutes
Per hour (p. 179)245
Health-care
assistant surgery
25 10.42 Clinical support
worker, duration of
contact 25 minutes
Per hour of patient-related work
(p. 179)245
Home visit nurse/GP 70/101 85.50 50% nurse, 50%
GP; duration of visit
1 hour nurse and
23.4 minutes GP
Per hour of home visiting nurse
(including qualifications and travel)
(p. 175) and per out-of-surgery GP
visit lasting 23.4 minutes (including
qualifications and travel) (p. 183)245
New medicine
service (pharmacist)
69 11.50 Duration of contact
10 minutes
Per hour of patient-related activities
including qualifications (p. 172)245
NHS walk-in service 56 56.00 A&E services: walk-in centres: not
leading to admitted. Average cost
of HRG codes VB01Z, VB02Z,
VB03Z, VB04Z, VB05Z,VB06Z,
VB07Z, VB08Z, VB09Z and VB11Z246
Nurse specialist
surgery
49 20.42 Duration of contact
25 minutes
Per hour including qualifications
(p. 178)245
Nurse specialist
telephone
49 12.25 Duration of contact
15 minutes
Per hour including qualifications
(p. 178)245
Nurse surgery 53 22.08 Duration of contact
25 minutes
Per hour of face-to-face contact
including qualifications (p. 180)245
Nurse telephone 41 10.25 Duration of contact
15 minutes
Per hour including qualifications
(p. 180)245
Out of hours 70 70.00 GP surgery contact
cost plus 20% for
out of hours
including nights,
weekends and bank
holidays
Per patient contact lasting
17.2 minutes, excluding direct care
staff costs, with qualification costs
(p. 183)245
A&E, no admission 173 173.00 Ambulance services – see and treat
or refer: HRG code ASS01246
Phlebotomist
surgery
25 6.25 Clinical support
worker, duration of
contact 15 minutes
Per hour of patient-related work
(p. 179)245
Physician’s assistant
surgery
91 30.33 Duration of contact
20 minutes
Per hour of client contact, nurse
advanced (includes lead specialist,
clinical nurse specialist, senior
specialist), including qualifications
(p. 181)245
Physiotherapy 33 19.25 Duration of contact
35 minutes
Per hour including qualifications
(p. 167)245
Psychologist 136 136.00 Duration of contact
1 hour
Per hour of client contact (p. 171)245
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TABLE 88 Unit costs used for costing investigations
Costing item Unit cost (£) Assumption Reference
Complex echocardiogram 85 Direct access: diagnostic services.
HRG code EA45Z246
Electrocardiogram monitoring
and stress testing
61 Direct access: diagnostic services.
HRG code EA47Z246
Minor cardiac procedures 74 Direct access: diagnostic services.
HRG code EA44Z246
Complex oesophageal, stomach
or duodenum procedures
569 Direct access: diagnostic services.
HRG code FZ81B246
Minor therapeutic or diagnostic
general abdomen procedures
34 Direct access: diagnostic services.
HRG code FZ13C246
Minor lower genital tract
procedures category 2
33 Direct access: diagnostic services.
HRG code MA23Z246
Other infections (genitourinary
medicine)
70 Direct access: diagnostic services.
HRG code WA10Z246
CT scan 114 Average cost for different types
of CT scan, ≥ 19 years
Direct access: diagnostic imaging.
HRG codes RA08A, RA09A,
RA10Z, RA11Z, RA12Z,RA13Z and
RA14Z246
DEXA scan 75 Direct access: diagnostic imaging.
HRG code RA15Z246
MRI scan 185 Average cost for different types
of MRI scan, ≥ 19 years
Direct access: diagnostic imaging.
HRG codes RA01A, RA02A,
RA03Z, RA04Z, RA05Z, RA06Z
and RA07Z246
Nuclear medicine 454 Average cost for nuclear
medicine categories 1–8
Direct access: diagnostic imaging.
HRG codes RA35Z, RA36Z,
RA37Z, RA38Z, RA39Z, RA40Z
and RA42Z246
Simple echocardiogram 62 Direct access: diagnostic imaging.
HRG code RA60A246
Ultrasound scan 57 Average cost for different types
of MRI, ≥ 19 years
Direct access: diagnostic imaging.
HRG codes RA23Z, RA24Z,
RA25Z, RA26Z and RA27Z246
Radiography plain film 30 Direct access: diagnostic services.
HRG code DAPF246
Examination, follow-up or
special screening, with
complications
26 Direct access: diagnostic services.
HRG code WA20Y246
Biochemistry 1 Direct access: pathology services.
HRG code DAP841246
Cytology 18 Direct access: pathology services.
HRG code DAP838246
Haematology 3 Direct access: pathology services.
HRG code DAP823246
Histology/histopathology 31 Direct access: pathology services.
HRG code DAP824246
Immunology 8 Direct access: pathology services.
HRG code DAP830246
continued
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TABLE 88 Unit costs used for costing investigations (continued )
Costing item Unit cost (£) Assumption Reference
INR anticoagulant monitoring 21 All NHS trusts and NHS
foundation trusts – outpatient
attendances data246
Microbiology/virology 8 Direct access: pathology services.
HRG code DAP831246
Other pathology 6 Direct access: pathology services.
HRG code DAP842246
Phlebotomy 3 Direct access: pathology services.
HRG code DAP839246
Full pulmonary function testing 52 Direct access: diagnostic services.
HRG code DZ52Z246
Lung volume studies 73 Direct access: diagnostic services.
HRG code DZ45Z246
Simple airflow studies
(e.g. spirometry)
54 Direct access: diagnostic services.
HRG code DZ44Z246
Other procedures for
non-trauma
26 Direct access: diagnostic services.
HRG code HB99Z246
Diagnostic vascular radiology or
other transluminal diagnostic
procedures
69 Direct access: diagnostic services.
HRG code QZ16A246
Examination, follow-up or
special screening, without
complications
32 Direct access: diagnostic services.
HRG code WA20W246
24-hour blood pressure
monitoring
32 Diagnostic services –
examination, follow-up or
special screening, without CC
Direct access: diagnostic services.
HRG code WA20Y246
24-hour Holter ECG 61 Diagnostic services –
electrocardiogram monitoring
and stress testing
Direct access: diagnostic services.
HRG code EA47Z246
ECG 61 Diagnostic services –
electrocardiogram monitoring
and stress testing
Direct access: diagnostic services.
HRG code EA47Z246
Faecal microscopy: culture and
sensitivity
8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
Faecal occult blood test 6 Pathology services – other Direct access: pathology services.
HRG code DAP842246
Fasting glucose 1 Pathology services –
biochemistry
Direct access: pathology services.
HRG code DAP841246
Gastroscopy 31 Diagnostic services – minor
endoscopic or percutaneous,
hepatobiliary or pancreatic
procedures, ≥ 19 years
Direct access: diagnostic services.
HRG code GB04D246
Helicobacter pylori antigen test 8 Pathology services –
immunology
Direct access: pathology services.
HRG code DAP830246
Histopathology 31 Pathology services – histology/
histopathology
Direct access: pathology services.
HRG code DAP824246
Nail mycology 8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
Nasal swab 8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
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TABLE 88 Unit costs used for costing investigations (continued )
Costing item Unit cost (£) Assumption Reference
Skin histology 31 Pathology services –
histology/histopathology
Direct access: pathology services.
HRG code DAP824246
Sputum analysis 8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
Sputum culture 8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
Stool sample 8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
Stool sample H. pylori test 8 Pathology services –
immunology
Direct access: pathology services.
HRG code DAP830246
Throat swab for microscopy:
culture and sensitivity
8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
Urine microalbumin and
creatinine
1 Pathology services –
biochemistry
Direct access: pathology services.
HRG code DAP841246
Urine pregnancy test 1 Pathology services –
biochemistry
Direct access: pathology services.
HRG code DAP841246
Vaginal swab microscopy:
culture and sensitivity
8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
Wound swab culture 8 Pathology services –
microbiology/virology
Direct access: pathology services.
HRG code DAP831246
CC, clinical consultation; CT, computerised tomography; DEXA, dual-energy X-ray absorptiometry; ECG, electrocardiography;
INR, international normalised ratio; MRI, magnetic resonance imaging.
TABLE 89 Unit costs used for costing referrals to primary care
Costing item Unit cost (£)
Cost of
consultation (£) Assumption Reference
Acupuncture 33.00 19.25 Duration of contact
35 minutes
Per hour including qualifications.
Community physiotherapist (p. 167)245
Audiology 56.48 56.48 Audiology – outpatient attendances.
HRG code 840246
Chiropody 30.00 30.00 Duration of contact
60 minutes
Per hour, community chiropodist/
podiatrist (p. 170)245
Community diabetes
team
49.00 20.42 Duration of contact
25 minutes
Per hour, nurse specialist surgery
including qualifications (p. 178)245
Community
lymphoedema
service
49.00 20.42 Duration of contact
25 minutes
Per hour, nurse specialist surgery
including qualifications (p. 178)245
Community mental
health team
2528.00 2528.00 Average cost per case, community
mental health team for adults with
mental health problems (p. 200)245
Community
physiotherapy
33.00 67.38 3.5 sessions;
duration of contact
35 minutes
Per hour including qualifications
(p. 167)245
Community
rehabilitation
2749.00 2749.00 Per episode, community rehabilitation
unit (p. 42)245
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TABLE 89 Unit costs used for costing referrals to primary care (continued )
Costing item Unit cost (£)
Cost of
consultation (£) Assumption Reference
Continence service 49.00 20.42 Duration of contact
25 minutes
Per hour, nurse specialist surgery
including qualifications (p. 178)245
Dietetics 34.00 28.33 Duration of contact
50 minutes
Per hour including qualifications
(p. 216)245
District nursing 58.00 101.50 3.5 contacts;
duration of contact
30 minutes
Per hour of patient-related work,
community nurse (district nursing
sister, district nurse), including
qualifications (p. 175)245
Deep vein
thrombosis service
21.00 21.00 Outpatient attendances. HRG code
324246
Exercise/weight loss/
lifestyle programme
174.00 174.00 Per person, public health
interventions, physiotherapy/physical
activity (p. 117)245
GPSI dermatology 58.00 58.00 Per patient contact lasting
17.2 minutes, GP surgery excluding
direct care staff costs, with
qualification costs (p. 183)245
Home treatment
team
58.00 101.50 3.5 contacts;
duration of contact
30 minutes
Per hour of patient-related work,
community nurse (district nursing
sister, district nurse) including
qualifications (p. 175)245
Minor ailments clinic 69.00 11.50 Duration of contact
10 minutes
Per hour of patient-related activities,
community pharmacist including
qualifications (p. 172)245
Nursing care 58.00 101.50 3.5 contacts;
duration of contact
30 minutes
Per hour of patient-related work,
community nurse (district nursing
sister, district nurse) including
qualifications (p. 175)245
Occupational
therapy
33.00 16.50 Duration of contact
30 minutes
Per hour including qualifications
(p. 168)245
Optometry 61.01 61.01 Optometry. Outpatient attendances.
HRG code 662246
Orthotics 93.00 93.00 Unit cost taken from Secondary User
Service database (London centre
download)
Other GP for minor
surgery
58.00 58.00 Per patient contact lasting
17.2 minutes, excluding direct care
staff costs, with qualification costs,
(p. 183)245
Physiotherapy 33.00 67.38 3.5 contacts;
duration of contact
35 minutes
Per hour including qualifications
(p. 167)245
Podiatry 30.00 30.00 Duration of contact
60 minutes
Per hour, community chiropodist/
podiatrist (p. 170)245
Pulmonary
rehabilitation
2749.00 2749.00 Per episode, community rehabilitation
unit (p. 42)245
Psychology IAPT 136/65 100.50 50% psychologist,
50% counselling;
duration of contact
1 hour
Per hour of client contact,
psychologist (p. 171), counselling
(p. 53)245
Rehabilitation 2749.00 2749.00 Per episode, community rehabilitation
unit (p. 42)245
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TABLE 89 Unit costs used for costing referrals to primary care (continued )
Costing item Unit cost (£)
Cost of
consultation (£) Assumption Reference
Social services 214.00 107.00 Duration of contact
30 minutes
Per hour of face-to-face contact,
social worker (adult services) including
qualification costs (p. 183)245
Stop smoking clinic 46–179 135.50 Mid-range Per person, public health
interventions, drug therapies for
smoking cessation (p. 117)245
Bereavement care
service
59.00 59.00 aCounselling, per consultation (p. 53)245
GPSI, GP with a special interest.
a 5 Department of Health. Bereavement Care Services: A Synthesis of the Literature. Final Report of Review Commissioned
by DH to Support Implementation of the End of Life Care Strategy. URL: www.gov.uk/government/uploads/system/
uploads/attachment_data/file/215799/dh_123810.pdf (accessed 18 November 2013).
Prescription costing flow chart
PCA database 2011–12 Cost
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No
NoYes
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Check writing and spelling
BNF 2011
BNF 2013
NHS Drug Tariff 2013
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(e.g. Boots)
Alternative item from
PCA database 2011–12
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Alternative item from
PCA database 2011–12
(proprietary)
COPERS
database
FIGURE 58 Prescription costing flow chart. MIMS, Monthly Index of Medical Specialties.
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General practice and patient information sheets
 
 
 
 
 
COPERS STUDY 
COping with persistent Pain, Effectiveness Research into Self-management 
GENERAL PRACTICE INFORMATION SHEET 
 
What is the purpose of the study? 
To conduct a randomised controlled trial to explore the effectiveness and cost effectiveness of a 
newly developed self-management course for those with chronic musculoskeletal pain. 
 
What will happen if my practice takes part in the study? 
If you take part, you will help to identify patients living with chronic pain and recruit them for the 
COPERS study. We will ask you to search your electronic records, use your existing knowledge of 
patients and put up adverts in the public areas of your surgery to help generate patient interest. The 
identified patients will be screened by the clinician for suitability. Those eligible for inclusion will be 
sent an invitation letter from the clinic, with an attached reply slip to complete if they are interested 
and a patient information leaflet. The study team (who are trained and CRB checked) will then follow 
up patients who have indicated they might be interested in taking part. Interested patients can contact 
the study team directly via email, phone or reply slip, we will send them a baseline questionnaire and 
a trial consent form and enrol them in the study once consent is confirmed and they are randomised. 
The study team will provide the envelopes, information leaflets, consent forms, postage stamps and 
pre-paid envelopes. The General Practice will be required to print out the invitation and reminder 
letters on clinic headed paper and provide the study team with an anonymised list of patients they 
have contacted (i.e. gender, age and ethnicity).  
We will also need to review patient records at 12 months; patient consent will have been sought for 
this.  
The general practices participating in the study will receive payment for their part in recruiting 
participants to the study. 
 
What does the study involve for patients? 
Patients will be asked to participate in a two arm randomised controlled trial. One arm of the trial will 
be the intervention, the self-management group based course, and the other the control or relaxation 
arm of the trial. Those on the course will be booked onto a three day course (10.00 till 3.00 every 
other day over a week) with a two hour follow up two weeks later. The course will teach them 
techniques to manage their pain. This will include: pain education, acceptance, cognitive behavioural 
therapy, attention control and distraction, relaxation, imagery, visualisation, posture and movement. 
Those in the control arm will be given a relaxation pack with instructions about relaxation technique 
and an audio CD.  
Participants will be required to complete a baseline questionnaire, a self-efficacy questionnaire 12 
weeks after randomisation and two further questionnaires at 6 and 12 months.  
 
What happens next and who can I ask if I have any questions? 
Please return the reply slip indicating whether you would like to take part in the study. 
Please contact Dr Dawn Carnes on 020 7882 2546 if you have queries. Alternatively you can email at 
d.carnes@qmul.ac.uk. The correspondence address is Dr Dawn Carnes, COPERS Study Manager, 
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 Centre for Primary Care and Public Health, Barts and The London School of Medicine and Dentistry, 
2 Newark Street, London, E1 2AT.  
 
Has the study got approval and who is it funded by?  
The study has been approved by Cambridgeshire 4 Research Ethics Committee (11/EE/0046) and by 
(Research Governance office at PCT or new consortia). Indemnity insurance and sponsorship is 
provided by Barts and The London Joint Research Office, 5 Walden St, London E1 2EF. The study is 
funded by the National Institute for Health Research. ISRCTN: 24426731 
 
Who is responsible for this study? 
Professor Stephanie Taylor, Centre for Primary Care and Public Health, Barts and The London 
School of Medicine and Dentistry, 2 Newark Street, E1 2AT and Professor Martin Underwood at 
Warwick Medical School, Clinical Trials Unit, Gibbet Hill Road, Coventry CV4 7AL.  
 
WE LOOK FORWARD TO YOUR SUPPORT IN THE STUDY 
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We would like to take part in the study. 
 
 
Practice 
Name ..................... 
 
Key 
Contact .. .......................... 
 
Address ........................................................................................................................  
 .....................................................................................................................................................  
 .....................................................................................................................................................  
Email ............................................................................................................................  
Telephone number(s) .................................................................................................  
 
 
Convenient times to contact 
us ............................................................ 
 
 
Signed ..............     
 
Date. ............ 
 
Please sign and return this form in the FREEPOST envelope provided. 
 
 
 
Office Use Only 
 
Date received . 
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ha
ve
 a
ns
w
er
ed
 a
ll 
yo
ur
 
qu
es
tio
ns
. T
he
n 
fil
l o
ut
 th
e 
tri
al
 c
on
se
nt
 fo
rm
 a
nd
 
th
e 
ba
se
lin
e 
qu
es
tio
nn
ai
re
 a
nd
 p
os
t t
he
m
 b
ac
k 
to
 
us
 u
si
ng
 th
e 
FR
E
E
P
O
S
T 
en
ve
lo
pe
 p
ro
vi
de
d 
(n
o 
st
am
p 
is
 re
qu
ire
d)
. 
W
he
n 
w
e 
re
ce
iv
e 
yo
ur
 tr
ia
l c
on
se
nt
 fo
rm
 a
nd
 
ba
se
lin
e 
qu
es
tio
nn
ai
re
 w
e 
m
ak
e 
su
re
 y
ou
r d
et
ai
ls
 
ar
e 
st
or
ed
 w
ith
 a
n 
an
on
ym
ou
s 
st
ud
y 
id
en
tif
ic
at
io
n 
nu
m
be
r. 
W
e 
w
ill
 th
en
 te
le
ph
on
e 
yo
u 
to
 c
he
ck
 y
ou
 
ar
e 
ha
pp
y 
to
 b
e 
in
 th
e 
st
ud
y 
an
d 
un
de
rs
ta
nd
 th
e 
pr
oc
es
s.
 W
e 
w
ill
 th
en
 ra
nd
om
ly
 a
llo
ca
te
 y
ou
 to
 
th
e 
co
ur
se
 o
r r
el
ax
at
io
n 
gr
ou
p.
  
If 
yo
u 
ar
e 
al
lo
ca
te
d 
to
 th
e 
co
ur
se
 w
e 
w
ill
 a
gr
ee
 a
 
co
ur
se
 d
at
e 
su
ita
bl
e 
fo
r y
ou
 a
nd
 if
 y
ou
 a
re
 
al
lo
ca
te
d 
to
 th
e 
re
la
xa
tio
n 
gr
ou
p 
w
e 
w
ill
 p
os
t o
ut
 
yo
ur
 b
oo
kl
et
 a
nd
 C
D
 a
nd
 in
st
ru
ct
io
ns
.  
A
re
 th
er
e 
an
y 
ris
ks
 in
 ta
ki
ng
 p
ar
t?
 
W
e 
do
 n
ot
 fo
re
se
e 
an
y 
ris
ks
 to
 y
ou
r h
ea
lth
 in
 
ta
ki
ng
 p
ar
t i
n 
th
e 
st
ud
y.
 
W
ho
 w
ill
 k
no
w
 th
at
 I 
am
 ta
ki
ng
 p
ar
t?
 
Th
e 
on
ly
 p
eo
pl
e 
w
ho
 w
ill
 k
no
w
 th
at
 y
ou
 a
re
 ta
ki
ng
 
pa
rt 
ar
e 
th
e 
st
ud
y 
te
am
 a
nd
 y
ou
r G
P
.  
 
W
ha
t w
ill
 y
ou
 d
o 
w
ith
 th
e 
re
su
lts
 o
f t
he
 
st
ud
y?
 
W
e 
w
ill
 p
re
se
nt
 th
e 
fin
di
ng
s 
in
 a
 s
tu
dy
 re
po
rt 
an
d 
in
 m
ed
ic
al
 jo
ur
na
ls
. Y
ou
 w
ill
 n
ot
 b
e 
id
en
tif
ie
d 
in
 
an
y 
of
 th
e 
pu
bl
ic
at
io
ns
. T
he
 s
tu
dy
 te
am
 w
ill
 m
ak
e 
su
re
 th
at
 y
ou
 k
no
w
 a
bo
ut
 th
e 
re
su
lts
 th
ro
ug
h 
a 
ne
w
sl
et
te
r a
nd
 y
ou
 c
an
 lo
ok
 a
t o
ur
 w
eb
si
te
: 
w
w
w
.ic
m
s.
qm
ul
.a
c.
uk
/c
hs
/p
ct
u/
cu
rr
en
t_
pr
oj
ec
ts
/c
op
er
s/
25
50
7.
ht
m
l  
 W
ill
 m
y 
de
ta
ils
 b
e 
ke
pt
 c
on
fid
en
tia
l?
  
Y
es
. Y
ou
r p
er
so
na
l d
et
ai
ls
 w
ill
 b
e 
ke
pt
 s
tri
ct
ly
 
co
nf
id
en
tia
l f
ro
m
 o
ut
si
de
 s
ou
rc
es
. A
ny
 
in
fo
rm
at
io
n 
ab
ou
t y
ou
 w
hi
ch
 le
av
es
 y
ou
r G
P 
pr
ac
tic
e 
w
ill
 h
av
e 
yo
ur
 n
am
e 
an
d 
ad
dr
es
s 
re
m
ov
ed
 s
o 
th
at
 y
ou
 c
an
no
t b
e 
re
co
gn
is
ed
 fr
om
 
it.
 T
he
 o
nl
y 
re
as
on
 w
e 
w
ou
ld
 b
re
ak
 c
on
fid
en
tia
lit
y 
w
ou
ld
 b
e 
in
 a
n 
em
er
ge
nc
y.
  I
f y
ou
r o
w
n 
he
al
th
, o
r 
so
m
eb
od
y 
el
se
’s
 h
ea
lth
 w
as
 in
 d
an
ge
r, 
w
e 
w
ou
ld
 
co
nt
ac
t y
ou
r G
P
. 
W
ho
 is
 re
sp
on
si
bl
e 
fo
r t
hi
s 
st
ud
y?
 
P
ro
fe
ss
or
 S
te
ph
an
ie
 T
ay
lo
r (
Lo
nd
on
), 
P
ro
fe
ss
or
 
M
ar
tin
 U
nd
er
w
oo
d 
(W
ar
w
ic
k)
. T
he
 N
at
io
na
l 
In
st
itu
te
 fo
r H
ea
lth
 R
es
ea
rc
h 
ha
s 
fu
nd
ed
 th
e 
st
ud
y 
(T
hi
s 
is
 a
 g
ov
er
nm
en
t f
un
de
d 
re
se
ar
ch
 
bo
dy
). 
Th
e 
C
am
br
id
ge
sh
ire
 4
 R
es
ea
rc
h 
E
th
ic
s 
C
om
m
itt
ee
 a
pp
ro
ve
d 
th
e 
st
ud
y 
an
d 
Q
ue
en
 M
ar
y 
U
ni
ve
rs
ity
 o
f L
on
do
n 
pr
ov
id
e 
th
e 
in
de
m
ni
ty
 
in
su
ra
nc
e 
co
ve
r. 
W
ha
t h
ap
pe
ns
 if
 th
er
e 
is
 a
 p
ro
bl
em
? 
 
Q
ue
en
 M
ar
y 
U
ni
ve
rs
ity
 o
f L
on
do
n 
ha
s 
ag
re
ed
 
th
at
 if
 in
 th
e 
un
lik
el
y 
ev
en
t t
ha
t y
ou
 a
re
 h
ar
m
ed
 
as
 a
 re
su
lt 
of
 y
ou
r p
ar
tic
ip
at
io
n 
in
 th
e 
st
ud
y,
 y
ou
 
w
ill
 b
e 
co
m
pe
ns
at
ed
, p
ro
vi
de
d 
th
at
, o
n 
th
e 
ba
la
nc
e 
of
 p
ro
ba
bi
lit
ie
s,
 a
n 
in
ju
ry
 w
as
 c
au
se
d 
as
 
a 
di
re
ct
 re
su
lt 
of
 th
e 
in
te
rv
en
tio
n 
yo
u 
re
ce
iv
ed
 
du
rin
g 
th
e 
co
ur
se
 o
f t
he
 s
tu
dy
. T
he
se
 s
pe
ci
al
 
co
m
pe
ns
at
io
n 
ar
ra
ng
em
en
ts
 a
pp
ly
 w
he
re
 a
n 
in
ju
ry
 is
 c
au
se
d 
to
 y
ou
 th
at
 w
ou
ld
 n
ot
 h
av
e 
oc
cu
rr
ed
 if
 y
ou
 w
er
e 
no
t i
n 
th
e 
tri
al
. T
he
se
 
ar
ra
ng
em
en
ts
 d
o 
no
t a
ffe
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 y
ou
r r
ig
ht
 to
 p
ur
su
e 
a 
cl
ai
m
 th
ro
ug
h 
le
ga
l a
ct
io
n.
  
If 
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u 
ha
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 a
 c
om
pl
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nt
: 
P
le
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e 
co
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t P
at
ie
nt
 A
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y 
Li
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n 
S
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vi
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u 
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 c
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ce
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s 
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g 
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iv
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 o
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on
ta
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u 
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 c
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w
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 q
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m
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Participant questionnaires
 
 
 
 
 
COPERS STUDY  
 
COping with persistent Pain, Effectiveness Research into Self-management  
 
BASELINE QUESTIONNAIRE 
Confidential 
 
Dear Participant.  
 The aim of this questionnaire is to find out your current health state and feelings 
about living with chronic pain before you participate in the COPERS study. Please read 
the questions carefully. If you have any difficulties with the questionnaire please call the 
study team in London 020 7882 2546 or Warwick 024 7657 2905. 
 
THANK YOU for being part of our study. We look forward to receiving your questionnaire. 
 
COPERS Study Team 
 
 
Section 1. ABOUT YOUR PAIN 
 
Please answer every question by marking the answer as indicated. If you are unsure 
about how to answer a question, please give the best answer you can. 
 
1. How is your health in general? Please tick ( ) one 
Very good Good Fair Bad Very bad 
     
2. How long have you had your pain? Please tick ( ) one 
0 – 3 
months 
4 – 12 
months 
13 months 
– 2 years 3 – 4 years 5 – 6 years 7 - 10 years 
More than 
10 years 
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Section 1. ABOUT YOUR PAIN continued... 
For the following questions with a scale of 0-10, please tick one 
number/box only. 
 
 
 
3. How would you rate your pain on a 0-10 scale at the present time, that is  
right now, where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’?  
Please tick ( ) one 
No 
pain      
    Pain as 
bad as 
could be 
0 1 2 3 4 5 6 7 8 9 10 
4. In the past six months, how intense was your worst pain rated on a 0-10 
scale where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’? Please tick 
( ) one 
No 
pain      
    Pain as 
bad as 
could be 
0 1 2 3 4 5 6 7 8 9 10 
           
5. In the past six months, on average, how intense was your pain rated on 
a 0-10 scale, where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’? (That  
is, your usual pain at times you were experiencing pain) Please tick ( ) one 
No 
pain      
    Pain as 
bad as 
could be 
0 1 2 3 4 5 6 7 8 9 10 
           
6. About how many days in the last six months have you been kept from 
your usual activities (work, school or housework) because of this pain? 
Please tick ( ) one 
                                                                                                                                  
0 – 6 days  
                                                                                                                                  
7 – 14 days  
                                                                                                                                  
15 – 30 days  
                                                                                                                                
31 or more days  
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  Section 1. ABOUT YOUR PAIN continued... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. In the past six months, how much has this pain interfered with your 
daily activities rated on a 0-10 scale where 0 is ‘no interference’ and 10 
‘unable to carry on activities’? Please tick ( ) one 
No 
interference      
    Unable to 
carry on 
activities 
0 1 2 3 4 5 6 7 8 9 10 
           
8. In the past six months, how much has this pain changed your ability to 
take part in recreational, social and family activities where 0 is ‘no 
change’ and 10 is ‘extreme change’? Please tick ( ) one 
No 
change      
    Extreme 
change 
0 1 2 3 4 5 6 7 8 9 10 
9. In the past six months, how much has this pain changed your ability to 
work (including housework) where 0 is ‘no change’ and 10 is ‘extreme 
change’? Please tick ( ) one 
No 
change      
    Extreme 
change 
0 1 2 3 4 5 6 7 8 9 10 
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 Section 2. QUALITY OF LIFE 
 
Please tick which statements best describe your own health state today. 
1. Mobility Please tick ( ) one 
  I have no problems walking about   
               I have some problems walking about  
    I am confined to bed  
 
2. Self-care Please tick ( ) one 
                                      I have no problems with self-care  
                           I have some problems washing or dressing myself  
                    I am unable to wash or dress myself  
 
3. Usual activities such as work, study, housework family or leisure  
Please tick ( ) one 
I have no problems with performing my usual activities  
            I have some problems with performing my usual activities  
         I am unable to perform my usual activities  
 
4. Pain/Discomfort Please tick ( ) one 
I have no pain or discomfort  
                  I have moderate pain or discomfort  
                   I have extreme pain or discomfort 
 
5. Anxiety/Depression Please tick ( ) one 
                     I am not anxious or depressed  
          I am moderately anxious or depressed  
    I am extremely anxious or depressed  
Participant ID No.: .  
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 Section 3. CONFIDENCE 
 
Please indicate how confident you are that you can do the following things at 
present, despite the pain, where 0 is ‘not at all confident’ and 6 is ‘completely 
confident’. 
 
** Remember, these questions are not asking whether or not you have been 
doing these things, but rather how confident you are that you could do them at 
present, despite the pain. 
1. I can enjoy things, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
2. I can do most household chores (e.g. tidying up, washing dishes etc), 
despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
 
3. I can socialise with my friends or family members as often as I used 
to, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
4. I can cope with my pain in most situations Please tick ( ) one 
Not confident Completely confident
0 1 2 3 4 5 6 
       
 
5. I can do some form of work, despite the pain (‘work’ includes 
housework, paid and unpaid work) Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
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 Section 3. CONFIDENCE continued ... 
6. I can still do many of the things I enjoy doing, such as hobbies or 
leisure activity, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
7. I can cope with my pain without medication Please tick ( ) one 
 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
8. I can still accomplish most of my goals in life, despite the pain 
Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
9. I can live a normal lifestyle, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
10. I can gradually become more active despite the pain Please tick ( ) 
one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
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 Section 4. MOOD 
Please read each item and tick the reply which comes closest to how you have 
been feeling in the past week.  
 
Don’t take too long over your replies: your immediate reaction to each item will 
probably be more accurate than a long thought out response. 
 
1. I feel tense or “wound up”  
Please tick ( ) one 
2. I still enjoy the things I used to 
enjoy Please tick ( ) one 
Most of the time       Definitely as much  
       A lot of the time          Not quite as much  
    From time to time, occasionally          Only a little  
    Not at all    Hardly at all  
 
 
3. I get a sort of frightened feeling 
as if something awful is about to 
happen Please tick ( ) one 
4. I can laugh and see the funny 
side of things 
Please tick ( ) one 
Very definitely and quite badly    As much as I always could  
   Yes, but not too badly  Not quite so much now  
A little but it doesn’t worry me     Definitely not so much now  
 Not at all         Not at all 
 
 
5. Worrying thoughts go through 
my mind Please tick ( ) one 
6. I feel cheerful  
Please tick ( ) one 
      A great deal of the time                     Not at all  
               A lot of the time  Not often  
From time to time but not too often  Sometimes  
Only occasionally  Most of the time  
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 Section 4. MOOD continued ... 
7. I can sit at ease and feel relaxed 
Please tick ( ) one 
8. I feel as if I am slowed down  
Please tick ( ) one 
 Definitely  Nearly all of the time  
Usually Very often 
Not often  Sometimes  
Not at all  Not at all  
 
 
9. I get a sort of frightened feeling 
like "butterflies” in the stomach  
Please tick ( ) one 
10. I have lost interest in my 
appearance  
Please tick ( ) one 
Not at all  Definitely  
                                       Occasionally  I don’t take as much care as I should  
 Quite often  I may not take quite as much care  
 Very often  I take just as much care as ever  
 
 
11. I feel restless as though I have 
to be on the move  
Please tick ( ) one 
12. I look forward with enjoyment to 
things  
Please tick ( ) one 
Very much indeed  As much as I ever did  
Quite a lot  Rather less than I used to  
Not very much  Definitely less than I used to  
Not at all  Hardly at all  
 
13. I get sudden feelings of panic 
Please tick ( ) one 
14. I can enjoy a good book or radio 
or TV programme Please tick ( ) 
one
Very often indeed  Often  
Quite often  Sometimes  
Not very often   Not often  
Not at all Very seldom 
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 Section 5. COPING 
Below you will find a list of statements. Please rate the truth of each statement 
as it applies to you by ticking one response, where 0 is ‘never true’ and 6 is 
‘always true’.  
 
1. I am getting on with the business of living no matter what my level of pain is  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
2. My life is going well, even though I have chronic pain Please tick ( ) one  
Never true      Always true 
0 1 2 3 4 5 6 
       
 
3. It’s OK to experience pain Please tick ( ) one  
Never true      Always true 
0 1 2 3 4 5 6 
       
 
4. I would gladly sacrifice important things in my life to control this pain better Please 
tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
5. It’s not necessary for me to control my pain in order to handle my life well Please 
tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
6. Although things have changed, I am living a normal life despite my chronic pain 
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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 Section 5. COPING Continued... 
 
 
 
8. There are many activities I do when I feel pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
9. I lead a full life even though I have chronic pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
10. Controlling pain is less important than other goals in my life Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
11. My thoughts and feelings about pain must change before I can take important 
steps in my life Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
12. Despite the pain, I am now sticking to a certain course in my life Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
  
7. I need to concentrate on getting rid of my pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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 Section 5. COPING continued ... 
 
13. Keeping my pain level under control takes first priority whenever I’m doing 
something Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
 
15. When my pain increases, I can still take care of my responsibilities Please tick ( ) 
one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
16. I will have better control over my life if I can control my negative thoughts about 
pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
17. I avoid putting myself in situations where my pain might increase Please tick ( ) 
one 
Never true      Always true
0 1 2 3 4 5 6 
 
18. My worries and fears about what pain will do to me are true Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
  
14. Before I can make any serious plans, I have to get some control over my pain 
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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 Section 5. COPING continued ... 
 
19. It’s a relief to realise that I don’t have to change my pain to get on with my life 
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
20. I have to struggle to do things when I have pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
Participant ID No.: .  
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 Section 6. SOCIAL LIFE 
 
Below you will find a list of statements. Please indicate how strongly you 
agree or disagree with the following statements by ticking the response which 
best describes you now. 
1. I am doing interesting things in 
my life Please tick ( ) one 
2. Most days I am doing some of 
the things I really enjoy Please tick 
( ) one 
    Strongly disagree  Strongly disagree  
Disagree  Disagree  
Agree  Agree  
Strongly agree  Strongly agree  
 
3. I try to make the most of my life 
Please tick ( ) one 
4. I have plans to do enjoyable 
things for myself over the next few 
days Please tick ( ) one 
Strongly disagree Strongly disagree 
Disagree  Disagree  
Agree  Agree  
Strongly agree  Strongly agree  
 
5. I feel like I am actively involved in life 
Please tick ( ) one 
                                       Strongly disagree  
                                                      Disagree  
                                                           Agree  
                                            Strongly agree  
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 Section 7. FURTHER DETAILS 
 
1. Date of birth  2. NHS number 
 
3. Gender Please tick ( ) one 4. Living arrangements Please tick 
( ) one 
Male  Female  Alone  With others  
 
5. Describe your English language fluency Please tick ( ) one 
Fluent Good Below Average Poor 
    
 
6. What is your ethnic group? (please choose one section from A to E then 
tick one box to best describe your ethnic group or background) 
A. White  
Please tick ( ) one 
B. Black or Black British  
Please tick ( ) one 
British Caribbean 
Irish  African  
Any other white background (write 
below)  
Any other black background (write 
below)  
  
C. Asian or Asian British  
Please tick ( ) one 
D. Mixed  
Please tick ( ) one 
Indian    White & Black Caribbean  
Pakistani    White & Black African  
Bangladeshi       White & Asian  
 Any other Asian background (write 
below)  
Any other mixed background (write 
below)  
  
E. Other ethnic group Please tick ( ) 
one 
  
Chinese                Arab  
Other ethnic group (write below)  
 
 
You can find this number on your prescriptions
Participant ID No.: .  
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 Section 7. FURTHER DETAILS continued ... 
 
7. Which of the following best describes you? Please tick ( ) one 
Employed (full or part time, including self employment)  
Unemployed and looking for work  
  At school or in full time education  
Unable to work due to long term sickness  
  Looking after your home/family  
Retired from paid work  
  Other (please write below)  
 
 
8. How old were you when you left full time education (e.g. school, 
college or university? Please tick ( ) one 
I did not receive a formal education  
Age 12 or less  
Age 13 to 16  
Age 17 to 19  
Age 20 or over  
I am still in full time education  
Other (please write below)  
  
 
THANK YOU FOR FILLING IN THE QUESTIONNAIRE 
 
 
Please return to the study team using the FREEPOST envelope provided (no 
postage stamp required)  
 
HEAD OFFICE: COPERS STUDY  
CENTRE FOR PRIMARY CARE AND PUBLIC HEALTH, BLIZARD 
INSTITUTE,  
2 Newark Street, London, E1 2AT 
Participant ID No.: .  
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 Participant ID No............................... 
 
 
 
 
 
 
 
COPERS STUDY  
COping with persistent Pain, Effectiveness Research into Self-
management 
 
 
FOLLOW-UP 
QUESTIONNAIRE 
AT 12 WEEKS 
Confidential 
 
 
Dear Participant.  
 The aim of this questionnaire is to find out your current feelings about 
living with chronic pain after you participated in the COPERS study. Please 
read the questions carefully. If you have any difficulties with the questionnaire 
please call the study team on 020 7882 2546. 
 
THANK YOU for being part of our study. We look forward to receiving your 
questionnaire. 
 
COPERS Study Team 
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 Section 1. CONFIDENCE 
Please indicate how confident you are that you can do the following things at 
present, despite the pain, where 0 is ‘not at all confident’ and 6 is ‘completely 
confident’. 
 
** Remember, these questions are not asking whether or not you have been 
doing these things, but rather how confident you are that you could do them at 
present, despite the pain. 
1. I can enjoy things, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
2. I can do most household chores (e.g. tidying up, washing dishes etc), 
despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
3. I can socialise with my friends or family members as often as I used 
to, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
4. I can cope with my pain in most situations Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
5. I can do some form of work, despite the pain (‘work’ includes 
housework, paid and unpaid work) Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
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 Section 1. CONFIDENCE continued ... 
6. I can still do many of the things I enjoy doing, such as hobbies or 
leisure activity, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
7. I can cope with my pain without medication Please tick ( ) one 
 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
8. I can still accomplish most of my goals in life, despite the pain  
Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
9. I can live a normal lifestyle, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
10. I can gradually become more active despite the pain  
Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
THANK YOU FOR FILLING IN THE QUESTIONNAIRE 
Please return to the study team using the FREEPOST envelope provided (no 
postage stamp required)  
 
HEAD OFFICE: COPERS STUDY  
CENTRE FOR PRIMARY CARE AND PUBLIC HEALTH, BLIZARD 
INSTITUTE,  
2 Newark Street, London, E1 2AT 
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COPERS STUDY  
COping with persistent Pain, Effectiveness Research into Self-management  
 
 
FOLLOW-UP QUESTIONNAIRE  
AT 6 MONTHS 
Confidential 
 
Dear Participant.  
The aim of this questionnaire is to find out your current health state and feelings 
about living with chronic pain after you participated in the COPERS study. Please read 
the questions carefully. If you have any difficulties with the questionnaire please call the 
study team on 020 7882 2546. 
 
THANK YOU for being part of our study. We look forward to receiving your questionnaire. 
 
COPERS Study Team 
 
 
Section 1. ABOUT YOUR PAIN 
Please answer every question by marking the answer as indicated. If you are unsure 
about how to answer a question, please give the best answer you can. 
 
 
1. How is your health in general?: Please tick ( ) one  
Very good Good Fair Bad Very bad 
     
Participant ID No.: .  
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Section 1. ABOUT YOUR PAIN continued... 
For the following questions with a scale of 0-10, please tick one number only. 
 
 
 
 
 
 
 
 
 
 
2. How would you rate your pain on a 0-10 scale at the present time that is, right 
now, where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’?  
Please tick ( ) one  
No 
pain      
    Pain as 
bad as 
could be 
0 1 2 3 4 5 6 7 8 9 10 
           
3. In the past six months, how intense was your worst pain rated on a 0-10 scale 
where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’? Please tick ( ) one  
No 
pain      
    Pain as 
bad as 
could be 
0 1 2 3 4 5 6 7 8 9 10 
           
4. In the past six months, on average, how intense was your pain rated on a 0-10 
scale, where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’? (That is, your usual 
pain at times you were experiencing pain) Please tick ( ) one  
No 
pain      
    Pain as 
bad as 
could be 
0 1 2 3 4 5 6 7 8 9 10 
           
5. About how many days in the last six months have you been kept from your usual 
activities (work, school or housework) because of this pain? Please tick ( ) one  
                                                                                                                                          0 – 6 days  
                                                                                                                                        7 – 14 days  
                                                                                                                                      15 – 30 days  
                                                                                                                                31 or more days  
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  Section 1. ABOUT YOUR PAIN continued... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. In the past six months, how much has this pain interfered with your daily 
activities rated on a 0-10 scale where 0 is ‘no interference’ and 10 ‘unable to carry 
on activities’? Please tick ( ) one  
No 
interference      
    Unable to 
carry on 
activities 
0 1 2 3 4 5 6 7 8 9 10 
           
7. In the past six months, how much has this pain changed your ability to take part 
in recreational, social and family activities where 0 is ‘no change’ and 10 is ‘extreme 
change’? Please tick ( ) one  
No 
change      
    Extreme 
change 
0 1 2 3 4 5 6 7 8 9 10 
           
8. In the past six months, how much has this pain changed your ability to work 
(including housework) where 0 is ‘no change’ and 10 is ‘extreme change’? Please 
tick ( ) one  
No 
change      
    Extreme 
change 
0 1 2 3 4 5 6 7 8 9 10 
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Section 2. QUALITY OF LIFE 
 
Please tick which statements best describe your own health state today 
1. Mobility Please tick ( ) one  
                                                                                           I have no problems in walking about   
                                                                                      I have some problems in walking about  
                                                                                                                      I am confined to bed  
 
2. Self-care Please tick ( ) one  
                                                                                                I have no problems with self-care  
                                                                   I have some problems washing or dressing myself  
                                                                                           I am unable to wash or dress myself  
 
3. Usual activities such as work, study, housework family or leisure  
Please tick ( ) one  
                                                           I have no problems with performing my usual activities  
                                                      I have some problems with performing my usual activities  
                                                                                 I am unable to perform my usual activities  
 
4. Pain/Discomfort Please tick ( ) one  
                                                                                                         I have no pain or discomfort  
                                                                                             I have moderate pain or discomfort  
                                                                                                I have extreme pain or discomfort  
 
5. Anxiety/Depression Please tick ( ) one  
                                                                                                     I am not anxious or depressed  
                                                                                        I am moderately anxious or depressed  
                                                                                          I am extremely anxious or depressed  
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Section 3. CONFIDENCE 
 
Please indicate how confident you are that you can do the following things at present, 
despite the pain, where 0 is ‘not at all confident’ and 6 is ‘completely confident’. 
 
** Remember, these questions are not asking whether or not you have been doing these 
things, but rather how confident you are that you could do them at present, despite the 
pain. 
1. I can enjoy things, despite the pain Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
2. I can do most household chores (e.g. tidying up, washing dishes etc), despite 
the pain Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
3. I can socialise with my friends or family members as often as I used to, despite 
the pain Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
4. I can cope with my pain in most situations Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
5. I can do some form of work, despite the pain (‘work’ includes housework, paid 
and unpaid work) Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
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Section 3. CONFIDENCE continued ... 
6. I can still do many of the things I enjoy doing, such as hobbies or leisure 
activity, despite the pain Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
7. I can cope with my pain without medication Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
8. I can still accomplish most of my goals in life, despite the pain  
Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
9. I can live a normal lifestyle, despite the pain Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
10. I can gradually become more active despite the pain Please tick ( ) one  
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
APPENDIX 6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
336
Section 4. MOOD 
Please read each item and tick the reply which comes closest to how you have been 
feeling in the past week.  
 
Don’t take too long over your replies: your immediate reaction to each item will probably 
be more accurate than a long thought out response. 
 
 
1. I feel tense or “wound up”  
Please tick ( ) one  
2. I still enjoy the things I used to enjoy 
Please tick ( ) one  
                                          Most of the time                                        Definitely as much  
                                          A lot of the time                                         Not quite as much  
                From time to time, occasionally                                                     Only a little  
                                                      Not at all                                                    Hardly at all  
 
 
3. I get a sort of frightened feeling as if 
something awful is about to happen 
Please tick ( ) one  
4. I can laugh and see the funny side of 
things 
Please tick ( ) one  
                  Very definitely and quite badly                           As much as I always could  
                                Yes, but not too badly                                 Not quite so much now  
                  A little but it doesn’t worry me                         Definitely not so much now  
                                                      Not at all                                                         Not at all  
 
 
5. Worrying thoughts go through my 
mind Please tick ( ) one  
6. I feel cheerful  
Please tick ( ) one  
                              A great deal of the time                                                        Not at all  
                                          A lot of the time                                                        Not often  
          From time to time but not too often                                                     Sometimes  
                                       Only occasionally                                             Most of the time  
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Section 4. MOOD continued ... 
7. I can sit at ease and feel relaxed 
Please tick ( ) one  
8. I feel as if I am slowed down  
Please tick ( ) one  
                                                     Definitely                                     Nearly all of the time  
                                                         Usually                                                       Very often  
                                                      Not often                                                     Sometimes  
                                                      Not at all                                                         Not at all  
 
 
9. I get a sort of frightened feeling like 
"butterflies” in the stomach  
Please tick ( ) one  
10. I have lost interest in my appearance 
Please tick ( ) one  
                                                      Not at all                                                        Definitely  
                                               Occasionally         I don’t take as much care as I should  
                                                   Quite often               I may not take quite as much care  
                                                    Very often                  I take just as much care as ever  
 
 
11. I feel restless as though I have to be 
on the move Please tick ( ) one  
12. I look forward with enjoyment to 
things Please tick ( ) one  
                                       Very much indeed  As much as I ever did  
                                                    Quite a lot  Rather less than I used to  
                                             Not very much  Definitely less than I used to  
                                                      Not at all  Hardly at all  
 
 
13. I get sudden feelings of panic  
Please tick ( ) one  
14. I can enjoy a good book or radio or 
TV programme Please tick ( ) one  
                                       Very often indeed  Often  
                                                   Quite often  Sometimes  
                                             Not very often  Not often  
                                                      Not at all  Very seldom  
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Section 5. COPING 
Below you will find a list of statements. Please rate the truth of each statement as it  
applies to you by ticking one response, where 0 is ‘never true’ and 6 is ‘always true’.  
 
1. I am getting on with the business of living no matter what my level of pain is Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
2. My life is going well, even though I have chronic pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
3. It’s OK to experience pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
4. I would gladly sacrifice important things in my life to control this pain better Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
5. It’s not necessary for me to control my pain in order to handle my life well Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
6. Although things have changed, I am living a normal life despite my chronic pain Please tick ( ) 
one  
Never true      Always true 
0 1 2 3 4 5 6 
       
7. I need to concentrate on getting rid of my pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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Section 5. COPING Continued... 
8. There are many activities I do when I feel pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
9. I lead a full life even though I have chronic pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
10. Controlling pain is less important than other goals in my life Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
11. My thoughts and feelings about pain must change before I can take important steps in my life 
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
12. Despite the pain, I am now sticking to a certain course in my life Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
13. Keeping my pain level under control takes first priority whenever I’m doing something  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
14. Before I can make any serious plans, I have to get some control over my pain  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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Section 5. COPING continued ... 
 
15. When my pain increases, I can still take care of my responsibilities Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
16. I will have better control over my life if I can control my negative thoughts about pain  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
17. I avoid putting myself in situations where my pain might increase Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
18. My worries and fears about what pain will do to me are true Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
 
19. It’s a relief to realise that I don’t have to change my pain to get on with my life  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
20. I have to struggle to do things when I have pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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Section 6. SOCIAL LIFE 
 
Below you will find a list of statements. Please indicate how strongly you agree or 
disagree with the following statements by ticking the response which best describes you 
now. 
1. I am doing interesting things in my 
life Please tick ( ) one 
2. Most days I am doing some of the 
things I really enjoy Please tick ( ) one 
                                       Strongly disagree                                          Strongly disagree  
                                                      Disagree                                                         Disagree  
                                                           Agree                                                              Agree  
                                            Strongly agree                                               Strongly agree  
 
3. I try to make the most of my life 
Please tick ( ) one 
4. I have plans to do enjoyable things 
for myself over the next few days Please 
tick ( ) one 
                                       Strongly disagree                                          Strongly disagree  
                                                      Disagree                                                         Disagree  
                                                           Agree                                                              Agree  
                                            Strongly agree                                               Strongly agree  
 
5. I feel like I am actively involved in life 
Please tick ( ) one 
                                       Strongly disagree  
                                                      Disagree  
                                                           Agree  
                                            Strongly agree  
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Section 8. PRIVATE HEALTHCARE USE 
 
These questions are about any PRIVATE healthcare use outside the NHS over the last 6 
months for your chronic pain.  
1. In the last 6 months how many times 
have you seen the following people 
privately for your pain? 
                                                       Number  
                                                       of visits 
 2. In the last 6 months, have you had any 
tests or treatments done privately?  
For example, scans, x-rays, blood tests or 
injections etc.               
                                                              Number 
                                                         of tests 
 Private doctor    Description of test                           
                              
___________________________ 
___________________________ 
___________________________ 
___________________________ 
 
___________________________ 
 
___________________________ 
 
___________________________ 
 
Private nurse   
Private physiotherapist   
Osteopath   
Chiropractor   
Acupuncturist   
Other (please specify) 
___________________________ 
  
Other (please specify) 
___________________________ 
  
    
3. In the last 6 months how much money 
have you spent on medicines for your 
pain?  
For example, pain relief tablets, gels, 
homeopathic remedies etc.                     Amount 
 4. In the last 6 months have you bought 
any devices or disability aids for your 
pain?  
For example, a TENS machine, walking stick, 
strapping, mobility scooters etc.            Amount 
Description                                                  £        Description      £  
______________________________   ___________________________ 
___________________________ 
 
___________________________ 
 
___________________________ 
______________________________   
______________________________   
______________________________   
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Section 8. PRIVATE HEALTHCARE USE continued ... 
 
5. In the last 6 months, how many times 
have you been admitted for private 
hospital care and stayed overnight?             
 
Reason and Duration                           Number   
                                                         of nights 
   6. In the last 6 months, how much money 
have you spent on any of the following 
because of your pain? 
                                                
 £ 
1) ___________________________   Help at home For example, cleaning and cooking 
 
_____________________________   Personal care For example, washing and dressing 
 
_____________________________   Transport For example, taxis 
 
2) ___________________________   Household maintenance For example, gardening and repairs 
 
_____________________________   Other (please specify)  
 
_____________________________   _____________________________ 
 
 
3) ___________________________ 
  
_____________________________ 
 
_____________________________ 
  
_____________________________ 
 
_____________________________ 
  
_____________________________ 
 
Comments   
_____________________________ 
 
_____________________________ 
  
_____________________________ 
 
     
 
THANK YOU FOR FILLING IN THE QUESTIONNAIRE 
 
Please return to the study team using the FREEPOST envelope provided (no postage 
stamp required)  
HEAD OFFICE: COPERS STUDY  
CENTRE FOR PRIMARY CARE AND PUBLIC HEALTH, BLIZARD INSTITUTE,  
2 Newark Street, London, E1 2AT
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COPERS - COping with persistent Pain, Effectiveness Research in 
Self-management  
FOLLOW UP QUESTIONNAIRE 
AT 12 MONTHS  
Confidential 
 
Dear Participant.  
 The aim of this questionnaire is find out your current health state and feelings 
about living with chronic pain after you participated in the COPERS study. Please read 
the questions carefully. If you have any difficulties with the questionnaire please call the 
study team on 020 7882 2546. 
 
 
Section 1. ABOUT YOUR PAIN 
 
Please answer every question by marking the answer as indicated. If you are unsure 
about how to answer a question, please give the best answer you can. 
1. How is your health in general?: Please tick ( ) one 
Very good Good Fair Bad Very bad 
     
 
 
 
 
 
Participant ID No.: .  
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Section 1. ABOUT YOUR PAIN continued... 
For the following questions with a scale of 0-10, please tick one number only. 
 
2. How would you rate your pain on a 0-10 scale at the present time, that is right 
now, where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’?  
Please tick ( ) one 
No pain       Pain as bad as could be 
0 1 2 3 4 5 6 7 8 9 10 
           
 
 
 
5. About how many days in the last six months have you been kept from 
your usual activities (work, school or housework) because of this pain? 
Please tick ( ) one 
  0 – 6 days  
7 – 14 days  
15 – 30 days  
31 or more days  
 
 
3. In the past six months, how intense was your worst pain rated on a 0-10 scale 
where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’? Please tick ( ) one 
No pain       Pain as bad as could be 
0 1 2 3 4 5 6 7 8 9 10 
           
4. In the past six months, on average, how intense was your pain rated on a 0-10 
scale, where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’? (That is, your usual 
pain at times you were experiencing pain) Please tick ( ) one 
No pain       Pain as bad as could be 
0 1 2 3 4 5 6 7 8 9 10 
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  Section 1. ABOUT YOUR PAIN continued... 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
6. In the past six months, how much has this pain interfered with your daily 
activities rated on a 0-10 scale where 0 is ‘no interference’ and 10 ‘unable to carry 
on activities’? Please tick ( ) one 
No interference     Unable to carry on activities 
0 1 2 3 4 5 6 7 8 9 10 
           
7. In the past six months, how much has this pain changed your ability to take part 
in recreational, social and family activities where 0 is ‘no change’ and 10 is 
‘extreme change’? Please tick ( ) one 
No change        Extreme change 
0 1 2 3 4 5 6 7 8 9 10 
           
8. In the past six months, how much has this pain changed your ability to work 
(including housework) where 0 is ‘no change’ and 10 is ‘extreme change’? Please 
tick ( ) one 
No change       Extreme change 
0 1 2 3 4 5 6 7 8 9 10 
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Section 2. QUALITY OF LIFE 
 
Please tick which statements best describe your own health state today 
1. Mobility Please tick ( ) one 
I have no problems in walking about   
I have some problems in walking about  
I am confined to bed  
 
2. Self-care Please tick ( ) one 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
 
3. Usual activities such as work, study, housework family or leisure  
Please tick ( ) one 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
 
4. Pain/Discomfort Please tick ( ) one 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
5. Anxiety/Depression Please tick ( ) one 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
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Section 3. CONFIDENCE 
 
Please indicate how confident you are that you can do the following things at present, 
despite the pain, where 0 is ‘not at all confident’ and 6 is ‘completely confident’ 
 
** Remember, these questions are not asking whether or not you have been doing these 
things, but rather how confident you are that you could do them at present, despite the 
pain 
1. I can enjoy things, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
2. I can do most household chores (e.g. tidying up, washing dishes etc), despite 
the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
3. I can socialise with my friends or family members as often as I used to, despite 
the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
4. I can cope with my pain in most situations Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
5. I can do some form of work, despite the pain (‘work’ includes housework, paid 
and unpaid work) Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
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Section 3. CONFIDENCE continued ... 
6. I can still do many of the things I enjoy doing, such as hobbies or leisure 
activity, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
7. I can cope with my pain without medication Please tick ( ) one 
 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
8. I can still accomplish most of my goals in life, despite the pain  
Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
9. I can live a normal lifestyle, despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
       
 
10. I can gradually become more active despite the pain Please tick ( ) one 
Not confident    Completely confident 
0 1 2 3 4 5 6 
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Section 4. MOOD 
Please read each item and tick the reply which comes closest to how you have been 
feeling in the past week.  
 
Don’t take too long over your replies: your immediate reaction to each item will probably 
be more accurate than a long thought out response. 
 
 
1. I feel tense or “wound up”  
Please tick ( ) one 
2. I still enjoy the things I used to enjoy 
Please tick ( ) one 
                                          Most of the time                                        Definitely as much  
                                          A lot of the time                                         Not quite as much  
                From time to time, occasionally                                                     Only a little  
                                                      Not at all                                                    Hardly at all  
 
 
3. I get a sort of frightened feeling as if 
something awful is about to happen 
Please tick ( ) one 
4. I can laugh and see the funny side of 
things 
Please tick ( ) one 
                  Very definitely and quite badly                           As much as I always could  
                                Yes, but not too badly                                 Not quite so much now  
                  A little but it doesn’t worry me                         Definitely not so much now  
                                                      Not at all                                                         Not at all  
 
 
5. Worrying thoughts go through my 
mind Please tick ( ) one 
6. I feel cheerful  
Please tick ( ) one 
                              A great deal of the time                                                        Not at all  
                                          A lot of the time                                                        Not often  
          From time to time but not too often                                                     Sometimes  
                                       Only occasionally                                             Most of the time  
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Section 4. MOOD continued ... 
7. I can sit at ease and feel relaxed 
Please tick ( ) one 
8. I feel as if I am slowed down  
Please tick ( ) one 
                                                     Definitely                                     Nearly all of the time  
                                                         Usually                                                       Very often  
                                                      Not often                                                     Sometimes  
                                                      Not at all                                                         Not at all  
 
 
9. I get a sort of frightened feeling like 
"butterflies” in the stomach  
Please tick ( ) one 
10. I have lost interest in my appearance 
Please tick ( ) one 
                                                      Not at all                                                        Definitely  
                                               Occasionally         I don’t take as much care as I should  
                                                   Quite often               I may not take quite as much care  
                                                    Very often                  I take just as much care as ever  
 
 
11. I feel restless as though I have to be 
on the move Please tick ( ) one 
12. I look forward with enjoyment to 
things Please tick ( ) one 
                                       Very much indeed  As much as I ever did  
                                                    Quite a lot  Rather less than I used to  
                                             Not very much  Definitely less than I used to  
                                                      Not at all  Hardly at all  
 
 
13. I get sudden feelings of panic  
Please tick ( ) one 
14. I can enjoy a good book or radio or 
TV programme Please tick ( ) one 
                                       Very often indeed  Often  
                                                   Quite often  Sometimes  
                                             Not very often  Not often  
                                                      Not at all  Very seldom  
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Section 5. COPING 
Below you will find a list of statements. Please rate the truth of each statement as it has 
applies to you by ticking one response, where 0 is ‘never true’ and 6 is ‘always true’.  
 
1. I am getting on with the business of living no matter what my level of pain is Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
2. My life is going well, even though I have chronic pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
3. It’s OK to experience pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
4. I would gladly sacrifice important things in my life to control this pain better Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
5. It’s not necessary for me to control my pain in order to handle my life well Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
6. Although things have changed, I am living a normal life despite my chronic pain  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
7. I need to concentrate on getting rid of my pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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Section 5. COPING Continued... 
8. There are many activities I do when I feel pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
9. I lead a full life even though I have chronic pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
10. Controlling pain is less important than other goals in my life Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
11. My thoughts and feelings about pain must change before I can take important steps in my life 
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
12. Despite the pain, I am now sticking to a certain course in my life Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
13. Keeping my pain level under control takes first priority whenever I’m doing something  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
14. Before I can make any serious plans, I have to get some control over my pain  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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Section 5. COPING continued ... 
 
15. When my pain increases, I can still take care of my responsibilities Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
16. I will have better control over my life if I can control my negative thoughts about pain  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
17. I avoid putting myself in situations where my pain might increase Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
18. My worries and fears about what pain will do to me are true Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
 
 
19. It’s a relief to realise that I don’t have to change my pain to get on with my life  
Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
       
20. I have to struggle to do things when I have pain Please tick ( ) one 
Never true      Always true 
0 1 2 3 4 5 6 
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Section 6. SOCIAL LIFE 
 
Below you will find a list of statements. Please indicate how strongly you agree or 
disagree with the following statements by ticking the response which best describes you 
now. 
1. I am doing interesting things in my 
life Please tick ( ) one 
2. Most days I am doing some of the 
things I really enjoy Please tick ( ) one 
                                       Strongly disagree                                          Strongly disagree  
                                                      Disagree                                                         Disagree  
                                                           Agree                                                              Agree  
                                            Strongly agree                                               Strongly agree  
 
3. I try to make the most of my life 
Please tick ( ) one 
4. I have plans to do enjoyable things 
for myself over the next few days  
Please tick ( ) one 
                                       Strongly disagree                                          Strongly disagree  
                                                      Disagree                                                         Disagree  
                                                           Agree                                                              Agree  
                                            Strongly agree                                               Strongly agree  
 
5. I feel like I am actively involved in life 
Please tick ( ) one 
                                       Strongly disagree  
                                                      Disagree  
                                                           Agree  
                                            Strongly agree  
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Section 8. PRIVATE HEALTHCARE USE 
 
These questions are about any PRIVATE healthcare use outside the NHS over the last 6 
months for your chronic pain.  
1. In the last 6 months how many times 
have you seen the following people 
privately for your pain? 
                                                       Number  
                                                       of visits 
 2. In the last 6 months, have you had any 
tests or treatments done privately?  
For example, scans, x-rays, blood tests or 
injections etc.               
                                                              Number 
                                                         of tests 
 Private doctor    Description of test                           
                              
___________________________ 
___________________________ 
___________________________ 
___________________________ 
 
___________________________ 
 
___________________________ 
 
___________________________ 
 
Private nurse   
Private physiotherapist   
Osteopath   
Chiropractor   
Acupuncturist   
Other (please specify) 
___________________________ 
  
Other (please specify) 
___________________________ 
  
    
3. In the last 6 months how much money 
have you spent on medicines for your 
pain?  
For example, pain relief tablets, gels, 
homeopathic remedies etc                      Amount 
 4. In the last 6 months have you bought 
any devices or disability aids for your 
pain?  
For example, a TENS machine, walking stick, 
strapping, mobility scooters etc             Amount  
 Description                                                £         Description      £  
______________________________   ___________________________ 
___________________________ 
 
___________________________ 
 
___________________________ 
______________________________   
______________________________   
______________________________   
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Section 8. PRIVATE HEALTHCARE USE continued ... 
 
5. In the last 6 months, how many times 
have you been admitted to hospital and 
stayed overnight?                                            
 
Reason and Duration                           Number    
                                                         of nights 
  6. In the last 6 months, how much money 
have you spent on any of the following 
because of your pain? 
                                                
 £ 
1) ___________________________   Help at home For example, cleaning and cooking 
 
_____________________________   Personal care For example, washing and dressing 
 
_____________________________   Transport For example, taxis 
 
2) ___________________________   Household maintenance For example, gardening and repairs 
 
_____________________________   Other (please specify)  
 
_____________________________   _____________________________ 
 
 
3) ___________________________ 
  
_____________________________ 
 
_____________________________ 
  
_____________________________ 
 
_____________________________ 
  
_____________________________ 
 
Comments   
_____________________________ 
 
_____________________________ 
  
_____________________________ 
 
     
 
THANK YOU FOR FILLING IN THE QUESTIONNAIRE 
 
Please return to the study team using the FREEPOST envelope provided (no postage 
stamp required)  
HEAD OFFICE: COPERS STUDY  
CENTRE FOR PRIMARY CARE AND PUBLIC HEALTH, BLIZARD INSTITUTE,  
2 Newark Street, London, E1 2AT 
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Detailed recruitment process
Participants were to be recruited in three ways:
1. electronic searches using the clinic databases
2. GP/clinician referrals during face-to-face consultations
3. advertisements in clinics.
The electronic searches were conducted by clinic staff with the support of a primary care research network
research officer and/or the COPERS research study team pending appropriate NHS approvals.
We tested a search strategy to identify the most appropriate patients using GPs’ electronic patient
registers. A general practice staff member conducted several searches of the practice electronic records to
identify the most appropriate domains and search terms; these search results were reviewed by a clinician
in the practice to check the appropriateness of the sample. Two people then independently searched the
clinic records electronically using the same search instructions to test the reliability of the output and the
search method and subsequent validity.
The first stage of the search was to identify registered patients who had consulted within the last 3 months;
then, within this group, the second stage was to search for prescribing information about repeat prescriptions
for antidepressant medication, hypnotics and analgesia. Finally, we searched by symptoms: low back pain,
backache, musculoskeletal, connective tissue disorders and pain. This generated a list of potential
participants. Each clinic designated a key contact to liaise with the primary care research network and the
study team; these personnel were trained to conduct their own searches by the study team and were given a
study manual outlining the standard protocols necessary for the study. They were given support and advice
as required.
From previous searches and test runs we estimated that this type of search yielded around 5% of the
registered patients, which supported other epidemiological research estimates that 5–10% of the
population experience chronic pain.
A list of potential participants was produced and screened by the clinicians to check suitability; no
vulnerable people were to be approached (see inclusion and exclusion criteria in Chapter 9). The study
team was provided with a pooled anonymous data set to allow response rates to be calculated. This list
contained gender, age (not date of birth) and ethnicity (if recorded). Once the list had been finalised the
study representative printed off invitation letters from the patients’ GP or clinician. These were placed in
preprepared envelopes that contained the consent to approach form, a patient information leaflet and a
Freepost envelope to return the consent to approach form to the study team. A single postal reminder was
sent after 10–14 days. Any interested patients were able to complete a consent to approach form and
send this to the study team, or telephone or e-mail the study team directly to express interest and find out
more about the study. Those who found out about the study from the waiting room advertisements
contacted the study team directly or picked up an invitation pack from the GP receptionists. In these cases
the study team screened and checked suitability to participate by using the inclusion and exclusion criteria
as a checklist. GPs and clinicians were informed of all patients enrolled into the study but they were not
informed of their allocation.
Informed consent procedures
Consent was requested for participation in the trial, audio-recording of the courses, the use of anonymised
data and permission to check health records at 12 months (for extracting data about health-care resource
use). The consent process was as follows: (1) the expression of interest, either by mailed form or by
telephone or e-mail, triggered the mailing of a COPERS cover letter, the patient information sheet, the trial
consent form and the baseline questionnaire; and (2) any patients who wanted to be part of the study
returned their signed trial consent form and the baseline questionnaire.
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Participants were then telephoned to:
l introduce the study team
l check that consent was valid and informed (at this point the consent form was countersigned by the
study team member and confirmed as valid if appropriate)
l check their questionnaire for completeness
l It was at this point that participants were formally enrolled in the study.
Participants were then randomised and informed of their allocation. If allocated to the control group they
were told about the process involved, were sent a relaxation CD with instructions and the Pain Toolkit
booklet and were asked to continue with their usual GP care. They received further questionnaires at
12 weeks and 6 and 12 months. If allocated to the intervention they were offered the opportunity of
participating in a course.
Criteria for withdrawal
All participants were free to withdraw from the study at any time and without having to give any
explanation. On formal withdrawal from the study we ceased to collect further data.
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Relaxation information
 
 
 
 
 
COPERS STUDY  
COping with persistent Pain, Effectiveness Research 
into Self-management  
 
Relaxation CD Training 
Pack 
 
London 020 7882 2546 
Warwick 024 7657 2905
Contents 
Introduction 
Suggested Training Programme 
Further information 
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Introduction 
 
Relaxation is not all about sitting in front of the TV or having a glass of wine to chill out at the 
end of the day. It involves body awareness to gradually relax all of the muscles until the 
tension is released from your body and your mind is calm. There are different ways to help 
the relaxation process such as breathing exercises and mind focussing techniques like 
repeating a word such as “calm” or “relax” quietly in your head to help ‘still’ your mind.  
For this relaxation course we are going to use ‘sequential muscle relaxation’ and breathing 
exercises as our basic relaxation sequence. We are then going to build on this using the 
mind focussing techniques of ‘visualisation’ and ‘mindfulness’ to help calm the mind.  
What is sequential muscle relaxation?  
Sequential muscle relaxation means you become aware of all of the areas of your body from 
top to toe in sequence and you concentrate on relaxing the muscles for each body area 
before you move on to the next. This ensures that you don’t forget to relax common areas 
that hold tension such as the forehead, jaw, shoulders and hands. 
What are mind focussing techniques?  
Visualisation is a technique where you use your imagination to recreate the details of a place 
where you would naturally feel more relaxed. This might be a favourite holiday destination, a 
familiar calming place you have experienced in the past or somewhere you may have read 
about. The idea is to focus you mind on recreating all the sights, sounds, smells and other 
sensations that you experience in this relaxing place. You become immersed and engrossed 
in the place. 
Mindfulness is a type of meditation technique. Whilst sitting still and relaxing most people 
have a continuous stream of thoughts popping into the mind. One type of mindfulness 
exercise is to acknowledge each thought as it comes along and imagine placing it on leaf 
which floats away downstream (or on a cloud drifting past in the sky) then drawing your 
attention back to the present. The idea is not to fight the thoughts but to let them come and 
go naturally but returning your focus to your relaxation practice each time. 
Both of these mind focussing techniques enhance the relaxation by calming the mind. 
How can these techniques help me? 
Relaxation benefits people with chronic pain in two main ways. First it reduces muscle 
tension and stiffness which may be contributing to your pain and secondly it calms the mind 
and improves mood which in turn helps to further reduce muscle tension.  In addition you 
may also find that if practised regularly, your sleep patterns may improve and you have more 
energy as a result. 
You might say that it’s too difficult to relax with chronic pain, but if you practise relaxation 
can be achieved even though your pain may not disappear completely.  
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Relaxation takes practice just like any other skill. When you become more accomplished at it 
you may find you are able to relax in any situation without the need for voice guidance. The 
benefits of relaxation increase if you can learn to relax your body in a noisy stressful 
situation or when you feel particularly anxious or agitated. 
How do you know it works? 
You might think that relaxation techniques and meditation skills are just for those practising 
yoga or tai chi but it is used in many healthcare fields. For example, people suffering from 
heart disease are encouraged to use relaxation techniques to reduce the amount of stress 
related hormones like adrenaline and cortisol in the blood which have negative impacts on 
the body’s heart and blood circulatory system.   
Arthritis support organisations (Arthritis Research UK and Arthritis Care) also recommend 
relaxation techniques for pain caused by muscle tension around joints. In addition, mental 
health charities such as the Mental Health Foundation and Mind support the use of 
relaxation techniques to reduce stress levels and anxiety.  
Research in people with fibromyalgia, chronic pain, heart disease, low back pain and other 
chronic diseases has shown that relaxation and mind focussing techniques may have 
positive effects on physical function and self-confidence in ability to do things as well as 
improvements in mental health.   
The COPERS team are interested in finding out how relaxation techniques impact on 
chronic pain sufferers in the long term. We have provided you with a CD to help you learn to 
relax. 
What’s on the CD? 
The CD has 3 audio tracks on it suitable for playing on your computer or your CD player. If 
you would like the tracks in MP3 format for your portable music player you can either ask the 
study team to send you a CD with the MP3s or if you have an Internet connection you can 
download them from our COPERS website under the link ‘patient information’ 
www.icms.qmul.ac.uk/chs/pctu/current_projects/copers/25507.html  
The files are between 9 and 15 Mb in size. 
TRACK 1:  Relaxation and breathing (about 11 minutes) 
TRACK 2:  Relaxation and visualisation (about 12 minutes) 
TRACK 3:  Relaxation and mindfulness (about 11 minutes) 
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
363
Suggested Training Programme 
Getting started 
When you start the training, try to find somewhere quiet and peaceful. This will help you to 
concentrate. Also make sure you have enough time to spare, you will need about 10 
minutes.  
Making yourself comfortable 
Ensure that as much of your body is supported as possible including your arms and feet. 
You can be lying down or seated (after a lot of practice people can relax whilst standing and 
in any environment). If you are seated use the arms of the chair to rest your arms with your 
feet flat on the floor. Make sure your legs and arms are not crossed. Don’t worry if you have 
to shift around and move a bit during the relaxation; just make sure you are as comfortable 
as you can be. Finally, make sure you are warm, particularly your hands and feet. 
You can practise relaxation at any time of the day.  You may find that the relaxation sends 
you to sleep. This is fine but make sure that you do not have any pressing engagements or 
responsibilities that you should be alert for. It can be used to ‘recharge your batteries’ before 
they run down completely or it can be used to help you get to sleep. 
You do not have to do all of the three relaxation exercises if you don’t want to. Choose which 
one(s) works for you. If you find that you can’t complete the whole guided session don’t 
worry, just do as much as you can. Similarly, if you have time to stay in your relaxed state for 
longer than the voice guidance suggests to then feel free to do so. Think of it as beneficial 
‘time out’ for yourself. 
How often and when? 
Try to do one of the relaxation practices once per day for the three weeks of the study and 
as much as you can thereafter.  
It might be easier to incorporate it into your normal routine for example: before your morning 
coffee or at bed time.  
Note: If you try the relaxation straight after a meal your body will probably go into a sleepy 
state while it digests food so you are more likely to doze off before you complete the 
relaxation sequence. 
Further information 
British Heart Foundation 
www.bhf.org.uk 
Mental Health Foundation 
www.mentalhealth.org.uk 
Get Self Help 
www.getselfhelp.co.uk 
COPERS MP3 downloads and further information about the study are available from 
www.icms.qmul.ac.uk/chs/pctu/current_projects/copers/25507.html 
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Relaxation scripts 
TRACK 1 – Relaxation and breathing 
Script (read slowly with a calm low voice) 
Please make yourself comfortable; ensuring that as much of your body is supported as 
possible including your arms and feet. If you are seated rest your arms on the arms of the 
chair, with your feet flat on the floor. Make sure you legs and arms are not crossed. Don’t 
worry if you have to shift around and move a bit during the relaxation; just make sure you are 
as comfortable as you can be. Finally, make sure you are warm, particularly your hands and 
feet. 
First, close your eyes, feeling your body supported and just listen to the noises around you. 
You may hear some noise outside, focus on it....................really listen to what you can hear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now focus on the noises in the room around you. What can you hear? Really listen to the 
sounds around you. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now become aware of the sound of your own breathing, in and out. Listen to the air as it 
moves around and through you, your abdomen gently rising and falling as you breathe.   
Pause (count slowly 1 and 2 and 3 and 4) 
Now slow your breathing down, and take a slightly longer breath in, all the way in, and pause 
for a very small moment before you breathe out again. Let the breath out of your body nice 
and slowly and controlled, all the way out.  
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Remember, slow your breathing down, and take a slightly longer breath in, all the way in, 
and pause for a very small moment before you breathe out again. Let the breath out of your 
body nice and slowly and controlled, all the way out.  
Just nice slow easy breathing, letting your body relax, feeling heavy and supported. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now you are going to focus on different parts of your body and just check that they are nice 
and relaxed.  
First of all think about your feet, just relax them. All loose and floppy. Then your ankles and 
calves, nice and relaxed, letting any muscle tension disappear, nice and relaxed.  
Pause (count slowly 1 and 2 and 3 and 4) 
Focus on your knees, relax them, feel any tension disappear, breathing in and out. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now bring your attention to your upper legs. Make sure the muscles are relaxed. Breathe in 
and out and on the outward breath really relax and feel any tension disappear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Become aware of your buttocks, pressing down. Just relax, sinking down, nice and heavy, 
nice and relaxed. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now think about your lower back muscles. Breathe in and out, nice and slowly, nice and 
relaxed. Focus on your tummy muscles, letting everything go loose, just relax. 
Pause (count slowly 1 and 2 and 3 and 4) 
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Now to your shoulders. Let them hang into a relaxed position.  Nice and loose. Let your arms 
feel nice and heavy, relaxed. Feel the tension disappear from your upper arms, your elbows, 
your forearms, your wrists, your hands and your fingers. Let everything relax, nice and loose 
nice and floppy.  
Pause (count slowly 1 and 2 and 3 and 4) 
Focus on the muscles in your neck, let them go, feel the tension disappear, let your neck 
relax. You’re nice and relaxed nearly everywhere, so think about any tension you may hold in 
your head and face.   Notice how your forehead feels, if it’s creased and frowning let your 
eyebrows fall and your forehead smooth out. Let them relax, breathing in and out. Next think 
about your eyes, relax your eyes and also your cheeks, just let the tension drift away, breathe 
in and out. 
Pause (count slowly 1 and 2 and 3 and 4) 
Relax your jaw and relax your mouth. Feel your whole body nice and relaxed. 
Enjoy this moment and know when you are tense you can always do this on your own and 
feel the tension disappear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Breathing nice and slowly, and start to become more aware of the sound of your breathing, in 
and out. 
Now start to notice the sounds around you, gradually becoming more aware of the room, 
aware of your toes and your fingers.  
And when you are ready just slowly open your eyes.  Gently wiggle your fingers and toes. 
Breathe deeply and stretch. 
END 
  Text adapted from http://www.getselfhelp.co.uk/relax.htm  
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TRACK 2 – Relaxation and visualisation. Script (read slowly with a calm 
low voice) 
Please make yourself comfortable; ensuring that as much of your body is supported as 
possible including your arms and feet. If you are seated rest your arms on the arms of the 
chair, with your feet flat on the floor. Make sure you legs and arms are not crossed. Don’t 
worry if you have to shift around and move a bit during the relaxation; just make sure you are 
as comfortable as you can be. Finally, make sure you are warm, particularly your hands and 
feet. 
First, close your eyes, feeling your body supported and just listen to the noises around you. 
You may hear some noise outside, focus on it....................really listen to what you can hear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now focus on the noises in the room around you. What can you hear? Really listen to the 
sounds around you. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now become aware of the sound of your own breathing, in and out. Listen to the air as it 
moves around and through you, your abdomen gently rising and falling as you breathe.   
Pause (count slowly 1 and 2 and 3 and 4) 
Now slow your breathing down, and take a slightly longer breath in, all the way in, and pause 
for a very small moment before you breathe out again. Let the breath out of your body nice 
and slowly and controlled, all the way out.  
Remember, slow your breathing down, and take a slightly longer breath in, all the way in, 
and pause for a very small moment before you breathe out again. Let the breath out of your 
body nice and slowly and controlled, all the way out.  
Just nice slow easy breathing, letting your body relax, feeling heavy and supported. 
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Pause (count slowly 1 and 2 and 3 and 4) 
Now you are going to focus on different parts of your body and just check that they are nice 
and relaxed.  
First of all think about your feet, just relax them. All loose and floppy. Then your ankles and 
calves, nice and relaxed, letting any muscle tension disappear, nice and relaxed.  
Pause (count slowly 1 and 2 and 3 and 4) 
Focus on your knees, relax them, feel any tension disappear, breathing in and out. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now bring your attention to your upper legs. Make sure the muscles are relaxed. Breathe in 
and out and on the outward breath really relax and feel any tension disappear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Become aware of your buttocks, pressing down. Just relax, sinking down, nice and heavy, 
nice and relaxed. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now think about your lower back muscles. Breathe in and out, nice and slowly, nice and 
relaxed. Focus on your tummy muscles, letting everything go loose, just relax. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now to your shoulders, let them hang into a relaxed position.  Nice and loose. Let your arms 
feel nice and heavy, relaxed. Feel the tension disappear from your upper arms, your elbows, 
your forearms, your wrists, your hands and your fingers. Let everything relax, nice and loose 
nice and floppy.  
Pause (count slowly 1 and 2 and 3 and 4) 
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Focus on the muscles in your neck, let them go, feel the tension disappear, let your neck 
relax. You’re nice and relaxed nearly everywhere, so think about any tension you may hold in 
your head and face.   Notice how your forehead feels, if it’s creased and frowning let your 
eyebrows fall and your forehead smooth out. Let them relax, breathing in and out. Next think 
about your eyes, relax your eyes and also your cheeks, just let the tension drift away, breathe 
in and out. 
Pause (count slowly 1 and 2 and 3 and 4) 
Relax your jaw and relax your mouth. Feel your whole body nice and relaxed. 
Enjoy this moment and know when you are tense you can always do this on your own and 
feel the tension disappear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Whilst you are in this relaxed state, imagine a place where you can feel content, calm and 
happy.  
Pause (count slowly 1 and 2 and 3 and 4) 
Recall the details of this place. Whereabouts are you? What can you see around you? How 
are you passing the time? What are you wearing? Are you with anyone else? What are they 
doing in this scene? Really focus in on the details of the scene. 
Pause (count slowly 1 and 2 and 3 and 4) 
Consider the air temperature. Can you feel any sensations on your skin? Are there any smells 
or sounds. How do you feel when you are here? Remember this place where you feel calm 
and happy. You can go back to it whenever you want. 
I am going to pause for a moment know and let you enjoy your place of tranquillity and 
contentment.  
Pause  
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Breathing nice and slowly, and start to become more aware of the sound of your breathing, in 
and out. 
Now start to notice the sounds around you, gradually becoming more aware of the room, 
aware of your toes and your fingers.  
And when you are ready just slowly open your eyes.  Gently wiggle your fingers and toes. 
Breathe deeply and stretch. 
END 
Text adapted from http://www.getselfhelp.co.uk/imagery.htm   
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TRACK 3 – Relaxation and mindfulness of thoughts 
Script (read slowly with a calm low voice) 
Please make yourself comfortable; ensuring that as much of your body is supported as 
possible including your arms and feet. If you are seated rest your arms on the arms of the 
chair, with your feet flat on the floor. Make sure you legs and arms are not crossed. Don’t 
worry if you have to shift around and move a bit during the relaxation; just make sure you are 
as comfortable as you can be. Finally, make sure you are warm, particularly your hands and 
feet. 
First, close your eyes, feeling your body supported and just listen to the noises around you. 
You may hear some noise outside, focus on it....................really listen to what you can hear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now focus on the noises in the room around you. What can you hear? Really listen to the 
sounds around you. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now become aware of the sound of your own breathing, in and out. Listen to the air as it 
moves around and through you, your abdomen gently rising and falling as you breathe.   
Pause (count slowly 1 and 2 and 3 and 4) 
Now slow your breathing down, and take a slightly longer breath in, all the way in, and pause 
for a very small moment before you breathe out again. Let the breath out of your body nice 
and slowly and controlled, all the way out.  
Remember, slow your breathing down, and take a slightly longer breath in, all the way in, 
and pause for a very small moment before you breathe out again. Let the breath out of your 
body nice and slowly and controlled, all the way out.  
Just nice slow easy breathing, letting your body relax, feeling heavy and supported. 
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Pause (count slowly 1 and 2 and 3 and 4) 
Now you are going to focus on different parts of your body and just check that they are nice 
and relaxed.  
First of all think about your feet, just relax them. All loose and floppy. Then your ankles and 
calves, nice and relaxed, letting any muscle tension disappear, nice and relaxed.  
Pause (count slowly 1 and 2 and 3 and 4) 
Focus on your knees, relax them, feel any tension disappear, breathing in and out. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now bring your attention to your upper legs. Make sure the muscles are relaxed. Breathe in 
and out and on the outward breath really relax and feel any tension disappear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Become aware of your buttocks, pressing down. Just relax, sinking down, nice and heavy, 
nice and relaxed. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now think about your lower back muscles. Breathe in and out, nice and slowly, nice and 
relaxed. Focus on your tummy muscles, letting everything go loose, just relax. 
Pause (count slowly 1 and 2 and 3 and 4) 
Now to your shoulders. Let them hang into a relaxed position.  Nice and loose. Let your arms 
feel nice and heavy, relaxed. Feel the tension disappear from your upper arms, your elbows, 
your forearms, your wrists, your hands and your fingers. Let everything relax, nice and loose 
nice and floppy.  
Pause (count slowly 1 and 2 and 3 and 4) 
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Focus on the muscles in your neck, let them go, feel the tension disappear, let your neck 
relax. You’re nice and relaxed nearly everywhere, so think about any tension you may hold in 
your head and face.   Notice how your forehead feels, if it’s creased and frowning let your 
eyebrows fall and your forehead smooth out. Let them relax, breathing in and out. Next think 
about your eyes, relax you eyes and also your cheeks, just let the tension drift away, breathe 
in and out. 
Pause (count slowly 1 and 2 and 3 and 4) 
Relax your jaw and relax your mouth. Feel your whole body nice and relaxed. 
Enjoy this moment and know when you are tense you can always do this on your own and 
feel the tension disappear. 
Pause (count slowly 1 and 2 and 3 and 4) 
Whilst in your relaxed state, start to notice the thoughts that come into your mind.  As you 
notice each thought, imagine putting those words onto a leaf as it floats by on a stream.  Put 
each thought that you notice onto a leaf, and watch it drift on by, meandering on the surface 
of the water.  There's no need to look for the thoughts, or to remain alert waiting for them to 
come.  Just let them come, and as they do, place them onto a leaf. 
Your attention will wander, particularly so at first, and that's okay - it's what your mind does.  
As soon as you notice your mind wandering, gently bring your focus back to the thoughts, 
placing them onto the leaves and watching them drift by. 
Pause and give about 1 minute to allow time to  visualise 
Breathing nice and slowly, and start to become more aware of the sound of your breathing, in 
and out. 
Now start to notice the sounds around you, gradually becoming more aware of the room, 
aware of your toes and your fingers.  
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And when you are ready just slowly open your eyes.  Gently wiggle your fingers and toes. 
Breathe deeply and stretch. 
END 
Text adapted from http://www.getselfhelp.co.uk/imagery.htm 
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
375
Statistical analysis plan
Improving the self-management of 
chronic pain: COPERS 
 
Statistical Analysis Plan 
 
Version: 1.0 
Date: 03/10/2013 
                          
Person(s) contributing to the analysis plan 
Name(s) and 
position(s) 
Brennan Kahan 
Dawn Carnes 
Kate Homer 
Karla Diaz-Ordaz 
Miland Joshi 
Stephen Bremner 
Sandra Eldridge 
Stephanie Taylor 
Martin Underwood 
Authorisation 
Position Chief or principal investigator 
Name Professor Stephanie Taylor 
Signature  
Date   
Position Senior trial statistician 
Name Professor Sandra Eldridge 
Signature 
 
 
 
Date  
Position Trial Steering Committee statistician  
Name  Dr. Obi Ukoumunne 
 
Tick once reviewed  
 
Date  
 
APPENDIX 6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
376
1. INTRODUCTION 
Purpose of statistical analysis plan 
 
The purpose of this document is to provide details of the statistical analyses and 
presentation of results to be reported within the principal paper(s) of the COPERS 
trial. Subsequent papers of a more exploratory nature (including those involving 
baseline data only) will not be bound by this strategy but will be expected to 
follow the broad principles laid down within it.  Any exploratory, post-hoc or 
unplanned analyses will be clearly identified as such in the respective study 
analysis report. 
 
The structure and content of this document provides sufficient detail to meet the 
requirements identified by the International Conference on Harmonisation (ICH) 
and PCTU_SOP_SP 01_Statistical Analysis.   
 
The ethics application was submitted in Feb 2011, and approval was granted on 
18/03/2011. 
 
The following were reviewed in preparation for a preliminary version of this 
document: 
• ICH E9 Guidance on statistical principles for clinical trials 
• ICH E3 Structure and content of clinical study reports 
• CONSORT guidelines for the reporting of randomised trials 
 
Stephen Bremner was responsible for the original statistical analysis strategy in 
the protocol. Brennan Kahan and Karla Diaz-Ordaz have written the statistical 
analysis plan under the direction of Sandra Eldridge. Dawn Carnes, Kate Homer, 
Martin Underwood, and Stephanie Taylor have also contributed to the writing of 
this statistical analysis plan. Sandy Smith has designed the database to collate and 
store the data from the questionnaires. 
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This document has been developed prior to examination of unblinded trial data. 
This plan is intended not to change or contradict the general aims of the protocol, 
but rather expand  
on them. In the event of a discrepancy the analyses described here will supersede 
those in earlier  
documents. 
2. STUDY OBJECTIVES AND ENDPOINTS 
2.1 Primary Objective 
• To test the effectiveness and cost-effectiveness of a group self-
management courses for people with persistent pain. 
2.2 Secondary objectives 
• To test the hypothesis that treatment effectiveness is moderated by 
baseline self-efficacy  
• To test the hypothesis that long-term (12 month) effectiveness is mediated 
by change in self-efficacy between baseline and three months.  
2.3 Outcome measures 
Primary outcome 
The primary outcome is the disability subsection of the Chronic Pain Grade 
questionnaire (CPG disability) (Von Korff, 1992) at 12 months post 
randomisation.  
 
This outcome is a composite of three questions assessing the extent to which the 
participant’s pain has interfered with or changed their ability to perform their 
daily activities, work, or take part in recreational, social, and family activities in 
the previous six months. Each of the three questions is rated on a scale of 0-10, 
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with 0 reflecting no change or interference, and 10 reflecting extreme change or 
interference.  
 
The primary outcome is the mean of these three questions, multiplied by 10; i.e. if 
X1, X2, and X3 represent the three questions, and Y represents the primary 
outcome, then Y=10*(X1+X2+X3)/3. The primary outcome is therefore recorded 
on a scale from 0-100, with higher scores reflecting larger interference or change 
in the participant’s ability to perform daily activities, work, or take part in 
recreational, social, and family activities.  
Secondary outcomes 
1) CPG disability at 6 months post randomisation 
2) CPG pain intensity score at 6 and 12 months post randomisation.  
3)  PSEQ (Pain Self-Efficacy Questionnaire) score at 6 and 12 months post 
randomisation 
4) HADS (Hospital Anxiety and Depression Scale) Anxiety score at 6 and 12 
months post randomisation 
5) HADS (Hospital Anxiety and Depression Scale) Depression score at 6 and 12 
months post randomisation 
6) CPAQ (Coping Pain and Acceptance Questionnaire) score at 6 and 12 months 
post randomisation 
7) HEIQ (Health Education Impact Questionnaire) Social integration score at 6 
and 12 months post randomisation 
8) EQ-5D at 6 and 12 months post randomisation 
9) Census global health question at 6 and 12 months post randomisation 
10) Total Defined Daily Doses (Total DDD) consumed of psychotropic drugs up 
to 12 months post-randomisation  
11) Total DDD consumed of analgesics (including all opioids and other CNS 
drugs) for pain up to 12 months post randomisation  
12) Total DDD consumed of weak opioids up to 12 months post randomisation  
13) Total DDD consumed of strong opioids up to 12 months post randomisation  
14) Proportion of participants using weak opioids at 12 months post randomisation 
(defined as having received a prescription for a weak opioid up to twelve 
weeks before the 12 month follow-up date) 
15) Proportion of participants using strong opioids at 12 months post 
randomisation (defined as having received a prescription for a strong opioid 
up to twelve weeks before the 12 month follow-up date) 
A guide to how outcomes are derived is available in the appendix. 
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3. STUDY METHODS 
3.1 Overall study design and plan 
Target for randomisation: 391 intervention and 294 control participants  
Date of first randomisation: 6th September 2011 
Date of last randomisation: 18th July 2012 
Trial design:  Individually randomized, parallel group   
Blinding: It was not possible to blind participants. Data entry and telephone 
follow-up are blinded   
Randomised Interventions: Intervention with usual care vs Modified attention 
control (relaxation) with usual care   
Target allocation ratio: 1:1.33 (control: intervention)              
3.2 Selection of study population  
Inclusion criteria:  
• Adults (aged 18 or over) with chronic musculoskeletal pain 
 
The International Association for the Study of Pain (IASP) defines chronic pain as 
that which has  
persisted beyond normal tissue healing time - usually interpreted as three months 
(IASP 1986).  
Examples include osteoarthritis, any chronic musculoskeletal pain, chronic 
widespread pain and  
fibromyalgia; we excluded inflammatory arthritis such as rheumatoid arthritis. We 
included people with chronic pain and a past history of cancer where the chronic 
pain arose from non-malignant causes. 
Exclusion criteria:  
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• Inability to give informed consent 
• Not fluent in English 
• Serious active co-morbidity that is more disabling to the individual than 
chronic pain 
• Serious mental health issues that would make it difficult for an individual 
to participate in the group course 
• People with a life expectancy of less than six months 
• Substance misuse that would make it difficult for an individual to 
participate in the group course  
• People with chronic pain arising from malignant disease because this 
requires specific management  
3.3 Method of treatment assignment and randomisation 
Participants were assigned to the intervention or control group in a 1.33 to 1 ratio 
(intervention: control) using stratified permuted blocks with randomly varying 
block lengths of 7 and 14. Site of recruitment was used as a stratification factor. 
Treatment assignments were carried out via a remote computerized randomisation 
service. 
3.4 Treatment masking (blinding) 
All parties were blind to allocation up to the point of randomisation and all 
baseline data were  
collected by self-completed questionnaire prior to randomisation.  
 
After allocation, we could not blind researchers to participants’ treatment 
allocation in their own location.  
 
Follow-up data collected by telephone by trial research personnel was blind to 
treatment allocation (the London team collected data from Warwick site 
participants and vice versa). Because participants were aware of their treatment 
allocation, we used a standardised script asking participants not to divulge their 
allocation to the data collector. All other data were collected by self-completed 
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questionnaires and / or electronic databanks returned to the trial team for data 
entry.  
 
The statistician analysing the data will not be blinded once any information on 
allocation has been received. As far as possible, data cleaning and checking by the 
statistician will be completed prior to information about which participants are in 
the control group and which in the intervention group being disclosed to them. 
3.5 Sample size  
The sample size calculation was based on detecting a standardised mean 
difference of 0.3 in pain related disability between intervention and control 
groups, with a power of 80% at the 5% significance level. This effect size was 
commensurate with the largest change seen in a recent systematic review of expert 
patient programmes[2], and also with the sort of change effected by interventions 
for other chronic pain syndromes, such as low back pain, on any continuous 
outcome measure[3]. A simple sample size calculation indicated that we would 
require data on 350 subjects.  We inflated the sample size because of the 
possibility of a ‘clustering’ effect in the group intervention arm and chose the ratio 
between intervention and control participants to increase statistical efficiency [4].  
Using an intra-cluster correlation coefficient (ICC) of 0.1, and assuming on 
average nine individuals providing data from each group results in 480 individuals 
needed with 275 in the intervention group and 205 in control the control group 
(1.33:1 intervention:control). Allowing, conservatively, for a 30% loss to follow-
up (from an average of 13 individuals recruited per group) we sought to 
randomise 685 participants (391 intervention participants and 294 controls).  
3.6 Trial Consent  
 Consent was gained for: participating in the trial, audio-recording the intervention 
sessions and accessing medical records at 12 months.  
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4. DATA COLLECTION 
Data were collected at four time points: baseline, 12 weeks, 6 months and 12 
months post randomisation. All data were collected via postal self- report 
questionnaires, except for data about participant co-morbidities and use of pain 
related medication, which were obtained from the participant’s GP record.  
Recruitment began in August 2011, finished in July 2012; follow-up was 
complete d in August2013.   
4. 1 Baseline data collection 
Descriptive data:  
• Age  
• Gender  (Male/Female) 
• Ethnicity (White, Black or Black British, Asian or Asian British, Mixed, 
Other) 
• English language fluency (Fluent, Good, Below Average, Poor)  
• Age at which formal education ended  (no formal education, age 12 or 
less, age 13 to 16, age 17 to 19, age 20 or over, still in full time education, 
other)(   
• Employment status (employed, unemployed and looking for work, at 
school or in full time education, unable to work due to long term sickness, 
looking after home or family, retired from paid work, other) 
• Number of body systems affected by co-morbid conditions 
(musculoskeletal, cardiovascular, tegumental, gastrointestinal, 
genitourinary, mental health, ENT/optical, respiratory, neurological, 
endocrine/metabolic/immune, other)   
• Time kept from usual activities due to pain in last 6 months (0-6 days, 7-
14 days, 15-30 days, 31 or more days) 
• Site recruited (London, Warwick) 
• Duration of pain (0-3 months, 4-12 months, 13 months to 2 years, 3-4 
years, 5-6 years, 7-10 years, more than 10 years) 
• Living arrangements (lives alone, lives with others) 
• Overall CPG score 
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 Outcomes measured at baseline: 
• CPG disability 
• CPG pain intensity  
•  HADS Anxiety  
• HADS Depression 
• EQ-5D  
• PSEQ   
• CPAQ   
• HEIQ   
• Census global health question  
• Total amount of drugs taken above the DDD in three months prior to 
randomization (psychotropic, weak opioids, strong opioids, analgesics) 
• Opioids prescriptions (strong and weak opioids) 
 
4.2 Twelve weeks data collection 
• PSEQ 
4.3 Six months data collection 
• CPG disability 
• CPG pain intensity  
•  HADS Anxiety  
• HADS Depression 
• EQ-5D  
• PSEQ   
• CPAQ   
• HEIQ   
• Census global health question  
• Private healthcare use during previous 6 months (In addition to the core seven 
questionnaires (4.1 (b) above) at six months we also asked participants about 
their non-NHS health care resource use: private health care hospital stays, 
private tests, private consultations, privately purchased prescriptions/meds and 
devices and expenditure on social support such as transport and home help in 
the previous 6 months) 
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4.4 Twelve months data collection 
• CPG disability 
• CPG pain intensity  
•  HADS Anxiety  
• HADS Depression 
• EQ-5D  
• PSEQ   
• CPAQ   
• HEIQ   
• Census global health question  
• Private healthcare use during previous 6 months (see 6 month data collection 
for details) 
• Total amount of drugs taken above the DDD during follow-up (psychotropic, 
weak opioids, strong opioids, analgesics) 
• Opioids prescriptions (strong and weak opioids) 
• Other courses or activities attended during follow-up outside of COPERS trial: 
pain management course, expert patient programme or other self management 
course, other wellness or wellbeing course, return to work course, frequency 
of relaxation techniques (never, rarely, daily, weekly, monthly) 
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5. GENERAL ISSUES FOR STATISTICAL ANALYSIS 
5. 1 Blinding of the statistical analysis 
Analysis cannot be blinded because of the allocation ratio. As far as possible all 
cleaning and checking of the data will be done before the statistician has access to 
the allocation codes. 
5. 2 Database  
We will use a Microsoft™ Access 2007 bespoke database incorporating SQL and 
VBA programming code developed by PCTU.  
Data quality 
Single data entry was performed. 100% data entry check was performed for the 
primary outcome (CPG disability), EQ-5D, and randomisation code. This was 
performed by somebody other than the person who entered the data, and involved 
checking the values entered on the database matched the questionnaire. A subset 
(approximately 10%) of questionnaires at baseline, 12 weeks, 6 months, and 12 
months were checked by comparing the values entered on the database to the 
questionnaire.  
 
Database lock 
Once the trial team has completed all data entry and checking, the database will be 
date stamped and transferred to a read-only location on the appropriate server. The 
statistician responsible for the analysis will conduct or oversee additional data 
checks. Any necessary changes will be communicated to the appropriate member 
of the data management team as detailed in PCTU SOP PCTU_DM_04. This 
process will be repeated until the statistician and data management team are 
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satisfied that all identifiable errors have been corrected. At this point, the database 
will be locked by removing access rights. After database lock, the database will be 
date stamped and transferred to a read-only location on the appropriate server. 
This dataset will be used for analysis. The database will not be locked until 
version 1.0 of the Statistical Analysis Plan has been finalised and signed off.      
 
5. 3 Analysis software 
The analysis will be carried out using Stata version 12. Other packages such as R, 
SAS, or REALCOM may be used if necessary.  
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6. DESCRIPTIVE ANALYSES OF TRIAL 
6. 1 Recruitment flow chart  
Community 
physio invites 
Secondary care 
invites  
GPs invites 
 
Interest expressed 
Not interested, can not 
commit, not eligible 
Allocated study ID and sent baseline questionnaire 
Did not return questionnaire, 
consent not given, can’t attend  
Patient returns questionnaire and trial consent form 
Participants randomised.  
N=703 
GPs, secondary care, comm. Physio  
Control n =  Intervention n =  
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6.3 Representativeness of sample 
The age, gender and ethnic profile of randomised participants will be examined to 
see if they are typical of the UK population with chronic pain. For example one 
UK population survey showed the age in a sample of people with chronic pain to 
have a mean and SD of 55 and 16.7, and the proportion of males being 41% 
(399/966) (Parsons et al 2007). We will also examine the gender of participants 
who expressed an interest in the trial (were assigned a study ID), but were not 
randomised 
 
Certain baseline characteristics will be compared between participants who were 
lost to follow-up vs. other participants (table 9). Overall numbers lost to follow-up 
will be included in the CONSORT flow chart.  
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7. ANALYSIS PRINCIPLES 
7.1 GENERAL ANALYSIS PRINCIPLES 
 
The main analysis for each outcome will use intention-to-treat (ITT) principles, 
meaning that all participants with a recorded outcome will be included in the 
analysis, and will be analysed according to the treatment group to which they 
were randomised. More information on which participants will be included in 
each analysis is available in sections 7.2 and 7.4. All p-values will be two sided, 
and the significance level is set at 5%. 
 
Analyses for all outcomes will be presented as:  
 
• The number of participants included in the analysis, by treatment group;  
• A summary measure of the outcome, by treatment group (e.g. mean (SD) 
for continuous outcomes, number (%) for binary outcomes, etc). Only 
participants with a completely recorded outcome will be used to calculate 
the summary measure (e.g. participants who complete only 1 of 3 
components of the CPG disability score will not be included in the 
calculation of the summary measure);  
• A treatment effect, with a 95% confidence interval;  
• A two-sided p-value.  
 
All analyses will account for clustering by course in the intervention arm. 
Participants in the control arm (who do not attend courses), will act as their own 
cluster (i.e. each participant in the control arm will belong to a ‘course’ where 
they are the only member).     
 
Site of recruitment (London or Midlands), age, gender, and the HADS depression 
score at baseline will be included as covariates in each analysis. Additionally, for 
continuous outcomes (CPG disability, CPG pain intensity, PSEQ, HADS Anxiety, 
HADS Depression, CPAQ, HEIQ, and EQ-5D), the outcome measured at baseline 
will be included in the analysis. Continuous covariates (age, HADS depression 
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
391
score, outcome measured at baseline) will be assumed to have a linear relationship 
with the outcome. 
 
7.2 Primary analysis 
 
The primary outcome (CPG disability at 12 months) will be analysed using a 
mixed-effects linear regression model, with ‘course’ as a random effect. 
Restricted maximum likelihood (REML) will be used. The model will include site 
of recruitment, age, gender, HADS depression score, and CPG disability at 
baseline as covariates.  
 
All participants who completed at least one of the three questions which form the 
CPG disability score at either 6 or 12 months will be included in the analysis. 
Participants who did not fill out any portion of the CPG disability score at either 6 
or 12 months will be excluded from the analysis. It should be noted that CPG 
disability will be analysed separately at 6 and 12 months.  
 
Multiple imputation (MI) will be used to account for participants who have an 
observed outcome at 6 months, but are missing the outcome at 12 months, as well 
as participants who completed some, but not all, of the questions on the CPG 
disability score at 12 months. 20 imputations will be performed, and results will 
be combined using Rubin’s Rules. Only participants who will be included in the 
analysis will be included in the imputation model. Imputation will be performed 
separately within each treatment arm. The imputation model will include the three 
questions which form the CPG disability score at baseline, 6 months, and 12 
months, as well as site of recruitment, age, gender, the HADS depression score at 
baseline, and employment status (employed or in full time education vs not 
employed or in full time education) (14 variables in total). In the intervention arm, 
multilevel imputation will be performed, with ‘course’ included in the imputation 
model as a random effect.   
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Missing data in any of the covariates to be adjusted for in the analysis (site of 
recruitment, age, gender, HADS depression score, CPT disability and baseline) 
will be accounted for using the same multiple imputation model as above. 
 
Sensitivity analyses 
Method of accounting for missing data 
We will perform three sensitivity analyses for the primary outcome to assess the 
robustness of the results to other methods of account for missing data. The first 
sensitivity analysis involves specifying a different imputation model than that 
used in the primary analysis, and the last two sensitivity analyses involve re-
analyse the primary outcome using two approaches which are not based on MI.  
 
• We will determine which baseline covariates are associated with loss to 
follow-up, and include them in the imputation model. The analysis model 
will be the same as that described in 7.2, except for the inclusion of 
additional covariates in the imputation model. 
• We will perform a complete case analysis, where all participants who did 
not complete all components of the CPG disability score at 12 months will 
be excluded from the analysis. The analysis model will be the same as that 
described in 7.2, except missing baseline covariates will be replaced using 
mean imputation.  
• We will analyse the three components which form the CPG disability 
score at 12 months, rather than the CPG disability score itself. This will be 
done by performing a multivariate analysis, where each of the three 
components from the 12 month score are included in the model as 
outcomes (i.e. each participant will have three outcomes). A three-level 
mixed-effects model will be used, with random effects for ‘course’ and for 
participant. Treatment-by-question interactions will be included, allowing 
the treatment effect to vary for each of the three components. An overall 
treatment effect for CPG disability at 12 months will be estimated using 
the lincom function in Stata to combine the treatment estimates from the 
three separate components. As above, missing baseline covariates will be 
replaced using mean imputation. 
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Participants with no completed follow-ups 
The primary analysis has assumed that the excluded participants (those not 
completing any questions on the CPG disability questionnaire at both 6 and 12 
months) were missing at random (i.e. they were missing based on the covariates 
included in the analysis model). To assess the robustness to departures from this 
assumption, the primary outcome will be assessed under a range of missing-not-at-
random scenarios. This will be done using the formula ∆ = ∆primary + Y1P1 – Y2P2, 
where ∆ is the treatment effect under the missing-not-at-random scenario, ∆primary is 
the treatment effect from the primary analysis, Y1 and Y2 are the assumed mean 
responses for participants with missing data in treatment groups 1 and 2 respectively, 
and P1 and P2 are the proportion of participants who were excluded from the analysis 
in groups 1 and 2 respectively. The standard error for ∆ is assumed to be 
approximately equal to the standard error for ∆primary.  Y2 will be varied between 10, 
25, 50, 75, and 90, and for each value of Y2, Y1 will be set to Y2 - 10, Y2, and Y2 + 
10. For example, for Y2 = 25, Y1 will vary between 15, 25, and 35. 
Re-definition of primary endpoint 
The primary outcome is a composite of three questions. The first question (Q1) 
assesses to what extent the participant’s pain has interfered with daily activities in the 
previous six months. This is assessed on a scale of 0-10, with higher scores indicating 
more interference. The last two questions assess to what extent the participant’s pain 
has changed their ability to (a) take part in recreational, social, and family activities 
(Q2); and (b) work (Q3). Both these questions are measured on a scale from 0-10, 
with higher scores indicating more extreme change.  
 
For the last two questions, higher change scores are meant to represent a higher 
negative change, however it is possible that some participants have misinterpreted 
this, and have recorded a high score to indicate a large positive change. We will 
therefore perform a sensitivity analysis by redefining the outcome for participants 
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whose scores indicate they may have misinterpreted the intended direction of the 
questions relating to change.  
For participants with a score of 2 or less for Q1 (indicating very little interference in 
daily activities) and a score of 8 or higher on either Q2 or Q3 (intending to indcate an 
extreme negative change in their ability to take part in social activities or to work), we 
will assume the participant has misinterpreted the intended direction of the scale for 
Q2 or Q3 (as it is inconsistent for the pain to have had very little interference in daily 
activities, and for there to have been an extreme negative change in the participant’s 
ability to take part in activities or work). We will therefore rescore Q2 or Q3 based on 
a reverse scale (i.e. a score of 10 will be rescored as 0, 9 will be rescored as 1, and 8 
will be rescored as 2). We will then re-analyse the outcome using the same method as 
for the main analysis 
 
7.3 Subgroup analyses 
Subgroup analyses will be performed for the primary outcome (CPG disability at 12 
months). All subgroup analyses analyses will be performed using the same analysis 
model as for the primary outcome, but will also include the subgroup of interest and a 
treatment-by-subgroup interaction. Interaction tests will be considered significant at 
the 5% level. No correction will be made for multiple tests.  
 
The following subgroups will be assessed: 
 (i) Non-pain:  
• Co-morbidity: ≤3 vs. >3 co-morbidities, including musculoskeletal 
• Living arrangements: living alone vs. living with others 
• Baseline self-efficacy: PSEQ score 0-20 (not likely to be confident) vs. 21-
39 (more likely to be confident and to self manage) vs.  ≥40 (confident) 
(Nicholas 2006, 2007) 
•  Socioeconomic status (SES) (based on Index of Multiple Deprivation 
2010, calculated from participant postcodes via GIS: lower social class 
(less than observed median in data) vs higher social class (equal or greater 
than observed median in data)   
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(ii) Pain-related:  
• Pain duration: 0-12 months vs 13 months to 4 years vs 5 or more years 
• Baseline pain intensity: CPG intensity score 0-3 (low) vs 4-7 (medium) vs 
8-10 (high) 
• Baseline pain-related disability: CPG disability score 0-3 (low) vs 4-7 
(medium) vs 8-10 (high) 
• Baseline depression: HADS depression score <11 vs ≥11 
 
7.4 Analysis of secondary outcomes 
 
CPG disability at 6 months 
This outcome will be analysed using the same methods as CPG disability at 12 
months. 
 
CPG pain intensity, HADS Anxiety, HADS Depression, and HEIQ  at 6 and 12 
months 
These outcomes will be analysed using the same methods as CPG disability at 6 
and 12 months. 
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PSEQ at 6 and 12 months 
This outcome will be analysed using the same methods as CPG disability at 6 and 
12 months, except the individual components of the PSEQ score at 12 weeks will 
also be included in the imputation model. 
 
CPAQ at 6 and 12 months 
This outcome will be analysed using the same methods as CPG disability at 6 and 
12 months, with the exception of how CPAQ at baseline is included in the MI 
model. CPAQ is a composite of 20 questions – including each of these questions 
at each time point in the imputation model would lead to 60 variables being 
included (20 questions at baseline, 20 at 6 months, and 20 at 12 months) which 
may cause problems. We will therefore include only the individual questions for 
CPAQ at 6 and 12 months in the imputation model, and include the full CPAQ 
score at baseline (leading to 41 variables rather than 60). For participants who are 
missing CPAQ at baseline, we will use mean imputation.  
 
EQ-5D at 6 and 12 months 
The EQ-5D will be analysed using the same analysis model as the primary 
outcome (i.e. mixed-effects linear regression model, with course as a random 
effect, adjusted for site of recruitment, age, gender, HADS depression score, and 
EQ-5D at baseline).  
 
All participants who fully complete the EQ-5D score at either 6 or 12 months will 
be included in the analysis. EQ-5D scores with missing components will be 
regarded as completely missing. 
 
MI will be used to account for participants who are missing the outcome at either 
6 or 12 months. The MI strategy will be the same as that for the primary and other 
secondary outcomes, except instead of imputing the individual components of the 
EQ-5D score, we will impute the whole score.  
 
Census global health question at 6 and 12 months 
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This outcome will be analysed using a mixed-effects ordered logistic regression 
model, with ‘course’ as a random effect. Site of recruitment, age, gender, HADS 
depression score, and the outcome at baseline will be included as fixed covariates.  
 
All participants who completed the census global health question score at either 6 
or 12 months will be included in the analysis. 
 
MI will be used to account for participants who are missing the outcome at either 
6 or 12 months. The MI strategy will be the same as that for the primary and other 
secondary outcomes, except we will impute the whole score (as there are no 
individual components).  
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Total DDDs up to 12 months post-randomisation for psychotropic drugs, drugs 
for pain, weak  opioids, and strong opioids 
These outcomes will be analysed using a mixed-effects linear regression model, 
with ‘course’ as a random effect. Restricted maximum likelihood (REML) will be 
used. The model will include site of recruitment, age, gender, HADS depression 
score, and Total DDD in 3 months before randomisation at baseline as covariates. 
All participants who have data on Total DDD up to 12 months post-randomisation 
will be included in the analysis. Mean imputation will be used for missing 
baseline covariates. 
 
Proportion of participants using weak opioids and strong opioids at 12 months 
post-randomisation 
These outcomes will be analysed using a mixed-effects logistic regression model, 
with ‘course’ as a random effect. The model will include site of recruitment, age, 
gender, HADS depression score, and weak or strong (depending on outcome) 
opioid use at baseline (defined as a prescription for weak or strong) opioids in the 
12 weeks before randomization) as covariates. All participants who have data on 
whether they had had a weak/strong opioid prescription at 12 months will be 
included in the analysis.  
 
7.5 Adherence-adjusted analysis 
 
As a secondary analysis, CPG disability, CPG pain intensity, PSEQ, HADS 
anxiety, HADS depression, CPAQ, HEIQ, and EQ-5D, all at 12 months will be 
re-analysed to obtain a complier average causal effect of treatment (CACE). We 
define ‘compliers’ as those who attend more than half of the course (i.e. those 
present for at least 12 of the 24 course components). The compliers can only be 
observed in the intervention arm, where an indicator variable will indentify 
whether the individual complied. The compliers’ class is unobserved in the 
control arm.   
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We assume the Stable Unit Treatment Value Assumption (SUTVA), namely:  (a) 
no interference between study units (the outcome for each participant depends 
only on their own treatment assignment and not the treatment assignment of any 
other participant), and (b) consistency, which implies that the observed outcome 
for each participant will equal one of the potential outcomes, no matter how the 
treatment was received. 
  
In addition for identification, we assume (a) monotonicity: there are no defiers; 
and (b) exclusion restriction: treatment allocation only has an effect on outcome 
through treatment received and the effect of assignment is completely mediated by 
treatment exposure. .  
Under the assumptions stated above, we will use randomisation as an instrumental 
variable for treatment received and obtain a CACE treatment estimate by a two-
stage least square instrumental variable regression (using STATA command 
ivregress). We will run two analyses, one without any covariates and another 
one which includes all the baseline covariates included in the primary analysis 
models, namely CPG disability score at baseline, site of recruitment, age, gender, 
and the HADS depression score at baseline.  The covariate-adjusted CACE will be 
considered the primary CACE analysis. 
 
 We will assume that missing data are missing at random and use the same 
multiply imputed datasets produced for the primary analyses.  We will analyse 
each of multiply imputed sets, using robust estimation for the variance (using the 
option vce(cluster clustvar)) to  account for the possible clustering by 
course group; finally obtaining MI estimates using Rubin’s rules as before. 
 
 
7.6 Mediator analyses 
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We will perform a mediator analysis to obtain the direct and indirect effects of 
treatment on the CPG disability score at both 6 and 12 months, using self-efficacy 
(PSEQ) at 12 weeks as a mediator.  
We will use a structural linear mean model that allows for the interaction of 
randomisation with moderator, and perform an instrumental variable analysis 
(ivregress in STATA), using the interaction of randomization and baseline PSEQ 
as an instrument for the mediator, and including the interaction between 
randomisation and PSEQ at 12 weeks in the model.  
To study the combined effect of compliance and self-efficacy, we will do a second 
mediation analysis. Let Y denote the outcome (CPG disability score ), R the group as 
randomised, C   the binary compliance (as defined in Section 7.5)  and S the self-
efficacy measure (PSEQ, the mediator). We will use the following structural model: 
E[Yi(R=1) − Yi(R=0)| , Ci = 1 & Si = s] = βc c+ βs s  + βcs cs,  where  βcs represents the 
effect moderation of self-efficacy on those that comply.  
This equation implies an exclusion restriction – the expected treatment effect being 
zero when less than half of the sessions are attended (though we allow for a self-
efficacy to have a non-zero effect on outcome). For identification, we will use 
randomisation as an instrument for compliance, and randomisation by PSEQ at 
baseline interaction as an instrument for the mediator.  
We will test the strength of the instruments using estat firststage post-
estimation command in STATA.  Low values of the R2 or F statistic of the joint 
correlation of the mediator and the two instruments are indicative of weak instruments 
(rule of thumb F statistic less than 10 indicates weak instruments, Stock and Yogo 
2005).  If the instruments are weak, the estimates will still be unbiased but the 
standard error obtained by 2SLS are incorrect; in this case, we will use LIML 
estimation. 
For both instrumental variable regressions, we will use the same multiply imputed 
datasets as the primary analyses and analyse each of them using the robust standard 
DOI: 10.3310/pgfar04140 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
401
error estimate (vce(cluster clustvar)) to account for possible clustering by 
session groups; finally obtaining MI estimates using Rubin’s rules as before. 
As a sensitivity analysis to our instrumental variables approach, assuming that there is 
no unmeasured mediator-outcome confounding, we will use the same structural mean 
model as above on the complete cases, and fit the model with the paramed 
command in STATA which allows for treatment-mediator interactions. We will 
include CPG disability score, HADS score, HEIQ , CPAQ  and EQ5D at baseline in 
the model as they are considered to be a priori mediator-outcome confounders (by 
randomisation, there is no confounders of treatment-outcome, and treatment-mediator 
associations).  
For the model estimating the combined effect of compliance and mediator,  we will 
assume we measured all confounders of the mediator-outcome and compliance-
outcome associations, these are CPG disability score, HADS score, HEIQ , CPAQ  
and EQ5D at baseline and include them in the model, which we will fit to the 
complete case dataset using the command paramed in  STATA.  
 
7.7 Additional data summaries 
The following additional data summaries will be produced: 
 
• The mean (SD) for the change from baseline for CPG disability, CPG pain 
intensity, PSEQ, HADS anxiety, HADS depression, CPAQ, HEIQ, and the 
EQ-5D at both 6 and 12 months.  
• The effect size (based on Cohen’s D, i.e. the treatment effect divided by 
the standard deviation) for CPG disability, CPG pain intensity, PSEQ, 
HADS anxiety, HADS depression, CPAQ, HEIQ, and the EQ-5D at both 6 
and 12 months. 
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8. Tables 
 
The following tables will be produced: 
 
Table 1 – baseline characteristics 
 Intervention 
(n=…) 
Control (n=…) 
Age (years) – mean (SD)   
Male – no. (%)   
Living arrangements – no. (%)   
          Alone   
          With others   
Ethnicity – no. (%)   
          White   
          Black   
          Asian   
          Mixed   
          Other   
English language fluency – no. (%)   
          Fluent   
          Good   
          Below average   
          Poor   
Age at which formal education ended – no. 
(%) 
  
          No formal education received    
          12 years or less   
          13 to 16 years   
          17 to 19 years   
          20 years or later   
          Still in full time education   
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          Other   
Employment status – no. (%)   
          Employed, including self employed 
(full or part time) 
  
          Unemployed and looking for work   
          At school or in full time education   
          Unable to work due to long term 
sickness 
  
          Looking after home/family   
          Retired from paid work   
          Other   
Time kept from usual activities due to pain 
in past 6 months 
  
          0-6 days   
          7-14 days   
          15-30 days   
          31 or more days   
State of health – no. (%)   
          Very good   
          Good   
          Fair   
          Bad   
          Very Bad   
Duration of pain – no. (%)   
          0-3 months   
          4-12 months   
          13 months – 2 years   
          3-4 years   
          5-6 years   
          7-10 years   
          More than 10 years   
CPG overall – mean (SD)   
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CPG disability – mean (SD)   
CPG pain intensity – mean (SD)   
PSEQ – mean (SD)   
HADS depression – mean (SD)   
HADS anxiety – mean (SD)   
CPAQ – mean (SD)   
HEIQ – mean (SD)   
EQ-5D – mean (SD)   
Number of co-morbidities – median (IQR)   
Total amount of drugs taken above the 
Defined Daily Dose (DDD) in three 
months prior to randomisation 
  
          Psychotropic – median (IQR)   
          Weak opioids – median (IQR)   
          Strong opioids – median (IQR)   
          Analgesics (including opioids, non-
opioids, NSAIDS  and other CNS drugs, 
and oral and topical preparations)– median 
(IQR) 
  
          Drugs taken orally for neuropathic 
pain – median (IQR) 
  
          NSAID analgesics (both oral and 
topical) – median (IQR) 
  
Proportion of participants prescribed weak 
opioids – no. (%) 
  
Proportion of participants prescribed 
strong opioids – no. (%) 
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Table 2 – Number (%) of participants included in each analysis 
 Intervention 
(n=…) 
Control (n=…) 
CPG disability    
CPG pain intensity    
PSEQ score   
HADS Anxiety score    
HADS Depression score    
CPAQ score    
HEIQ score    
EQ-5D    
Census global health question   
Total amount of drugs taken above the 
Defined Daily Dose (DDD) in up to 12 
months post-randomisation 
  
          Psychotropic    
          Weak Opioids    
          Strong Opioids   
          Analgesics (including opioids and 
other CNS drugs) 
  
Proportion of participants using opioids at 12 
months post-randomisation 
  
          Weak opioids   
          Strong opioids   
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Table 3 – Main results for primary and secondary outcomes 
 Intervention 
(n=…) 
Control 
(n=…) 
Treatment effect 
(95% CI) 
P-value 
CPG disability – mean 
(SD) 
    
          12 months     
           6 months     
CPG pain intensity – 
mean (SD) 
    
          12 months     
           6 months     
PSEQ score – mean (SD)     
          12 months     
           6 months     
HADS Anxiety score – 
mean (SD) 
    
          12 months     
           6 months     
HADS Depression score – 
mean (SD) 
    
          12 months     
           6 months     
CPAQ score – mean (SD)     
          12 months     
           6 months     
HEIQ score – mean (SD)     
          12 months     
           6 months     
EQ-5D – mean (SD)     
          12 months     
           6 months     
Census global health 
question – mean (SD) 
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          12 months      
           6 months     
Total amount of drugs 
taken above the Defined 
Daily Dose (DDD) in up 
to 12 months post-
randomisation – median 
(IQR) 
    
          Psychotropic      
          Weak opioids      
          Strong opioids     
          Analgesics 
(including opioids and 
other CNS drugs) 
    
Proportion of participants 
using opioids at 12 
months post-
randomisation – no. (%) 
    
          Weak opioids     
          Strong opioids     
 
 
Table 4 – Results from sensitivity analyses for primary outcome 
 Treatment effect (95% 
CI) 
P-value 
Main analysis   
Complete case analysis   
Multivariate analysis   
Different imputation 
model 
  
CACE analysis   
Re-definition of primary 
outcome 
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Table 5 –Subgroup analyses for primary outcome (CPG disability at 12 
months) 
Subgroup Intervention 
– mean (SD) 
Control – 
mean (SD) 
Treatment effect 
(95% CI) 
P-value 
for 
interaction 
Non-pain     
Co-morbidity     
          0-3 (n=…)     
          4 or more (n=…)     
Living arrangements     
          Living alone (n=…)     
          Living with others 
(n=…) 
    
PSEQ     
          0-20 (n=…)     
          21-39 (n=…)     
          40-60 (n=…)     
Socioeconomic status     
          Lower (n=…)     
          Higher (n=…)     
Pain related     
Pain duration     
          0-12 months (n=…)     
          13 months to 4 years 
(n=…) 
    
          5 or more years 
(n=…) 
    
CPG intensity     
          0-3 (n=…)     
          4-7 (n=…)     
          8-10 (n=…)     
CPG disability     
          0-3 (n=…)     
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          4-7 (n=…)     
          8-10 (n=…)     
HADS depression score     
          0-10 (n=…)     
          11-21 (n=…)     
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Table 6 – Courses and activities outside of COPERS during follow-up period 
 Intervention 
(n=…) 
Control 
(n=…) 
Courses or activities attended during follow-up 
period outside of the COPERS trial 
  
          Pain management – no. (%)   
          Expert participant programme or other 
self-management course –  no. (%) 
  
          Other wellness or wellbeing courses – no. 
(%) 
  
          Return to work courses – no. (%)   
          Received psychological counseling or 
therapies – no. (%) 
  
Frequency of practicing relaxation and/or 
meditation during follow-up period – no. (%) 
  
          Daily   
          Weekly   
          Monthly   
          Rarely   
          Never   
 
 
 
Table 7 – Change from baseline summaries 
 Change from baseline – mean (SD) 
Outcome 6 months 12 months 
CPG disability   
CPG pain intensity   
PSEQ score   
HADS Anxiety score   
HADS Depression score   
CPAQ score   
HEIQ score   
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EQ-5D   
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Table 8 – Standardised differences based on Cohen’s D 
Outcome Treatment effect (95% CI) 
CPG disability   
          12 months  
           6 months  
CPG pain intensity   
          12 months  
           6 months  
PSEQ score   
          12 months  
           6 months  
HADS Anxiety score   
          12 months  
           6 months  
HADS Depression score   
          12 months  
           6 months  
CPAQ score   
          12 months  
           6 months  
HEIQ score   
          12 months  
           6 months  
EQ-5D   
          12 months  
           6 months  
*Effect sizes were calculated by dividing the treatment effect and the confidence 
limits by the estimated standard deviation 
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Table 9 – Differences between responders and participants lost to follow-up 
 Responder 
(n=…) 
Lost to 
follow-up 
(n=…) 
Odds ratio for 
non-response 
(95% CI) 
P-value 
Age (years) – mean (SD)     
Male – no. (%)     
Ethnicity – no. (%)     
          White     
          Black     
          Asian     
          Mixed or other     
English language fluency 
– no. (%) 
    
          Fluent or good     
          Below average or 
poor 
    
Age at which formal 
education ended – no. (%) 
    
Employment status – no. 
(%) 
    
          Employed      
          Other     
CPG disability at baseline 
– mean (SD) 
    
CPG pain intensity at 
baseline – mean (SD) 
    
PSEQ at baseline – mean 
(SD) 
    
HADS depression at 
baseline – mean (SD) 
    
HADS anxiety at baseline 
– mean (SD) 
    
CPAQ at baseline – mean     
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(SD) 
Number of co-morbidities 
– median (IQR) 
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Table 10 – ICC estimates 
Outcome ICC 
CPG disability   
          12 months  
           6 months  
CPG pain intensity   
          12 months  
           6 months  
PSEQ score   
          12 months  
           6 months  
HADS Anxiety score   
          12 months  
           6 months  
HADS Depression score   
          12 months  
           6 months  
CPAQ score   
          12 months  
           6 months  
HEIQ score   
          12 months  
           6 months  
EQ-5D   
          12 months  
           6 months  
Census global health question   
          12 months   
           6 months  
Total amount of drugs taken above the Defined Daily 
Dose (DDD) up to 12 months post-randomisation  
 
          Psychotropic   
          Weak opioids   
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          Strong opioids  
          Analgesics   
Proportion of participants using opioids at 12 months 
post-randomisation  
 
          Weak opioids  
          Strong opioids  
Compliance  
           Continuous scale (0-24 components attended)  
           Binary scale (attended 12 or more components)  
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Appendix I.  Methods of calculating derived variables 
 
CPG disability at 6 months 
This is derived in the same method as the CPG disability score at 12 months (as 
described in section 2.3). 
 
CPG pain intensity score at 6 and 12 months.  
This is a composite of three questions which assess the participant’s pain intensity at 
present, and the maximum and average intensity over the past 6 months. Each 
question is scored on a scale of 0-10. The outcome is the mean of the three questions, 
multiplied by 10. Its range is from 0-100, with higher scores indicating worse pain. 
 
PSEQ (Pain Self-Efficacy Questionnaire) score at 6 and 12 months 
This is a composite of 10 questions which ascertain the participant’s level of 
confidence to live a normal life despite their pain. Each question is scored on a scale 
of 0-6. The outcome is the sum of all 10 questions. Its range is 0-60, with higher 
scores indicating higher levels of confidence.  
 
HADS (Hospital Anxiety and Depression Scale) Anxiety score at 6 and 12 
months 
This is a composite of 7 questions which ascertains the extent of the participant’s 
anxiety (these are the odd number questions of the HADS questionnaire). Each 
question has four answers ranging from not experiencing a symptom at all scored as 
0, to experiencing a symptom nearly all the time scored as 3. The outcome is the sum 
of each question. Its range is 0-21, with higher scores indicating more severe anxiety.  
 
HADS (Hospital Anxiety and Depression Scale) Depression score at 6 and 12 
months 
This is a composite of 7 questions which ascertains the extent of the participant’s 
depression (these are the even number questions of the HADS questionnaire). Each 
question has four answers ranging from not experiencing a symptom at all scored as 
0, to experiencing a symptom nearly all the time scored as 3. The outcome is the sum 
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of each question. Its range is 0-21, with higher scores indicating more severe 
depression.  
 
CPAQ (Coping Pain and Acceptance Questionnaire) score at 6 and 12 months 
This is a composite of 20 questions which ascertain the participant’s ability to cope 
with their pain. Each question is scored on a scale of 0-6, with 0 indicating the 
statement is never true, and 6 indicating the statement is always true. There are two 
subscales: Pain Willingness and Activities Engagement. The statements in the Pain 
Willingness subscale are reverse scored, so that an answer of ‘Always true’ gives a 
score of 0, and a score of ‘Never true’ gives a score of 6. The outcome is the sum of 
each question. Its range is 0-120, with higher scores indicating a better ability to cope.  
 
 
HEIQ (Health Education Impact Questionnaire) score at 6 and 12 months 
This is a composite of 5 questions which ascertain the extent to which the participant 
is able to enjoy life. Each question has four answers ranging from Strongly Agree 
(scored as 4) to Strongly Disagree (scored as 1). The outcome is the sum of each 
question. It’s range is 4-20, with higher scores indicating more enjoyment in life.   
 
EQ-5D at 6 and 12 months 
This is a composite of 5 questions which ascertain whether the participant has any 
problems with mobility, self-care, performing their usual activities, pain or 
discomfort, or anxiety or depression. Each question has three answers ranging from 
‘No problems’ (scored as 1) to the worst category (scored as 3). The outcome score 
will be derived using the method described in the SPSS manual.  
 
CPG overall (baseline variable) 
The CPG overall score is a composite of the CPG disability, the CPG pain intensity, 
and another question assessing the number of days off usual activities due to pain. 
This question has four categories: 0-6 days, 7-14 days, 15-30 days and 31 or more 
days. Categories are assigned 0 points for 0-6 days through to 3 points for 31 + days.  
 
CPG pain intensity is grouped as <50 vs ≥50, and CPG disability is grouped as 0 (0-
29 points), 1 (30-49 points), 2 (50-69 points), or 3 (70-100 points). An overall 
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disability score is then formed by adding the points from the grouped CPG disability 
score (range 0-3) to the points assigned for the number of days off work (range 0-3), 
giving an overall range of 0-6. 
 
 
CPG Calculation 
Grade 0 Pain free: No pain problems in the last 6 months 
Grade I Low pain disability and low pain intensity: Characteristic pain 
intensity <50 and <3 disability points  
Grade II Low disability-high intensity: Pain intensity of 50 or more and <3 
disability points.  
Grade III High disability- moderately limiting: 3-4 disability points, regardless 
of pain intensity 
Grade IV High disability – severely limiting: 5-6 disability points 
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Drugs Data Analysis 
Total Defined Daily Doses (Total DDD) consumed 
The Total DDD for each drug is defined as: 
 
Total DDDDrugA = (StrengthMedA x quantityMedA)/DDDMedA 
 
The Total DDD for a group of medications (e.g. the Total DDD for opioids) is the 
sum of the Total DDD for each drug within that medication group (e.g. each drug 
which is considered an opioid). For example, if there are three drugs (drugs A, B, and 
C), the TotalDDDopioid is defined as: 
 
TotalDDDopioid = TotalDDDDrugA + TotalDDDDrugB + TotalDDDDrugC 
 
The DDD (used in the denominator of the calculation for the TotalDDD) is 
determined in the first instance by the WHO register, then by precedent in other trials 
(OPERA and TOIB), and then by clinician consensus.  For compound drugs, e.g. co-
codamol we will separate out components (paracetamol & codeine) and work out the 
DDD for each component drug. 
 
Data 
Medications used over a 15 month period have been collected from GP participant 
records. We extracted drug name and strength used, plus quantity and the dates i.e. 
number of times the medication was prescribed. We have used the prescription cost 
analysis database to attach a cost to each individual preparation used. Using the 
World Health Organization (WHO)-defined daily dose for each drug we will generate 
number of days of medication used by British National Formulary chapter and 
subchapter.  
We consider the following outcomes: 
 
1) Total Defined Daily Doses (Total DDD) consumed of psychotropic drugs 
(Table 11) up to 12 months post randomisation  
2) Total DDD consumed of all analgesics up to 12 months post randomisation 
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3) Total DDD consumed of weak opioids up to 12 months post-randomisation (as 
defined by BNF 4.7.2 are codeine, dihydrocodeine and meptazionol ) 
4) Total DDD consumed of all NSAID analgesics (oral and topical combined) up 
to 12 months post randomisation 
5) Total DDD consumed of all CNS drugs for neuropathic pain (see Table11) up 
to 12 months post-randomisation 
6) Total DDD consumed of strong opioids up to 12 months post-randomisation 
(as defined by BNF 4.7.2, all opioids prescribed other than the ones listed 
above as weak) 
 
 
Calculations for psychotropic drugs will be based on BNF subchapters 4.1, and 4.3, 
opioids based on BNF paragraph 4.7.2, and analgesics including opioids based on 
BNF paragraphs 4.7.1, 4.7.2, 4.7.3, and paragraphs10.1.1, 10.2.2, and 10.3.2.  
 
We will work out DDD for BNF chapter 4 and 10 groups of drugs, these are drugs 
used for treating chronic pain (see table below). We will exclude all drugs 
administered as injections, but we will include soluble drugs, gels and liquids.  
Table 11- Pain related drugs  
 Chapter Subchapter Paragraph Comments 
Psychotropi
c drugs  
4. Central 
Nervous 
System   
4.1. 
Hypnotics 
and 
Anxiolytics 
 
4.1.1 Hypnotics 
4.1.2.Anxiolyti
cs   
 
NOT: chloral 
and 
derivatives, 
clomethiazol
e or  
antihistamine
s 
 4.3. 
Antidepressa
nt drugs  
 
4.3.2 
Monoamine-
oxidase 
inhibitors 
4.3.3. Selective 
serotonin re-
uptake 
inhibitors 
4.3.4 Other anti 
depressant 
drugs 
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Analgesic 
drugs 
 4.7 
Analgesics 
 
4.7.1 Non 
opioid 
analgesics 
4.7.2. Opioid 
analgesics 
4.7.3 
Neuropathic 
and functional 
pain 
4.8.1 
Gabapentin 
and 
pregabalin 
feature as an 
anti-epileptic 
but also 
feature in 
4.7.3 
Neuropathic 
and 
functional 
pain  
 
For this 
analysis 
4.3.1 
tricyclic anti-
depressants 
are included 
in section 
4.7.3 
 
10. 
Musculoskelet
al and joint 
diseases 
(exclude 
steroids, 
DMARDS) 
 
10.1 Drugs 
used in 
rheumatic 
diseases and 
gout 
10.1.1 Non-
steroidal anti 
inflammatories  
Exclude 
aspirin 
No steroids 
 
 10.2 Drugs 
used in 
neuromuscula
r disorders 
10.2.2 Skeletal 
muscle 
relaxants 
 
 
 10.3 Drugs 
for the relief 
of soft tissue 
inflammation 
10.3.2 
Rubefacients 
and other 
topical anti-
rheumatics 
 
Not enzymes 
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Appendix 7 Fidelity, adherence and competence
Adherence and competence assessment sheets
Day 1, session 2: pain information – adherence
COPERS course code:
Reviewer:
Review date:
Aim: to increase understanding about chronic pain.
Item
number Item
Adherence
measure Comments
1 Was the DVD played? Yes (2)
Unsure (1)
No (0)
2 Did the facilitator(s) pose Q1 (What do you think about the consultant saying
that pain comes from the muscles?) after 5 minutes 35 seconds of the DVD?
Yes (2)
Unsure (1)
No (0)
3 Did the facilitator(s) pose Q2 (What do you think about this model of pain? Is it
missing anything?) after 9 minutes 24 seconds of the DVD?
Yes (2)
Unsure (1)
No (0)
4 Did the facilitator(s) pose Q3 (How do you feel about the consultant saying
there is no cure?) after 12 minutes 13 seconds of the DVD?
Yes (2)
Unsure (1)
No (0)
5 Did the facilitator(s) pose Q4 (How do you feel about the Bert Trautmann
example?) at the end of the DVD?
Yes (2)
Unsure (1)
No (0)
6 Did the facilitator(s) reiterate the aims of the course as explained at the end of
the DVD?
Yes (2)
Unsure (1)
No (0)
Total adherence score
Percentage adherence score (total adherence score/12 × 100)
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Day 1, session 2: pain Information – competence
Item
Competence
measure Comments
Introduction Did the facilitator(s) introduce the aims/rationale of the session? Yes (2)
Unsure (1)
No (0)
Discussion Did the facilitator(s) create opportunities for discussion and encourage
individual disclosure of narratives and participation?
Yes (2)
Unsure (1)
No (0)
Summary Did the facilitator(s) consolidate/embed the group’s learning at the end of
the session?
Yes (2)
Unsure (1)
No (0)
Linking Did the facilitator(s) link the completed session to other sessions? Yes (2)
Unsure (1)
No (0)
Total competence score
Percentage competence score (total competence score/8 × 100)
Overall session impression score (‘How well did you think the overall aims of the session were met?’)
Excellent Did not go well Comments
1 2 3 4
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Day 1, session 3: acceptance: the uninvited guest – adherence
COPERS course code:
Reviewer:
Review date:
Aim: to relate the scenario about the unwanted and uninvited guest to chronic pain.
Item
number Item
Adherence
measure Comments
1 Did the facilitator(s) read the street party story to the group? Yes (2)
Unsure (1)
No (0)
2 Did the facilitator(s) ask the group to discuss how the women handled the
issue of the ‘uninvited guest’?
Yes (2)
Unsure (1)
No (0)
3 Did the facilitator(s) encourage the group to relate to the story of the
‘uninvited guest’ as an analogy for their pain?
Yes (2)
Unsure (1)
No (0)
Total adherence score
Percentage adherence score (total adherence score/6 × 100)
Day 1, session 3: acceptance: the uninvited guest – competence
Item
Competence
measure Comments
Introduction Did the facilitator(s) introduce the aims/rationale of the session? Yes (2)
Unsure (1)
No (0)
Discussion Did the facilitator(s) create opportunities for discussion and encourage
individual disclosure of narratives and participation?
Yes (2)
Unsure (1)
No (0)
Summary Did the facilitator(s) consolidate/embed the group’s learning at the end of
the session?
Yes (2)
Unsure (1)
No (0)
Linking Did the facilitator(s) link the completed session to other sessions? Yes (2)
Unsure (1)
No (0)
Total competence score
Percentage competence score (total competence score/8 × 100)
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Overall session impression score (‘How well did you think the overall aims of the session were met?’)
Excellent Did not go well Comments
4 3 2 1
Day 1, session 5: the pain cycle, unhelpful emotions and behaviours –
adherence
COPERS course code:
Reviewer:
Review date:
Aim: to explain the pain cycle and understand the process and the unhelpful things that we do to keep us
in that cycle.
Item
number Item
Adherence
measure Comments
1 Did the facilitator(s) show and explain the persistent pain cycle to the group? Yes (2)
Unsure (1)
No (0)
2 Did the facilitator(s) ask the group to generate a list of unhelpful things that
may keep them in the pain cycle?
Yes (2)
Unsure (1)
No (0)
3 Did the facilitator(s) distribute and/or mention handout 1? (Unhelpful coping
strategies.) Please refer to reviewer guidance below
Yes (2)
Unsure (1)
No (0)
4 Did the facilitator(s) distribute and/or mention handout 2? (Depressive
symptom checklist.) Please refer to reviewer guidance below
Yes (2)
Unsure (1)
No (0)
5 Did the facilitator(s) ask the group to generate a list of things that they could
do to escape from the pain cycle?
Yes (2)
Unsure (1)
No (0)
6 Did the facilitator(s) distribute and/or mention handout 3? (Escape routes from
the pain cycle.) Please refer to reviewer guidance below
Yes (2)
Unsure (1)
No (0)
Total adherence score
Percentage adherence score (total adherence score/12 × 100)
Reviewer guidance: if, on listening to the audio-recording, the score for this item is ‘unsure’ (1) or ‘no’ (0),
please refer to the observation notes for this session to determine whether the handouts were/were not
distributed and amend the adherence score accordingly.
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Day 1, session 5: the pain cycle, unhelpful emotions and behaviours –
competence
Item
Competence
measure Comments
Introduction Did the facilitator(s) introduce the aims/rationale of the session? Yes (2)
Unsure (1)
No (0)
Discussion Did the facilitator(s) create opportunities for discussion and encourage
individual disclosure of narratives and participation?
Yes (2)
Unsure (1)
No (0)
Summary Did the facilitator(s) consolidate/embed the group’s learning at the end of
the session?
Yes (2)
Unsure (1)
No (0)
Linking Did the facilitator(s) link the completed session to other sessions? Yes (2)
Unsure (1)
No (0)
Total competence score
Percentage competence score (total competence score/8 × 100)
Overall session impression score (‘How well did you think the overall aims of the session were met?’)
Excellent Did not go well Comments
4 3 2 1
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Day 2, session 9: identifying problems, goal-setting, action planning –
adherence
COPERS course code:
Reviewer:
Review date:
Aim: to help the participants identify problems, brainstorm solutions, set goals and devise action plans, as
a means of escaping the pain cycle.
Item
number Item
Adherence
measure Comments
1 Did the facilitator(s) explain the process of identifying problems, brainstorming
solutions, thinking about advantages/disadvantages to solutions and
goal-setting?
Yes (2)
Unsure (1)
No (0)
2 Did the facilitator(s) explain the SMART process to the group? Yes (2)
Unsure (1)
No (0)
3 Did the facilitator(s) distribute and/or mention handout 5 (SMART)? Please refer
to reviewer guidance below
Yes (2)
Unsure (1)
No (0)
4a Did the facilitator(s) go through an example of the SMART process with the
group?
Yes (2)
Unsure (1)
No (0)
4b Group exercise: did the facilitator(s) divide the participants into smaller groups/
pairs to tackle a chosen problem on their own?
Yes (2)
Unsure (1)
No (0)
5 Group exercise: were the groups given the opportunity to give feedback about
the process of problem-solving?
Yes (2)
Unsure (1)
No (0)
6 Did the facilitator(s) distribute and/or mention handout 6 (goal-setting
examples)? Please refer to reviewer guidance below
Yes (2)
Unsure (1)
No (0)
7 Did the facilitator(s) distribute and/or mention handout 7 (tips for a good
night’s sleep)? Please refer to reviewer guidance below.
Yes (2)
Unsure (1)
No (0)
Total adherence score
Percentage score (total adherence score/16 × 100)
Smart, Smart, Achievable, Relevant and Timed goals.
Reviewer guidance: if, on listening to the audio-recording, the score for this item is ‘unsure’ (1) or ‘no’ (0),
please refer to the observation notes for this session to determine whether the handouts were/were not
distributed and amend the adherence score accordingly.
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Day 2, session 9: identifying problems, goal-setting, action planning –
competence
Item
Competence
measure Comments
Introduction Did the facilitator(s) introduce the aims/rationale of the session? Yes (2)
Unsure (1)
No (0)
Discussion Did the facilitator(s) create opportunities for discussion and encourage
individual disclosure of narratives and participation?
Yes (2)
Unsure (1)
No (0)
Summary Did the facilitator(s) consolidate/embed the group’s learning at the end of
the session?
Yes (2)
Unsure (1)
No (0)
Linking Did the facilitator(s) link the completed session to other sessions? Yes (2)
Unsure (1)
No (0)
Total competence score
Percentage competence score (total competence score/8 × 100)
Overall session impression score (‘How well did you think the overall aims of the session were met?’)
Excellent Did not go well Comments
4 3 2 1
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Day 2, session 10: barriers to change, unhelpful thinking – adherence
COPERS course code:
Reviewer:
Review date:
Aim: to introduce ideas about unhelpful thoughts, automatic thoughts and errors in thinking.
Item
number Item
Adherence
measure Comments
1 Did the facilitator(s) distribute handout 8 (typical unhelpful/negative thoughts
and thinking)?
Yes (2)
Unsure (1)
No (0)
2 Did the facilitator(s) read the titles and describe the unhelpful thoughts in the
list to the group for their consideration?
Yes (2)
Unsure (1)
No (0)
3 Did the facilitator(s) use the unhelpful thought ‘flash cards’ to generate group
discussion?
Yes (2)
Unsure (1)
No (0)
4 Did the facilitator(s) read the ‘Sam’s morning’ scenario to the group with
appropriate pauses for participants to ‘spot’ and name the negative thoughts?
Yes (2)
Unsure (1)
No (0)
5 Did the facilitator(s) distribute and/or mention handout 9 (unhelpful thoughts
checklist)? Please refer to reviewer guidance below
Yes (2)
Unsure (1)
No (0)
6 Did the facilitator(s) invite the group to consider ‘Sam’s morning’ again from
an unemotional standpoint?
Yes (2)
Unsure (1)
No (0)
Total adherence score
Percentage adherence score (total adherence score/12 × 100)
Reviewer guidance: if, on listening to the audio-recording, the score for this item is ‘unsure’ (1) or ‘no’ (0),
please refer to the observation notes for this session to determine whether the handouts were/were not
distributed and amend the adherence score accordingly.
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Day 2, session 10: barriers to change, unhelpful thinking – competence
Item
Competence
measure Comments
Introduction Did the facilitator(s) introduce the aims/rationale of the session? Yes (2)
Unsure (1)
No (0)
Discussion Did the facilitator(s) create opportunities for discussion and encourage
individual disclosure of narratives and participation?
Yes (2)
Unsure (1)
No (0)
Summary Did the facilitator(s) consolidate/embed the group’s learning at the end of
the session?
Yes (2)
Unsure (1)
No (0)
Linking Did the facilitator(s) link the completed session to other sessions? Yes (2)
Unsure (1)
No (0)
Total competence score
Percentage competence score (total compliance score/8 × 100)
Overall session impression score (‘How well did you think the overall aims of the session were met?’)
Excellent Did not go well Comments
4 3 2 1
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Day 2, session 11: barriers to change, reframing negatives to positives –
adherence
COPERS course code:
Reviewer:
Review date:
Aim: to identify reasons why people stay in the pain cycle and barriers to change.
Item
number Item
Adherence
measure Comments
1 Did the facilitator(s) ask the group to consider the ‘cons’ of pain? Yes (2)
Unsure (1)
No (0)
2 Did the facilitator(s) ask the group to consider the ‘pros’ of pain? Yes (2)
Unsure (1)
No (0)
3 Did the facilitator(s) use a flip chart to encourage a consideration of the
‘pros’ and ‘cons’ of pain?
Yes (2)
Unsure (1)
No (0)
4 Did the facilitator(s) use the example of ‘going to the gym’ (slide 16) to
demonstrate reframing ‘cons’ to ‘cans’?
Yes (2)
Unsure (1)
No (0)
5 Did the facilitators(s) use the group-generated ‘cons’ of pain and ask the
group to reframe them to ‘cans’
Yes (2)
Unsure (1)
No (0)
Total adherence score
Percentage adherence score (total adherence score/10 × 100)
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Day 2, session 11: barriers to change, reframing negatives to positives –
competence
Item
Competence
measure Comments
Introduction Did the facilitator(s) introduce the aims/rationale of the session? Yes (2)
Unsure (1)
No (0)
Discussion Did the facilitator(s) create opportunities for discussion and encourage
individual disclosure of narratives and participation?
Yes (2)
Unsure (1)
No (0)
Summary Did the facilitator(s) consolidate/embed the group’s learning at the end of
the session?
Yes (2)
Unsure (1)
No (0)
Linking Did the facilitator(s) link the completed session to other sessions? Yes (2)
Unsure (1)
No (0)
Total competence score
Percentage competence score (total competence score/8 × 100)
Overall session impression score (‘How well did you think the overall aims of the session were met?’)
Excellent Did not go well Comments
4 3 2 1
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Day 2, session 12: attention control and distraction – adherence
COPERS course code:
Reviewer:
Review date:
Aim: to learn how to focus the mind away from pain thoughts.
Item
number Item
Adherence
measure Comments
1 Did the facilitator(s) ask the group NOT to think about food for 30 seconds? Yes (2)
Unsure (1)
No (0)
2 Did the facilitator(s) ask the group what happened when they tried not to
think about food?
Yes (2)
Unsure (1)
No (0)
3 Did the facilitator(s) ask the group NOT to think about their pain for 30
seconds?
Yes (2)
Unsure (1)
No (0)
4 Did the facilitator(s) ask the group if their pain felt better or worse as they
focused on it?
Yes (2)
Unsure (1)
No (0)
5 Did the facilitator(s) ask the group to close their eyes and recall a time when
they were content calm and happy?
Yes (2)
Unsure (1)
No (0)
6 Did the facilitator(s) ask the group what happened to their pain while they
were doing this exercise?
Yes (2)
Unsure (1)
No (0)
Total adherence score
Percentage adherence score (total adherence score/12 × 100)
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Day 2, session 12: attention control and distraction – competence
Item
Competence
measure Comments
Introduction Did the facilitator(s) introduce the aims/rationale of the session? Yes (2)
Unsure (1)
No (0)
Discussion Did the facilitator(s) create opportunities for discussion and encourage
individual disclosure of narratives and participation?
Yes (2)
Unsure (1)
No (0)
Summary Did the facilitator(s) consolidate/embed the group’s learning at the end of
the session?
Yes (2)
Unsure (1)
No (0)
Linking Did the facilitator(s) link the completed session to other sessions? Yes (2)
Unsure (1)
No (0)
Total competence score
Percentage competence score (total competence score/8 × 100)
Overall session impression score (‘How well did you think the overall aims of the session were met?’)
Excellent Did not go well Comments
4 3 2 1
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Appendix 8 Results: number of participants in
each analyses
TABLE 90 Number of participants included in each analysis
Analysisa Control (N= 300), n (%) Intervention (N= 403), n (%)
CPG pain-related disability score 278 (93) 374 (93)
CPG pain intensity score 260 (87) 364 (90)
PSEQ score 270 (90) 373 (93)
HADS anxiety score 261 (87) 364 (90)
HADS depression score 261 (87) 364 (90)
CPAQ score 261 (87) 364 (90)
heiQ score 261 (87) 363 (90)
EQ-5D score 275 (92) 372 (92)
Census global health question 260 (87) 364 (90)
Drug data up to 12 months post randomisation 258 (86) 350 (87)
a For CPG pain-related disability, CPG pain intensity, PSEQ, HADS anxiety, HADS depression, CPAQ, heiQ, EQ-5D and the
census global health questionnaire, the same number of participants were included in the analyses at both 6 months
and 12 months.
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